data_1n91_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1n91 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.504 ' O ' ' CB ' ' A' ' 7' ' ' ALA . 62.0 p . . . . . 0 N--CA 1.439 -0.981 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.504 ' CB ' ' O ' ' A' ' 6' ' ' SER . . . 151.19 -25.85 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.449 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -159.51 151.44 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.595 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 m -139.05 136.2 35.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.326 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.418 ' O ' ' CG2' ' A' ' 10' ' ' VAL . 30.8 m -101.35 99.8 9.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.262 0.553 . . . . 0.0 110.181 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -80.28 -151.97 0.08 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.533 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -107.77 6.79 27.89 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -117.77 -25.35 6.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.488 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 170.25 -126.91 1.4 Allowed Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -147.89 150.77 34.73 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.97 0.414 . . . . 0.0 111.208 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.7 t -106.88 139.63 27.76 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.117 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.74 102.65 9.6 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.548 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 9.1 mtm180 -107.91 111.04 22.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.02 -179.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.1 pp -142.02 -179.64 6.34 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.904 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -111.06 105.22 13.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.756 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.0 mm -71.96 135.25 28.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.573 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -124.12 87.72 53.23 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.672 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.2 161.67 42.47 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.622 2.214 . . . . 0.0 112.555 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.26 46.9 2.53 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.661 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.411 ' O ' ' CB ' ' A' ' 26' ' ' SER . . . -92.22 -70.95 0.67 Allowed 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.411 ' CB ' ' O ' ' A' ' 25' ' ' ALA . 0.9 OUTLIER 160.01 -22.09 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.06 179.3 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -171.36 140.73 1.47 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.049 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.9 86.89 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 121.429 0.633 . . . . 0.0 109.918 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.49 133.53 46.36 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.481 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -89.16 86.91 2.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.237 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -113.71 19.33 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.853 -178.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -143.74 37.39 1.45 Allowed Glycine 0 C--N 1.333 0.406 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 21.3 mt -73.27 120.11 18.43 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.798 -0.701 . . . . 0.0 109.913 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.426 ' HD1' ' HG2' ' A' ' 37' ' ' GLU . 26.8 t-80 -102.05 157.97 16.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.023 0.44 . . . . 0.0 111.383 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.97 -18.76 73.01 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.48 -18.35 8.5 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.426 ' HG2' ' HD1' ' A' ' 34' ' ' HIS . 11.2 mm-40 -134.32 -176.43 4.2 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.988 0.423 . . . . 0.0 110.66 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 55.6 t -143.66 121.98 6.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.5 ttpp -121.86 113.7 20.01 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.879 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.1 p -114.88 142.88 26.05 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.921 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -107.84 107.67 18.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.322 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.415 HG13 ' N ' ' A' ' 43' ' ' THR . 1.4 tp -93.15 148.12 4.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.415 ' N ' HG13 ' A' ' 42' ' ' ILE . 14.1 t -95.28 38.79 1.13 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.05 0.452 . . . . 0.0 110.831 -178.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.99 144.59 28.86 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.013 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.498 ' HG2' ' CB ' ' A' ' 50' ' ' GLN . 3.7 Cg_exo -51.98 175.36 0.07 OUTLIER 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 123.059 2.506 . . . . 0.0 112.441 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.92 3.67 5.88 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 123.134 2.556 . . . . 0.0 113.342 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.5 p -102.68 143.99 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.597 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.466 ' O ' ' C ' ' A' ' 49' ' ' GLY . 3.7 m-20 -62.06 -60.92 2.91 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.018 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.466 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . -30.72 -43.98 0.08 OUTLIER Glycine 0 CA--C 1.53 1.026 0 N-CA-C 111.744 -0.543 . . . . 0.0 111.744 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.498 ' CB ' ' HG2' ' A' ' 45' ' ' PRO . 0.8 OUTLIER -82.6 -42.07 18.73 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.478 0.18 . . . . 0.0 111.28 -179.612 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 48' ' ' ASP . . . -68.17 -54.16 19.89 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.948 0.404 . . . . 0.0 109.966 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 48' ' ' ASP . 19.3 t-20 -48.72 -44.72 38.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.147 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 58.2 m -54.56 -44.7 73.14 Favored 'General case' 0 N--CA 1.461 0.075 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.46 -42.58 82.79 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.059 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.0 tp -54.45 -60.69 3.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.625 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -58.04 -23.41 21.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.2 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.401 ' O ' ' C ' ' A' ' 58' ' ' PHE . 32.8 tttp -79.32 -65.49 0.99 Allowed 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.528 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.401 ' C ' ' O ' ' A' ' 57' ' ' LYS . 3.8 t80 -36.33 -55.37 0.81 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.89 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -68.42 -66.16 0.61 Allowed 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.157 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -40.07 -36.28 0.83 Allowed Glycine 0 CA--C 1.529 0.963 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.066 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -82.02 -60.76 2.11 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.762 0.315 . . . . 0.0 111.112 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -58.61 -40.71 84.04 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.533 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -86.27 -18.26 32.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.266 -0.425 . . . . 0.0 109.916 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.9 mtm180 60.41 4.16 0.66 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.759 178.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.439 HG11 ' N ' ' A' ' 66' ' ' ALA . 6.1 t -65.42 -125.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 120.905 0.383 . . . . 0.0 110.154 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.439 ' N ' HG11 ' A' ' 65' ' ' VAL . . . -145.65 164.15 32.65 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.23 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.9 ptmt -75.28 -27.75 59.5 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.496 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.1 t -78.38 -14.74 59.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.637 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.402 ' O ' ' O ' ' A' ' 84' ' ' LYS . 0.9 OUTLIER -97.73 -15.02 20.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.752 179.718 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.9 t -95.43 99.6 9.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.906 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -107.48 121.55 60.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.503 -179.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 63.0 mt -84.94 95.41 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.168 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -72.86 -4.06 29.47 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.92 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 10.6 mttp 165.9 142.31 0.02 OUTLIER 'General case' 0 C--N 1.339 0.151 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.6 -15.36 6.7 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -35.03 -39.08 0.09 Allowed 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.4 mt -132.13 10.4 4.55 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -123.55 154.03 17.34 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -55.91 -27.7 53.32 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.949 0.404 . . . . 0.0 110.044 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -69.0 160.7 30.45 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.548 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 7.7 tttt -150.87 137.86 19.14 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -140.62 75.93 1.53 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 52.6 mt -82.56 151.03 4.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.908 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.436 ' HE3' ' N ' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -123.45 122.57 38.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.751 179.808 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.436 ' N ' ' HE3' ' A' ' 84' ' ' LYS . 1.9 mp -99.79 104.82 16.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.823 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.426 HG23 HD12 ' A' ' 86' ' ' ILE . 43.4 mt -87.64 149.8 3.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.437 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 0.4 OUTLIER 43.64 54.11 10.71 Favored Pre-proline 0 CA--C 1.532 0.262 0 CA-C-O 120.816 0.341 . . . . 0.0 110.11 -179.799 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.437 ' CD ' ' N ' ' A' ' 87' ' ' ASN . 2.7 Cg_endo -45.16 146.13 2.96 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.979 2.452 . . . . 0.0 112.202 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -121.26 -38.33 2.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.503 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -143.96 117.73 9.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.062 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.9 tt -111.25 116.74 50.79 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.237 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -65.29 151.05 86.54 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 122.351 2.034 . . . . 0.0 111.734 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -51.47 -35.16 54.35 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.786 2.324 . . . . 0.0 111.991 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -45.23 -58.29 3.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.378 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.7 t -77.39 -19.89 14.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.245 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.63 -30.8 61.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.907 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.18 -22.91 31.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.635 0.255 . . . . 0.0 111.213 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -99.85 -16.19 18.13 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.163 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 87.7 mt -104.55 -35.66 3.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.062 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.324 -179.442 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.481 ' O ' ' CB ' ' A' ' 7' ' ' ALA . 15.1 m . . . . . 0 N--CA 1.435 -1.175 0 CA-C-O 121.107 0.479 . . . . 0.0 110.078 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.481 ' CB ' ' O ' ' A' ' 6' ' ' SER . . . 153.99 -19.61 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.034 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.0 p -154.67 154.27 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.276 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.2 m -144.89 117.82 8.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.363 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.8 m -88.27 97.75 7.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.792 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.84 -155.32 0.06 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.434 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -107.62 10.45 29.09 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -123.24 -24.67 4.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.312 -178.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.447 ' HA3' ' HZ2' ' A' ' 84' ' ' LYS . . . 172.06 -125.15 1.15 Allowed Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.466 ' N ' ' HZ2' ' A' ' 84' ' ' LYS . 0.8 OUTLIER -152.36 148.45 27.51 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 120.862 0.363 . . . . 0.0 111.344 -179.631 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.4 t -107.29 142.72 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.751 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.504 ' HB3' ' HZ1' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -115.37 104.6 11.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.001 0.429 . . . . 0.0 110.322 179.866 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.543 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 2.3 mtm180 -105.96 119.28 38.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.194 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.494 ' CD2' ' NZ ' ' A' ' 81' ' ' LYS . 3.9 pp -149.59 179.65 7.82 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.281 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -105.71 99.36 8.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.515 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.2 mm -69.31 124.9 26.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.599 ' NE2' ' O ' ' A' ' 23' ' ' PRO . 0.3 OUTLIER -121.23 86.64 43.37 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.945 -179.493 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.599 ' O ' ' NE2' ' A' ' 22' ' ' GLN . 3.4 Cg_exo -74.11 161.1 41.59 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.706 2.271 . . . . 0.0 111.735 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.502 ' CB ' ' O ' ' A' ' 23' ' ' PRO . 2.5 mmpt? 88.33 30.05 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.275 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -99.16 172.64 7.24 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.2 m -75.64 -12.77 60.27 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.069 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -176.68 163.4 2.33 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.154 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.484 ' HA ' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -79.43 90.98 5.06 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.269 0.556 . . . . 0.0 109.532 177.866 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.2 m -132.15 134.28 45.23 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.526 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -86.69 73.34 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.92 18.68 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 114.863 -1.062 . . . . 0.0 112.35 -178.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -143.41 38.29 1.4 Allowed Glycine 0 N--CA 1.459 0.209 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 12.1 mt -74.06 128.94 36.84 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.533 -0.833 . . . . 0.0 110.192 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 56.7 t60 -111.75 156.33 22.1 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.174 0.512 . . . . 0.0 111.355 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.24 -25.75 66.93 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -119.18 -13.04 9.37 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 121.226 -0.19 . . . . 0.0 110.737 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -134.81 -178.27 5.0 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.868 0.366 . . . . 0.0 110.503 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 43.0 t -143.6 117.73 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -116.37 110.36 18.59 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.702 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.9 p -110.8 136.16 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.821 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 28' ' ' ASP . . . -100.83 111.12 23.27 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.4 tt -101.68 151.02 5.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.8 t -91.06 19.85 5.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.676 -177.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.33 168.87 9.45 Favored Pre-proline 0 C--N 1.328 -0.351 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.488 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -78.87 166.87 22.92 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 123.402 2.735 . . . . 0.0 111.94 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -74.77 8.52 2.29 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 123.027 2.485 . . . . 0.0 112.551 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.8 p -95.89 150.4 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.43 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.449 ' O ' ' N ' ' A' ' 52' ' ' ASN . 0.7 OUTLIER -64.21 -61.78 2.03 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.114 -179.33 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . -33.28 -56.52 0.56 Allowed Glycine 0 CA--C 1.529 0.956 0 N-CA-C 111.971 -0.451 . . . . 0.0 111.971 -179.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.434 ' N ' ' CD ' ' A' ' 50' ' ' GLN . 3.0 mp0 -78.09 -49.89 13.07 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.64 -60.38 3.94 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.882 0.372 . . . . 0.0 110.546 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.449 ' N ' ' O ' ' A' ' 48' ' ' ASP . 39.3 t-20 -42.32 -54.27 3.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.836 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.8 m -41.57 -51.67 3.9 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.75 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.99 -48.59 75.82 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.166 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.3 mp -47.53 -45.86 27.13 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.672 0.272 . . . . 0.0 110.928 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -66.45 -26.77 38.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.223 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 15.1 ttmm -82.18 -48.08 11.73 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.515 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -53.02 -49.32 66.49 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.737 -0.21 . . . . 0.0 111.424 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.469 ' CD2' ' N ' ' A' ' 59' ' ' LEU . 3.8 mm? -79.56 -41.56 26.95 Favored 'General case' 0 C--O 1.225 -0.237 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.62 -38.5 71.9 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.464 ' CG ' ' N ' ' A' ' 62' ' ' GLN . 5.9 ptmm? -81.91 -42.77 19.05 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.464 ' N ' ' CG ' ' A' ' 61' ' ' LYS . 33.0 mm-40 -71.22 -45.91 62.27 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.727 0.299 . . . . 0.0 111.024 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -84.26 -18.15 37.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.164 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.0 mtp180 60.67 15.94 6.21 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.02 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.7 m -89.6 149.76 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -49.34 157.64 0.47 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.355 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -73.43 -28.5 62.01 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.591 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.5 t -71.86 -11.8 60.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.901 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -97.93 -10.51 24.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.198 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.8 t -95.81 98.68 8.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.4 t -111.16 122.8 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.25 -178.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.3 mt -84.48 88.89 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.898 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.418 ' O ' ' CB ' ' A' ' 74' ' ' LYS . 33.3 mt-10 -66.66 0.44 2.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.309 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.418 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 8.2 mttm 160.44 127.67 0.0 OUTLIER 'General case' 0 C--N 1.34 0.159 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.456 ' O ' ' C ' ' A' ' 76' ' ' GLU . . . 140.35 -8.88 2.93 Favored Glycine 0 CA--C 1.517 0.176 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.456 ' C ' ' O ' ' A' ' 75' ' ' GLY . 6.3 mm-40 -29.95 -47.65 0.08 Allowed 'General case' 0 N--CA 1.466 0.335 0 O-C-N 123.757 0.328 . . . . 0.0 111.054 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.0 tt -126.83 -42.39 1.76 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.187 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -55.52 153.57 13.64 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 116.289 -0.414 . . . . 0.0 112.255 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.594 ' HE ' ' N ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -62.78 -34.06 76.47 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.003 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.423 ' O ' ' HA2' ' A' ' 75' ' ' GLY . 25.3 t60 -68.49 143.99 54.79 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.543 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 9.8 tttm -139.59 145.72 38.92 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.211 -178.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.412 ' HG2' ' NE2' ' A' ' 80' ' ' HIS . 2.4 mt-30 -146.94 79.05 1.51 Allowed 'General case' 0 C--O 1.233 0.2 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.465 ' CD1' ' HE2' ' A' ' 81' ' ' LYS . 40.2 mt -82.38 143.39 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.045 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.466 ' HZ2' ' N ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -109.67 121.06 44.37 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.671 -179.569 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.5 mp -105.33 94.39 3.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.274 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 55.5 mt -82.27 144.38 10.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 55.36 79.25 0.35 Allowed Pre-proline 0 C--N 1.33 -0.248 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.203 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -74.56 128.94 12.27 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.77 2.313 . . . . 0.0 112.36 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -112.32 -29.7 7.44 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.236 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -143.64 114.28 7.6 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.189 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.5 tt -109.2 110.17 60.48 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.456 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -65.81 174.6 5.41 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 122.353 2.035 . . . . 0.0 112.03 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.447 ' O ' ' N ' ' A' ' 97' ' ' ALA . 3.2 Cg_exo -71.83 -19.81 26.81 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.661 2.241 . . . . 0.0 112.201 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -49.48 -59.3 3.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.96 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 54.8 t -78.99 -25.54 13.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.288 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.2 -28.81 61.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.138 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 93' ' ' PRO . . . -65.43 -21.34 66.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.185 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.8 pp -116.68 -8.18 11.46 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.13 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.4 mm -103.88 -47.97 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.3 m120 . . . . . 0 C--N 1.332 -0.159 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.425 179.77 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.496 ' O ' ' CB ' ' A' ' 7' ' ' ALA . 5.9 m . . . . . 0 N--CA 1.436 -1.167 0 CA-C-O 121.141 0.496 . . . . 0.0 110.449 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.496 ' CB ' ' O ' ' A' ' 6' ' ' SER . . . 150.89 -18.96 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.109 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.401 ' CG2' ' N ' ' A' ' 9' ' ' THR . 1.7 p -155.65 154.69 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.801 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.401 ' N ' ' CG2' ' A' ' 8' ' ' VAL . 0.9 OUTLIER -137.9 143.32 40.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.093 -179.913 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.2 m -113.6 105.02 17.93 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.48 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -92.22 -154.94 0.4 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.36 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -107.6 5.4 26.92 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -113.52 -22.05 10.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.614 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.458 ' CA ' ' HZ3' ' A' ' 84' ' ' LYS . . . 164.62 -124.05 1.22 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.19 153.86 35.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.983 0.42 . . . . 0.0 111.398 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.1 t -110.84 131.86 60.88 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.962 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.2 tp -109.47 102.73 11.58 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.976 0.417 . . . . 0.0 110.44 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 49.2 mtt180 -104.08 119.33 38.7 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.534 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.5 pp -148.01 179.62 7.61 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.203 0.525 . . . . 0.0 111.553 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -112.13 106.22 14.78 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.517 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.8 mm -76.58 135.14 27.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.026 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -122.18 91.2 49.09 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.493 -0.776 . . . . 0.0 108.917 178.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -72.2 154.02 56.78 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.685 2.257 . . . . 0.0 112.822 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.2 mtmp? 76.63 42.64 0.15 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.59 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -100.24 167.85 10.17 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 178.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 98.1 p -62.05 -19.43 62.89 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.199 -0.6 . . . . 0.0 109.962 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -176.29 170.63 2.57 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.53 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.482 ' HA ' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -83.27 90.3 7.11 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.667 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.3 m -131.06 143.63 50.83 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.775 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.03 74.33 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.289 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -103.64 19.05 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.608 -177.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.41 ' HA3' ' HB3' ' A' ' 39' ' ' LYS . . . -144.41 35.87 1.51 Allowed Glycine 0 C--N 1.332 0.35 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 15.2 mt -71.19 122.09 19.54 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.596 -0.802 . . . . 0.0 109.929 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -110.25 162.52 14.53 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.495 -178.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -72.89 -28.21 67.33 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -110.68 -9.74 14.51 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -144.6 -178.82 6.19 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-O 120.861 0.363 . . . . 0.0 110.796 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 55.3 t -143.39 113.74 2.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.41 ' HB3' ' HA3' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -112.35 118.48 35.34 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.876 -179.688 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.8 p -123.02 133.19 69.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.006 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.482 ' O ' ' HA ' ' A' ' 28' ' ' ASP . . . -98.27 126.6 43.82 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.8 tt -116.4 145.75 21.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.8 t -87.21 23.01 1.93 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.835 -178.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.9 143.86 27.41 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.834 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.477 ' HG2' ' CB ' ' A' ' 50' ' ' GLN . 3.4 Cg_exo -55.78 166.34 2.95 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.566 2.177 . . . . 0.0 111.934 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -76.52 11.56 1.85 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.985 2.457 . . . . 0.0 112.255 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.427 HG13 ' H ' ' A' ' 50' ' ' GLN . 9.5 p -94.72 150.16 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.236 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -63.83 -53.35 52.1 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.881 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -39.91 -47.95 3.31 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 121.234 -0.508 . . . . 0.0 111.904 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.477 ' CB ' ' HG2' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -85.02 -50.17 7.68 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -178.894 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.57 -49.92 75.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.983 0.42 . . . . 0.0 110.433 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -57.69 -52.32 65.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.054 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.5 p -52.28 -47.47 65.86 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.88 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -61.31 -47.03 87.81 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-O 120.726 0.298 . . . . 0.0 110.281 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.43 -61.41 2.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.545 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -55.36 -21.63 9.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.649 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -85.11 -60.66 1.97 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.034 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -53.9 -38.69 65.08 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.151 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.69 -39.33 20.31 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.675 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.08 -37.42 93.89 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.2 ptmm? -80.74 -31.3 36.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.546 0.213 . . . . 0.0 111.297 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.59 -46.51 21.95 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.007 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -85.88 -18.4 32.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.488 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 32.7 mtp180 59.22 5.03 0.52 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.926 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.463 HG12 ' N ' ' A' ' 66' ' ' ALA . 21.8 t -65.32 -118.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 121.027 0.441 . . . . 0.0 110.088 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.463 ' N ' HG12 ' A' ' 65' ' ' VAL . . . -148.55 155.62 41.37 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.034 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.06 -29.48 63.0 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -75.77 -13.92 60.31 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.883 179.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -103.18 -15.6 15.97 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.97 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.7 t -88.42 99.91 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.2 t -105.49 117.0 50.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.25 -178.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.431 ' C ' ' H ' ' A' ' 74' ' ' LYS . 51.8 mt -87.86 85.48 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.376 178.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -67.54 5.22 0.84 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.708 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.431 ' H ' ' C ' ' A' ' 72' ' ' ILE . 7.2 mttp 162.43 142.1 0.01 OUTLIER 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.435 ' HA2' ' O ' ' A' ' 80' ' ' HIS . . . 127.95 -12.79 6.46 Favored Glycine 0 C--N 1.323 -0.186 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 75' ' ' GLY . 5.8 mt-10 -33.83 -47.1 0.24 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.417 -0.392 . . . . 0.0 111.151 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.5 tp -125.45 -43.84 1.88 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.44 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -59.64 151.88 35.94 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.9 mtt85 -63.05 -29.31 70.72 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.435 ' O ' ' HA2' ' A' ' 75' ' ' GLY . 0.5 OUTLIER -68.05 157.82 34.34 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.056 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 6.4 tttt -156.09 147.27 22.39 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.662 -178.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.21 111.61 5.22 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.405 ' CD1' HG12 ' A' ' 72' ' ' ILE . 6.1 mm -109.68 140.14 29.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.609 -178.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.458 ' HZ3' ' CA ' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -109.87 111.59 23.1 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.048 179.801 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.8 mp -96.51 99.89 9.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.351 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 36.9 mt -85.23 148.66 4.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.578 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 46.1 58.31 16.08 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.651 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -46.05 129.27 12.41 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.882 2.388 . . . . 0.0 112.06 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 41.1 tp60 -109.69 -30.01 8.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.699 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -147.65 121.61 9.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.609 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 tt -112.33 113.37 51.34 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.067 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -68.59 157.77 60.46 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.419 2.079 . . . . 0.0 112.202 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -51.82 -27.73 28.24 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 123.035 2.49 . . . . 0.0 111.893 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -53.82 -59.4 4.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.834 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 16.9 t -76.57 -20.9 14.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.871 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.6 -31.7 60.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.7 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -65.74 -19.71 66.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.249 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 77.0 mt -102.09 -21.07 14.51 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.048 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 66.1 mt -98.73 -31.89 3.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.991 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.5 m120 . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.459 179.839 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.428 ' O ' ' CB ' ' A' ' 7' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.441 -0.883 0 CA-C-O 121.32 0.581 . . . . 0.0 109.76 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 6' ' ' SER . . . 159.68 -17.59 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.584 -1.189 . . . . 0.0 109.206 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.0 p -160.28 160.01 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.575 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 m -150.95 125.6 9.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.427 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 m -91.65 101.28 12.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.062 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -79.58 -158.04 0.15 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.11 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -107.05 11.26 29.86 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -124.07 -18.92 5.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.337 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.43 -123.71 1.17 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.427 ' N ' ' HZ3' ' A' ' 84' ' ' LYS . 0.3 OUTLIER -149.24 138.34 21.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.0 0.429 . . . . 0.0 111.391 -179.747 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.6 t -99.39 106.35 18.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.198 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.0 tp -87.39 114.0 23.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.024 0.44 . . . . 0.0 111.142 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.551 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 14.8 mtt-85 -111.17 126.29 54.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.658 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.446 ' HB2' HG12 ' A' ' 38' ' ' VAL . 0.8 OUTLIER -149.45 175.16 11.72 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 121.956 0.884 . . . . 0.0 112.86 -179.038 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -106.23 91.81 3.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 113.867 -1.515 . . . . 0.0 108.565 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.405 HG13 ' NZ ' ' A' ' 81' ' ' LYS . 1.0 OUTLIER -73.53 131.14 35.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.222 -178.104 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.14 88.8 53.62 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.903 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.14 161.0 39.05 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.767 2.311 . . . . 0.0 112.793 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 20.3 mtmt 73.59 48.61 0.15 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.207 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.48 ' O ' ' CB ' ' A' ' 26' ' ' SER . . . -99.55 -62.88 1.18 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 25' ' ' ALA . 4.3 t 153.08 -28.52 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.991 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.443 ' CG ' ' O ' ' A' ' 26' ' ' SER . 79.1 mtt180 -163.4 142.1 8.11 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.81 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.47 94.22 0.08 Allowed 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.448 0.642 . . . . 0.0 109.973 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.4 p -123.02 126.88 47.95 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.874 -179.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -92.07 63.01 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -96.56 17.89 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 114.583 -1.19 . . . . 0.0 112.338 -177.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . -141.59 22.6 2.52 Favored Glycine 0 C--N 1.32 -0.351 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -178.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.409 ' CD2' HG11 ' A' ' 38' ' ' VAL . 19.3 mt -59.45 120.66 9.78 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.07 -0.565 . . . . 0.0 109.824 178.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.428 ' HD1' ' H ' ' A' ' 35' ' ' GLY . 2.3 t60 -111.6 155.06 23.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.492 -178.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.428 ' H ' ' HD1' ' A' ' 34' ' ' HIS . . . -66.93 -19.7 69.97 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.649 -0.981 . . . . 0.0 110.649 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -121.15 -5.07 9.48 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.555 0.217 . . . . 0.0 110.614 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.405 ' O ' ' O ' ' A' ' 34' ' ' HIS . 57.2 mt-10 -148.54 -178.46 6.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.991 0.424 . . . . 0.0 110.651 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.446 HG12 ' HB2' ' A' ' 19' ' ' LEU . 6.8 t -141.72 110.96 2.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 13.0 mtpt -110.36 103.15 11.76 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.146 -0.621 . . . . 0.0 110.785 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.7 p -114.27 136.43 50.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.701 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.455 ' HB1' ' CB ' ' A' ' 25' ' ' ALA . . . -99.98 93.95 6.03 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.979 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.7 tt -80.04 148.59 5.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.3 t -93.81 29.41 2.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.001 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.37 161.09 26.46 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.855 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -77.21 177.61 8.65 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 123.478 2.785 . . . . 0.0 112.093 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -77.31 5.5 5.05 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 123.168 2.578 . . . . 0.0 112.644 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.418 HG13 ' H ' ' A' ' 50' ' ' GLN . 11.7 p -98.96 155.86 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 120.791 0.329 . . . . 0.0 110.738 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 49' ' ' GLY . 0.1 OUTLIER -69.41 -61.37 1.82 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.055 -179.709 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . -34.87 -51.93 0.83 Allowed Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.884 -0.486 . . . . 0.0 111.884 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.418 ' H ' HG13 ' A' ' 47' ' ' VAL . 2.4 mm100 -76.39 -50.56 13.87 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.74 -61.72 2.22 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.766 0.317 . . . . 0.0 110.915 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -47.07 -39.85 13.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.731 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.5 m -61.25 -51.39 69.14 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.586 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.425 ' O ' ' N ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -55.85 -57.98 9.79 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.572 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -44.16 -57.93 3.15 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.044 0.45 . . . . 0.0 110.262 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.3 t -54.36 -26.07 15.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.127 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 54' ' ' HIS . 8.4 ttpt -85.17 -63.46 1.32 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.918 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -50.74 -41.8 56.78 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.203 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.1 tp -84.67 -40.43 17.41 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.504 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -58.99 -33.64 75.08 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.0 ptmt -80.59 -37.27 31.57 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 120.59 0.233 . . . . 0.0 111.035 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -74.94 -42.39 57.79 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.431 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.414 ' CD1' HG21 ' A' ' 85' ' ' ILE . 0.7 OUTLIER -86.09 -18.83 31.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.535 179.767 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.4 mtp180 60.47 8.1 1.55 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.777 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.8 m -67.53 177.03 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -89.63 164.81 14.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.948 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -21.2 62.6 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -86.55 -12.65 48.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.464 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -101.62 -1.17 33.4 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.492 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 p -110.94 100.69 11.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.014 0.435 . . . . 0.0 110.014 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 79.7 t -114.22 116.92 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.756 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.45 ' C ' ' H ' ' A' ' 74' ' ' LYS . 76.3 mt -89.94 88.48 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.23 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -72.81 10.3 0.91 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.671 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.45 ' H ' ' C ' ' A' ' 72' ' ' ILE . 7.6 mttp 167.93 145.59 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 123.59 -17.01 7.87 Favored Glycine 0 CA--C 1.518 0.269 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -39.18 -44.33 1.19 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.655 -0.273 . . . . 0.0 111.066 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.18 -43.43 0.79 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.192 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.96 151.47 52.47 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -60.82 -32.67 72.03 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.9 p-80 -68.89 129.97 41.45 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 177.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.6 OUTLIER -137.86 141.5 40.72 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 120.196 -0.601 . . . . 0.0 110.49 -177.312 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -139.48 114.62 9.63 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.7 mt -117.01 135.87 55.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.396 -178.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.427 ' HZ3' ' N ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -104.67 106.67 17.26 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.876 -179.819 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.428 ' N ' ' CD1' ' A' ' 85' ' ' ILE . 1.5 mp -94.68 92.06 3.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.067 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 55.5 mt -77.47 155.39 5.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.733 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 38.39 73.32 0.78 Allowed Pre-proline 0 N--CA 1.464 0.243 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.005 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -74.32 132.92 16.98 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.673 2.249 . . . . 0.0 111.847 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -110.63 -24.16 10.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.089 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -147.52 120.19 8.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.255 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.9 tt -113.96 119.55 40.66 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.951 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -66.26 147.72 83.75 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 122.224 1.949 . . . . 0.0 112.522 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -51.03 -30.22 30.43 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 123.048 2.498 . . . . 0.0 112.24 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -54.23 -57.77 9.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.699 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.5 t -75.11 -21.66 16.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.732 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.42 ' O ' ' N ' ' A' ' 100' ' ' ASN . . . -75.59 -34.53 60.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.024 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.71 -20.1 32.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.738 0.304 . . . . 0.0 111.075 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 27.2 mt -103.04 -25.1 13.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.077 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 86.1 mt -96.65 -27.69 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.872 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.42 ' N ' ' O ' ' A' ' 96' ' ' ALA . 3.3 t-20 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.679 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.497 ' O ' ' CB ' ' A' ' 7' ' ' ALA . 22.7 t . . . . . 0 N--CA 1.435 -1.184 0 CA-C-O 121.134 0.492 . . . . 0.0 110.195 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.497 ' CB ' ' O ' ' A' ' 6' ' ' SER . . . 152.63 -17.48 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.563 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.448 ' CG2' ' N ' ' A' ' 9' ' ' THR . 0.7 OUTLIER -160.27 157.73 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.6 -179.809 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.448 ' N ' ' CG2' ' A' ' 8' ' ' VAL . 1.1 m -147.66 134.46 20.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.136 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.2 m -102.65 104.0 15.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.224 0.535 . . . . 0.0 110.492 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 35.9 m-20 -87.2 -149.98 0.16 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.166 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -107.18 2.68 24.95 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -109.17 -22.23 12.2 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.441 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 160.47 -122.14 1.1 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.424 ' N ' ' HZ1' ' A' ' 84' ' ' LYS . 0.3 OUTLIER -147.36 147.31 30.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.946 0.403 . . . . 0.0 111.244 -179.722 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.1 t -103.85 137.23 33.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.488 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.03 99.17 7.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.935 0.398 . . . . 0.0 110.521 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.516 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 38.7 mtt180 -97.3 114.76 26.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.836 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.42 HD13 ' CD1' ' A' ' 21' ' ' ILE . 4.3 pp -147.05 179.75 7.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.284 0.564 . . . . 0.0 111.664 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -113.81 95.78 5.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.949 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.42 ' CD1' HD13 ' A' ' 19' ' ' LEU . 1.1 tp -75.35 130.78 35.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.273 -178.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.403 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 1.3 tp60 -120.51 91.83 47.13 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.638 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.461 ' O ' ' HB2' ' A' ' 24' ' ' LYS . 3.1 Cg_exo -71.66 165.29 32.99 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.454 2.103 . . . . 0.0 112.29 -178.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 23' ' ' PRO . 16.5 mtmm 77.37 37.25 0.26 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.511 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -102.41 167.41 9.97 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 17.0 t -75.41 -10.32 59.34 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 119.996 -0.682 . . . . 0.0 109.666 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.7 ttp180 -176.6 163.8 2.42 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.666 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.501 ' HA ' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -84.82 95.22 8.92 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.613 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.1 m -126.42 135.66 51.68 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.722 -178.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -91.01 76.1 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.3 17.55 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.053 -178.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.427 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . -142.4 21.75 2.4 Favored Glycine 0 C--N 1.32 -0.322 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 19.4 mt -57.75 107.01 0.41 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.434 ' O ' ' O ' ' A' ' 37' ' ' GLU . 44.7 t-80 -94.46 157.4 16.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.559 -178.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -66.6 -29.26 74.47 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -112.41 -10.08 13.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.737 -0.231 . . . . 0.0 110.472 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.434 ' O ' ' O ' ' A' ' 34' ' ' HIS . 8.4 mt-10 -140.68 -176.81 4.79 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.975 0.417 . . . . 0.0 110.734 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 45.9 t -142.78 112.79 2.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.439 ' HZ2' ' CB ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -111.13 132.69 54.08 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.262 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.5 p -147.59 124.18 2.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.651 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' A' ' 28' ' ' ASP . . . -86.94 122.4 30.75 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 21.2 tt -109.33 147.95 13.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.1 t -90.66 38.42 0.95 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.937 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -105.24 139.14 19.85 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.449 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.54 ' HG2' ' CB ' ' A' ' 50' ' ' GLN . 3.2 Cg_exo -56.25 170.47 1.16 Allowed 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 122.689 2.259 . . . . 0.0 112.572 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.61 24.74 0.45 Allowed 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 123.36 2.707 . . . . 0.0 113.391 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.41 HG13 ' H ' ' A' ' 50' ' ' GLN . 13.9 p -120.28 138.2 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.446 ' O ' ' C ' ' A' ' 49' ' ' GLY . 0.7 OUTLIER -53.75 -58.87 5.66 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.104 -179.427 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . -34.65 -52.9 0.81 Allowed Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.54 ' CB ' ' HG2' ' A' ' 45' ' ' PRO . 43.1 mm-40 -78.12 -39.37 41.47 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.07 -62.87 1.2 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.834 0.35 . . . . 0.0 110.511 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.439 ' N ' ' O ' ' A' ' 48' ' ' ASP . 46.2 t-20 -43.58 -47.24 7.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.876 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 18.4 m -52.99 -57.55 9.99 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.305 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -51.5 -50.75 59.29 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.787 0.327 . . . . 0.0 110.679 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -50.91 -43.77 59.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.198 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -69.37 -27.12 33.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.99 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -79.32 -60.5 2.34 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.842 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -46.9 -58.39 3.98 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.249 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.408 ' O ' ' HB2' ' A' ' 63' ' ' PHE . 4.6 mp -71.17 -41.47 70.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.103 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -51.17 -35.42 34.03 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.3 mttp -80.92 -58.26 3.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.662 0.268 . . . . 0.0 111.02 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -56.03 -43.87 78.21 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.102 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.408 ' HB2' ' O ' ' A' ' 59' ' ' LEU . 1.6 m-85 -82.72 -18.54 40.47 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.111 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.2 mtt-85 61.59 8.48 2.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.533 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.2 m -82.9 163.14 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.3 156.63 31.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.806 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 28.2 pttt -70.96 -28.58 64.58 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -71.42 -11.94 61.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.927 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.428 ' O ' ' O ' ' A' ' 84' ' ' LYS . 80.8 mt-30 -100.14 -7.94 24.25 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.335 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.0 t -104.06 97.76 5.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.4 t -116.78 123.18 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -178.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.459 ' C ' ' H ' ' A' ' 74' ' ' LYS . 54.3 mt -82.33 84.55 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.166 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -60.25 -3.68 0.67 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.035 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.459 ' H ' ' C ' ' A' ' 72' ' ' ILE . 5.3 mttp 168.15 116.55 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.081 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.419 ' HA3' ' HZ1' ' A' ' 81' ' ' LYS . . . 148.62 -10.43 1.08 Allowed Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -34.14 -41.03 0.1 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.3 tp -131.47 -42.96 1.04 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.701 0.286 . . . . 0.0 111.355 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.5 149.2 48.67 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.785 -0.526 . . . . 0.0 111.785 -178.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.99 -29.43 69.68 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.406 ' O ' ' HA2' ' A' ' 75' ' ' GLY . 76.5 t60 -67.27 145.85 54.75 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 177.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -144.73 154.02 42.3 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 119.706 -0.798 . . . . 0.0 111.537 -177.195 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -162.87 78.71 0.47 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 46.8 mt -80.46 153.61 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.398 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.451 ' HE3' ' N ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -120.47 111.86 18.24 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.969 -178.973 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.451 ' N ' ' HE3' ' A' ' 84' ' ' LYS . 1.4 mp -100.54 102.85 14.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.182 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.438 HD13 HG21 ' A' ' 86' ' ' ILE . 55.3 mt -85.99 153.55 3.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.551 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 18.4 m-20 40.05 79.77 0.31 Allowed Pre-proline 0 N--CA 1.467 0.41 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.692 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.51 146.1 30.51 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 123.014 2.476 . . . . 0.0 112.65 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 60.6 mm-40 -124.12 -28.91 3.66 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.043 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -146.8 117.48 7.57 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.138 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.9 tt -114.36 120.49 38.07 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.599 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.2 141.22 92.68 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.479 2.119 . . . . 0.0 112.342 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -50.49 -33.94 40.18 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 123.266 2.644 . . . . 0.0 112.632 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -53.04 -54.43 35.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.13 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 16.3 t -72.22 -19.45 19.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.0 -25.44 58.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.809 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -62.53 -26.34 68.51 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.888 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 20.1 mt -94.99 -10.94 29.42 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.5 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 97.6 mt -102.36 -30.98 2.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.943 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 . . . . . 0 N--CA 1.462 0.15 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.821 -179.738 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.478 ' O ' ' CB ' ' A' ' 7' ' ' ALA . 9.6 p . . . . . 0 N--CA 1.44 -0.948 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.478 ' CB ' ' O ' ' A' ' 6' ' ' SER . . . 157.87 -17.46 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.985 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.454 ' CG2' ' N ' ' A' ' 9' ' ' THR . 0.2 OUTLIER -159.38 157.76 2.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.843 -179.607 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.454 ' N ' ' CG2' ' A' ' 8' ' ' VAL . 1.3 m -144.62 141.78 29.66 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.349 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 m -107.19 101.36 12.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.298 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.412 HD22 ' CG2' ' A' ' 16' ' ' VAL . 14.8 m-80 -81.24 -155.4 0.12 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.311 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -107.65 10.52 29.02 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -122.83 -25.26 4.66 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.241 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.62 -129.11 1.54 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.46 158.74 43.79 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.171 0.51 . . . . 0.0 111.31 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.412 ' CG2' HD22 ' A' ' 11' ' ' ASN . 3.8 t -110.03 138.47 37.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.329 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.445 ' O ' ' HA ' ' A' ' 82' ' ' GLN . 0.1 OUTLIER -115.61 91.16 3.52 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.689 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.414 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 4.6 mtm180 -97.06 109.26 22.05 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.4 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 pp -145.42 178.89 7.77 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.878 0.371 . . . . 0.0 110.998 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -110.93 104.62 13.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.3 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.7 mm -70.68 126.72 31.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.38 86.24 55.04 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.129 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -74.77 161.18 39.76 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.634 2.223 . . . . 0.0 111.84 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.6 mtmt 73.87 43.48 0.32 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.007 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -91.66 -71.12 0.65 Allowed 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.2 p 162.51 -23.12 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.016 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -171.75 143.16 1.64 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.041 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.05 89.66 0.04 OUTLIER 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.673 0.749 . . . . 0.0 110.055 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.3 m -130.77 127.28 38.4 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.192 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -83.29 65.62 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -94.03 18.28 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 114.669 -1.151 . . . . 0.0 113.016 -177.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -143.05 39.14 1.35 Allowed Glycine 0 N--CA 1.46 0.289 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 22.9 mt -77.78 117.69 19.4 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.557 -0.822 . . . . 0.0 109.799 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.599 ' CD2' ' H ' ' A' ' 35' ' ' GLY . 11.0 t-160 -102.25 159.46 15.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.416 -178.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.599 ' H ' ' CD2' ' A' ' 34' ' ' HIS . . . -73.47 -19.66 79.72 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -115.96 -14.05 11.26 Favored 'General case' 0 N--CA 1.461 0.11 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -143.39 -176.23 4.86 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.322 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 73.2 t -144.15 121.12 5.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.37 118.48 29.56 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.646 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.5 p -113.42 135.01 54.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.064 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -100.0 104.8 16.42 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.509 HD13 ' CE1' ' A' ' 54' ' ' HIS . 0.6 OUTLIER -99.39 156.19 3.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 -179.147 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.432 ' H ' HG13 ' A' ' 42' ' ' ILE . 8.4 t -93.22 26.75 2.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.744 -178.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.0 167.44 12.01 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.866 0.365 . . . . 0.0 110.913 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.487 ' HG2' ' CB ' ' A' ' 50' ' ' GLN . 3.6 Cg_exo -77.98 177.63 8.56 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 123.56 2.84 . . . . 0.0 112.165 179.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -77.5 0.75 9.47 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 123.009 2.473 . . . . 0.0 111.435 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.2 m -93.19 160.16 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.666 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 52' ' ' ASN . 2.3 m-20 -82.21 -47.34 12.59 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.905 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -43.07 -46.8 6.39 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.487 ' CB ' ' HG2' ' A' ' 45' ' ' PRO . 0.9 OUTLIER -81.49 -49.81 10.15 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 121.219 -0.192 . . . . 0.0 111.511 -179.453 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.53 -56.53 20.25 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.837 0.351 . . . . 0.0 110.06 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.452 ' N ' ' O ' ' A' ' 48' ' ' ASP . 30.8 t-20 -46.12 -46.38 17.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.086 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.5 p -50.18 -48.14 54.24 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.604 ' C ' ' ND1' ' A' ' 54' ' ' HIS . 0.0 OUTLIER -63.05 -45.58 91.56 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.11 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.591 ' N ' ' CG ' ' A' ' 54' ' ' HIS . 0.1 OUTLIER -49.24 -60.92 2.39 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.308 -178.537 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -53.7 -26.53 13.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.795 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 58' ' ' PHE . 19.1 tttt -82.16 -72.64 0.43 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.058 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.406 ' C ' ' O ' ' A' ' 57' ' ' LYS . 0.8 OUTLIER -33.85 -64.09 0.24 Allowed 'General case' 0 N--CA 1.467 0.377 0 O-C-N 123.167 0.292 . . . . 0.0 111.292 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.429 ' CD2' ' N ' ' A' ' 59' ' ' LEU . 3.6 mm? -64.99 -37.96 89.39 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.17 -41.53 78.94 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.1 -52.54 7.27 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.066 0.46 . . . . 0.0 110.229 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.1 mm100 -56.11 -49.72 73.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.711 -178.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.443 ' CD2' HG21 ' A' ' 85' ' ' ILE . 2.3 m-85 -87.14 -18.99 29.14 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.627 -0.261 . . . . 0.0 111.393 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 18.6 mtt180 59.98 4.1 0.57 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.582 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.409 ' H ' ' C ' ' A' ' 63' ' ' PHE . 33.6 m -76.35 152.3 5.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.77 158.74 0.29 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.542 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.68 -29.56 65.91 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.308 0.575 . . . . 0.0 109.66 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.32 -13.88 59.84 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.59 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -89.93 -6.26 55.9 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.259 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.4 t -106.0 97.23 5.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.6 t -114.42 124.53 71.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.206 0.527 . . . . 0.0 111.814 -178.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 64.2 mt -86.95 93.22 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.435 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -77.35 -1.66 31.12 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.938 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 38.8 tttt 179.6 118.95 0.05 Allowed 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.543 ' O ' ' C ' ' A' ' 76' ' ' GLU . . . 146.66 -20.27 1.65 Allowed Glycine 0 CA--C 1.516 0.122 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.543 ' C ' ' O ' ' A' ' 75' ' ' GLY . 11.1 mp0 -10.6 -66.59 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 O-C-N 124.291 0.642 . . . . 0.0 112.037 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.7 tt -118.65 -42.87 2.71 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.369 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -51.11 157.68 2.49 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 44.4 mtt-85 -68.14 -16.44 64.0 Favored 'General case' 0 CA--C 1.519 -0.231 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.516 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.507 ' CD2' ' N ' ' A' ' 81' ' ' LYS . 16.1 t60 -69.17 155.95 39.52 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.507 ' N ' ' CD2' ' A' ' 80' ' ' HIS . 36.1 tttt -148.68 125.37 11.12 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.139 -0.625 . . . . 0.0 109.997 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.445 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 8.3 tt0 -131.55 104.74 7.13 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.406 HD12 HG21 ' A' ' 83' ' ' ILE . 15.9 mm -102.09 129.69 53.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.767 -178.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.99 99.33 9.08 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.443 HG21 ' CD2' ' A' ' 63' ' ' PHE . 2.2 mp -89.53 96.62 6.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.139 -178.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 33.4 mt -82.2 146.09 7.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.717 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 51.89 75.04 0.69 Allowed Pre-proline 0 N--CA 1.463 0.215 0 CA-C-O 120.759 0.314 . . . . 0.0 110.529 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -74.27 130.48 14.13 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 122.594 2.196 . . . . 0.0 112.096 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 21.4 mm100 -114.55 -26.08 8.06 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.948 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -145.39 116.18 7.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.399 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.1 tt -112.56 114.45 50.02 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.064 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -67.13 145.62 73.67 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.29 1.993 . . . . 0.0 111.504 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -51.61 -19.69 7.87 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 122.62 2.214 . . . . 0.0 111.873 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -61.14 -56.31 22.31 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.97 0.414 . . . . 0.0 110.331 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.25 -25.39 12.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.745 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.447 ' O ' ' ND2' ' A' ' 100' ' ' ASN . . . -75.41 -44.61 43.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.975 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.442 ' HA ' HD22 ' A' ' 100' ' ' ASN . . . -50.33 -19.78 0.91 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.57 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 80.5 mt -102.42 -25.44 13.63 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.944 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.412 HD11 HG23 ' A' ' 99' ' ' ILE . 95.8 mt -92.14 -21.18 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.997 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.476 ' N ' HD21 ' A' ' 100' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.463 0.199 0 CA-C-O 120.658 0.266 . . . . 0.0 111.096 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.467 ' HG ' ' H ' ' A' ' 7' ' ' ALA . 6.7 t . . . . . 0 N--CA 1.44 -0.926 0 CA-C-O 121.304 0.573 . . . . 0.0 110.349 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.467 ' H ' ' HG ' ' A' ' 6' ' ' SER . . . 156.36 -20.65 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.735 -1.12 . . . . 0.0 108.956 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.4 m -149.02 168.2 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.115 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 m -150.73 120.77 7.17 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.431 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.2 m -92.34 97.09 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.194 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -82.68 -163.27 0.68 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.189 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -101.39 11.71 38.7 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -119.16 -24.11 6.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.11 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.456 ' HA3' ' HZ2' ' A' ' 84' ' ' LYS . . . 165.87 -124.35 1.23 Allowed Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -150.87 150.77 31.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.976 0.417 . . . . 0.0 111.134 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.1 t -107.74 142.8 19.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.928 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -113.49 96.28 5.8 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 22.9 mtp85 -104.47 110.86 23.29 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.789 -179.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.0 pp -147.52 179.66 7.51 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.051 0.453 . . . . 0.0 111.427 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.41 ' CE1' ' HB3' ' A' ' 79' ' ' ARG . 16.0 t80 -108.36 114.64 28.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.086 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.9 mm -84.26 133.78 28.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.928 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -120.87 87.48 42.95 Favored Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -70.09 156.82 61.6 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.62 2.213 . . . . 0.0 113.413 -178.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? 69.83 49.79 0.5 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.239 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.405 ' O ' ' CB ' ' A' ' 26' ' ' SER . . . -96.68 -66.92 0.87 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' A' ' 25' ' ' ALA . 1.1 m 158.56 -24.41 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.293 -0.867 . . . . 0.0 108.724 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -171.1 144.24 2.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.87 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.47 92.8 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 59.8 p -124.29 130.19 52.08 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.52 -178.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -94.78 63.55 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.49 ' O ' ' CG1' ' A' ' 31' ' ' VAL . 92.7 t -96.03 19.51 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.944 -178.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -144.04 32.08 1.81 Allowed Glycine 0 C--N 1.334 0.457 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 31.8 mt -66.61 126.24 28.29 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.63 -0.785 . . . . 0.0 109.926 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.428 ' O ' ' O ' ' A' ' 37' ' ' GLU . 23.2 t-80 -112.67 157.41 21.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.042 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.06 -27.54 73.66 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -109.26 -14.49 14.46 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 115.569 -0.315 . . . . 0.0 110.81 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.428 ' O ' ' O ' ' A' ' 34' ' ' HIS . 9.0 mt-10 -141.94 -177.67 5.32 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.001 0.429 . . . . 0.0 111.081 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 70.7 t -143.97 115.98 2.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.707 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.4 ttpt -116.13 117.57 30.43 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.642 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.4 p -120.12 149.83 22.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.156 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -112.53 103.54 11.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.308 -0.406 . . . . 0.0 109.915 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.401 HG13 ' N ' ' A' ' 43' ' ' THR . 2.4 tp -86.11 146.36 6.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.401 ' N ' HG13 ' A' ' 42' ' ' ILE . 0.7 OUTLIER -87.31 17.15 4.58 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.755 -178.28 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.12 149.77 36.08 Favored Pre-proline 0 C--O 1.234 0.276 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.55 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.407 ' HG2' ' CB ' ' A' ' 50' ' ' GLN . 3.9 Cg_exo -51.54 175.9 0.06 OUTLIER 'Trans proline' 0 N--CA 1.491 1.371 0 C-N-CA 123.241 2.627 . . . . 0.0 112.212 178.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -80.21 0.36 10.08 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 123.23 2.62 . . . . 0.0 112.982 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -87.79 158.61 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.988 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.445 ' O ' ' N ' ' A' ' 52' ' ' ASN . 17.5 m-20 -73.55 -57.57 3.9 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.001 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . -36.65 -46.4 1.11 Allowed Glycine 0 CA--C 1.529 0.969 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.417 ' N ' ' CD ' ' A' ' 50' ' ' GLN . 2.1 mp0 -82.73 -52.16 7.03 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.25 -56.05 26.26 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.937 0.399 . . . . 0.0 110.403 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' A' ' 48' ' ' ASP . 40.1 t-20 -46.34 -54.65 8.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.47 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.7 m -48.81 -52.54 23.49 Favored 'General case' 0 C--O 1.23 0.066 0 C-N-CA 120.624 -0.431 . . . . 0.0 110.107 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -56.33 -56.12 25.01 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.539 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.3 mp -43.3 -60.45 1.69 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.273 0.558 . . . . 0.0 110.134 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.7 t -57.85 -29.33 35.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.312 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -76.3 -68.31 0.6 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.262 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -39.09 -48.28 1.65 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.503 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.473 ' CD1' ' HZ2' ' A' ' 81' ' ' LYS . 7.4 mp -76.93 -34.79 57.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.84 0.353 . . . . 0.0 110.072 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.36 -35.65 61.36 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.01 -52.16 7.73 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.919 0.39 . . . . 0.0 110.428 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -59.25 -46.93 87.19 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.848 -178.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.423 ' C ' ' H ' ' A' ' 65' ' ' VAL . 2.4 m-85 -86.13 -19.11 30.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.076 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.2 mtt85 59.24 5.27 0.55 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.352 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.423 ' H ' ' C ' ' A' ' 63' ' ' PHE . 27.0 m -67.35 175.33 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.199 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -86.67 163.44 17.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.263 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.401 ' O ' HG12 ' A' ' 70' ' ' VAL . 29.1 pttt -70.91 -21.29 62.39 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.658 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.77 -8.76 59.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.296 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -108.43 -5.15 16.78 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.463 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.505 ' CG1' ' O ' ' A' ' 70' ' ' VAL . 9.8 p -101.21 101.1 11.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 121.286 0.565 . . . . 0.0 110.373 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 59.7 t -115.94 124.9 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 52.6 mt -84.85 93.67 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.905 178.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -70.01 -16.05 63.11 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.159 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt 174.81 163.9 0.24 Allowed 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.57 -2.05 73.06 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -37.94 -31.94 0.05 Allowed 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -127.04 -45.04 1.58 Allowed 'General case' 0 C--O 1.233 0.187 0 C-N-CA 121.061 -0.255 . . . . 0.0 111.0 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.404 ' C ' ' N ' ' A' ' 80' ' ' HIS . . . -58.84 148.22 39.55 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.41 ' HB3' ' CE1' ' A' ' 20' ' ' TYR . 10.4 mtt180 -50.19 -18.55 0.6 Allowed 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.404 ' N ' ' C ' ' A' ' 78' ' ' GLY . 1.7 m80 -69.87 165.35 21.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.493 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 2.0 tttt -151.97 132.87 14.18 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -139.77 82.06 1.86 Allowed 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.483 ' CD1' ' HZ1' ' A' ' 81' ' ' LYS . 92.2 mt -95.11 139.61 18.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.839 -179.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.475 ' HE3' ' N ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -108.49 126.44 52.91 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.211 -179.129 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.475 ' N ' ' HE3' ' A' ' 84' ' ' LYS . 1.4 mp -106.1 98.75 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.967 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.401 ' O ' ' C ' ' A' ' 87' ' ' ASN . 95.5 mt -80.59 151.8 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 86' ' ' ILE . 1.5 m-80 38.09 85.41 0.16 Allowed Pre-proline 0 N--CA 1.464 0.226 0 O-C-N 123.235 0.334 . . . . 0.0 110.804 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -72.32 133.09 20.36 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.403 2.068 . . . . 0.0 112.365 -179.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -108.08 -30.19 8.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.419 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -147.31 121.05 9.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.123 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.9 tt -113.39 114.17 48.03 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.454 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -66.01 173.86 6.58 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 121.985 1.79 . . . . 0.0 111.069 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.66 -19.19 21.64 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.445 2.097 . . . . 0.0 111.591 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -52.94 -62.5 1.61 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.255 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.3 t -73.57 -24.58 20.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.975 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.4 -28.4 65.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.666 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.62 -22.29 8.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.551 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.9 mt -108.02 -41.55 4.91 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.784 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.455 HD13 HG21 ' A' ' 99' ' ' ILE . 79.0 mt -76.24 -13.57 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.767 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.078 179.566 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.513 0 CA-C-O 121.224 0.535 . . . . 0.0 110.141 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -153.62 -16.81 0.14 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.239 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.416 ' CG2' ' N ' ' A' ' 9' ' ' THR . 0.7 OUTLIER -160.88 155.72 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.488 179.632 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.416 ' N ' ' CG2' ' A' ' 8' ' ' VAL . 1.8 m -150.37 139.81 21.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.683 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.84 105.67 19.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.85 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -92.4 -152.29 0.31 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.595 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -107.59 5.33 26.87 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -109.4 -23.1 11.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.163 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 161.93 -125.48 1.43 Allowed Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -145.26 145.69 31.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.981 0.42 . . . . 0.0 110.971 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.2 t -105.58 129.0 59.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.84 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.28 99.81 8.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.215 0.531 . . . . 0.0 110.446 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.515 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -103.56 127.18 51.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.037 -179.876 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.415 ' HB2' HG13 ' A' ' 38' ' ' VAL . 0.6 OUTLIER -149.88 176.69 10.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.512 0.672 . . . . 0.0 112.121 -179.196 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -108.0 92.66 4.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.638 -1.165 . . . . 0.0 108.792 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.475 HG21 ' HA ' ' A' ' 79' ' ' ARG . 1.6 tp -75.77 137.01 23.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.037 -178.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.01 93.87 42.86 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.915 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -73.54 157.33 49.02 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.478 2.119 . . . . 0.0 112.226 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt 72.33 47.93 0.26 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.106 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.463 ' CB ' ' CB ' ' A' ' 41' ' ' ALA . . . -95.92 -68.37 0.8 Allowed 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.414 ' CB ' ' O ' ' A' ' 25' ' ' ALA . 6.1 p 157.38 -24.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.504 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 44.4 ttm180 -171.29 139.85 1.38 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.206 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.42 93.62 0.35 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.393 0.616 . . . . 0.0 109.999 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.8 m -124.92 129.09 49.67 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.654 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.56 63.03 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -93.67 17.67 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.725 -178.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.453 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . -143.38 28.25 2.08 Favored Glycine 0 C--N 1.318 -0.444 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -178.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.444 ' CD2' HG12 ' A' ' 38' ' ' VAL . 10.7 mt -60.81 111.01 1.47 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.431 ' HD1' ' H ' ' A' ' 35' ' ' GLY . 3.7 t60 -99.44 152.53 19.88 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.398 -178.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.431 ' H ' ' HD1' ' A' ' 34' ' ' HIS . . . -67.75 -15.5 66.75 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -121.94 -17.38 7.32 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.747 0.308 . . . . 0.0 110.392 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -139.05 -173.03 3.47 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.833 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.444 HG12 ' CD2' ' A' ' 33' ' ' LEU . 16.9 t -142.7 112.87 2.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 5.6 mtpt -110.89 109.36 19.5 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.035 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.7 p -121.98 132.44 70.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.458 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.463 ' CB ' ' CB ' ' A' ' 25' ' ' ALA . . . -99.65 99.86 10.77 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.272 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.6 tt -84.66 149.52 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.4 t -95.59 48.24 1.14 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.016 0.436 . . . . 0.0 110.626 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.502 ' HB2' HE21 ' A' ' 50' ' ' GLN . . . -118.79 142.89 32.56 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.529 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.566 ' O ' ' NE2' ' A' ' 50' ' ' GLN . 1.6 Cg_endo -54.51 169.66 0.72 Allowed 'Trans proline' 0 N--CA 1.503 2.058 0 C-N-CA 123.751 2.967 . . . . 0.0 112.236 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -83.56 87.09 1.29 Allowed 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.831 2.354 . . . . 0.0 111.081 177.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.65 ' CG2' ' H ' ' A' ' 48' ' ' ASP . 9.8 p -172.24 -160.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.65 ' H ' ' CG2' ' A' ' 47' ' ' VAL . 1.7 m-20 -88.03 -66.89 0.87 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.041 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -44.55 -28.77 1.65 Allowed Glycine 0 CA--C 1.526 0.734 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.35 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.716 ' CG ' ' H ' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -61.9 -69.78 0.23 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.206 0.527 . . . . 0.0 111.474 -179.644 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.716 ' H ' ' CG ' ' A' ' 50' ' ' GLN . . . -80.63 -39.84 26.69 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.224 -178.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -54.01 -54.96 31.87 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.359 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.4 p -64.12 -48.7 75.07 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.0 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.99 -52.81 63.99 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.652 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.5 tp -49.36 -58.3 5.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.028 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -53.74 -23.41 8.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.6 ttpp -85.16 -64.75 1.1 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.494 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -45.7 -59.77 2.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.382 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.0 tp -70.74 -48.0 56.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.951 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -49.21 -30.1 10.45 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -81.16 -63.06 1.48 Allowed 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.772 0.32 . . . . 0.0 111.217 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -58.63 -36.76 74.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.671 -178.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.455 ' HB3' ' CG2' ' A' ' 65' ' ' VAL . 1.4 m-85 -87.02 -18.96 29.39 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 56.7 11.05 0.81 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.371 -0.832 . . . . 0.0 112.642 178.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.495 ' CG1' ' H ' ' A' ' 66' ' ' ALA . 2.2 t -69.15 -141.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.871 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.495 ' H ' ' CG1' ' A' ' 65' ' ' VAL . . . -125.39 156.39 38.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.918 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 46.0 pttt -69.55 -26.29 64.42 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.13 -16.44 37.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.35 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -97.03 -20.63 17.91 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.566 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.444 ' CG1' ' O ' ' A' ' 70' ' ' VAL . 14.8 p -101.53 98.14 6.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 t -115.2 131.32 67.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.96 -178.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.403 ' C ' ' H ' ' A' ' 74' ' ' LYS . 68.1 mt -83.04 91.01 2.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.42 ' O ' ' CB ' ' A' ' 74' ' ' LYS . 7.8 mt-10 -57.91 -7.01 0.64 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.666 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.42 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 3.5 mtpp 162.11 126.48 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 132.77 -3.08 4.94 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -40.8 -30.53 0.13 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.8 tt -128.5 -37.85 1.77 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 121.023 -0.271 . . . . 0.0 111.654 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -70.99 158.32 53.72 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.772 -0.531 . . . . 0.0 111.772 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.475 ' HA ' HG21 ' A' ' 21' ' ' ILE . 13.3 mtm180 -61.41 -29.32 69.86 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.2 p-80 -69.01 146.99 52.24 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 5.8 ttmm -139.64 142.27 37.02 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.53 -178.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.409 ' HG2' ' C ' ' A' ' 81' ' ' LYS . 2.1 mm100 -144.3 80.72 1.65 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 81.9 mt -81.85 156.13 4.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.234 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.431 ' HE3' ' N ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -136.25 104.94 5.81 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.828 -179.64 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.431 ' N ' ' HE3' ' A' ' 84' ' ' LYS . 3.1 mp -96.81 103.12 14.3 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.796 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 53.7 mt -85.6 133.44 29.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.883 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 51.4 t30 52.16 82.47 0.24 Allowed Pre-proline 0 CA--C 1.53 0.202 0 CA-C-O 120.906 0.384 . . . . 0.0 110.03 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -69.73 144.79 55.29 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.61 2.207 . . . . 0.0 112.497 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -117.99 -29.77 5.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.118 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.419 ' O ' ' HA ' ' A' ' 63' ' ' PHE . 33.5 tt0 -147.12 122.27 10.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.785 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.3 tt -116.6 117.28 38.18 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.073 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -69.4 143.54 52.9 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 122.333 2.022 . . . . 0.0 112.165 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -49.25 -25.15 9.28 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 122.945 2.43 . . . . 0.0 111.899 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -61.35 -56.89 15.31 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.564 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.3 t -71.39 -19.83 20.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.33 -22.97 57.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.502 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -64.55 -19.26 65.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.006 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 67.9 mt -105.68 -16.7 14.61 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.31 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 44.1 mt -104.17 -36.53 4.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.81 0.338 . . . . 0.0 110.659 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.923 -179.979 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.591 0 CA-C-O 121.283 0.563 . . . . 0.0 110.382 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -144.55 -30.23 0.46 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.291 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.9 m -147.07 165.75 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.817 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 m -151.29 130.5 12.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.725 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.4 m -95.19 97.6 6.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.115 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -84.93 -163.02 0.76 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.297 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -102.67 9.79 39.03 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -117.77 -21.47 8.43 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 114.682 -1.145 . . . . 0.0 110.461 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.41 -126.49 1.51 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -144.37 150.99 38.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.858 0.361 . . . . 0.0 110.693 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 35.8 t -105.51 143.05 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.208 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 82' ' ' GLN . 0.5 OUTLIER -124.49 92.23 3.61 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.976 0.417 . . . . 0.0 110.762 -179.82 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.498 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 2.3 mmm-85 -95.87 113.49 25.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.428 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.418 ' CB ' HG12 ' A' ' 38' ' ' VAL . 0.6 OUTLIER -139.69 171.8 13.71 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.593 0.711 . . . . 0.0 112.672 -178.711 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -102.57 94.88 5.88 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.289 -1.323 . . . . 0.0 108.121 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -72.32 128.63 35.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.52 -177.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -125.4 90.1 51.34 Favored Pre-proline 0 C--O 1.232 0.159 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.905 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.27 156.24 37.34 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.67 2.246 . . . . 0.0 111.975 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt 72.19 53.15 0.18 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.658 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.501 ' CB ' ' HB2' ' A' ' 41' ' ' ALA . . . -99.65 -59.83 1.64 Allowed 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 25' ' ' ALA . 0.4 OUTLIER 157.44 -31.45 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.142 179.41 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.434 ' CG ' ' O ' ' A' ' 26' ' ' SER . 18.5 mtm180 -167.05 146.75 5.38 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.344 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.449 ' HA ' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -64.08 92.36 0.08 Allowed 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.078 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.61 120.1 24.7 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.851 -178.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -84.24 76.47 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.44 ' O ' ' CG1' ' A' ' 31' ' ' VAL . 41.3 t -107.01 19.56 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 114.858 -1.064 . . . . 0.0 112.069 -177.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -143.56 27.72 2.07 Favored Glycine 0 C--N 1.333 0.366 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 15.9 mt -62.62 126.69 28.18 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.955 -0.623 . . . . 0.0 110.094 179.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -113.25 157.02 22.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.165 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -69.57 -20.1 75.29 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.516 -1.033 . . . . 0.0 110.516 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -116.17 -17.09 10.91 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.831 -0.184 . . . . 0.0 110.609 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -140.53 -174.99 4.11 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.831 0.348 . . . . 0.0 110.537 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.418 HG12 ' CB ' ' A' ' 19' ' ' LEU . 14.8 t -142.74 113.33 2.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -107.99 112.36 24.89 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.396 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.9 p -117.0 144.42 24.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.349 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.501 ' HB2' ' CB ' ' A' ' 25' ' ' ALA . . . -110.23 100.84 9.66 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.47 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.5 tt -91.91 148.14 4.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.408 ' O ' ' OG1' ' A' ' 43' ' ' THR . 0.0 OUTLIER -91.73 28.3 1.82 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.503 -179.079 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.96 163.2 19.22 Favored Pre-proline 0 C--O 1.235 0.303 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.107 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.437 ' HG2' ' CB ' ' A' ' 50' ' ' GLN . 3.4 Cg_exo -77.55 176.46 10.03 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 123.433 2.756 . . . . 0.0 111.978 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -77.05 3.6 6.5 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 123.071 2.514 . . . . 0.0 112.606 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.8 p -99.2 148.09 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.719 0.295 . . . . 0.0 110.564 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' A' ' 52' ' ' ASN . 1.3 t0 -66.94 -52.41 43.26 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.033 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . -37.05 -51.95 1.58 Allowed Glycine 0 CA--C 1.531 1.058 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.452 ' N ' ' CD ' ' A' ' 50' ' ' GLN . 2.0 mp0 -82.72 -45.53 14.31 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.39 -58.8 4.51 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.155 0.503 . . . . 0.0 110.376 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.5 ' N ' ' O ' ' A' ' 48' ' ' ASP . 11.5 t-20 -46.88 -49.92 19.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.93 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.5 p -55.73 -48.34 75.37 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.791 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -54.47 -59.79 4.22 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.296 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -44.86 -57.91 3.46 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.916 0.388 . . . . 0.0 110.532 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -54.27 -32.21 23.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.912 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 34.3 tttm -76.75 -65.97 0.87 Allowed 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.704 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -46.67 -56.18 6.54 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.072 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.7 tp -64.49 -58.74 5.57 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.751 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -46.03 -29.54 3.42 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.634 -0.586 . . . . 0.0 111.634 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.1 mttp -80.91 -63.84 1.32 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.961 0.41 . . . . 0.0 111.103 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.498 HE22 ' CG ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -58.75 -31.91 68.77 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.118 -178.668 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.483 ' CD2' ' OE1' ' A' ' 62' ' ' GLN . 0.8 OUTLIER -88.84 -19.56 25.77 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.402 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 67.15 2.06 2.63 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.734 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.419 ' CG2' ' HB3' ' A' ' 63' ' ' PHE . 2.0 t -68.2 -136.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.038 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.08 167.79 21.31 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.905 0.383 . . . . 0.0 111.295 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.5 ptmt -73.42 -25.41 60.51 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.327 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.8 t -79.91 -20.17 46.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.965 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.428 ' O ' ' O ' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -95.96 -11.69 26.19 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.261 179.782 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.424 HG11 ' CG2' ' A' ' 83' ' ' ILE . 54.8 t -100.63 99.24 8.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.231 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.5 t -112.98 116.43 52.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.239 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.449 ' C ' ' H ' ' A' ' 74' ' ' LYS . 67.2 mt -88.06 87.06 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.186 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -76.35 15.18 0.62 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.164 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.449 ' H ' ' C ' ' A' ' 72' ' ' ILE . 8.9 tttt 174.33 137.74 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 76' ' ' GLU . . . 128.28 -14.95 6.16 Favored Glycine 0 CA--C 1.518 0.264 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -178.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 75' ' ' GLY . 12.2 tt0 -30.68 -57.81 0.21 Allowed 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.855 0.385 . . . . 0.0 111.293 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.2 mt -133.43 -33.44 1.1 Allowed 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.848 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.58 145.47 45.6 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.901 -0.879 . . . . 0.0 110.901 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 15.7 mtp180 -58.38 -33.51 69.68 Favored 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -68.86 138.76 54.97 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 177.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 2.2 ttmm -145.42 151.99 39.12 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 119.961 -0.696 . . . . 0.0 110.203 -177.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.41 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 19.6 tt0 -148.24 123.59 10.28 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.424 ' CG2' HG11 ' A' ' 70' ' ' VAL . 9.7 mt -120.45 143.18 33.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.583 -178.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.439 ' HE3' ' N ' ' A' ' 85' ' ' ILE . 0.2 OUTLIER -114.16 106.62 14.58 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.2 -179.454 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.439 ' N ' ' HE3' ' A' ' 84' ' ' LYS . 2.4 mp -91.39 101.6 12.66 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.36 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 64.4 mt -81.16 143.66 11.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.031 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 47.31 77.15 0.48 Allowed Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.778 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -74.08 144.54 33.99 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 122.87 2.38 . . . . 0.0 112.003 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -107.43 -39.78 5.55 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.65 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -147.51 125.5 12.04 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 120.98 0.419 . . . . 0.0 109.977 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.4 tt -107.01 112.86 63.06 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.359 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.498 ' CG ' HE22 ' A' ' 62' ' ' GLN . 3.4 Cg_exo -70.44 153.78 65.54 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.683 2.256 . . . . 0.0 112.623 -179.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.411 ' O ' ' N ' ' A' ' 97' ' ' ALA . 2.6 Cg_endo -47.96 -30.27 13.45 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 123.273 2.648 . . . . 0.0 111.897 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 65.6 tt0 -51.71 -59.25 4.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.736 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -84.04 -24.54 7.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.157 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.24 -19.88 59.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.972 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 93' ' ' PRO . . . -66.41 -25.27 66.69 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.111 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 18.7 mt -103.67 -14.61 16.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.001 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 46.8 mt -103.6 -50.45 9.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.346 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.59 179.594 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 36' ' ' ASP . 79.1 p . . . . . 0 N--CA 1.442 -0.861 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.447 ' CB ' ' O ' ' A' ' 6' ' ' SER . . . 158.96 -22.26 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.664 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.0 p -157.31 154.86 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.072 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 m -150.71 144.57 25.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.523 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.8 m -113.61 103.71 15.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.326 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -93.26 -152.65 0.33 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.301 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -106.1 2.76 27.41 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -107.77 -22.36 12.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.38 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.436 ' HA3' ' HZ2' ' A' ' 84' ' ' LYS . . . 159.37 -122.05 1.1 Allowed Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -148.58 138.6 22.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.006 0.431 . . . . 0.0 111.255 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 71.8 t -100.91 141.43 17.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.1 tp -122.34 104.17 9.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.187 0.518 . . . . 0.0 110.787 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.502 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 1.1 mtt-85 -94.02 127.71 39.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.682 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.405 HD13 ' N ' ' A' ' 21' ' ' ILE . 2.2 pp -153.18 178.29 9.9 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.618 0.723 . . . . 0.0 112.482 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -111.0 95.7 5.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.442 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.441 HG13 ' NZ ' ' A' ' 81' ' ' LYS . 0.3 OUTLIER -72.59 127.17 34.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.439 -178.321 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -119.9 90.46 43.89 Favored Pre-proline 0 N--CA 1.462 0.172 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.033 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.443 ' O ' ' HB2' ' A' ' 24' ' ' LYS . 3.1 Cg_exo -74.91 151.5 40.07 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.66 2.24 . . . . 0.0 112.788 -179.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 23' ' ' PRO . 6.4 mtmp? 79.73 43.45 0.06 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.982 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.401 ' CB ' ' CB ' ' A' ' 41' ' ' ALA . . . -101.8 169.46 8.79 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 177.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.0 p -63.28 -19.24 64.4 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.073 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.451 ' O ' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -176.59 163.09 2.34 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.151 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.447 ' HA ' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -80.76 93.03 6.13 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.398 0.618 . . . . 0.0 109.476 178.179 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.49 135.83 48.36 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.782 -178.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -90.56 66.23 0.49 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-O 121.637 0.732 . . . . 0.0 109.455 178.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.418 ' O ' ' CG1' ' A' ' 31' ' ' VAL . 41.3 t -98.32 18.77 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.417 -178.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -143.6 32.12 1.86 Allowed Glycine 0 C--N 1.333 0.368 0 N-CA-C 110.376 -1.089 . . . . 0.0 110.376 -178.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 19.1 mt -71.26 122.38 20.13 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.838 -0.681 . . . . 0.0 110.13 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.787 ' HD1' ' H ' ' A' ' 36' ' ' ASP . 37.8 t-80 -110.01 157.03 19.72 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.287 -178.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.79 -22.55 70.23 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.787 ' H ' ' HD1' ' A' ' 34' ' ' HIS . 29.3 m-20 -121.53 0.54 9.96 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.433 ' O ' ' O ' ' A' ' 34' ' ' HIS . 5.1 mm-40 -148.45 176.38 10.35 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-O 121.07 0.462 . . . . 0.0 110.249 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 30.3 t -142.56 108.68 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -109.77 107.79 17.91 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.295 -178.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.8 p -117.74 131.31 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.592 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.451 ' O ' ' O ' ' A' ' 27' ' ' ARG . . . -100.45 107.72 19.52 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.7 tt -97.42 152.26 4.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.4 t -92.97 21.55 5.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.44 -178.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.1 160.89 54.03 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.821 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.414 ' HG2' ' CB ' ' A' ' 50' ' ' GLN . 3.9 Cg_exo -76.51 171.59 17.77 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 123.269 2.646 . . . . 0.0 112.169 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.11 8.33 2.51 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 123.25 2.633 . . . . 0.0 112.745 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.437 HG11 ' H ' ' A' ' 50' ' ' GLN . 14.4 p -101.37 142.62 15.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.404 ' O ' ' N ' ' A' ' 52' ' ' ASN . 0.2 OUTLIER -62.53 -45.7 91.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.262 -179.261 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -45.11 -54.42 7.08 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.298 -0.477 . . . . 0.0 111.919 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.437 ' H ' HG11 ' A' ' 47' ' ' VAL . 15.5 mt-30 -80.44 -38.1 30.76 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 -179.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.35 -60.26 2.58 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.863 0.363 . . . . 0.0 110.687 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.404 ' N ' ' O ' ' A' ' 48' ' ' ASP . 37.3 t-20 -50.53 -40.97 53.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.512 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.7 t -52.9 -50.87 63.05 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.787 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -54.75 -55.09 33.73 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.889 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.511 ' HG ' ' NZ ' ' A' ' 81' ' ' LYS . 3.4 mm? -49.39 -51.27 36.15 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.66 -0.416 . . . . 0.0 109.895 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -56.35 -26.82 23.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.88 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 61' ' ' LYS . 6.0 ttpm? -84.29 -64.95 1.07 Allowed 'General case' 0 C--O 1.227 -0.13 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.286 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -51.69 -54.82 24.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.121 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.09 -53.3 47.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.66 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -53.89 -42.91 70.75 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-N 116.363 -0.38 . . . . 0.0 112.153 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 3.9 ttpt -73.94 -44.22 55.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.589 0.233 . . . . 0.0 111.028 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 -65.35 -43.48 90.71 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.074 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.417 ' C ' ' H ' ' A' ' 65' ' ' VAL . 3.6 m-85 -85.91 -19.22 30.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.879 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.9 mtt-85 60.44 5.27 0.83 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.927 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.417 ' H ' ' C ' ' A' ' 63' ' ' PHE . 34.5 m -76.12 155.17 5.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.53 159.14 0.78 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.524 -178.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.8 pttp -69.94 -27.16 64.52 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.892 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.7 t -81.25 -12.33 59.14 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.257 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.441 ' OE1' ' N ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -89.97 -12.99 37.08 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.598 -179.78 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.1 p -105.6 100.1 9.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-O 121.161 0.505 . . . . 0.0 110.325 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.2 t -117.24 122.08 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.907 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.471 ' C ' ' H ' ' A' ' 74' ' ' LYS . 46.7 mt -89.96 90.76 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.635 178.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -66.46 3.98 0.85 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.95 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.471 ' H ' ' C ' ' A' ' 72' ' ' ILE . 10.4 mttt 169.53 140.62 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 76' ' ' GLU . . . 130.88 -16.99 5.25 Favored Glycine 0 C--N 1.321 -0.294 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -178.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 75' ' ' GLY . 50.3 mt-10 -35.11 -46.32 0.33 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.373 -0.414 . . . . 0.0 111.034 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.4 tt -130.02 -42.97 1.22 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.872 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -60.88 159.01 28.3 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.842 -0.503 . . . . 0.0 111.842 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.4 mtm-85 -72.99 -32.8 65.41 Favored 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -69.42 144.48 53.33 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 177.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.511 ' NZ ' ' HG ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -152.38 150.64 29.91 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 118.96 -1.096 . . . . 0.0 111.507 -177.714 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -147.79 113.42 5.68 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 8.4 mt -109.63 132.27 58.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.348 -178.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.436 ' HZ2' ' HA3' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -102.93 117.43 34.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.271 -179.315 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.401 HG21 ' CD2' ' A' ' 63' ' ' PHE . 1.8 mp -105.59 98.94 7.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.209 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.43 HG21 HD13 ' A' ' 86' ' ' ILE . 20.6 mt -81.51 151.52 4.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.478 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 9.4 m-20 42.11 80.48 0.28 Allowed Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.861 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -73.31 133.58 19.53 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.771 2.314 . . . . 0.0 112.455 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -118.26 -26.38 6.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.533 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -145.86 117.49 8.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.939 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.3 tt -112.11 113.98 51.49 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.509 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -65.9 143.49 73.26 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.253 1.968 . . . . 0.0 111.757 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.403 ' O ' ' N ' ' A' ' 97' ' ' ALA . 2.7 Cg_endo -49.01 -24.56 7.61 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.956 2.437 . . . . 0.0 111.684 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -59.47 -58.77 7.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.401 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.0 t -75.98 -24.85 16.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.513 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.557 ' O ' ' N ' ' A' ' 100' ' ' ASN . . . -75.28 -28.56 59.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.784 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 93' ' ' PRO . . . -54.95 -31.23 60.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.62 0.248 . . . . 0.0 111.198 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.26 -4.72 48.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.078 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 51.2 mm -116.95 -18.48 6.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.729 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.557 ' N ' ' O ' ' A' ' 96' ' ' ALA . 1.1 m-80 . . . . . 0 C--N 1.332 -0.195 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.005 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 mtt . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -125.61 -106.78 0.33 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.44 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -135.66 87.81 0.24 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 17.4 m -149.05 -46.62 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-O 120.702 0.287 . . . . 0.0 110.325 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 1.8 ttm 56.09 91.57 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.17 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.504 ' O ' ' CB ' ' A' ' 7' ' ' ALA . 62.0 p -126.19 -169.68 2.06 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.504 ' CB ' ' O ' ' A' ' 6' ' ' SER . . . 151.19 -25.85 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.449 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -159.51 151.44 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.595 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 m -139.05 136.2 35.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.326 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.418 ' O ' ' CG2' ' A' ' 10' ' ' VAL . 30.8 m -101.35 99.8 9.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.262 0.553 . . . . 0.0 110.181 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -80.28 -151.97 0.08 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.533 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -107.77 6.79 27.89 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -117.77 -25.35 6.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.488 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 170.25 -126.91 1.4 Allowed Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -147.89 150.77 34.73 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.97 0.414 . . . . 0.0 111.208 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.7 t -106.88 139.63 27.76 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.117 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.74 102.65 9.6 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.548 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 9.1 mtm180 -107.91 111.04 22.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.02 -179.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.1 pp -142.02 -179.64 6.34 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.904 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -111.06 105.22 13.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.756 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.0 mm -71.96 135.25 28.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.573 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -124.12 87.72 53.23 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.672 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.2 161.67 42.47 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.622 2.214 . . . . 0.0 112.555 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.26 46.9 2.53 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.661 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.411 ' O ' ' CB ' ' A' ' 26' ' ' SER . . . -92.22 -70.95 0.67 Allowed 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.411 ' CB ' ' O ' ' A' ' 25' ' ' ALA . 0.9 OUTLIER 160.01 -22.09 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.06 179.3 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -171.36 140.73 1.47 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.049 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.9 86.89 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 121.429 0.633 . . . . 0.0 109.918 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.49 133.53 46.36 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.481 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -89.16 86.91 2.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.237 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -113.71 19.33 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.853 -178.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -143.74 37.39 1.45 Allowed Glycine 0 C--N 1.333 0.406 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 21.3 mt -73.27 120.11 18.43 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.798 -0.701 . . . . 0.0 109.913 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.426 ' HD1' ' HG2' ' A' ' 37' ' ' GLU . 26.8 t-80 -102.05 157.97 16.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.023 0.44 . . . . 0.0 111.383 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.97 -18.76 73.01 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.48 -18.35 8.5 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.426 ' HG2' ' HD1' ' A' ' 34' ' ' HIS . 11.2 mm-40 -134.32 -176.43 4.2 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.988 0.423 . . . . 0.0 110.66 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 55.6 t -143.66 121.98 6.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.5 ttpp -121.86 113.7 20.01 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.879 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.1 p -114.88 142.88 26.05 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.921 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -107.84 107.67 18.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.322 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.415 HG13 ' N ' ' A' ' 43' ' ' THR . 1.4 tp -93.15 148.12 4.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.415 ' N ' HG13 ' A' ' 42' ' ' ILE . 14.1 t -95.28 38.79 1.13 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.05 0.452 . . . . 0.0 110.831 -178.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.99 144.59 28.86 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.013 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.498 ' HG2' ' CB ' ' A' ' 50' ' ' GLN . 3.7 Cg_exo -51.98 175.36 0.07 OUTLIER 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 123.059 2.506 . . . . 0.0 112.441 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.92 3.67 5.88 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 123.134 2.556 . . . . 0.0 113.342 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.5 p -102.68 143.99 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.597 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.466 ' O ' ' C ' ' A' ' 49' ' ' GLY . 3.7 m-20 -62.06 -60.92 2.91 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.018 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.466 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . -30.72 -43.98 0.08 OUTLIER Glycine 0 CA--C 1.53 1.026 0 N-CA-C 111.744 -0.543 . . . . 0.0 111.744 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.498 ' CB ' ' HG2' ' A' ' 45' ' ' PRO . 0.8 OUTLIER -82.6 -42.07 18.73 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.478 0.18 . . . . 0.0 111.28 -179.612 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 48' ' ' ASP . . . -68.17 -54.16 19.89 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.948 0.404 . . . . 0.0 109.966 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 48' ' ' ASP . 19.3 t-20 -48.72 -44.72 38.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.147 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 58.2 m -54.56 -44.7 73.14 Favored 'General case' 0 N--CA 1.461 0.075 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.46 -42.58 82.79 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.059 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.0 tp -54.45 -60.69 3.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.625 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -58.04 -23.41 21.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.2 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.401 ' O ' ' C ' ' A' ' 58' ' ' PHE . 32.8 tttp -79.32 -65.49 0.99 Allowed 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.528 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.401 ' C ' ' O ' ' A' ' 57' ' ' LYS . 3.8 t80 -36.33 -55.37 0.81 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.89 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -68.42 -66.16 0.61 Allowed 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.157 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -40.07 -36.28 0.83 Allowed Glycine 0 CA--C 1.529 0.963 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.066 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -82.02 -60.76 2.11 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.762 0.315 . . . . 0.0 111.112 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -58.61 -40.71 84.04 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.533 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -86.27 -18.26 32.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.266 -0.425 . . . . 0.0 109.916 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.9 mtm180 60.41 4.16 0.66 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.759 178.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.439 HG11 ' N ' ' A' ' 66' ' ' ALA . 6.1 t -65.42 -125.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 120.905 0.383 . . . . 0.0 110.154 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.439 ' N ' HG11 ' A' ' 65' ' ' VAL . . . -145.65 164.15 32.65 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.23 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.9 ptmt -75.28 -27.75 59.5 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.496 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.1 t -78.38 -14.74 59.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.637 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.402 ' O ' ' O ' ' A' ' 84' ' ' LYS . 0.9 OUTLIER -97.73 -15.02 20.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.752 179.718 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.9 t -95.43 99.6 9.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.906 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -107.48 121.55 60.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.503 -179.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 63.0 mt -84.94 95.41 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.168 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -72.86 -4.06 29.47 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.92 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 10.6 mttp 165.9 142.31 0.02 OUTLIER 'General case' 0 C--N 1.339 0.151 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.6 -15.36 6.7 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -35.03 -39.08 0.09 Allowed 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.4 mt -132.13 10.4 4.55 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -123.55 154.03 17.34 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -55.91 -27.7 53.32 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.949 0.404 . . . . 0.0 110.044 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -69.0 160.7 30.45 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.548 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 7.7 tttt -150.87 137.86 19.14 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -140.62 75.93 1.53 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 52.6 mt -82.56 151.03 4.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.908 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.436 ' HE3' ' N ' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -123.45 122.57 38.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.751 179.808 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.436 ' N ' ' HE3' ' A' ' 84' ' ' LYS . 1.9 mp -99.79 104.82 16.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.823 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.426 HG23 HD12 ' A' ' 86' ' ' ILE . 43.4 mt -87.64 149.8 3.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.437 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 0.4 OUTLIER 43.64 54.11 10.71 Favored Pre-proline 0 CA--C 1.532 0.262 0 CA-C-O 120.816 0.341 . . . . 0.0 110.11 -179.799 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.437 ' CD ' ' N ' ' A' ' 87' ' ' ASN . 2.7 Cg_endo -45.16 146.13 2.96 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.979 2.452 . . . . 0.0 112.202 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -121.26 -38.33 2.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.503 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -143.96 117.73 9.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.062 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.9 tt -111.25 116.74 50.79 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.237 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -65.29 151.05 86.54 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 122.351 2.034 . . . . 0.0 111.734 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -51.47 -35.16 54.35 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.786 2.324 . . . . 0.0 111.991 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -45.23 -58.29 3.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.378 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.7 t -77.39 -19.89 14.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.245 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.63 -30.8 61.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.907 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.18 -22.91 31.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.635 0.255 . . . . 0.0 111.213 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -99.85 -16.19 18.13 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.163 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 87.7 mt -104.55 -35.66 3.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.062 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -82.97 -9.96 59.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.324 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.8 tp 47.77 82.76 0.04 OUTLIER 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.019 0.438 . . . . 0.0 110.499 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -65.59 -1.28 2.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.739 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -91.91 155.29 18.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.626 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 5.8 p-80 -143.43 153.08 42.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.196 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.44 ' CD2' ' N ' ' A' ' 105' ' ' HIS . 3.0 p80 -150.08 56.97 0.96 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.523 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 7.3 t-160 43.61 35.83 1.09 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.069 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 24.0 t60 -82.62 149.75 27.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.478 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 29.8 p-80 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.611 179.958 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.5 mtt . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -52.73 112.82 0.9 Allowed 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.686 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -94.12 -108.5 2.05 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.56 ' C ' ' H ' ' A' ' 6' ' ' SER . 0.9 OUTLIER -108.93 -23.09 4.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.57 0.224 . . . . 0.0 110.407 179.742 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 1.1 ttt -68.09 30.52 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.139 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.56 ' H ' ' C ' ' A' ' 4' ' ' VAL . 15.1 m -104.0 -168.53 1.51 Allowed 'General case' 0 N--CA 1.435 -1.175 0 CA-C-O 121.107 0.479 . . . . 0.0 110.078 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.481 ' CB ' ' O ' ' A' ' 6' ' ' SER . . . 153.99 -19.61 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.034 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.0 p -154.67 154.27 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.276 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.2 m -144.89 117.82 8.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.363 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.8 m -88.27 97.75 7.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.792 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.84 -155.32 0.06 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.434 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -107.62 10.45 29.09 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -123.24 -24.67 4.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.312 -178.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.447 ' HA3' ' HZ2' ' A' ' 84' ' ' LYS . . . 172.06 -125.15 1.15 Allowed Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.466 ' N ' ' HZ2' ' A' ' 84' ' ' LYS . 0.8 OUTLIER -152.36 148.45 27.51 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 120.862 0.363 . . . . 0.0 111.344 -179.631 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.4 t -107.29 142.72 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.751 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.504 ' HB3' ' HZ1' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -115.37 104.6 11.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.001 0.429 . . . . 0.0 110.322 179.866 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.543 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 2.3 mtm180 -105.96 119.28 38.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.194 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.494 ' CD2' ' NZ ' ' A' ' 81' ' ' LYS . 3.9 pp -149.59 179.65 7.82 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.281 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -105.71 99.36 8.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.515 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.2 mm -69.31 124.9 26.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.599 ' NE2' ' O ' ' A' ' 23' ' ' PRO . 0.3 OUTLIER -121.23 86.64 43.37 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.945 -179.493 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.599 ' O ' ' NE2' ' A' ' 22' ' ' GLN . 3.4 Cg_exo -74.11 161.1 41.59 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.706 2.271 . . . . 0.0 111.735 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.502 ' CB ' ' O ' ' A' ' 23' ' ' PRO . 2.5 mmpt? 88.33 30.05 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.275 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -99.16 172.64 7.24 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.2 m -75.64 -12.77 60.27 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.069 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -176.68 163.4 2.33 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.154 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.484 ' HA ' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -79.43 90.98 5.06 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.269 0.556 . . . . 0.0 109.532 177.866 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.2 m -132.15 134.28 45.23 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.526 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -86.69 73.34 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.92 18.68 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 114.863 -1.062 . . . . 0.0 112.35 -178.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -143.41 38.29 1.4 Allowed Glycine 0 N--CA 1.459 0.209 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 12.1 mt -74.06 128.94 36.84 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.533 -0.833 . . . . 0.0 110.192 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 56.7 t60 -111.75 156.33 22.1 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.174 0.512 . . . . 0.0 111.355 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.24 -25.75 66.93 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.4 ' HB3' ' O ' ' A' ' 4' ' ' VAL . 10.2 m-20 -119.18 -13.04 9.37 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 121.226 -0.19 . . . . 0.0 110.737 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -134.81 -178.27 5.0 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.868 0.366 . . . . 0.0 110.503 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 43.0 t -143.6 117.73 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -116.37 110.36 18.59 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.702 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.9 p -110.8 136.16 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.821 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 28' ' ' ASP . . . -100.83 111.12 23.27 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.4 tt -101.68 151.02 5.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.8 t -91.06 19.85 5.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.676 -177.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.33 168.87 9.45 Favored Pre-proline 0 C--N 1.328 -0.351 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.488 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -78.87 166.87 22.92 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 123.402 2.735 . . . . 0.0 111.94 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -74.77 8.52 2.29 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 123.027 2.485 . . . . 0.0 112.551 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.8 p -95.89 150.4 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.43 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.449 ' O ' ' N ' ' A' ' 52' ' ' ASN . 0.7 OUTLIER -64.21 -61.78 2.03 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.114 -179.33 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . -33.28 -56.52 0.56 Allowed Glycine 0 CA--C 1.529 0.956 0 N-CA-C 111.971 -0.451 . . . . 0.0 111.971 -179.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.434 ' N ' ' CD ' ' A' ' 50' ' ' GLN . 3.0 mp0 -78.09 -49.89 13.07 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.64 -60.38 3.94 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.882 0.372 . . . . 0.0 110.546 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.449 ' N ' ' O ' ' A' ' 48' ' ' ASP . 39.3 t-20 -42.32 -54.27 3.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.836 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.8 m -41.57 -51.67 3.9 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.75 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.99 -48.59 75.82 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.166 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.3 mp -47.53 -45.86 27.13 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.672 0.272 . . . . 0.0 110.928 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -66.45 -26.77 38.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.223 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 15.1 ttmm -82.18 -48.08 11.73 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.515 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -53.02 -49.32 66.49 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.737 -0.21 . . . . 0.0 111.424 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.469 ' CD2' ' N ' ' A' ' 59' ' ' LEU . 3.8 mm? -79.56 -41.56 26.95 Favored 'General case' 0 C--O 1.225 -0.237 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.62 -38.5 71.9 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.464 ' CG ' ' N ' ' A' ' 62' ' ' GLN . 5.9 ptmm? -81.91 -42.77 19.05 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.464 ' N ' ' CG ' ' A' ' 61' ' ' LYS . 33.0 mm-40 -71.22 -45.91 62.27 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.727 0.299 . . . . 0.0 111.024 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -84.26 -18.15 37.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.164 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.0 mtp180 60.67 15.94 6.21 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.02 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.7 m -89.6 149.76 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -49.34 157.64 0.47 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.355 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -73.43 -28.5 62.01 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.591 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.5 t -71.86 -11.8 60.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.901 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -97.93 -10.51 24.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.198 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.8 t -95.81 98.68 8.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.4 t -111.16 122.8 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.25 -178.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.3 mt -84.48 88.89 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.898 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.418 ' O ' ' CB ' ' A' ' 74' ' ' LYS . 33.3 mt-10 -66.66 0.44 2.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.309 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.418 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 8.2 mttm 160.44 127.67 0.0 OUTLIER 'General case' 0 C--N 1.34 0.159 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.456 ' O ' ' C ' ' A' ' 76' ' ' GLU . . . 140.35 -8.88 2.93 Favored Glycine 0 CA--C 1.517 0.176 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.456 ' C ' ' O ' ' A' ' 75' ' ' GLY . 6.3 mm-40 -29.95 -47.65 0.08 Allowed 'General case' 0 N--CA 1.466 0.335 0 O-C-N 123.757 0.328 . . . . 0.0 111.054 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.0 tt -126.83 -42.39 1.76 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.187 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -55.52 153.57 13.64 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 116.289 -0.414 . . . . 0.0 112.255 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.594 ' HE ' ' N ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -62.78 -34.06 76.47 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.003 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.423 ' O ' ' HA2' ' A' ' 75' ' ' GLY . 25.3 t60 -68.49 143.99 54.79 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.543 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 9.8 tttm -139.59 145.72 38.92 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.211 -178.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.412 ' HG2' ' NE2' ' A' ' 80' ' ' HIS . 2.4 mt-30 -146.94 79.05 1.51 Allowed 'General case' 0 C--O 1.233 0.2 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.465 ' CD1' ' HE2' ' A' ' 81' ' ' LYS . 40.2 mt -82.38 143.39 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.045 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.466 ' HZ2' ' N ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -109.67 121.06 44.37 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.671 -179.569 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.5 mp -105.33 94.39 3.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.274 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 55.5 mt -82.27 144.38 10.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 55.36 79.25 0.35 Allowed Pre-proline 0 C--N 1.33 -0.248 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.203 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -74.56 128.94 12.27 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.77 2.313 . . . . 0.0 112.36 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -112.32 -29.7 7.44 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.236 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -143.64 114.28 7.6 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.189 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.5 tt -109.2 110.17 60.48 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.456 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -65.81 174.6 5.41 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 122.353 2.035 . . . . 0.0 112.03 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.447 ' O ' ' N ' ' A' ' 97' ' ' ALA . 3.2 Cg_exo -71.83 -19.81 26.81 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.661 2.241 . . . . 0.0 112.201 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -49.48 -59.3 3.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.96 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 54.8 t -78.99 -25.54 13.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.288 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.2 -28.81 61.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.138 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 93' ' ' PRO . . . -65.43 -21.34 66.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.185 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.8 pp -116.68 -8.18 11.46 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.13 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.4 mm -103.88 -47.97 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -83.82 -11.12 57.48 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.425 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.1 tp 53.66 73.29 0.38 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.826 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -92.67 -8.72 43.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.535 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -76.07 93.7 3.34 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.882 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.406 ' C ' ' H ' ' A' ' 106' ' ' HIS . 5.4 t60 -167.61 -64.22 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.356 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -80.65 22.85 0.56 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.672 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.406 ' H ' ' C ' ' A' ' 104' ' ' HIS . 31.8 m170 51.51 -143.65 0.64 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.622 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -114.51 165.38 12.81 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.477 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 9.5 p-80 . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.455 179.874 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 mmt . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -157.77 110.65 2.43 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.553 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 155.93 37.72 0.02 OUTLIER Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.6 t 53.17 75.23 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-O 121.034 0.445 . . . . 0.0 110.411 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 3.4 ttt -84.58 66.78 9.7 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.182 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.496 ' O ' ' CB ' ' A' ' 7' ' ' ALA . 5.9 m -113.75 -168.59 1.37 Allowed 'General case' 0 N--CA 1.436 -1.167 0 CA-C-O 121.141 0.496 . . . . 0.0 110.449 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.496 ' CB ' ' O ' ' A' ' 6' ' ' SER . . . 150.89 -18.96 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.109 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.401 ' CG2' ' N ' ' A' ' 9' ' ' THR . 1.7 p -155.65 154.69 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.801 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.401 ' N ' ' CG2' ' A' ' 8' ' ' VAL . 0.9 OUTLIER -137.9 143.32 40.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.093 -179.913 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.2 m -113.6 105.02 17.93 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.48 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -92.22 -154.94 0.4 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.36 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -107.6 5.4 26.92 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -113.52 -22.05 10.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.614 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.458 ' CA ' ' HZ3' ' A' ' 84' ' ' LYS . . . 164.62 -124.05 1.22 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.19 153.86 35.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.983 0.42 . . . . 0.0 111.398 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.1 t -110.84 131.86 60.88 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.962 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.2 tp -109.47 102.73 11.58 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.976 0.417 . . . . 0.0 110.44 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 49.2 mtt180 -104.08 119.33 38.7 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.534 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.5 pp -148.01 179.62 7.61 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.203 0.525 . . . . 0.0 111.553 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -112.13 106.22 14.78 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.517 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.8 mm -76.58 135.14 27.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.026 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -122.18 91.2 49.09 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.493 -0.776 . . . . 0.0 108.917 178.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -72.2 154.02 56.78 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.685 2.257 . . . . 0.0 112.822 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.2 mtmp? 76.63 42.64 0.15 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.59 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -100.24 167.85 10.17 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 178.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 98.1 p -62.05 -19.43 62.89 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.199 -0.6 . . . . 0.0 109.962 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -176.29 170.63 2.57 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.53 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.482 ' HA ' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -83.27 90.3 7.11 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.667 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.3 m -131.06 143.63 50.83 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.775 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.03 74.33 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.289 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -103.64 19.05 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.608 -177.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.41 ' HA3' ' HB3' ' A' ' 39' ' ' LYS . . . -144.41 35.87 1.51 Allowed Glycine 0 C--N 1.332 0.35 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 15.2 mt -71.19 122.09 19.54 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.596 -0.802 . . . . 0.0 109.929 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -110.25 162.52 14.53 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.495 -178.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -72.89 -28.21 67.33 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -110.68 -9.74 14.51 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -144.6 -178.82 6.19 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-O 120.861 0.363 . . . . 0.0 110.796 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 55.3 t -143.39 113.74 2.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.41 ' HB3' ' HA3' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -112.35 118.48 35.34 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.876 -179.688 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.8 p -123.02 133.19 69.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.006 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.482 ' O ' ' HA ' ' A' ' 28' ' ' ASP . . . -98.27 126.6 43.82 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.8 tt -116.4 145.75 21.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.8 t -87.21 23.01 1.93 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.835 -178.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.9 143.86 27.41 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.834 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.477 ' HG2' ' CB ' ' A' ' 50' ' ' GLN . 3.4 Cg_exo -55.78 166.34 2.95 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.566 2.177 . . . . 0.0 111.934 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -76.52 11.56 1.85 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.985 2.457 . . . . 0.0 112.255 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.427 HG13 ' H ' ' A' ' 50' ' ' GLN . 9.5 p -94.72 150.16 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.236 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -63.83 -53.35 52.1 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.881 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -39.91 -47.95 3.31 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 121.234 -0.508 . . . . 0.0 111.904 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.477 ' CB ' ' HG2' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -85.02 -50.17 7.68 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -178.894 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.57 -49.92 75.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.983 0.42 . . . . 0.0 110.433 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -57.69 -52.32 65.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.054 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.5 p -52.28 -47.47 65.86 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.88 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -61.31 -47.03 87.81 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-O 120.726 0.298 . . . . 0.0 110.281 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.43 -61.41 2.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.545 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -55.36 -21.63 9.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.649 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -85.11 -60.66 1.97 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.034 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -53.9 -38.69 65.08 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.151 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.69 -39.33 20.31 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.675 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.08 -37.42 93.89 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.2 ptmm? -80.74 -31.3 36.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.546 0.213 . . . . 0.0 111.297 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.59 -46.51 21.95 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.007 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -85.88 -18.4 32.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.488 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 32.7 mtp180 59.22 5.03 0.52 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.926 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.463 HG12 ' N ' ' A' ' 66' ' ' ALA . 21.8 t -65.32 -118.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 121.027 0.441 . . . . 0.0 110.088 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.463 ' N ' HG12 ' A' ' 65' ' ' VAL . . . -148.55 155.62 41.37 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.034 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.06 -29.48 63.0 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -75.77 -13.92 60.31 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.883 179.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -103.18 -15.6 15.97 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.97 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.7 t -88.42 99.91 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.2 t -105.49 117.0 50.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.25 -178.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.431 ' C ' ' H ' ' A' ' 74' ' ' LYS . 51.8 mt -87.86 85.48 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.376 178.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -67.54 5.22 0.84 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.708 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.431 ' H ' ' C ' ' A' ' 72' ' ' ILE . 7.2 mttp 162.43 142.1 0.01 OUTLIER 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.435 ' HA2' ' O ' ' A' ' 80' ' ' HIS . . . 127.95 -12.79 6.46 Favored Glycine 0 C--N 1.323 -0.186 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 75' ' ' GLY . 5.8 mt-10 -33.83 -47.1 0.24 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.417 -0.392 . . . . 0.0 111.151 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.5 tp -125.45 -43.84 1.88 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.44 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -59.64 151.88 35.94 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.9 mtt85 -63.05 -29.31 70.72 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.435 ' O ' ' HA2' ' A' ' 75' ' ' GLY . 0.5 OUTLIER -68.05 157.82 34.34 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.056 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 6.4 tttt -156.09 147.27 22.39 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.662 -178.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.21 111.61 5.22 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.405 ' CD1' HG12 ' A' ' 72' ' ' ILE . 6.1 mm -109.68 140.14 29.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.609 -178.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.458 ' HZ3' ' CA ' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -109.87 111.59 23.1 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.048 179.801 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.8 mp -96.51 99.89 9.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.351 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 36.9 mt -85.23 148.66 4.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.578 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 46.1 58.31 16.08 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.651 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -46.05 129.27 12.41 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.882 2.388 . . . . 0.0 112.06 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 41.1 tp60 -109.69 -30.01 8.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.699 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -147.65 121.61 9.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.609 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 tt -112.33 113.37 51.34 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.067 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -68.59 157.77 60.46 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.419 2.079 . . . . 0.0 112.202 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -51.82 -27.73 28.24 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 123.035 2.49 . . . . 0.0 111.893 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -53.82 -59.4 4.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.834 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 16.9 t -76.57 -20.9 14.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.871 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.6 -31.7 60.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.7 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -65.74 -19.71 66.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.249 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 77.0 mt -102.09 -21.07 14.51 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.048 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 66.1 mt -98.73 -31.89 3.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.991 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -72.18 -12.26 61.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.459 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.9 tp 71.9 -61.21 0.5 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.366 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 50.57 -94.97 0.03 OUTLIER 'General case' 0 C--O 1.232 0.165 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 21.5 t60 52.7 17.71 0.88 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.636 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.4 ' CG ' ' N ' ' A' ' 105' ' ' HIS . 8.2 t60 -75.67 167.65 21.49 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.549 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.4 ' N ' ' CG ' ' A' ' 104' ' ' HIS . 59.1 m80 -63.64 178.94 0.53 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.669 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.546 ' CG ' ' H ' ' A' ' 107' ' ' HIS . 26.7 t60 -95.59 -136.33 0.22 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.674 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.546 ' H ' ' CG ' ' A' ' 106' ' ' HIS . 85.6 t60 -156.42 70.83 0.68 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.013 0.435 . . . . 0.0 110.05 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 79.9 t60 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.419 -179.908 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.9 mmt . . . . . 0 N--CA 1.492 1.666 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 61.42 20.96 11.61 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.678 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -67.11 -106.31 0.02 OUTLIER Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.4 t -126.25 -31.86 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.87 0.367 . . . . 0.0 110.349 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.76 99.76 11.12 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.613 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.428 ' O ' ' CB ' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -126.03 131.48 52.17 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 121.32 0.581 . . . . 0.0 109.76 178.5 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 6' ' ' SER . . . 159.68 -17.59 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.584 -1.189 . . . . 0.0 109.206 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.0 p -160.28 160.01 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.575 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 m -150.95 125.6 9.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.427 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 m -91.65 101.28 12.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.062 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -79.58 -158.04 0.15 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.11 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -107.05 11.26 29.86 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -124.07 -18.92 5.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.337 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.43 -123.71 1.17 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.427 ' N ' ' HZ3' ' A' ' 84' ' ' LYS . 0.3 OUTLIER -149.24 138.34 21.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.0 0.429 . . . . 0.0 111.391 -179.747 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.6 t -99.39 106.35 18.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.198 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.0 tp -87.39 114.0 23.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.024 0.44 . . . . 0.0 111.142 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.551 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 14.8 mtt-85 -111.17 126.29 54.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.658 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.446 ' HB2' HG12 ' A' ' 38' ' ' VAL . 0.8 OUTLIER -149.45 175.16 11.72 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 121.956 0.884 . . . . 0.0 112.86 -179.038 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -106.23 91.81 3.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 113.867 -1.515 . . . . 0.0 108.565 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.405 HG13 ' NZ ' ' A' ' 81' ' ' LYS . 1.0 OUTLIER -73.53 131.14 35.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.222 -178.104 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.14 88.8 53.62 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.903 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.14 161.0 39.05 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.767 2.311 . . . . 0.0 112.793 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 20.3 mtmt 73.59 48.61 0.15 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.207 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.48 ' O ' ' CB ' ' A' ' 26' ' ' SER . . . -99.55 -62.88 1.18 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 25' ' ' ALA . 4.3 t 153.08 -28.52 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.991 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.443 ' CG ' ' O ' ' A' ' 26' ' ' SER . 79.1 mtt180 -163.4 142.1 8.11 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.81 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.47 94.22 0.08 Allowed 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.448 0.642 . . . . 0.0 109.973 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.4 p -123.02 126.88 47.95 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.874 -179.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -92.07 63.01 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -96.56 17.89 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 114.583 -1.19 . . . . 0.0 112.338 -177.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . -141.59 22.6 2.52 Favored Glycine 0 C--N 1.32 -0.351 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -178.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.409 ' CD2' HG11 ' A' ' 38' ' ' VAL . 19.3 mt -59.45 120.66 9.78 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.07 -0.565 . . . . 0.0 109.824 178.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.428 ' HD1' ' H ' ' A' ' 35' ' ' GLY . 2.3 t60 -111.6 155.06 23.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.492 -178.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.428 ' H ' ' HD1' ' A' ' 34' ' ' HIS . . . -66.93 -19.7 69.97 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.649 -0.981 . . . . 0.0 110.649 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -121.15 -5.07 9.48 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.555 0.217 . . . . 0.0 110.614 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.405 ' O ' ' O ' ' A' ' 34' ' ' HIS . 57.2 mt-10 -148.54 -178.46 6.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.991 0.424 . . . . 0.0 110.651 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.446 HG12 ' HB2' ' A' ' 19' ' ' LEU . 6.8 t -141.72 110.96 2.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 13.0 mtpt -110.36 103.15 11.76 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.146 -0.621 . . . . 0.0 110.785 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.7 p -114.27 136.43 50.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.701 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.455 ' HB1' ' CB ' ' A' ' 25' ' ' ALA . . . -99.98 93.95 6.03 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.979 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.7 tt -80.04 148.59 5.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.3 t -93.81 29.41 2.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.001 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.37 161.09 26.46 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.855 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -77.21 177.61 8.65 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 123.478 2.785 . . . . 0.0 112.093 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -77.31 5.5 5.05 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 123.168 2.578 . . . . 0.0 112.644 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.418 HG13 ' H ' ' A' ' 50' ' ' GLN . 11.7 p -98.96 155.86 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 120.791 0.329 . . . . 0.0 110.738 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 49' ' ' GLY . 0.1 OUTLIER -69.41 -61.37 1.82 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.055 -179.709 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . -34.87 -51.93 0.83 Allowed Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.884 -0.486 . . . . 0.0 111.884 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.418 ' H ' HG13 ' A' ' 47' ' ' VAL . 2.4 mm100 -76.39 -50.56 13.87 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.74 -61.72 2.22 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.766 0.317 . . . . 0.0 110.915 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -47.07 -39.85 13.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.731 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.5 m -61.25 -51.39 69.14 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.586 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.425 ' O ' ' N ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -55.85 -57.98 9.79 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.572 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -44.16 -57.93 3.15 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.044 0.45 . . . . 0.0 110.262 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.3 t -54.36 -26.07 15.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.127 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 54' ' ' HIS . 8.4 ttpt -85.17 -63.46 1.32 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.918 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -50.74 -41.8 56.78 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.203 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.1 tp -84.67 -40.43 17.41 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.504 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -58.99 -33.64 75.08 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.0 ptmt -80.59 -37.27 31.57 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 120.59 0.233 . . . . 0.0 111.035 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -74.94 -42.39 57.79 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.431 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.414 ' CD1' HG21 ' A' ' 85' ' ' ILE . 0.7 OUTLIER -86.09 -18.83 31.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.535 179.767 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.4 mtp180 60.47 8.1 1.55 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.777 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.8 m -67.53 177.03 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -89.63 164.81 14.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.948 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -21.2 62.6 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -86.55 -12.65 48.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.464 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -101.62 -1.17 33.4 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.492 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 p -110.94 100.69 11.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.014 0.435 . . . . 0.0 110.014 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 79.7 t -114.22 116.92 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.756 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.45 ' C ' ' H ' ' A' ' 74' ' ' LYS . 76.3 mt -89.94 88.48 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.23 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -72.81 10.3 0.91 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.671 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.45 ' H ' ' C ' ' A' ' 72' ' ' ILE . 7.6 mttp 167.93 145.59 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 123.59 -17.01 7.87 Favored Glycine 0 CA--C 1.518 0.269 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -39.18 -44.33 1.19 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.655 -0.273 . . . . 0.0 111.066 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.18 -43.43 0.79 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.192 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.96 151.47 52.47 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -60.82 -32.67 72.03 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.9 p-80 -68.89 129.97 41.45 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 177.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.6 OUTLIER -137.86 141.5 40.72 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 120.196 -0.601 . . . . 0.0 110.49 -177.312 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -139.48 114.62 9.63 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.7 mt -117.01 135.87 55.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.396 -178.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.427 ' HZ3' ' N ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -104.67 106.67 17.26 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.876 -179.819 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.428 ' N ' ' CD1' ' A' ' 85' ' ' ILE . 1.5 mp -94.68 92.06 3.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.067 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 55.5 mt -77.47 155.39 5.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.733 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 38.39 73.32 0.78 Allowed Pre-proline 0 N--CA 1.464 0.243 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.005 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -74.32 132.92 16.98 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.673 2.249 . . . . 0.0 111.847 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -110.63 -24.16 10.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.089 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -147.52 120.19 8.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.255 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.9 tt -113.96 119.55 40.66 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.951 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -66.26 147.72 83.75 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 122.224 1.949 . . . . 0.0 112.522 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -51.03 -30.22 30.43 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 123.048 2.498 . . . . 0.0 112.24 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -54.23 -57.77 9.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.699 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.5 t -75.11 -21.66 16.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.732 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.42 ' O ' ' N ' ' A' ' 100' ' ' ASN . . . -75.59 -34.53 60.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.024 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.71 -20.1 32.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.738 0.304 . . . . 0.0 111.075 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 27.2 mt -103.04 -25.1 13.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.077 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 86.1 mt -96.65 -27.69 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.872 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.42 ' N ' ' O ' ' A' ' 96' ' ' ALA . 3.3 t-20 -84.9 -11.04 56.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.679 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.7 tp -68.11 -80.77 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.031 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 48.97 23.36 0.7 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.017 0.437 . . . . 0.0 110.47 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -143.01 117.4 9.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.795 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -50.7 147.48 4.73 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.11 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -157.48 -159.18 0.81 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.275 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 5.0 m80 -143.61 129.04 19.0 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.408 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.43 ' CG ' ' N ' ' A' ' 108' ' ' HIS . 49.9 p-80 -139.31 -41.86 0.46 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.574 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.43 ' N ' ' CG ' ' A' ' 107' ' ' HIS . 3.4 t60 . . . . . 0 C--N 1.331 -0.197 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.426 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.5 mtm . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -163.41 -60.51 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.573 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 177.93 73.52 0.06 OUTLIER Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.7 p -97.24 7.09 8.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-O 120.826 0.346 . . . . 0.0 110.703 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 13.1 ttm -157.03 51.6 0.48 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.65 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.497 ' O ' ' CB ' ' A' ' 7' ' ' ALA . 22.7 t -99.89 -168.77 1.64 Allowed 'General case' 0 N--CA 1.435 -1.184 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.195 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.497 ' CB ' ' O ' ' A' ' 6' ' ' SER . . . 152.63 -17.48 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.563 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.448 ' CG2' ' N ' ' A' ' 9' ' ' THR . 0.7 OUTLIER -160.27 157.73 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.6 -179.809 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.448 ' N ' ' CG2' ' A' ' 8' ' ' VAL . 1.1 m -147.66 134.46 20.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.136 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.2 m -102.65 104.0 15.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.224 0.535 . . . . 0.0 110.492 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 35.9 m-20 -87.2 -149.98 0.16 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.166 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -107.18 2.68 24.95 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -109.17 -22.23 12.2 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.441 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 160.47 -122.14 1.1 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.424 ' N ' ' HZ1' ' A' ' 84' ' ' LYS . 0.3 OUTLIER -147.36 147.31 30.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.946 0.403 . . . . 0.0 111.244 -179.722 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.1 t -103.85 137.23 33.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.488 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.03 99.17 7.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.935 0.398 . . . . 0.0 110.521 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.516 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 38.7 mtt180 -97.3 114.76 26.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.836 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.42 HD13 ' CD1' ' A' ' 21' ' ' ILE . 4.3 pp -147.05 179.75 7.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.284 0.564 . . . . 0.0 111.664 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -113.81 95.78 5.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.949 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.42 ' CD1' HD13 ' A' ' 19' ' ' LEU . 1.1 tp -75.35 130.78 35.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.273 -178.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.403 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 1.3 tp60 -120.51 91.83 47.13 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.638 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.461 ' O ' ' HB2' ' A' ' 24' ' ' LYS . 3.1 Cg_exo -71.66 165.29 32.99 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.454 2.103 . . . . 0.0 112.29 -178.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 23' ' ' PRO . 16.5 mtmm 77.37 37.25 0.26 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.511 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -102.41 167.41 9.97 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 17.0 t -75.41 -10.32 59.34 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 119.996 -0.682 . . . . 0.0 109.666 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.7 ttp180 -176.6 163.8 2.42 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.666 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.501 ' HA ' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -84.82 95.22 8.92 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.613 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.1 m -126.42 135.66 51.68 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.722 -178.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -91.01 76.1 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.3 17.55 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.053 -178.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.427 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . -142.4 21.75 2.4 Favored Glycine 0 C--N 1.32 -0.322 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 19.4 mt -57.75 107.01 0.41 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.434 ' O ' ' O ' ' A' ' 37' ' ' GLU . 44.7 t-80 -94.46 157.4 16.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.559 -178.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -66.6 -29.26 74.47 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -112.41 -10.08 13.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.737 -0.231 . . . . 0.0 110.472 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.434 ' O ' ' O ' ' A' ' 34' ' ' HIS . 8.4 mt-10 -140.68 -176.81 4.79 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.975 0.417 . . . . 0.0 110.734 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 45.9 t -142.78 112.79 2.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.439 ' HZ2' ' CB ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -111.13 132.69 54.08 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.262 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.5 p -147.59 124.18 2.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.651 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' A' ' 28' ' ' ASP . . . -86.94 122.4 30.75 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 21.2 tt -109.33 147.95 13.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.1 t -90.66 38.42 0.95 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.937 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -105.24 139.14 19.85 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.449 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.54 ' HG2' ' CB ' ' A' ' 50' ' ' GLN . 3.2 Cg_exo -56.25 170.47 1.16 Allowed 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 122.689 2.259 . . . . 0.0 112.572 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.61 24.74 0.45 Allowed 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 123.36 2.707 . . . . 0.0 113.391 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.41 HG13 ' H ' ' A' ' 50' ' ' GLN . 13.9 p -120.28 138.2 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.446 ' O ' ' C ' ' A' ' 49' ' ' GLY . 0.7 OUTLIER -53.75 -58.87 5.66 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.104 -179.427 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . -34.65 -52.9 0.81 Allowed Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.54 ' CB ' ' HG2' ' A' ' 45' ' ' PRO . 43.1 mm-40 -78.12 -39.37 41.47 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.07 -62.87 1.2 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.834 0.35 . . . . 0.0 110.511 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.439 ' N ' ' O ' ' A' ' 48' ' ' ASP . 46.2 t-20 -43.58 -47.24 7.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.876 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 18.4 m -52.99 -57.55 9.99 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.305 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -51.5 -50.75 59.29 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.787 0.327 . . . . 0.0 110.679 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -50.91 -43.77 59.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.198 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -69.37 -27.12 33.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.99 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -79.32 -60.5 2.34 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.842 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -46.9 -58.39 3.98 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.249 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.408 ' O ' ' HB2' ' A' ' 63' ' ' PHE . 4.6 mp -71.17 -41.47 70.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.103 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -51.17 -35.42 34.03 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.3 mttp -80.92 -58.26 3.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.662 0.268 . . . . 0.0 111.02 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -56.03 -43.87 78.21 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.102 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.408 ' HB2' ' O ' ' A' ' 59' ' ' LEU . 1.6 m-85 -82.72 -18.54 40.47 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.111 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.2 mtt-85 61.59 8.48 2.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.533 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.2 m -82.9 163.14 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.3 156.63 31.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.806 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 28.2 pttt -70.96 -28.58 64.58 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -71.42 -11.94 61.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.927 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.428 ' O ' ' O ' ' A' ' 84' ' ' LYS . 80.8 mt-30 -100.14 -7.94 24.25 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.335 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.0 t -104.06 97.76 5.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.4 t -116.78 123.18 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -178.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.459 ' C ' ' H ' ' A' ' 74' ' ' LYS . 54.3 mt -82.33 84.55 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.166 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -60.25 -3.68 0.67 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.035 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.459 ' H ' ' C ' ' A' ' 72' ' ' ILE . 5.3 mttp 168.15 116.55 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.081 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.419 ' HA3' ' HZ1' ' A' ' 81' ' ' LYS . . . 148.62 -10.43 1.08 Allowed Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -34.14 -41.03 0.1 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.3 tp -131.47 -42.96 1.04 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.701 0.286 . . . . 0.0 111.355 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.5 149.2 48.67 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.785 -0.526 . . . . 0.0 111.785 -178.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.99 -29.43 69.68 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.406 ' O ' ' HA2' ' A' ' 75' ' ' GLY . 76.5 t60 -67.27 145.85 54.75 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 177.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -144.73 154.02 42.3 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 119.706 -0.798 . . . . 0.0 111.537 -177.195 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -162.87 78.71 0.47 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 46.8 mt -80.46 153.61 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.398 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.451 ' HE3' ' N ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -120.47 111.86 18.24 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.969 -178.973 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.451 ' N ' ' HE3' ' A' ' 84' ' ' LYS . 1.4 mp -100.54 102.85 14.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.182 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.438 HD13 HG21 ' A' ' 86' ' ' ILE . 55.3 mt -85.99 153.55 3.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.551 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 18.4 m-20 40.05 79.77 0.31 Allowed Pre-proline 0 N--CA 1.467 0.41 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.692 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.51 146.1 30.51 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 123.014 2.476 . . . . 0.0 112.65 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 60.6 mm-40 -124.12 -28.91 3.66 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.043 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -146.8 117.48 7.57 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.138 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.9 tt -114.36 120.49 38.07 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.599 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.2 141.22 92.68 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.479 2.119 . . . . 0.0 112.342 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -50.49 -33.94 40.18 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 123.266 2.644 . . . . 0.0 112.632 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -53.04 -54.43 35.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.13 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 16.3 t -72.22 -19.45 19.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.0 -25.44 58.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.809 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -62.53 -26.34 68.51 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.888 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 20.1 mt -94.99 -10.94 29.42 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.5 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 97.6 mt -102.36 -30.98 2.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.943 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -78.05 -42.42 32.38 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.821 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.406 ' O ' ' N ' ' A' ' 103' ' ' HIS . 2.0 tt 74.9 -45.65 0.58 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.698 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 101' ' ' LEU . 51.5 mt-10 -37.55 97.78 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 O-C-N 123.355 0.409 . . . . 0.0 110.427 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.52 ' O ' ' CG ' ' A' ' 103' ' ' HIS . 11.5 p-80 -137.27 66.78 1.45 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.444 -178.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -45.71 -78.72 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.978 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -147.24 108.58 4.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.92 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.437 ' O ' ' CG ' ' A' ' 106' ' ' HIS . 49.1 t-80 48.61 57.77 5.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.119 0.485 . . . . 0.0 109.965 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -79.62 104.91 10.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.242 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.73 179.861 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.4 mmt . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -169.42 -51.56 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.788 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 89.85 -10.14 74.82 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.3 t 50.09 64.81 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 110.439 -0.208 . . . . 0.0 110.439 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 32.83 95.75 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 O-C-N 123.659 0.599 . . . . 0.0 112.024 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.478 ' O ' ' CB ' ' A' ' 7' ' ' ALA . 9.6 p -124.36 -168.33 1.79 Allowed 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.478 ' CB ' ' O ' ' A' ' 6' ' ' SER . . . 157.87 -17.46 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.985 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.454 ' CG2' ' N ' ' A' ' 9' ' ' THR . 0.2 OUTLIER -159.38 157.76 2.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.843 -179.607 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.454 ' N ' ' CG2' ' A' ' 8' ' ' VAL . 1.3 m -144.62 141.78 29.66 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.349 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 m -107.19 101.36 12.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.298 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.412 HD22 ' CG2' ' A' ' 16' ' ' VAL . 14.8 m-80 -81.24 -155.4 0.12 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.311 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -107.65 10.52 29.02 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -122.83 -25.26 4.66 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.241 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.62 -129.11 1.54 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.46 158.74 43.79 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.171 0.51 . . . . 0.0 111.31 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.412 ' CG2' HD22 ' A' ' 11' ' ' ASN . 3.8 t -110.03 138.47 37.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.329 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.445 ' O ' ' HA ' ' A' ' 82' ' ' GLN . 0.1 OUTLIER -115.61 91.16 3.52 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.689 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.414 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 4.6 mtm180 -97.06 109.26 22.05 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.4 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 pp -145.42 178.89 7.77 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.878 0.371 . . . . 0.0 110.998 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -110.93 104.62 13.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.3 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.7 mm -70.68 126.72 31.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.38 86.24 55.04 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.129 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -74.77 161.18 39.76 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.634 2.223 . . . . 0.0 111.84 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.6 mtmt 73.87 43.48 0.32 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.007 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -91.66 -71.12 0.65 Allowed 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.2 p 162.51 -23.12 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.016 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -171.75 143.16 1.64 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.041 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.05 89.66 0.04 OUTLIER 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.673 0.749 . . . . 0.0 110.055 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.3 m -130.77 127.28 38.4 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.192 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -83.29 65.62 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -94.03 18.28 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 114.669 -1.151 . . . . 0.0 113.016 -177.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -143.05 39.14 1.35 Allowed Glycine 0 N--CA 1.46 0.289 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 22.9 mt -77.78 117.69 19.4 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.557 -0.822 . . . . 0.0 109.799 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.599 ' CD2' ' H ' ' A' ' 35' ' ' GLY . 11.0 t-160 -102.25 159.46 15.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.416 -178.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.599 ' H ' ' CD2' ' A' ' 34' ' ' HIS . . . -73.47 -19.66 79.72 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -115.96 -14.05 11.26 Favored 'General case' 0 N--CA 1.461 0.11 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -143.39 -176.23 4.86 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.322 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 73.2 t -144.15 121.12 5.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.37 118.48 29.56 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.646 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.5 p -113.42 135.01 54.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.064 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -100.0 104.8 16.42 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.509 HD13 ' CE1' ' A' ' 54' ' ' HIS . 0.6 OUTLIER -99.39 156.19 3.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 -179.147 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.432 ' H ' HG13 ' A' ' 42' ' ' ILE . 8.4 t -93.22 26.75 2.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.744 -178.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.0 167.44 12.01 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.866 0.365 . . . . 0.0 110.913 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.487 ' HG2' ' CB ' ' A' ' 50' ' ' GLN . 3.6 Cg_exo -77.98 177.63 8.56 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 123.56 2.84 . . . . 0.0 112.165 179.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -77.5 0.75 9.47 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 123.009 2.473 . . . . 0.0 111.435 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.2 m -93.19 160.16 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.666 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 52' ' ' ASN . 2.3 m-20 -82.21 -47.34 12.59 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.905 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -43.07 -46.8 6.39 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.487 ' CB ' ' HG2' ' A' ' 45' ' ' PRO . 0.9 OUTLIER -81.49 -49.81 10.15 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 121.219 -0.192 . . . . 0.0 111.511 -179.453 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.53 -56.53 20.25 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.837 0.351 . . . . 0.0 110.06 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.452 ' N ' ' O ' ' A' ' 48' ' ' ASP . 30.8 t-20 -46.12 -46.38 17.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.086 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.5 p -50.18 -48.14 54.24 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.604 ' C ' ' ND1' ' A' ' 54' ' ' HIS . 0.0 OUTLIER -63.05 -45.58 91.56 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.11 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.591 ' N ' ' CG ' ' A' ' 54' ' ' HIS . 0.1 OUTLIER -49.24 -60.92 2.39 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.308 -178.537 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -53.7 -26.53 13.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.795 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 58' ' ' PHE . 19.1 tttt -82.16 -72.64 0.43 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.058 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.406 ' C ' ' O ' ' A' ' 57' ' ' LYS . 0.8 OUTLIER -33.85 -64.09 0.24 Allowed 'General case' 0 N--CA 1.467 0.377 0 O-C-N 123.167 0.292 . . . . 0.0 111.292 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.429 ' CD2' ' N ' ' A' ' 59' ' ' LEU . 3.6 mm? -64.99 -37.96 89.39 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.17 -41.53 78.94 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.1 -52.54 7.27 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.066 0.46 . . . . 0.0 110.229 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.1 mm100 -56.11 -49.72 73.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.711 -178.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.443 ' CD2' HG21 ' A' ' 85' ' ' ILE . 2.3 m-85 -87.14 -18.99 29.14 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.627 -0.261 . . . . 0.0 111.393 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 18.6 mtt180 59.98 4.1 0.57 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.582 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.409 ' H ' ' C ' ' A' ' 63' ' ' PHE . 33.6 m -76.35 152.3 5.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.77 158.74 0.29 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.542 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.68 -29.56 65.91 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.308 0.575 . . . . 0.0 109.66 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.32 -13.88 59.84 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.59 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -89.93 -6.26 55.9 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.259 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.4 t -106.0 97.23 5.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.6 t -114.42 124.53 71.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.206 0.527 . . . . 0.0 111.814 -178.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 64.2 mt -86.95 93.22 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.435 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -77.35 -1.66 31.12 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.938 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 38.8 tttt 179.6 118.95 0.05 Allowed 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.543 ' O ' ' C ' ' A' ' 76' ' ' GLU . . . 146.66 -20.27 1.65 Allowed Glycine 0 CA--C 1.516 0.122 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.543 ' C ' ' O ' ' A' ' 75' ' ' GLY . 11.1 mp0 -10.6 -66.59 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 O-C-N 124.291 0.642 . . . . 0.0 112.037 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.7 tt -118.65 -42.87 2.71 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.369 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -51.11 157.68 2.49 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 44.4 mtt-85 -68.14 -16.44 64.0 Favored 'General case' 0 CA--C 1.519 -0.231 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.516 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.507 ' CD2' ' N ' ' A' ' 81' ' ' LYS . 16.1 t60 -69.17 155.95 39.52 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.507 ' N ' ' CD2' ' A' ' 80' ' ' HIS . 36.1 tttt -148.68 125.37 11.12 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.139 -0.625 . . . . 0.0 109.997 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.445 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 8.3 tt0 -131.55 104.74 7.13 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.406 HD12 HG21 ' A' ' 83' ' ' ILE . 15.9 mm -102.09 129.69 53.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.767 -178.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.99 99.33 9.08 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.443 HG21 ' CD2' ' A' ' 63' ' ' PHE . 2.2 mp -89.53 96.62 6.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.139 -178.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 33.4 mt -82.2 146.09 7.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.717 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 51.89 75.04 0.69 Allowed Pre-proline 0 N--CA 1.463 0.215 0 CA-C-O 120.759 0.314 . . . . 0.0 110.529 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -74.27 130.48 14.13 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 122.594 2.196 . . . . 0.0 112.096 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 21.4 mm100 -114.55 -26.08 8.06 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.948 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -145.39 116.18 7.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.399 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.1 tt -112.56 114.45 50.02 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.064 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -67.13 145.62 73.67 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.29 1.993 . . . . 0.0 111.504 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -51.61 -19.69 7.87 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 122.62 2.214 . . . . 0.0 111.873 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -61.14 -56.31 22.31 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.97 0.414 . . . . 0.0 110.331 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.25 -25.39 12.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.745 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.447 ' O ' ' ND2' ' A' ' 100' ' ' ASN . . . -75.41 -44.61 43.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.975 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.442 ' HA ' HD22 ' A' ' 100' ' ' ASN . . . -50.33 -19.78 0.91 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.57 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 80.5 mt -102.42 -25.44 13.63 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.944 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.412 HD11 HG23 ' A' ' 99' ' ' ILE . 95.8 mt -92.14 -21.18 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.997 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.599 HD21 ' H ' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -94.68 -23.59 17.52 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.658 0.266 . . . . 0.0 111.096 -179.883 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.599 ' H ' HD21 ' A' ' 100' ' ' ASN . 2.0 tp 55.47 68.43 0.86 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.604 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.456 ' HG3' HD22 ' A' ' 100' ' ' ASN . 0.0 OUTLIER -86.71 -14.56 42.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.542 179.675 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 27.6 m80 -67.74 109.77 3.49 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.257 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.528 ' H ' ' HD1' ' A' ' 104' ' ' HIS . 0.0 OUTLIER -124.94 39.79 3.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.576 -179.873 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -61.0 96.78 0.05 Allowed 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.422 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.419 ' ND1' ' O ' ' A' ' 104' ' ' HIS . 16.7 p-80 -124.51 173.98 8.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.271 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 3.6 p80 -148.76 145.76 27.75 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.643 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 13.0 m80 . . . . . 0 CA--C 1.529 0.145 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.809 -179.833 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 tpt . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -54.1 126.52 23.05 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.74 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 5' ' ' MET . . . -86.2 -31.71 19.07 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.0 t 64.31 -71.72 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 120.725 0.297 . . . . 0.0 110.481 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.433 ' N ' ' O ' ' A' ' 3' ' ' GLY . 0.0 OUTLIER -94.1 98.29 10.88 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.063 179.404 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.467 ' HG ' ' H ' ' A' ' 7' ' ' ALA . 6.7 t -125.03 -167.75 1.72 Allowed 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.304 0.573 . . . . 0.0 110.349 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.467 ' H ' ' HG ' ' A' ' 6' ' ' SER . . . 156.36 -20.65 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.735 -1.12 . . . . 0.0 108.956 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.4 m -149.02 168.2 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.115 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 m -150.73 120.77 7.17 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.431 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.2 m -92.34 97.09 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.194 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -82.68 -163.27 0.68 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.189 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -101.39 11.71 38.7 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -119.16 -24.11 6.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.11 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.456 ' HA3' ' HZ2' ' A' ' 84' ' ' LYS . . . 165.87 -124.35 1.23 Allowed Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -150.87 150.77 31.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.976 0.417 . . . . 0.0 111.134 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.1 t -107.74 142.8 19.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.928 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -113.49 96.28 5.8 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 22.9 mtp85 -104.47 110.86 23.29 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.789 -179.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.0 pp -147.52 179.66 7.51 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.051 0.453 . . . . 0.0 111.427 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.41 ' CE1' ' HB3' ' A' ' 79' ' ' ARG . 16.0 t80 -108.36 114.64 28.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.086 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.9 mm -84.26 133.78 28.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.928 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -120.87 87.48 42.95 Favored Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -70.09 156.82 61.6 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.62 2.213 . . . . 0.0 113.413 -178.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? 69.83 49.79 0.5 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.239 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.405 ' O ' ' CB ' ' A' ' 26' ' ' SER . . . -96.68 -66.92 0.87 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' A' ' 25' ' ' ALA . 1.1 m 158.56 -24.41 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.293 -0.867 . . . . 0.0 108.724 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -171.1 144.24 2.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.87 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.47 92.8 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 59.8 p -124.29 130.19 52.08 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.52 -178.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -94.78 63.55 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.49 ' O ' ' CG1' ' A' ' 31' ' ' VAL . 92.7 t -96.03 19.51 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.944 -178.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -144.04 32.08 1.81 Allowed Glycine 0 C--N 1.334 0.457 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 31.8 mt -66.61 126.24 28.29 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.63 -0.785 . . . . 0.0 109.926 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.428 ' O ' ' O ' ' A' ' 37' ' ' GLU . 23.2 t-80 -112.67 157.41 21.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.042 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.06 -27.54 73.66 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -109.26 -14.49 14.46 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 115.569 -0.315 . . . . 0.0 110.81 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.428 ' O ' ' O ' ' A' ' 34' ' ' HIS . 9.0 mt-10 -141.94 -177.67 5.32 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.001 0.429 . . . . 0.0 111.081 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 70.7 t -143.97 115.98 2.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.707 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.4 ttpt -116.13 117.57 30.43 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.642 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.4 p -120.12 149.83 22.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.156 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -112.53 103.54 11.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.308 -0.406 . . . . 0.0 109.915 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.401 HG13 ' N ' ' A' ' 43' ' ' THR . 2.4 tp -86.11 146.36 6.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.401 ' N ' HG13 ' A' ' 42' ' ' ILE . 0.7 OUTLIER -87.31 17.15 4.58 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.755 -178.28 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.12 149.77 36.08 Favored Pre-proline 0 C--O 1.234 0.276 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.55 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.407 ' HG2' ' CB ' ' A' ' 50' ' ' GLN . 3.9 Cg_exo -51.54 175.9 0.06 OUTLIER 'Trans proline' 0 N--CA 1.491 1.371 0 C-N-CA 123.241 2.627 . . . . 0.0 112.212 178.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -80.21 0.36 10.08 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 123.23 2.62 . . . . 0.0 112.982 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -87.79 158.61 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.988 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.445 ' O ' ' N ' ' A' ' 52' ' ' ASN . 17.5 m-20 -73.55 -57.57 3.9 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.001 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . -36.65 -46.4 1.11 Allowed Glycine 0 CA--C 1.529 0.969 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.417 ' N ' ' CD ' ' A' ' 50' ' ' GLN . 2.1 mp0 -82.73 -52.16 7.03 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.25 -56.05 26.26 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.937 0.399 . . . . 0.0 110.403 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' A' ' 48' ' ' ASP . 40.1 t-20 -46.34 -54.65 8.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.47 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.7 m -48.81 -52.54 23.49 Favored 'General case' 0 C--O 1.23 0.066 0 C-N-CA 120.624 -0.431 . . . . 0.0 110.107 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -56.33 -56.12 25.01 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.539 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.3 mp -43.3 -60.45 1.69 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.273 0.558 . . . . 0.0 110.134 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.7 t -57.85 -29.33 35.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.312 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -76.3 -68.31 0.6 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.262 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -39.09 -48.28 1.65 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.503 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.473 ' CD1' ' HZ2' ' A' ' 81' ' ' LYS . 7.4 mp -76.93 -34.79 57.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.84 0.353 . . . . 0.0 110.072 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.36 -35.65 61.36 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.01 -52.16 7.73 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.919 0.39 . . . . 0.0 110.428 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -59.25 -46.93 87.19 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.848 -178.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.423 ' C ' ' H ' ' A' ' 65' ' ' VAL . 2.4 m-85 -86.13 -19.11 30.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.076 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.2 mtt85 59.24 5.27 0.55 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.352 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.423 ' H ' ' C ' ' A' ' 63' ' ' PHE . 27.0 m -67.35 175.33 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.199 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -86.67 163.44 17.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.263 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.401 ' O ' HG12 ' A' ' 70' ' ' VAL . 29.1 pttt -70.91 -21.29 62.39 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.658 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.77 -8.76 59.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.296 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -108.43 -5.15 16.78 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.463 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.505 ' CG1' ' O ' ' A' ' 70' ' ' VAL . 9.8 p -101.21 101.1 11.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 121.286 0.565 . . . . 0.0 110.373 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 59.7 t -115.94 124.9 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 52.6 mt -84.85 93.67 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.905 178.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -70.01 -16.05 63.11 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.159 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt 174.81 163.9 0.24 Allowed 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.57 -2.05 73.06 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -37.94 -31.94 0.05 Allowed 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -127.04 -45.04 1.58 Allowed 'General case' 0 C--O 1.233 0.187 0 C-N-CA 121.061 -0.255 . . . . 0.0 111.0 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.404 ' C ' ' N ' ' A' ' 80' ' ' HIS . . . -58.84 148.22 39.55 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.41 ' HB3' ' CE1' ' A' ' 20' ' ' TYR . 10.4 mtt180 -50.19 -18.55 0.6 Allowed 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.404 ' N ' ' C ' ' A' ' 78' ' ' GLY . 1.7 m80 -69.87 165.35 21.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.493 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 2.0 tttt -151.97 132.87 14.18 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -139.77 82.06 1.86 Allowed 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.483 ' CD1' ' HZ1' ' A' ' 81' ' ' LYS . 92.2 mt -95.11 139.61 18.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.839 -179.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.475 ' HE3' ' N ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -108.49 126.44 52.91 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.211 -179.129 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.475 ' N ' ' HE3' ' A' ' 84' ' ' LYS . 1.4 mp -106.1 98.75 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.967 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.401 ' O ' ' C ' ' A' ' 87' ' ' ASN . 95.5 mt -80.59 151.8 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 86' ' ' ILE . 1.5 m-80 38.09 85.41 0.16 Allowed Pre-proline 0 N--CA 1.464 0.226 0 O-C-N 123.235 0.334 . . . . 0.0 110.804 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -72.32 133.09 20.36 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.403 2.068 . . . . 0.0 112.365 -179.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -108.08 -30.19 8.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.419 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -147.31 121.05 9.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.123 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.9 tt -113.39 114.17 48.03 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.454 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -66.01 173.86 6.58 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 121.985 1.79 . . . . 0.0 111.069 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.66 -19.19 21.64 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.445 2.097 . . . . 0.0 111.591 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -52.94 -62.5 1.61 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.255 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.3 t -73.57 -24.58 20.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.975 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.4 -28.4 65.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.666 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.62 -22.29 8.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.551 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.9 mt -108.02 -41.55 4.91 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.784 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.455 HD13 HG21 ' A' ' 99' ' ' ILE . 79.0 mt -76.24 -13.57 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.767 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -104.6 -33.82 8.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.078 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.2 tp 48.04 72.37 0.27 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.155 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.512 ' O ' ' N ' ' A' ' 104' ' ' HIS . 5.4 mm-40 -89.17 -11.24 44.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.173 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 10.6 m80 -55.96 81.58 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.729 0.299 . . . . 0.0 110.217 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.649 ' HD1' ' N ' ' A' ' 105' ' ' HIS . 12.4 t-80 45.08 -138.16 0.47 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.177 -179.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.649 ' N ' ' HD1' ' A' ' 104' ' ' HIS . 1.8 m-70 64.74 -68.51 0.1 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.553 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.441 ' N ' ' O ' ' A' ' 104' ' ' HIS . 61.7 m170 37.8 63.32 0.8 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.871 0.367 . . . . 0.0 110.829 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.456 ' CG ' ' N ' ' A' ' 108' ' ' HIS . 8.5 p80 -48.75 -50.04 35.67 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.693 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.456 ' N ' ' CG ' ' A' ' 107' ' ' HIS . 83.2 t60 . . . . . 0 C--N 1.332 -0.153 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.35 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.415 ' HG3' ' H ' ' A' ' 2' ' ' ASP . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.415 ' H ' ' HG3' ' A' ' 1' ' ' MET . 22.7 t70 -164.33 -38.83 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.575 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.572 ' C ' ' H ' ' A' ' 5' ' ' MET . . . -99.93 -64.64 0.81 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.432 HG21 ' O ' ' A' ' 3' ' ' GLY . 0.8 OUTLIER 65.73 -20.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 122.81 0.444 . . . . 0.0 111.536 -179.814 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.572 ' H ' ' C ' ' A' ' 3' ' ' GLY . 0.3 OUTLIER -117.88 105.72 12.22 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 120.646 0.26 . . . . 0.0 110.403 179.541 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.64 111.34 14.86 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.224 0.535 . . . . 0.0 110.141 178.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -153.62 -16.81 0.14 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.239 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.416 ' CG2' ' N ' ' A' ' 9' ' ' THR . 0.7 OUTLIER -160.88 155.72 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.488 179.632 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.416 ' N ' ' CG2' ' A' ' 8' ' ' VAL . 1.8 m -150.37 139.81 21.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.683 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.84 105.67 19.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.85 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -92.4 -152.29 0.31 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.595 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -107.59 5.33 26.87 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -109.4 -23.1 11.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.163 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 161.93 -125.48 1.43 Allowed Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -145.26 145.69 31.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.981 0.42 . . . . 0.0 110.971 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.2 t -105.58 129.0 59.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.84 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.28 99.81 8.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.215 0.531 . . . . 0.0 110.446 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.515 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -103.56 127.18 51.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.037 -179.876 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.415 ' HB2' HG13 ' A' ' 38' ' ' VAL . 0.6 OUTLIER -149.88 176.69 10.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.512 0.672 . . . . 0.0 112.121 -179.196 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -108.0 92.66 4.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.638 -1.165 . . . . 0.0 108.792 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.475 HG21 ' HA ' ' A' ' 79' ' ' ARG . 1.6 tp -75.77 137.01 23.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.037 -178.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.01 93.87 42.86 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.915 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -73.54 157.33 49.02 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.478 2.119 . . . . 0.0 112.226 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt 72.33 47.93 0.26 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.106 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.463 ' CB ' ' CB ' ' A' ' 41' ' ' ALA . . . -95.92 -68.37 0.8 Allowed 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.414 ' CB ' ' O ' ' A' ' 25' ' ' ALA . 6.1 p 157.38 -24.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.504 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 44.4 ttm180 -171.29 139.85 1.38 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.206 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.42 93.62 0.35 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.393 0.616 . . . . 0.0 109.999 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.8 m -124.92 129.09 49.67 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.654 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.56 63.03 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -93.67 17.67 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.725 -178.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.453 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . -143.38 28.25 2.08 Favored Glycine 0 C--N 1.318 -0.444 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -178.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.444 ' CD2' HG12 ' A' ' 38' ' ' VAL . 10.7 mt -60.81 111.01 1.47 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.431 ' HD1' ' H ' ' A' ' 35' ' ' GLY . 3.7 t60 -99.44 152.53 19.88 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.398 -178.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.431 ' H ' ' HD1' ' A' ' 34' ' ' HIS . . . -67.75 -15.5 66.75 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -121.94 -17.38 7.32 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.747 0.308 . . . . 0.0 110.392 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -139.05 -173.03 3.47 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.833 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.444 HG12 ' CD2' ' A' ' 33' ' ' LEU . 16.9 t -142.7 112.87 2.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 5.6 mtpt -110.89 109.36 19.5 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.035 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.7 p -121.98 132.44 70.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.458 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.463 ' CB ' ' CB ' ' A' ' 25' ' ' ALA . . . -99.65 99.86 10.77 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.272 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.6 tt -84.66 149.52 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.4 t -95.59 48.24 1.14 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.016 0.436 . . . . 0.0 110.626 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.502 ' HB2' HE21 ' A' ' 50' ' ' GLN . . . -118.79 142.89 32.56 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.529 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.566 ' O ' ' NE2' ' A' ' 50' ' ' GLN . 1.6 Cg_endo -54.51 169.66 0.72 Allowed 'Trans proline' 0 N--CA 1.503 2.058 0 C-N-CA 123.751 2.967 . . . . 0.0 112.236 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -83.56 87.09 1.29 Allowed 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.831 2.354 . . . . 0.0 111.081 177.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.65 ' CG2' ' H ' ' A' ' 48' ' ' ASP . 9.8 p -172.24 -160.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.65 ' H ' ' CG2' ' A' ' 47' ' ' VAL . 1.7 m-20 -88.03 -66.89 0.87 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.041 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -44.55 -28.77 1.65 Allowed Glycine 0 CA--C 1.526 0.734 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.35 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.716 ' CG ' ' H ' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -61.9 -69.78 0.23 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.206 0.527 . . . . 0.0 111.474 -179.644 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.716 ' H ' ' CG ' ' A' ' 50' ' ' GLN . . . -80.63 -39.84 26.69 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.224 -178.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -54.01 -54.96 31.87 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.359 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.4 p -64.12 -48.7 75.07 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.0 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.99 -52.81 63.99 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.652 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.5 tp -49.36 -58.3 5.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.028 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -53.74 -23.41 8.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.6 ttpp -85.16 -64.75 1.1 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.494 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -45.7 -59.77 2.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.382 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.0 tp -70.74 -48.0 56.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.951 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -49.21 -30.1 10.45 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -81.16 -63.06 1.48 Allowed 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.772 0.32 . . . . 0.0 111.217 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -58.63 -36.76 74.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.671 -178.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.455 ' HB3' ' CG2' ' A' ' 65' ' ' VAL . 1.4 m-85 -87.02 -18.96 29.39 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 56.7 11.05 0.81 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.371 -0.832 . . . . 0.0 112.642 178.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.495 ' CG1' ' H ' ' A' ' 66' ' ' ALA . 2.2 t -69.15 -141.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.871 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.495 ' H ' ' CG1' ' A' ' 65' ' ' VAL . . . -125.39 156.39 38.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.918 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 46.0 pttt -69.55 -26.29 64.42 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.13 -16.44 37.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.35 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -97.03 -20.63 17.91 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.566 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.444 ' CG1' ' O ' ' A' ' 70' ' ' VAL . 14.8 p -101.53 98.14 6.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 t -115.2 131.32 67.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.96 -178.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.403 ' C ' ' H ' ' A' ' 74' ' ' LYS . 68.1 mt -83.04 91.01 2.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.42 ' O ' ' CB ' ' A' ' 74' ' ' LYS . 7.8 mt-10 -57.91 -7.01 0.64 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.666 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.42 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 3.5 mtpp 162.11 126.48 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 132.77 -3.08 4.94 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -40.8 -30.53 0.13 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.8 tt -128.5 -37.85 1.77 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 121.023 -0.271 . . . . 0.0 111.654 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -70.99 158.32 53.72 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.772 -0.531 . . . . 0.0 111.772 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.475 ' HA ' HG21 ' A' ' 21' ' ' ILE . 13.3 mtm180 -61.41 -29.32 69.86 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.2 p-80 -69.01 146.99 52.24 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 5.8 ttmm -139.64 142.27 37.02 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.53 -178.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.409 ' HG2' ' C ' ' A' ' 81' ' ' LYS . 2.1 mm100 -144.3 80.72 1.65 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 81.9 mt -81.85 156.13 4.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.234 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.431 ' HE3' ' N ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -136.25 104.94 5.81 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.828 -179.64 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.431 ' N ' ' HE3' ' A' ' 84' ' ' LYS . 3.1 mp -96.81 103.12 14.3 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.796 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 53.7 mt -85.6 133.44 29.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.883 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 51.4 t30 52.16 82.47 0.24 Allowed Pre-proline 0 CA--C 1.53 0.202 0 CA-C-O 120.906 0.384 . . . . 0.0 110.03 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -69.73 144.79 55.29 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.61 2.207 . . . . 0.0 112.497 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -117.99 -29.77 5.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.118 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.419 ' O ' ' HA ' ' A' ' 63' ' ' PHE . 33.5 tt0 -147.12 122.27 10.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.785 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.3 tt -116.6 117.28 38.18 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.073 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -69.4 143.54 52.9 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 122.333 2.022 . . . . 0.0 112.165 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -49.25 -25.15 9.28 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 122.945 2.43 . . . . 0.0 111.899 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -61.35 -56.89 15.31 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.564 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.3 t -71.39 -19.83 20.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.33 -22.97 57.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.502 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -64.55 -19.26 65.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.006 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 67.9 mt -105.68 -16.7 14.61 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.31 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 44.1 mt -104.17 -36.53 4.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.81 0.338 . . . . 0.0 110.659 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.436 ' O ' ' C ' ' A' ' 101' ' ' LEU . 10.5 t-20 -78.18 -5.78 52.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.923 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.436 ' C ' ' O ' ' A' ' 100' ' ' ASN . 3.8 mt -29.9 -91.49 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 O-C-N 123.701 0.625 . . . . 0.0 111.374 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 35.79 35.28 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.381 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 36.3 t60 -58.82 -49.48 77.54 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.429 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 10.3 p-80 -82.24 110.46 17.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.418 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -152.01 12.77 0.59 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.392 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 70.1 t60 -152.88 141.67 21.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.183 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.466 ' CG ' ' H ' ' A' ' 108' ' ' HIS . 17.7 t-160 -149.56 -126.25 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.261 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.466 ' H ' ' CG ' ' A' ' 107' ' ' HIS . 28.1 m80 . . . . . 0 C--N 1.331 -0.212 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.594 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.476 ' CG ' ' H ' ' A' ' 3' ' ' GLY . 2.5 p-10 -104.11 -94.09 0.33 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.903 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.476 ' H ' ' CG ' ' A' ' 2' ' ' ASP . . . 90.28 21.77 37.14 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 19.2 t 59.77 100.93 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 120.926 0.393 . . . . 0.0 111.021 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -96.9 94.39 7.19 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.574 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.2 117.7 22.84 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.283 0.563 . . . . 0.0 110.382 179.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -144.55 -30.23 0.46 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.291 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.9 m -147.07 165.75 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.817 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 m -151.29 130.5 12.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.725 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.4 m -95.19 97.6 6.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.115 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -84.93 -163.02 0.76 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.297 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -102.67 9.79 39.03 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -117.77 -21.47 8.43 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 114.682 -1.145 . . . . 0.0 110.461 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.41 -126.49 1.51 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -144.37 150.99 38.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.858 0.361 . . . . 0.0 110.693 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 35.8 t -105.51 143.05 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.208 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 82' ' ' GLN . 0.5 OUTLIER -124.49 92.23 3.61 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.976 0.417 . . . . 0.0 110.762 -179.82 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.498 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 2.3 mmm-85 -95.87 113.49 25.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.428 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.418 ' CB ' HG12 ' A' ' 38' ' ' VAL . 0.6 OUTLIER -139.69 171.8 13.71 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.593 0.711 . . . . 0.0 112.672 -178.711 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -102.57 94.88 5.88 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.289 -1.323 . . . . 0.0 108.121 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -72.32 128.63 35.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.52 -177.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -125.4 90.1 51.34 Favored Pre-proline 0 C--O 1.232 0.159 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.905 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.27 156.24 37.34 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.67 2.246 . . . . 0.0 111.975 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt 72.19 53.15 0.18 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.658 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.501 ' CB ' ' HB2' ' A' ' 41' ' ' ALA . . . -99.65 -59.83 1.64 Allowed 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 25' ' ' ALA . 0.4 OUTLIER 157.44 -31.45 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.142 179.41 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.434 ' CG ' ' O ' ' A' ' 26' ' ' SER . 18.5 mtm180 -167.05 146.75 5.38 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.344 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.449 ' HA ' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -64.08 92.36 0.08 Allowed 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.078 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.61 120.1 24.7 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.851 -178.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -84.24 76.47 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.44 ' O ' ' CG1' ' A' ' 31' ' ' VAL . 41.3 t -107.01 19.56 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 114.858 -1.064 . . . . 0.0 112.069 -177.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -143.56 27.72 2.07 Favored Glycine 0 C--N 1.333 0.366 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 15.9 mt -62.62 126.69 28.18 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.955 -0.623 . . . . 0.0 110.094 179.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -113.25 157.02 22.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.165 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -69.57 -20.1 75.29 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.516 -1.033 . . . . 0.0 110.516 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -116.17 -17.09 10.91 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.831 -0.184 . . . . 0.0 110.609 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -140.53 -174.99 4.11 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.831 0.348 . . . . 0.0 110.537 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.418 HG12 ' CB ' ' A' ' 19' ' ' LEU . 14.8 t -142.74 113.33 2.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -107.99 112.36 24.89 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.396 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.9 p -117.0 144.42 24.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.349 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.501 ' HB2' ' CB ' ' A' ' 25' ' ' ALA . . . -110.23 100.84 9.66 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.47 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.5 tt -91.91 148.14 4.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.408 ' O ' ' OG1' ' A' ' 43' ' ' THR . 0.0 OUTLIER -91.73 28.3 1.82 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.503 -179.079 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.96 163.2 19.22 Favored Pre-proline 0 C--O 1.235 0.303 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.107 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.437 ' HG2' ' CB ' ' A' ' 50' ' ' GLN . 3.4 Cg_exo -77.55 176.46 10.03 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 123.433 2.756 . . . . 0.0 111.978 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -77.05 3.6 6.5 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 123.071 2.514 . . . . 0.0 112.606 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.8 p -99.2 148.09 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.719 0.295 . . . . 0.0 110.564 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' A' ' 52' ' ' ASN . 1.3 t0 -66.94 -52.41 43.26 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.033 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . -37.05 -51.95 1.58 Allowed Glycine 0 CA--C 1.531 1.058 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.452 ' N ' ' CD ' ' A' ' 50' ' ' GLN . 2.0 mp0 -82.72 -45.53 14.31 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.39 -58.8 4.51 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.155 0.503 . . . . 0.0 110.376 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.5 ' N ' ' O ' ' A' ' 48' ' ' ASP . 11.5 t-20 -46.88 -49.92 19.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.93 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.5 p -55.73 -48.34 75.37 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.791 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -54.47 -59.79 4.22 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.296 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -44.86 -57.91 3.46 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.916 0.388 . . . . 0.0 110.532 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -54.27 -32.21 23.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.912 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 34.3 tttm -76.75 -65.97 0.87 Allowed 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.704 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -46.67 -56.18 6.54 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.072 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.7 tp -64.49 -58.74 5.57 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.751 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -46.03 -29.54 3.42 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.634 -0.586 . . . . 0.0 111.634 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.1 mttp -80.91 -63.84 1.32 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.961 0.41 . . . . 0.0 111.103 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.498 HE22 ' CG ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -58.75 -31.91 68.77 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.118 -178.668 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.483 ' CD2' ' OE1' ' A' ' 62' ' ' GLN . 0.8 OUTLIER -88.84 -19.56 25.77 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.402 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 67.15 2.06 2.63 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.734 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.419 ' CG2' ' HB3' ' A' ' 63' ' ' PHE . 2.0 t -68.2 -136.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.038 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.08 167.79 21.31 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.905 0.383 . . . . 0.0 111.295 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.5 ptmt -73.42 -25.41 60.51 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.327 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.8 t -79.91 -20.17 46.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.965 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.428 ' O ' ' O ' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -95.96 -11.69 26.19 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.261 179.782 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.424 HG11 ' CG2' ' A' ' 83' ' ' ILE . 54.8 t -100.63 99.24 8.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.231 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.5 t -112.98 116.43 52.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.239 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.449 ' C ' ' H ' ' A' ' 74' ' ' LYS . 67.2 mt -88.06 87.06 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.186 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -76.35 15.18 0.62 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.164 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.449 ' H ' ' C ' ' A' ' 72' ' ' ILE . 8.9 tttt 174.33 137.74 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 76' ' ' GLU . . . 128.28 -14.95 6.16 Favored Glycine 0 CA--C 1.518 0.264 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -178.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 75' ' ' GLY . 12.2 tt0 -30.68 -57.81 0.21 Allowed 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.855 0.385 . . . . 0.0 111.293 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.2 mt -133.43 -33.44 1.1 Allowed 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.848 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.58 145.47 45.6 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.901 -0.879 . . . . 0.0 110.901 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 15.7 mtp180 -58.38 -33.51 69.68 Favored 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -68.86 138.76 54.97 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 177.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 2.2 ttmm -145.42 151.99 39.12 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 119.961 -0.696 . . . . 0.0 110.203 -177.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.41 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 19.6 tt0 -148.24 123.59 10.28 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.424 ' CG2' HG11 ' A' ' 70' ' ' VAL . 9.7 mt -120.45 143.18 33.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.583 -178.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.439 ' HE3' ' N ' ' A' ' 85' ' ' ILE . 0.2 OUTLIER -114.16 106.62 14.58 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.2 -179.454 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.439 ' N ' ' HE3' ' A' ' 84' ' ' LYS . 2.4 mp -91.39 101.6 12.66 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.36 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 64.4 mt -81.16 143.66 11.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.031 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 47.31 77.15 0.48 Allowed Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.778 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -74.08 144.54 33.99 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 122.87 2.38 . . . . 0.0 112.003 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -107.43 -39.78 5.55 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.65 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -147.51 125.5 12.04 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 120.98 0.419 . . . . 0.0 109.977 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.4 tt -107.01 112.86 63.06 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.359 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.498 ' CG ' HE22 ' A' ' 62' ' ' GLN . 3.4 Cg_exo -70.44 153.78 65.54 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.683 2.256 . . . . 0.0 112.623 -179.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.411 ' O ' ' N ' ' A' ' 97' ' ' ALA . 2.6 Cg_endo -47.96 -30.27 13.45 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 123.273 2.648 . . . . 0.0 111.897 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 65.6 tt0 -51.71 -59.25 4.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.736 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -84.04 -24.54 7.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.157 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.24 -19.88 59.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.972 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 93' ' ' PRO . . . -66.41 -25.27 66.69 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.111 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 18.7 mt -103.67 -14.61 16.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.001 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 46.8 mt -103.6 -50.45 9.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.346 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -75.09 1.21 13.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.59 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 60.1 tp -53.36 -13.25 0.53 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.895 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 -71.4 52.61 0.19 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.969 0.414 . . . . 0.0 110.435 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -125.08 99.63 6.2 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.096 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -56.26 -21.4 23.47 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.925 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -46.03 101.84 0.03 OUTLIER 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.907 0.384 . . . . 0.0 110.589 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -72.71 6.06 2.74 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.018 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -48.9 101.6 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.597 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 20.6 m170 . . . . . 0 N--CA 1.462 0.161 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.74 -179.854 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.2 mmt . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -111.29 -77.02 0.59 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.628 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -101.4 -31.32 5.59 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.3 t 56.54 95.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-O 120.886 0.374 . . . . 0.0 110.617 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.478 ' N ' ' SD ' ' A' ' 5' ' ' MET . 0.0 OUTLIER -97.44 91.13 5.32 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.144 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 36' ' ' ASP . 79.1 p -127.53 -167.45 1.75 Allowed 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.447 ' CB ' ' O ' ' A' ' 6' ' ' SER . . . 158.96 -22.26 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.664 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.0 p -157.31 154.86 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.072 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 m -150.71 144.57 25.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.523 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.8 m -113.61 103.71 15.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.326 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -93.26 -152.65 0.33 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.301 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -106.1 2.76 27.41 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -107.77 -22.36 12.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.38 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.436 ' HA3' ' HZ2' ' A' ' 84' ' ' LYS . . . 159.37 -122.05 1.1 Allowed Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -148.58 138.6 22.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.006 0.431 . . . . 0.0 111.255 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 71.8 t -100.91 141.43 17.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.1 tp -122.34 104.17 9.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.187 0.518 . . . . 0.0 110.787 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.502 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 1.1 mtt-85 -94.02 127.71 39.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.682 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.405 HD13 ' N ' ' A' ' 21' ' ' ILE . 2.2 pp -153.18 178.29 9.9 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.618 0.723 . . . . 0.0 112.482 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -111.0 95.7 5.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.442 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.441 HG13 ' NZ ' ' A' ' 81' ' ' LYS . 0.3 OUTLIER -72.59 127.17 34.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.439 -178.321 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -119.9 90.46 43.89 Favored Pre-proline 0 N--CA 1.462 0.172 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.033 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.443 ' O ' ' HB2' ' A' ' 24' ' ' LYS . 3.1 Cg_exo -74.91 151.5 40.07 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.66 2.24 . . . . 0.0 112.788 -179.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 23' ' ' PRO . 6.4 mtmp? 79.73 43.45 0.06 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.982 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.401 ' CB ' ' CB ' ' A' ' 41' ' ' ALA . . . -101.8 169.46 8.79 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 177.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.0 p -63.28 -19.24 64.4 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.073 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.451 ' O ' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -176.59 163.09 2.34 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.151 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.447 ' HA ' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -80.76 93.03 6.13 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.398 0.618 . . . . 0.0 109.476 178.179 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.49 135.83 48.36 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.782 -178.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -90.56 66.23 0.49 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-O 121.637 0.732 . . . . 0.0 109.455 178.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.418 ' O ' ' CG1' ' A' ' 31' ' ' VAL . 41.3 t -98.32 18.77 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.417 -178.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -143.6 32.12 1.86 Allowed Glycine 0 C--N 1.333 0.368 0 N-CA-C 110.376 -1.089 . . . . 0.0 110.376 -178.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 19.1 mt -71.26 122.38 20.13 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.838 -0.681 . . . . 0.0 110.13 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.787 ' HD1' ' H ' ' A' ' 36' ' ' ASP . 37.8 t-80 -110.01 157.03 19.72 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.287 -178.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.79 -22.55 70.23 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.787 ' H ' ' HD1' ' A' ' 34' ' ' HIS . 29.3 m-20 -121.53 0.54 9.96 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.433 ' O ' ' O ' ' A' ' 34' ' ' HIS . 5.1 mm-40 -148.45 176.38 10.35 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-O 121.07 0.462 . . . . 0.0 110.249 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 30.3 t -142.56 108.68 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -109.77 107.79 17.91 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.295 -178.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.8 p -117.74 131.31 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.592 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.451 ' O ' ' O ' ' A' ' 27' ' ' ARG . . . -100.45 107.72 19.52 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.7 tt -97.42 152.26 4.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.4 t -92.97 21.55 5.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.44 -178.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.1 160.89 54.03 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.821 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.414 ' HG2' ' CB ' ' A' ' 50' ' ' GLN . 3.9 Cg_exo -76.51 171.59 17.77 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 123.269 2.646 . . . . 0.0 112.169 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.11 8.33 2.51 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 123.25 2.633 . . . . 0.0 112.745 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.437 HG11 ' H ' ' A' ' 50' ' ' GLN . 14.4 p -101.37 142.62 15.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.404 ' O ' ' N ' ' A' ' 52' ' ' ASN . 0.2 OUTLIER -62.53 -45.7 91.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.262 -179.261 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -45.11 -54.42 7.08 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.298 -0.477 . . . . 0.0 111.919 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.437 ' H ' HG11 ' A' ' 47' ' ' VAL . 15.5 mt-30 -80.44 -38.1 30.76 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 -179.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.35 -60.26 2.58 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.863 0.363 . . . . 0.0 110.687 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.404 ' N ' ' O ' ' A' ' 48' ' ' ASP . 37.3 t-20 -50.53 -40.97 53.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.512 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.7 t -52.9 -50.87 63.05 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.787 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -54.75 -55.09 33.73 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.889 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.511 ' HG ' ' NZ ' ' A' ' 81' ' ' LYS . 3.4 mm? -49.39 -51.27 36.15 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.66 -0.416 . . . . 0.0 109.895 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -56.35 -26.82 23.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.88 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 61' ' ' LYS . 6.0 ttpm? -84.29 -64.95 1.07 Allowed 'General case' 0 C--O 1.227 -0.13 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.286 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -51.69 -54.82 24.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.121 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.09 -53.3 47.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.66 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -53.89 -42.91 70.75 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-N 116.363 -0.38 . . . . 0.0 112.153 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 3.9 ttpt -73.94 -44.22 55.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.589 0.233 . . . . 0.0 111.028 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 -65.35 -43.48 90.71 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.074 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.417 ' C ' ' H ' ' A' ' 65' ' ' VAL . 3.6 m-85 -85.91 -19.22 30.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.879 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.9 mtt-85 60.44 5.27 0.83 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.927 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.417 ' H ' ' C ' ' A' ' 63' ' ' PHE . 34.5 m -76.12 155.17 5.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.53 159.14 0.78 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.524 -178.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.8 pttp -69.94 -27.16 64.52 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.892 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.7 t -81.25 -12.33 59.14 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.257 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.441 ' OE1' ' N ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -89.97 -12.99 37.08 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.598 -179.78 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.1 p -105.6 100.1 9.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-O 121.161 0.505 . . . . 0.0 110.325 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.2 t -117.24 122.08 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.907 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.471 ' C ' ' H ' ' A' ' 74' ' ' LYS . 46.7 mt -89.96 90.76 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.635 178.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -66.46 3.98 0.85 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.95 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.471 ' H ' ' C ' ' A' ' 72' ' ' ILE . 10.4 mttt 169.53 140.62 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 76' ' ' GLU . . . 130.88 -16.99 5.25 Favored Glycine 0 C--N 1.321 -0.294 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -178.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 75' ' ' GLY . 50.3 mt-10 -35.11 -46.32 0.33 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.373 -0.414 . . . . 0.0 111.034 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.4 tt -130.02 -42.97 1.22 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.872 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -60.88 159.01 28.3 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.842 -0.503 . . . . 0.0 111.842 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.4 mtm-85 -72.99 -32.8 65.41 Favored 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -69.42 144.48 53.33 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 177.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.511 ' NZ ' ' HG ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -152.38 150.64 29.91 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 118.96 -1.096 . . . . 0.0 111.507 -177.714 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -147.79 113.42 5.68 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 8.4 mt -109.63 132.27 58.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.348 -178.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.436 ' HZ2' ' HA3' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -102.93 117.43 34.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.271 -179.315 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.401 HG21 ' CD2' ' A' ' 63' ' ' PHE . 1.8 mp -105.59 98.94 7.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.209 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.43 HG21 HD13 ' A' ' 86' ' ' ILE . 20.6 mt -81.51 151.52 4.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.478 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 9.4 m-20 42.11 80.48 0.28 Allowed Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.861 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -73.31 133.58 19.53 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.771 2.314 . . . . 0.0 112.455 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -118.26 -26.38 6.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.533 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -145.86 117.49 8.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.939 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.3 tt -112.11 113.98 51.49 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.509 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -65.9 143.49 73.26 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.253 1.968 . . . . 0.0 111.757 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.403 ' O ' ' N ' ' A' ' 97' ' ' ALA . 2.7 Cg_endo -49.01 -24.56 7.61 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.956 2.437 . . . . 0.0 111.684 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -59.47 -58.77 7.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.401 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.0 t -75.98 -24.85 16.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.513 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.557 ' O ' ' N ' ' A' ' 100' ' ' ASN . . . -75.28 -28.56 59.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.784 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 93' ' ' PRO . . . -54.95 -31.23 60.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.62 0.248 . . . . 0.0 111.198 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.26 -4.72 48.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.078 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 51.2 mm -116.95 -18.48 6.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.729 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.557 ' N ' ' O ' ' A' ' 96' ' ' ALA . 1.1 m-80 -93.21 -8.5 42.19 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.005 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.443 ' C ' ' O ' ' A' ' 100' ' ' ASN . 11.8 mt -27.61 -92.92 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 O-C-N 123.579 0.549 . . . . 0.0 111.77 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 40.84 30.74 0.1 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.151 0.501 . . . . 0.0 110.736 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 28.2 t60 -75.1 0.39 16.31 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.834 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.468 ' C ' ' H ' ' A' ' 106' ' ' HIS . 0.8 OUTLIER -140.0 -32.81 0.6 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.279 -179.875 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -77.39 23.22 0.21 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.472 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.468 ' H ' ' C ' ' A' ' 104' ' ' HIS . 7.0 t60 -63.65 -100.79 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.572 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.434 ' N ' ' CG ' ' A' ' 106' ' ' HIS . 17.2 m170 48.1 -125.92 1.83 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.866 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.195 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.46 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.624 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 62.0 p . . . . . 0 N--CA 1.439 -0.981 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.624 ' HB2' ' O ' ' A' ' 6' ' ' SER . . . 151.19 -25.85 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.449 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 16' ' ' VAL . 0.7 OUTLIER -159.51 151.44 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.595 -179.768 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 m -139.05 136.2 35.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.326 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 10' ' ' VAL . 30.8 m -101.35 99.8 9.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.262 0.553 . . . . 0.0 110.181 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -80.28 -151.97 0.08 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.533 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -107.77 6.79 27.89 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -117.77 -25.35 6.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.488 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 170.25 -126.91 1.4 Allowed Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.468 ' N ' HD23 ' A' ' 15' ' ' LEU . 1.6 pt? -147.89 150.77 34.73 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.97 0.414 . . . . 0.0 111.208 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.46 ' O ' HG23 ' A' ' 8' ' ' VAL . 61.7 t -106.88 139.63 27.76 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.117 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.74 102.65 9.6 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.562 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 9.1 mtm180 -107.91 111.04 22.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.02 -179.202 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.648 HD13 HG12 ' A' ' 40' ' ' VAL . 4.1 pp -142.02 -179.64 6.34 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.904 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.623 ' N ' HD12 ' A' ' 19' ' ' LEU . 53.6 t80 -111.06 105.22 13.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.756 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.42 HD11 HD11 ' A' ' 55' ' ' LEU . 6.0 mm -71.96 135.25 28.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.573 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -124.12 87.72 53.23 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.672 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.2 161.67 42.47 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.622 2.214 . . . . 0.0 112.555 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.26 46.9 2.53 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.661 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.884 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . . . -92.22 -70.95 0.67 Allowed 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.411 ' CB ' ' O ' ' A' ' 25' ' ' ALA . 0.9 OUTLIER 160.01 -22.09 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.06 179.3 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -171.36 140.73 1.47 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.049 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.9 86.89 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 121.429 0.633 . . . . 0.0 109.918 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.49 133.53 46.36 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.481 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.521 HG23 HG23 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -89.16 86.91 2.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.237 179.039 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -113.71 19.33 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.853 -178.151 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -143.74 37.39 1.45 Allowed Glycine 0 C--N 1.333 0.406 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.826 ' CD2' HG13 ' A' ' 38' ' ' VAL . 21.3 mt -73.27 120.11 18.43 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.798 -0.701 . . . . 0.0 109.913 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.487 ' HB3' ' H ' ' A' ' 37' ' ' GLU . 26.8 t-80 -102.05 157.97 16.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.023 0.44 . . . . 0.0 111.383 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.97 -18.76 73.01 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.48 -18.35 8.5 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.487 ' H ' ' HB3' ' A' ' 34' ' ' HIS . 11.2 mm-40 -134.32 -176.43 4.2 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.988 0.423 . . . . 0.0 110.66 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.826 HG13 ' CD2' ' A' ' 33' ' ' LEU . 55.6 t -143.66 121.98 6.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.5 ttpp -121.86 113.7 20.01 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.879 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.648 HG12 HD13 ' A' ' 19' ' ' LEU . 10.1 p -114.88 142.88 26.05 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.921 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.884 ' HB1' ' HB2' ' A' ' 25' ' ' ALA . . . -107.84 107.67 18.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.322 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.419 HG13 ' N ' ' A' ' 43' ' ' THR . 1.4 tp -93.15 148.12 4.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.419 ' N ' HG13 ' A' ' 42' ' ' ILE . 14.1 t -95.28 38.79 1.13 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.05 0.452 . . . . 0.0 110.831 -178.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.99 144.59 28.86 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.013 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.511 ' HG2' ' CB ' ' A' ' 50' ' ' GLN . 3.7 Cg_exo -51.98 175.36 0.07 OUTLIER 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 123.059 2.506 . . . . 0.0 112.441 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.92 3.67 5.88 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 123.134 2.556 . . . . 0.0 113.342 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.5 p -102.68 143.99 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.597 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.466 ' O ' ' C ' ' A' ' 49' ' ' GLY . 3.7 m-20 -62.06 -60.92 2.91 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.018 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.466 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . -30.72 -43.98 0.08 OUTLIER Glycine 0 CA--C 1.53 1.026 0 N-CA-C 111.744 -0.543 . . . . 0.0 111.744 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.511 ' CB ' ' HG2' ' A' ' 45' ' ' PRO . 0.8 OUTLIER -82.6 -42.07 18.73 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.478 0.18 . . . . 0.0 111.28 -179.612 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 48' ' ' ASP . . . -68.17 -54.16 19.89 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.948 0.404 . . . . 0.0 109.966 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 48' ' ' ASP . 19.3 t-20 -48.72 -44.72 38.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.147 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 58.2 m -54.56 -44.7 73.14 Favored 'General case' 0 N--CA 1.461 0.075 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.46 -42.58 82.79 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.059 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.434 ' CD2' HD11 ' A' ' 83' ' ' ILE . 2.0 tp -54.45 -60.69 3.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.625 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -58.04 -23.41 21.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.2 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.401 ' O ' ' C ' ' A' ' 58' ' ' PHE . 32.8 tttp -79.32 -65.49 0.99 Allowed 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.528 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.401 ' C ' ' O ' ' A' ' 57' ' ' LYS . 3.8 t80 -36.33 -55.37 0.81 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.89 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.562 HD13 ' CD1' ' A' ' 63' ' ' PHE . 4.3 mm? -68.42 -66.16 0.61 Allowed 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.157 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -40.07 -36.28 0.83 Allowed Glycine 0 CA--C 1.529 0.963 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.066 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -82.02 -60.76 2.11 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.762 0.315 . . . . 0.0 111.112 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -58.61 -40.71 84.04 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.533 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.736 ' HB3' HG23 ' A' ' 65' ' ' VAL . 15.1 m-85 -86.27 -18.26 32.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.266 -0.425 . . . . 0.0 109.916 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.9 mtm180 60.41 4.16 0.66 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.759 178.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.736 HG23 ' HB3' ' A' ' 63' ' ' PHE . 6.1 t -65.42 -125.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 120.905 0.383 . . . . 0.0 110.154 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.485 ' N ' HG12 ' A' ' 65' ' ' VAL . . . -145.65 164.15 32.65 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.23 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.9 ptmt -75.28 -27.75 59.5 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.496 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.1 t -78.38 -14.74 59.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.637 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.402 ' O ' ' O ' ' A' ' 84' ' ' LYS . 0.9 OUTLIER -97.73 -15.02 20.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.752 179.718 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.465 HG13 HG23 ' A' ' 83' ' ' ILE . 10.9 t -95.43 99.6 9.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.906 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -107.48 121.55 60.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.503 -179.071 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 63.0 mt -84.94 95.41 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.168 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -72.86 -4.06 29.47 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.92 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 10.6 mttp 165.9 142.31 0.02 OUTLIER 'General case' 0 C--N 1.339 0.151 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.6 -15.36 6.7 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -35.03 -39.08 0.09 Allowed 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.4 mt -132.13 10.4 4.55 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -123.55 154.03 17.34 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -55.91 -27.7 53.32 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.949 0.404 . . . . 0.0 110.044 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -69.0 160.7 30.45 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.662 ' HE3' HD12 ' A' ' 83' ' ' ILE . 7.7 tttt -150.87 137.86 19.14 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -140.62 75.93 1.53 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.662 HD12 ' HE3' ' A' ' 81' ' ' LYS . 52.6 mt -82.56 151.03 4.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.908 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.447 ' HE3' ' N ' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -123.45 122.57 38.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.751 179.808 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.447 ' N ' ' HE3' ' A' ' 84' ' ' LYS . 1.9 mp -99.79 104.82 16.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.823 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 43.4 mt -87.64 149.8 3.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.437 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 57.5 t-20 43.64 54.11 10.71 Favored Pre-proline 0 CA--C 1.532 0.262 0 CA-C-O 120.816 0.341 . . . . 0.0 110.11 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.437 ' CD ' ' N ' ' A' ' 87' ' ' ASN . 2.7 Cg_endo -45.16 146.13 2.96 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.979 2.452 . . . . 0.0 112.202 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 -121.26 -38.33 2.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.503 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -143.96 117.73 9.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.062 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.9 tt -111.25 116.74 50.79 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.237 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -65.29 151.05 86.54 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 122.351 2.034 . . . . 0.0 111.734 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.617 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 2.5 Cg_endo -51.47 -35.16 54.35 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.786 2.324 . . . . 0.0 111.991 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -45.23 -58.29 3.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.378 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.7 t -77.39 -19.89 14.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.245 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.617 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -74.63 -30.8 61.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.907 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.18 -22.91 31.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.635 0.255 . . . . 0.0 111.213 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -99.85 -16.19 18.13 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.163 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 87.7 mt -104.55 -35.66 3.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.062 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.324 -179.442 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.624 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 15.1 m . . . . . 0 N--CA 1.435 -1.175 0 CA-C-O 121.107 0.479 . . . . 0.0 110.078 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.624 ' HB2' ' O ' ' A' ' 6' ' ' SER . . . 153.99 -19.61 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.034 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.0 p -154.67 154.27 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.276 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.2 m -144.89 117.82 8.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.363 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.405 ' H ' HG22 ' A' ' 10' ' ' VAL . 2.8 m -88.27 97.75 7.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.792 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.84 -155.32 0.06 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.434 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -107.62 10.45 29.09 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -123.24 -24.67 4.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.312 -178.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.576 ' HA3' ' HZ1' ' A' ' 84' ' ' LYS . . . 172.06 -125.15 1.15 Allowed Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -152.36 148.45 27.51 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 120.862 0.363 . . . . 0.0 111.344 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.4 t -107.29 142.72 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.751 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.51 ' HB3' ' HZ3' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -115.37 104.6 11.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.001 0.429 . . . . 0.0 110.322 179.866 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.557 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 2.3 mtm180 -105.96 119.28 38.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.194 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.663 HD11 HG12 ' A' ' 21' ' ' ILE . 3.9 pp -149.59 179.65 7.82 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.281 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.656 ' N ' HD12 ' A' ' 19' ' ' LEU . 53.9 t80 -105.71 99.36 8.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.515 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.663 HG12 HD11 ' A' ' 19' ' ' LEU . 2.2 mm -69.31 124.9 26.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.599 ' NE2' ' O ' ' A' ' 23' ' ' PRO . 0.3 OUTLIER -121.23 86.64 43.37 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.945 -179.493 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.599 ' O ' ' NE2' ' A' ' 22' ' ' GLN . 3.4 Cg_exo -74.11 161.1 41.59 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.706 2.271 . . . . 0.0 111.735 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.502 ' CB ' ' O ' ' A' ' 23' ' ' PRO . 2.5 mmpt? 88.33 30.05 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.275 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.906 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . . . -99.16 172.64 7.24 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.2 m -75.64 -12.77 60.27 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.069 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -176.68 163.4 2.33 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.154 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.492 ' HA ' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -79.43 90.98 5.06 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.269 0.556 . . . . 0.0 109.532 177.866 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.2 m -132.15 134.28 45.23 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.526 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.447 HG22 HD21 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -86.69 73.34 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.363 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.92 18.68 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 114.863 -1.062 . . . . 0.0 112.35 -178.121 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -143.41 38.29 1.4 Allowed Glycine 0 N--CA 1.459 0.209 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.807 ' CD2' HG13 ' A' ' 38' ' ' VAL . 12.1 mt -74.06 128.94 36.84 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.533 -0.833 . . . . 0.0 110.192 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.417 ' HB3' ' H ' ' A' ' 37' ' ' GLU . 13.0 t-80 -111.75 156.33 22.1 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.174 0.512 . . . . 0.0 111.355 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.24 -25.75 66.93 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -119.18 -13.04 9.37 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 121.226 -0.19 . . . . 0.0 110.737 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.417 ' H ' ' HB3' ' A' ' 34' ' ' HIS . 45.3 mm-40 -134.81 -178.27 5.0 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.868 0.366 . . . . 0.0 110.503 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.807 HG13 ' CD2' ' A' ' 33' ' ' LEU . 43.0 t -143.6 117.73 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -116.37 110.36 18.59 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.702 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.485 HG12 HD13 ' A' ' 19' ' ' LEU . 7.9 p -110.8 136.16 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.821 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.906 ' HB1' ' HB2' ' A' ' 25' ' ' ALA . . . -100.83 111.12 23.27 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.575 HD11 ' HB3' ' A' ' 54' ' ' HIS . 20.4 tt -101.68 151.02 5.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.8 t -91.06 19.85 5.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.676 -177.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.437 ' HB1' ' CD ' ' A' ' 45' ' ' PRO . . . -97.33 168.87 9.45 Favored Pre-proline 0 C--N 1.328 -0.351 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.488 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.58 ' HB2' HG12 ' A' ' 47' ' ' VAL . 3.7 Cg_exo -78.87 166.87 22.92 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 123.402 2.735 . . . . 0.0 111.94 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -74.77 8.52 2.29 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 123.027 2.485 . . . . 0.0 112.551 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.58 HG12 ' HB2' ' A' ' 45' ' ' PRO . 14.8 p -95.89 150.4 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.43 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.449 ' O ' ' N ' ' A' ' 52' ' ' ASN . 0.7 OUTLIER -64.21 -61.78 2.03 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.114 -179.33 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . -33.28 -56.52 0.56 Allowed Glycine 0 CA--C 1.529 0.956 0 N-CA-C 111.971 -0.451 . . . . 0.0 111.971 -179.232 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.434 ' N ' ' CD ' ' A' ' 50' ' ' GLN . 3.0 mp0 -78.09 -49.89 13.07 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.64 -60.38 3.94 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.882 0.372 . . . . 0.0 110.546 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.449 ' N ' ' O ' ' A' ' 48' ' ' ASP . 39.3 t-20 -42.32 -54.27 3.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.836 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.8 m -41.57 -51.67 3.9 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.75 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.575 ' HB3' HD11 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -63.99 -48.59 75.82 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.166 -179.952 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.3 mp -47.53 -45.86 27.13 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.672 0.272 . . . . 0.0 110.928 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -66.45 -26.77 38.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.223 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 15.1 ttmm -82.18 -48.08 11.73 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.515 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -53.02 -49.32 66.49 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.737 -0.21 . . . . 0.0 111.424 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.569 ' N ' HD22 ' A' ' 59' ' ' LEU . 3.8 mm? -79.56 -41.56 26.95 Favored 'General case' 0 C--O 1.225 -0.237 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.62 -38.5 71.9 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.464 ' CG ' ' N ' ' A' ' 62' ' ' GLN . 5.9 ptmm? -81.91 -42.77 19.05 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.464 ' N ' ' CG ' ' A' ' 61' ' ' LYS . 33.0 mm-40 -71.22 -45.91 62.27 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.727 0.299 . . . . 0.0 111.024 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.445 ' HB3' HG22 ' A' ' 65' ' ' VAL . 0.7 OUTLIER -84.26 -18.15 37.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.164 -179.889 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.0 mtp180 60.67 15.94 6.21 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.02 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.445 HG22 ' HB3' ' A' ' 63' ' ' PHE . 33.7 m -89.6 149.76 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -49.34 157.64 0.47 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.355 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -73.43 -28.5 62.01 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.591 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.5 t -71.86 -11.8 60.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.901 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -97.93 -10.51 24.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.198 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.8 t -95.81 98.68 8.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.4 t -111.16 122.8 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.25 -178.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.3 mt -84.48 88.89 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.898 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.418 ' O ' ' CB ' ' A' ' 74' ' ' LYS . 33.3 mt-10 -66.66 0.44 2.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.309 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.418 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 8.2 mttm 160.44 127.67 0.0 OUTLIER 'General case' 0 C--N 1.34 0.159 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.456 ' O ' ' C ' ' A' ' 76' ' ' GLU . . . 140.35 -8.88 2.93 Favored Glycine 0 CA--C 1.517 0.176 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.456 ' C ' ' O ' ' A' ' 75' ' ' GLY . 6.3 mm-40 -29.95 -47.65 0.08 Allowed 'General case' 0 N--CA 1.466 0.335 0 O-C-N 123.757 0.328 . . . . 0.0 111.054 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.0 tt -126.83 -42.39 1.76 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.187 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -55.52 153.57 13.64 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 116.289 -0.414 . . . . 0.0 112.255 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.625 ' HE ' ' N ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -62.78 -34.06 76.47 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.003 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.453 ' O ' ' HA2' ' A' ' 75' ' ' GLY . 25.3 t60 -68.49 143.99 54.79 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.838 ' CE ' HD12 ' A' ' 83' ' ' ILE . 9.8 tttm -139.59 145.72 38.92 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.211 -178.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.421 ' HG2' ' NE2' ' A' ' 80' ' ' HIS . 2.4 mt-30 -146.94 79.05 1.51 Allowed 'General case' 0 C--O 1.233 0.2 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.838 HD12 ' CE ' ' A' ' 81' ' ' LYS . 40.2 mt -82.38 143.39 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.045 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.576 ' HZ1' ' HA3' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -109.67 121.06 44.37 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.671 -179.569 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.526 HG22 ' O ' ' A' ' 85' ' ' ILE . 1.5 mp -105.33 94.39 3.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.274 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 55.5 mt -82.27 144.38 10.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 55.36 79.25 0.35 Allowed Pre-proline 0 C--N 1.33 -0.248 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.203 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -74.56 128.94 12.27 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.77 2.313 . . . . 0.0 112.36 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -112.32 -29.7 7.44 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.236 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -143.64 114.28 7.6 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.189 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.587 HG23 ' O ' ' A' ' 91' ' ' ILE . 3.5 tt -109.2 110.17 60.48 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.456 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -65.81 174.6 5.41 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 122.353 2.035 . . . . 0.0 112.03 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.666 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 3.2 Cg_exo -71.83 -19.81 26.81 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.661 2.241 . . . . 0.0 112.201 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -49.48 -59.3 3.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.96 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 54.8 t -78.99 -25.54 13.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.288 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.666 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -74.2 -28.81 61.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.138 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 93' ' ' PRO . . . -65.43 -21.34 66.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.185 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.8 pp -116.68 -8.18 11.46 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.13 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.49 HD13 ' HA ' ' A' ' 99' ' ' ILE . 17.4 mm -103.88 -47.97 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.3 m120 . . . . . 0 C--N 1.332 -0.159 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.425 179.77 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.614 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 5.9 m . . . . . 0 N--CA 1.436 -1.167 0 CA-C-O 121.141 0.496 . . . . 0.0 110.449 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.614 ' HB2' ' O ' ' A' ' 6' ' ' SER . . . 150.89 -18.96 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.109 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 16' ' ' VAL . 1.7 p -155.65 154.69 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.801 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.401 ' N ' ' CG2' ' A' ' 8' ' ' VAL . 0.9 OUTLIER -137.9 143.32 40.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.093 -179.913 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.2 m -113.6 105.02 17.93 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.48 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.435 HD21 HG23 ' A' ' 16' ' ' VAL . 9.6 m-80 -92.22 -154.94 0.4 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.36 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -107.6 5.4 26.92 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -113.52 -22.05 10.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.614 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.62 -124.05 1.22 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.19 153.86 35.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.983 0.42 . . . . 0.0 111.398 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.435 HG23 HD21 ' A' ' 11' ' ' ASN . 58.1 t -110.84 131.86 60.88 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.962 179.245 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.502 HD23 HD21 ' A' ' 59' ' ' LEU . 11.2 tp -109.47 102.73 11.58 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.976 0.417 . . . . 0.0 110.44 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.522 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 49.2 mtt180 -104.08 119.33 38.7 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.534 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.767 HD21 ' NZ ' ' A' ' 81' ' ' LYS . 3.5 pp -148.01 179.62 7.61 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.203 0.525 . . . . 0.0 111.553 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.576 ' N ' HD12 ' A' ' 19' ' ' LEU . 33.3 t80 -112.13 106.22 14.78 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.517 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.648 HG12 HD11 ' A' ' 19' ' ' LEU . 2.8 mm -76.58 135.14 27.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.026 -178.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -122.18 91.2 49.09 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.493 -0.776 . . . . 0.0 108.917 178.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -72.2 154.02 56.78 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.685 2.257 . . . . 0.0 112.822 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.2 mtmp? 76.63 42.64 0.15 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.59 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.904 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . . . -100.24 167.85 10.17 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 178.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 98.1 p -62.05 -19.43 62.89 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.199 -0.6 . . . . 0.0 109.962 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -176.29 170.63 2.57 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.53 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.482 ' HA ' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -83.27 90.3 7.11 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.667 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.3 m -131.06 143.63 50.83 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.775 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.561 HG22 HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -93.03 74.33 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.289 179.05 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -103.64 19.05 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.608 -177.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.431 ' HA3' ' HB3' ' A' ' 39' ' ' LYS . . . -144.41 35.87 1.51 Allowed Glycine 0 C--N 1.332 0.35 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.779 ' CD2' HG13 ' A' ' 38' ' ' VAL . 15.2 mt -71.19 122.09 19.54 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.596 -0.802 . . . . 0.0 109.929 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -110.25 162.52 14.53 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.495 -178.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -72.89 -28.21 67.33 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -110.68 -9.74 14.51 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -144.6 -178.82 6.19 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-O 120.861 0.363 . . . . 0.0 110.796 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.779 HG13 ' CD2' ' A' ' 33' ' ' LEU . 55.3 t -143.39 113.74 2.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.431 ' HB3' ' HA3' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -112.35 118.48 35.34 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.876 -179.688 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.699 HG12 HD13 ' A' ' 19' ' ' LEU . 8.8 p -123.02 133.19 69.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.006 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.904 ' HB1' ' HB2' ' A' ' 25' ' ' ALA . . . -98.27 126.6 43.82 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.675 HD11 ' HB3' ' A' ' 54' ' ' HIS . 20.8 tt -116.4 145.75 21.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.8 t -87.21 23.01 1.93 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.835 -178.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.9 143.86 27.41 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.834 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.481 ' HG2' ' CB ' ' A' ' 50' ' ' GLN . 3.4 Cg_exo -55.78 166.34 2.95 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.566 2.177 . . . . 0.0 111.934 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -76.52 11.56 1.85 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.985 2.457 . . . . 0.0 112.255 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.622 HG13 ' H ' ' A' ' 50' ' ' GLN . 9.5 p -94.72 150.16 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.236 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -63.83 -53.35 52.1 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.881 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -39.91 -47.95 3.31 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 121.234 -0.508 . . . . 0.0 111.904 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.622 ' H ' HG13 ' A' ' 47' ' ' VAL . 1.2 tp60 -85.02 -50.17 7.68 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.57 -49.92 75.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.983 0.42 . . . . 0.0 110.433 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -57.69 -52.32 65.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.054 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.5 p -52.28 -47.47 65.86 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.88 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.675 ' HB3' HD11 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -61.31 -47.03 87.81 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-O 120.726 0.298 . . . . 0.0 110.281 179.393 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.565 HD21 ' NZ ' ' A' ' 81' ' ' LYS . 0.2 OUTLIER -49.43 -61.41 2.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.545 -179.785 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -55.36 -21.63 9.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.649 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -85.11 -60.66 1.97 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.034 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -53.9 -38.69 65.08 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.151 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.502 HD21 HD23 ' A' ' 17' ' ' LEU . 0.8 OUTLIER -83.69 -39.33 20.31 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.675 -179.79 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.08 -37.42 93.89 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.2 ptmm? -80.74 -31.3 36.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.546 0.213 . . . . 0.0 111.297 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.59 -46.51 21.95 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.007 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.775 ' HB3' HG23 ' A' ' 65' ' ' VAL . 40.6 m-85 -85.88 -18.4 32.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.488 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 32.7 mtp180 59.22 5.03 0.52 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.926 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.775 HG23 ' HB3' ' A' ' 63' ' ' PHE . 21.8 t -65.32 -118.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 121.027 0.441 . . . . 0.0 110.088 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.566 ' N ' HG12 ' A' ' 65' ' ' VAL . . . -148.55 155.62 41.37 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.034 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.06 -29.48 63.0 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -75.77 -13.92 60.31 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.883 179.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -103.18 -15.6 15.97 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.97 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.507 HG13 ' CG2' ' A' ' 83' ' ' ILE . 6.7 t -88.42 99.91 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.2 t -105.49 117.0 50.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.25 -178.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.413 HG12 ' CD1' ' A' ' 83' ' ' ILE . 51.8 mt -87.86 85.48 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.376 178.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -67.54 5.22 0.84 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.708 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.2 mttp 162.43 142.1 0.01 OUTLIER 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 80' ' ' HIS . . . 127.95 -12.79 6.46 Favored Glycine 0 C--N 1.323 -0.186 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 75' ' ' GLY . 5.8 mt-10 -33.83 -47.1 0.24 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.417 -0.392 . . . . 0.0 111.151 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.5 tp -125.45 -43.84 1.88 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.44 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -59.64 151.88 35.94 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.9 mtt85 -63.05 -29.31 70.72 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.465 ' O ' ' HA2' ' A' ' 75' ' ' GLY . 0.5 OUTLIER -68.05 157.82 34.34 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.056 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.767 ' NZ ' HD21 ' A' ' 19' ' ' LEU . 6.4 tttt -156.09 147.27 22.39 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.662 -178.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -147.21 111.61 5.22 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.507 ' CG2' HG13 ' A' ' 70' ' ' VAL . 6.1 mm -109.68 140.14 29.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.609 -178.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.87 111.59 23.1 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.048 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.573 HG23 HG21 ' A' ' 65' ' ' VAL . 1.8 mp -96.51 99.89 9.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.351 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 36.9 mt -85.23 148.66 4.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.578 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 46.1 58.31 16.08 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.651 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -46.05 129.27 12.41 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.882 2.388 . . . . 0.0 112.06 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.436 ' H ' HG22 ' A' ' 65' ' ' VAL . 41.1 tp60 -109.69 -30.01 8.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.699 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -147.65 121.61 9.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.609 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 tt -112.33 113.37 51.34 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.067 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -68.59 157.77 60.46 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.419 2.079 . . . . 0.0 112.202 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.66 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 2.5 Cg_endo -51.82 -27.73 28.24 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 123.035 2.49 . . . . 0.0 111.893 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -53.82 -59.4 4.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.834 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 16.9 t -76.57 -20.9 14.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.871 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.66 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -75.6 -31.7 60.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.7 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -65.74 -19.71 66.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.249 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 77.0 mt -102.09 -21.07 14.51 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.048 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 66.1 mt -98.73 -31.89 3.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.991 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.5 m120 . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.459 179.839 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.586 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.441 -0.883 0 CA-C-O 121.32 0.581 . . . . 0.0 109.76 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.586 ' HB2' ' O ' ' A' ' 6' ' ' SER . . . 159.68 -17.59 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.584 -1.189 . . . . 0.0 109.206 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.491 HG22 ' N ' ' A' ' 9' ' ' THR . 8.0 p -160.28 160.01 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.575 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.491 ' N ' HG22 ' A' ' 8' ' ' VAL . 1.7 m -150.95 125.6 9.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.427 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.407 HG22 ' H ' ' A' ' 10' ' ' VAL . 2.4 m -91.65 101.28 12.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.062 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -79.58 -158.04 0.15 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.11 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -107.05 11.26 29.86 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -124.07 -18.92 5.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.337 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.504 ' HA3' ' HZ3' ' A' ' 84' ' ' LYS . . . 166.43 -123.71 1.17 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.409 HD11 ' CZ ' ' A' ' 63' ' ' PHE . 0.3 OUTLIER -149.24 138.34 21.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.0 0.429 . . . . 0.0 111.391 -179.747 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 48.6 t -99.39 106.35 18.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.198 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.0 tp -87.39 114.0 23.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.024 0.44 . . . . 0.0 111.142 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.561 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 14.8 mtt-85 -111.17 126.29 54.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.658 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.463 ' HB2' HG12 ' A' ' 38' ' ' VAL . 0.8 OUTLIER -149.45 175.16 11.72 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 121.956 0.884 . . . . 0.0 112.86 -179.038 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -106.23 91.81 3.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 113.867 -1.515 . . . . 0.0 108.565 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.418 HG13 ' NZ ' ' A' ' 81' ' ' LYS . 1.0 OUTLIER -73.53 131.14 35.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.222 -178.104 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.14 88.8 53.62 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.903 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.14 161.0 39.05 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.767 2.311 . . . . 0.0 112.793 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 20.3 mtmt 73.59 48.61 0.15 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.207 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.933 ' CB ' ' HB1' ' A' ' 41' ' ' ALA . . . -99.55 -62.88 1.18 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 25' ' ' ALA . 4.3 t 153.08 -28.52 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.991 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.443 ' CG ' ' O ' ' A' ' 26' ' ' SER . 79.1 mtt180 -163.4 142.1 8.11 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.81 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.47 94.22 0.08 Allowed 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.448 0.642 . . . . 0.0 109.973 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.4 p -123.02 126.88 47.95 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.874 -179.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.673 HG22 HD21 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -92.07 63.01 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.454 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.607 HG13 ' O ' ' A' ' 31' ' ' VAL . 0.3 OUTLIER -96.56 17.89 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 114.583 -1.19 . . . . 0.0 112.338 -177.821 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . -141.59 22.6 2.52 Favored Glycine 0 C--N 1.32 -0.351 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -178.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.673 HD21 HG22 ' A' ' 30' ' ' ILE . 19.3 mt -59.45 120.66 9.78 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.07 -0.565 . . . . 0.0 109.824 178.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.405 ' O ' ' O ' ' A' ' 37' ' ' GLU . 2.3 t60 -111.6 155.06 23.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.492 -178.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -66.93 -19.7 69.97 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.649 -0.981 . . . . 0.0 110.649 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -121.15 -5.07 9.48 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.555 0.217 . . . . 0.0 110.614 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.405 ' O ' ' O ' ' A' ' 34' ' ' HIS . 57.2 mt-10 -148.54 -178.46 6.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.991 0.424 . . . . 0.0 110.651 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.463 HG12 ' HB2' ' A' ' 19' ' ' LEU . 6.8 t -141.72 110.96 2.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 13.0 mtpt -110.36 103.15 11.76 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.146 -0.621 . . . . 0.0 110.785 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.7 p -114.27 136.43 50.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.701 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.933 ' HB1' ' CB ' ' A' ' 25' ' ' ALA . . . -99.98 93.95 6.03 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.979 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.758 HD11 ' HB3' ' A' ' 54' ' ' HIS . 19.7 tt -80.04 148.59 5.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.3 t -93.81 29.41 2.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.001 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.37 161.09 26.46 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.855 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -77.21 177.61 8.65 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 123.478 2.785 . . . . 0.0 112.093 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -77.31 5.5 5.05 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 123.168 2.578 . . . . 0.0 112.644 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.437 HG13 ' H ' ' A' ' 50' ' ' GLN . 11.7 p -98.96 155.86 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 120.791 0.329 . . . . 0.0 110.738 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.42 ' N ' HG22 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -69.41 -61.37 1.82 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.055 -179.709 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . -34.87 -51.93 0.83 Allowed Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.884 -0.486 . . . . 0.0 111.884 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.437 ' H ' HG13 ' A' ' 47' ' ' VAL . 2.4 mm100 -76.39 -50.56 13.87 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.121 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.74 -61.72 2.22 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.766 0.317 . . . . 0.0 110.915 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -47.07 -39.85 13.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.731 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.5 m -61.25 -51.39 69.14 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.586 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.758 ' HB3' HD11 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -55.85 -57.98 9.79 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.572 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -44.16 -57.93 3.15 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.044 0.45 . . . . 0.0 110.262 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.3 t -54.36 -26.07 15.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.127 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.421 ' N ' ' O ' ' A' ' 54' ' ' HIS . 8.4 ttpt -85.17 -63.46 1.32 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.918 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -50.74 -41.8 56.78 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.203 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.1 tp -84.67 -40.43 17.41 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.504 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -58.99 -33.64 75.08 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.0 ptmt -80.59 -37.27 31.57 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 120.59 0.233 . . . . 0.0 111.035 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -74.94 -42.39 57.79 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.431 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.549 ' HB3' HG13 ' A' ' 65' ' ' VAL . 0.7 OUTLIER -86.09 -18.83 31.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.535 179.767 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.4 mtp180 60.47 8.1 1.55 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.777 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.894 HG11 HG23 ' A' ' 85' ' ' ILE . 35.8 m -67.53 177.03 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -89.63 164.81 14.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.948 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -21.2 62.6 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -86.55 -12.65 48.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.464 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -101.62 -1.17 33.4 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.492 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.557 ' O ' HG13 ' A' ' 70' ' ' VAL . 7.7 p -110.94 100.69 11.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.014 0.435 . . . . 0.0 110.014 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 79.7 t -114.22 116.92 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.756 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.426 ' C ' ' H ' ' A' ' 74' ' ' LYS . 76.3 mt -89.94 88.48 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.23 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -72.81 10.3 0.91 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.671 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.426 ' H ' ' C ' ' A' ' 72' ' ' ILE . 7.6 mttp 167.93 145.59 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.408 ' HA2' ' O ' ' A' ' 80' ' ' HIS . . . 123.59 -17.01 7.87 Favored Glycine 0 CA--C 1.518 0.269 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -39.18 -44.33 1.19 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.655 -0.273 . . . . 0.0 111.066 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.411 ' O ' HD13 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -134.18 -43.43 0.79 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.192 -179.71 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.96 151.47 52.47 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -60.82 -32.67 72.03 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.408 ' O ' ' HA2' ' A' ' 75' ' ' GLY . 3.9 p-80 -68.89 129.97 41.45 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 177.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.561 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.6 OUTLIER -137.86 141.5 40.72 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 120.196 -0.601 . . . . 0.0 110.49 -177.312 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -139.48 114.62 9.63 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.557 HD11 ' HD3' ' A' ' 81' ' ' LYS . 4.7 mt -117.01 135.87 55.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.396 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.504 ' HZ3' ' HA3' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -104.67 106.67 17.26 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.876 -179.819 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.894 HG23 HG11 ' A' ' 65' ' ' VAL . 1.5 mp -94.68 92.06 3.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.067 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.401 HG22 ' N ' ' A' ' 87' ' ' ASN . 55.5 mt -77.47 155.39 5.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.733 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.401 ' N ' HG22 ' A' ' 86' ' ' ILE . 3.1 m120 38.39 73.32 0.78 Allowed Pre-proline 0 N--CA 1.464 0.243 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.005 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -74.32 132.92 16.98 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.673 2.249 . . . . 0.0 111.847 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -110.63 -24.16 10.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.089 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -147.52 120.19 8.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.255 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.493 HG23 ' O ' ' A' ' 91' ' ' ILE . 3.9 tt -113.96 119.55 40.66 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.951 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -66.26 147.72 83.75 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 122.224 1.949 . . . . 0.0 112.522 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.679 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 2.5 Cg_endo -51.03 -30.22 30.43 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 123.048 2.498 . . . . 0.0 112.24 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -54.23 -57.77 9.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.699 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.436 ' H ' HG23 ' A' ' 95' ' ' VAL . 1.5 t -75.11 -21.66 16.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.732 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.679 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -75.59 -34.53 60.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.024 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.71 -20.1 32.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.738 0.304 . . . . 0.0 111.075 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 27.2 mt -103.04 -25.1 13.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.077 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 86.1 mt -96.65 -27.69 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.872 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.679 -179.812 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.619 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 22.7 t . . . . . 0 N--CA 1.435 -1.184 0 CA-C-O 121.134 0.492 . . . . 0.0 110.195 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.619 ' HB2' ' O ' ' A' ' 6' ' ' SER . . . 152.63 -17.48 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.563 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.448 ' CG2' ' N ' ' A' ' 9' ' ' THR . 0.7 OUTLIER -160.27 157.73 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.6 -179.809 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.448 ' N ' ' CG2' ' A' ' 8' ' ' VAL . 1.1 m -147.66 134.46 20.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.136 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 10' ' ' VAL . 33.2 m -102.65 104.0 15.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.224 0.535 . . . . 0.0 110.492 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 35.9 m-20 -87.2 -149.98 0.16 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.166 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -107.18 2.68 24.95 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -109.17 -22.23 12.2 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.441 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.49 ' HA3' ' HZ1' ' A' ' 84' ' ' LYS . . . 160.47 -122.14 1.1 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.508 HD11 ' CE2' ' A' ' 63' ' ' PHE . 0.3 OUTLIER -147.36 147.31 30.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.946 0.403 . . . . 0.0 111.244 -179.722 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.1 t -103.85 137.23 33.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.488 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.03 99.17 7.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.935 0.398 . . . . 0.0 110.521 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.526 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 38.7 mtt180 -97.3 114.76 26.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.836 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.596 ' C ' HD12 ' A' ' 19' ' ' LEU . 4.3 pp -147.05 179.75 7.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.284 0.564 . . . . 0.0 111.664 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.565 ' N ' HD12 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -113.81 95.78 5.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.949 179.522 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.1 tp -75.35 130.78 35.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.273 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.405 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -120.51 91.83 47.13 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.638 -179.388 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.454 ' O ' ' HB2' ' A' ' 24' ' ' LYS . 3.1 Cg_exo -71.66 165.29 32.99 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.454 2.103 . . . . 0.0 112.29 -178.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 23' ' ' PRO . 16.5 mtmm 77.37 37.25 0.26 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.511 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.921 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . . . -102.41 167.41 9.97 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 17.0 t -75.41 -10.32 59.34 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 119.996 -0.682 . . . . 0.0 109.666 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.7 ttp180 -176.6 163.8 2.42 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.666 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.503 ' HA ' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -84.82 95.22 8.92 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.613 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.1 m -126.42 135.66 51.68 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.722 -178.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.469 HG22 HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -91.01 76.1 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.689 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.3 17.55 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.053 -178.023 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . -142.4 21.75 2.4 Favored Glycine 0 C--N 1.32 -0.322 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.753 ' CD2' HG13 ' A' ' 38' ' ' VAL . 19.4 mt -57.75 107.01 0.41 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.434 ' O ' ' O ' ' A' ' 37' ' ' GLU . 44.7 t-80 -94.46 157.4 16.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.559 -178.291 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -66.6 -29.26 74.47 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -112.41 -10.08 13.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.737 -0.231 . . . . 0.0 110.472 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.434 ' O ' ' O ' ' A' ' 34' ' ' HIS . 8.4 mt-10 -140.68 -176.81 4.79 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.975 0.417 . . . . 0.0 110.734 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.753 HG13 ' CD2' ' A' ' 33' ' ' LEU . 45.9 t -142.78 112.79 2.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -111.13 132.69 54.08 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.262 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.526 HG13 ' O ' ' A' ' 40' ' ' VAL . 8.5 p -147.59 124.18 2.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.651 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.921 ' HB1' ' HB2' ' A' ' 25' ' ' ALA . . . -86.94 122.4 30.75 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.828 HD11 ' HB3' ' A' ' 54' ' ' HIS . 21.2 tt -109.33 147.95 13.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.1 t -90.66 38.42 0.95 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.937 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -105.24 139.14 19.85 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.449 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.548 ' HG2' ' CB ' ' A' ' 50' ' ' GLN . 3.2 Cg_exo -56.25 170.47 1.16 Allowed 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 122.689 2.259 . . . . 0.0 112.572 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.61 24.74 0.45 Allowed 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 123.36 2.707 . . . . 0.0 113.391 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.461 HG13 ' H ' ' A' ' 50' ' ' GLN . 13.9 p -120.28 138.2 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.446 ' O ' ' C ' ' A' ' 49' ' ' GLY . 0.7 OUTLIER -53.75 -58.87 5.66 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.104 -179.427 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . -34.65 -52.9 0.81 Allowed Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.548 ' CB ' ' HG2' ' A' ' 45' ' ' PRO . 43.1 mm-40 -78.12 -39.37 41.47 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.07 -62.87 1.2 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.834 0.35 . . . . 0.0 110.511 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.439 ' N ' ' O ' ' A' ' 48' ' ' ASP . 46.2 t-20 -43.58 -47.24 7.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.876 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 18.4 m -52.99 -57.55 9.99 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.305 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.828 ' HB3' HD11 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -51.5 -50.75 59.29 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.787 0.327 . . . . 0.0 110.679 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.651 HD12 HD11 ' A' ' 83' ' ' ILE . 3.1 mm? -50.91 -43.77 59.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.198 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -69.37 -27.12 33.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.99 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -79.32 -60.5 2.34 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.842 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -46.9 -58.39 3.98 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.249 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.413 ' O ' ' HB2' ' A' ' 63' ' ' PHE . 4.6 mp -71.17 -41.47 70.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.103 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -51.17 -35.42 34.03 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.3 mttp -80.92 -58.26 3.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.662 0.268 . . . . 0.0 111.02 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -56.03 -43.87 78.21 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.102 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.508 ' CE2' HD11 ' A' ' 15' ' ' LEU . 1.6 m-85 -82.72 -18.54 40.47 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.111 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.2 mtt-85 61.59 8.48 2.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.533 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.2 m -82.9 163.14 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.443 ' O ' HG23 ' A' ' 70' ' ' VAL . . . -65.3 156.63 31.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.806 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 28.2 pttt -70.96 -28.58 64.58 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -71.42 -11.94 61.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.927 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.428 ' O ' ' O ' ' A' ' 84' ' ' LYS . 80.8 mt-30 -100.14 -7.94 24.25 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.335 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 66' ' ' ALA . 31.0 t -104.06 97.76 5.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.4 t -116.78 123.18 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -178.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.424 ' C ' ' H ' ' A' ' 74' ' ' LYS . 54.3 mt -82.33 84.55 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.166 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.157 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -60.25 -3.68 0.67 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.035 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.424 ' H ' ' C ' ' A' ' 72' ' ' ILE . 5.3 mttp 168.15 116.55 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.081 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.567 ' HA3' ' HZ2' ' A' ' 81' ' ' LYS . . . 148.62 -10.43 1.08 Allowed Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -34.14 -41.03 0.1 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.3 tp -131.47 -42.96 1.04 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.701 0.286 . . . . 0.0 111.355 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.5 149.2 48.67 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.785 -0.526 . . . . 0.0 111.785 -178.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.462 ' HD3' ' H ' ' A' ' 79' ' ' ARG . 0.1 OUTLIER -60.99 -29.43 69.68 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.387 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.429 ' O ' ' HA2' ' A' ' 75' ' ' GLY . 76.5 t60 -67.27 145.85 54.75 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 177.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.567 ' HZ2' ' HA3' ' A' ' 75' ' ' GLY . 0.0 OUTLIER -144.73 154.02 42.3 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 119.706 -0.798 . . . . 0.0 111.537 -177.195 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -162.87 78.71 0.47 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.651 HD11 HD12 ' A' ' 55' ' ' LEU . 46.8 mt -80.46 153.61 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.398 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.49 ' HZ1' ' HA3' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -120.47 111.86 18.24 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.969 -178.973 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.474 ' N ' ' HE3' ' A' ' 84' ' ' LYS . 1.4 mp -100.54 102.85 14.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.182 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 55.3 mt -85.99 153.55 3.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.551 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 18.4 m-20 40.05 79.77 0.31 Allowed Pre-proline 0 N--CA 1.467 0.41 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.692 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.51 146.1 30.51 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 123.014 2.476 . . . . 0.0 112.65 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 60.6 mm-40 -124.12 -28.91 3.66 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.043 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -146.8 117.48 7.57 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.138 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.9 tt -114.36 120.49 38.07 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.599 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.2 141.22 92.68 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.479 2.119 . . . . 0.0 112.342 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.462 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 2.5 Cg_endo -50.49 -33.94 40.18 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 123.266 2.644 . . . . 0.0 112.632 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -53.04 -54.43 35.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.13 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 16.3 t -72.22 -19.45 19.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.462 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -75.0 -25.44 58.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.809 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -62.53 -26.34 68.51 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.888 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 20.1 mt -94.99 -10.94 29.42 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.5 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 97.6 mt -102.36 -30.98 2.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.943 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 . . . . . 0 N--CA 1.462 0.15 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.821 -179.738 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.639 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 9.6 p . . . . . 0 N--CA 1.44 -0.948 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.639 ' HB2' ' O ' ' A' ' 6' ' ' SER . . . 157.87 -17.46 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.985 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.454 ' CG2' ' N ' ' A' ' 9' ' ' THR . 0.2 OUTLIER -159.38 157.76 2.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.843 -179.607 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.454 ' N ' ' CG2' ' A' ' 8' ' ' VAL . 1.3 m -144.62 141.78 29.66 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.349 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 m -107.19 101.36 12.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.298 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -81.24 -155.4 0.12 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.311 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -107.65 10.52 29.02 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -122.83 -25.26 4.66 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.241 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.62 -129.11 1.54 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.425 HD11 ' CE2' ' A' ' 63' ' ' PHE . 0.2 OUTLIER -145.46 158.74 43.79 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.171 0.51 . . . . 0.0 111.31 -179.757 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.8 t -110.03 138.47 37.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.329 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.646 HD12 HD23 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -115.61 91.16 3.52 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.689 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 4.6 mtm180 -97.06 109.26 22.05 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.4 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.731 HD12 ' N ' ' A' ' 20' ' ' TYR . 3.4 pp -145.42 178.89 7.77 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.878 0.371 . . . . 0.0 110.998 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.731 ' N ' HD12 ' A' ' 19' ' ' LEU . 31.8 t80 -110.93 104.62 13.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.3 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.465 HG22 ' HD3' ' A' ' 23' ' ' PRO . 1.7 mm -70.68 126.72 31.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.38 86.24 55.04 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.129 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.465 ' HD3' HG22 ' A' ' 21' ' ' ILE . 3.3 Cg_exo -74.77 161.18 39.76 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.634 2.223 . . . . 0.0 111.84 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.6 mtmt 73.87 43.48 0.32 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.007 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.907 ' CB ' ' HB1' ' A' ' 41' ' ' ALA . . . -91.66 -71.12 0.65 Allowed 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.2 p 162.51 -23.12 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.016 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -171.75 143.16 1.64 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.041 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.403 ' HA ' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -63.05 89.66 0.04 OUTLIER 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.673 0.749 . . . . 0.0 110.055 179.493 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.3 m -130.77 127.28 38.4 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.192 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.538 HG22 HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -83.29 65.62 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.78 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -94.03 18.28 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 114.669 -1.151 . . . . 0.0 113.016 -177.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -143.05 39.14 1.35 Allowed Glycine 0 N--CA 1.46 0.289 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.851 ' CD2' HG13 ' A' ' 38' ' ' VAL . 22.9 mt -77.78 117.69 19.4 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.557 -0.822 . . . . 0.0 109.799 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.585 ' CD2' ' H ' ' A' ' 35' ' ' GLY . 11.0 t-160 -102.25 159.46 15.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.416 -178.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.585 ' H ' ' CD2' ' A' ' 34' ' ' HIS . . . -73.47 -19.66 79.72 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -115.96 -14.05 11.26 Favored 'General case' 0 N--CA 1.461 0.11 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.413 ' H ' ' HB3' ' A' ' 34' ' ' HIS . 19.2 mt-10 -143.39 -176.23 4.86 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.322 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.851 HG13 ' CD2' ' A' ' 33' ' ' LEU . 73.2 t -144.15 121.12 5.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.37 118.48 29.56 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.646 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.496 HG23 HG23 ' A' ' 30' ' ' ILE . 8.5 p -113.42 135.01 54.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.064 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.907 ' HB1' ' CB ' ' A' ' 25' ' ' ALA . . . -100.0 104.8 16.42 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.729 HD13 ' CE1' ' A' ' 54' ' ' HIS . 0.6 OUTLIER -99.39 156.19 3.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 -179.147 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.421 ' H ' HG13 ' A' ' 42' ' ' ILE . 8.4 t -93.22 26.75 2.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.744 -178.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.462 ' H ' HG23 ' A' ' 42' ' ' ILE . . . -97.0 167.44 12.01 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.866 0.365 . . . . 0.0 110.913 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.691 ' HB2' HG22 ' A' ' 47' ' ' VAL . 3.6 Cg_exo -77.98 177.63 8.56 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 123.56 2.84 . . . . 0.0 112.165 179.119 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -77.5 0.75 9.47 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 123.009 2.473 . . . . 0.0 111.435 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.691 HG22 ' HB2' ' A' ' 45' ' ' PRO . 35.2 m -93.19 160.16 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.666 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 52' ' ' ASN . 2.3 m-20 -82.21 -47.34 12.59 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.905 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -43.07 -46.8 6.39 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.501 ' NE2' HG21 ' A' ' 47' ' ' VAL . 0.9 OUTLIER -81.49 -49.81 10.15 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 121.219 -0.192 . . . . 0.0 111.511 -179.453 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.53 -56.53 20.25 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.837 0.351 . . . . 0.0 110.06 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.452 ' N ' ' O ' ' A' ' 48' ' ' ASP . 30.8 t-20 -46.12 -46.38 17.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.086 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.5 p -50.18 -48.14 54.24 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.729 ' CE1' HD13 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -63.05 -45.58 91.56 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.11 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.599 HD22 ' CE1' ' A' ' 54' ' ' HIS . 0.1 OUTLIER -49.24 -60.92 2.39 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.308 -178.537 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -53.7 -26.53 13.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.795 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.413 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 19.1 tttt -82.16 -72.64 0.43 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.058 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.406 ' C ' ' O ' ' A' ' 57' ' ' LYS . 0.8 OUTLIER -33.85 -64.09 0.24 Allowed 'General case' 0 N--CA 1.467 0.377 0 O-C-N 123.167 0.292 . . . . 0.0 111.292 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.429 ' CD2' ' N ' ' A' ' 59' ' ' LEU . 3.6 mm? -64.99 -37.96 89.39 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 64' ' ' ARG . . . -55.17 -41.53 78.94 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.413 ' HG3' ' O ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -81.1 -52.54 7.27 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.066 0.46 . . . . 0.0 110.229 179.531 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.1 mm100 -56.11 -49.72 73.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.711 -178.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.496 ' CD2' HG21 ' A' ' 85' ' ' ILE . 2.3 m-85 -87.14 -18.99 29.14 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.627 -0.261 . . . . 0.0 111.393 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.408 ' HA ' ' O ' ' A' ' 60' ' ' GLY . 18.6 mtt180 59.98 4.1 0.57 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.582 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.441 HG21 HG23 ' A' ' 85' ' ' ILE . 33.6 m -76.35 152.3 5.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.511 ' HB3' ' NE2' ' A' ' 69' ' ' GLN . . . -48.77 158.74 0.29 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.542 -179.097 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.68 -29.56 65.91 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.308 0.575 . . . . 0.0 109.66 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.32 -13.88 59.84 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.59 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.511 ' NE2' ' HB3' ' A' ' 66' ' ' ALA . 1.2 mp0 -89.93 -6.26 55.9 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.259 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.4 t -106.0 97.23 5.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.6 t -114.42 124.53 71.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.206 0.527 . . . . 0.0 111.814 -178.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 64.2 mt -86.95 93.22 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.435 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -77.35 -1.66 31.12 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.938 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 38.8 tttt 179.6 118.95 0.05 Allowed 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.543 ' O ' ' C ' ' A' ' 76' ' ' GLU . . . 146.66 -20.27 1.65 Allowed Glycine 0 CA--C 1.516 0.122 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.543 ' C ' ' O ' ' A' ' 75' ' ' GLY . 11.1 mp0 -10.6 -66.59 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 O-C-N 124.291 0.642 . . . . 0.0 112.037 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.7 tt -118.65 -42.87 2.71 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.369 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -51.11 157.68 2.49 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 44.4 mtt-85 -68.14 -16.44 64.0 Favored 'General case' 0 CA--C 1.519 -0.231 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.516 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 62.3 t-80 -69.17 155.95 39.52 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.483 ' CE ' HD21 ' A' ' 55' ' ' LEU . 36.1 tttt -148.68 125.37 11.12 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.139 -0.625 . . . . 0.0 109.997 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.442 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 8.3 tt0 -131.55 104.74 7.13 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 15.9 mm -102.09 129.69 53.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.767 -178.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.99 99.33 9.08 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.496 HG21 ' CD2' ' A' ' 63' ' ' PHE . 2.2 mp -89.53 96.62 6.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.139 -178.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 33.4 mt -82.2 146.09 7.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.717 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 51.89 75.04 0.69 Allowed Pre-proline 0 N--CA 1.463 0.215 0 CA-C-O 120.759 0.314 . . . . 0.0 110.529 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -74.27 130.48 14.13 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 122.594 2.196 . . . . 0.0 112.096 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 21.4 mm100 -114.55 -26.08 8.06 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.948 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -145.39 116.18 7.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.399 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.558 HG23 ' O ' ' A' ' 91' ' ' ILE . 4.1 tt -112.56 114.45 50.02 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.064 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -67.13 145.62 73.67 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.29 1.993 . . . . 0.0 111.504 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.603 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 2.7 Cg_endo -51.61 -19.69 7.87 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 122.62 2.214 . . . . 0.0 111.873 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -61.14 -56.31 22.31 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.97 0.414 . . . . 0.0 110.331 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.25 -25.39 12.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.745 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.603 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -75.41 -44.61 43.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.975 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -50.33 -19.78 0.91 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.57 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 80.5 mt -102.42 -25.44 13.63 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.944 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 95.8 mt -92.14 -21.18 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.997 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 33.3 p-10 . . . . . 0 N--CA 1.463 0.199 0 CA-C-O 120.658 0.266 . . . . 0.0 111.096 -179.883 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.604 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 6.7 t . . . . . 0 N--CA 1.44 -0.926 0 CA-C-O 121.304 0.573 . . . . 0.0 110.349 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.604 ' HB2' ' O ' ' A' ' 6' ' ' SER . . . 156.36 -20.65 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.735 -1.12 . . . . 0.0 108.956 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.4 m -149.02 168.2 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.115 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 m -150.73 120.77 7.17 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.431 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.2 m -92.34 97.09 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.194 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -82.68 -163.27 0.68 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.189 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -101.39 11.71 38.7 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -119.16 -24.11 6.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.11 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.521 ' HA3' ' HZ1' ' A' ' 84' ' ' LYS . . . 165.87 -124.35 1.23 Allowed Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.414 HD11 ' CE2' ' A' ' 63' ' ' PHE . 0.3 OUTLIER -150.87 150.77 31.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.976 0.417 . . . . 0.0 111.134 -179.582 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.1 t -107.74 142.8 19.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.928 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -113.49 96.28 5.8 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 22.9 mtp85 -104.47 110.86 23.29 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.789 -179.07 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.458 HD12 ' N ' ' A' ' 20' ' ' TYR . 3.0 pp -147.52 179.66 7.51 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.051 0.453 . . . . 0.0 111.427 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.458 ' N ' HD12 ' A' ' 19' ' ' LEU . 16.0 t80 -108.36 114.64 28.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.086 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.9 mm -84.26 133.78 28.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.928 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -120.87 87.48 42.95 Favored Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -70.09 156.82 61.6 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.62 2.213 . . . . 0.0 113.413 -178.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? 69.83 49.79 0.5 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.239 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.906 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . . . -96.68 -66.92 0.87 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' A' ' 25' ' ' ALA . 1.1 m 158.56 -24.41 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.293 -0.867 . . . . 0.0 108.724 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -171.1 144.24 2.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.87 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.47 92.8 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 59.8 p -124.29 130.19 52.08 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.52 -178.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.611 HG22 HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -94.78 63.55 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.111 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.734 ' O ' HG12 ' A' ' 31' ' ' VAL . 92.7 t -96.03 19.51 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.944 -178.095 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -144.04 32.08 1.81 Allowed Glycine 0 C--N 1.334 0.457 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.83 ' CD2' HG13 ' A' ' 38' ' ' VAL . 31.8 mt -66.61 126.24 28.29 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.63 -0.785 . . . . 0.0 109.926 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.428 ' O ' ' O ' ' A' ' 37' ' ' GLU . 23.2 t-80 -112.67 157.41 21.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.042 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.06 -27.54 73.66 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -109.26 -14.49 14.46 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 115.569 -0.315 . . . . 0.0 110.81 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.428 ' O ' ' O ' ' A' ' 34' ' ' HIS . 9.0 mt-10 -141.94 -177.67 5.32 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.001 0.429 . . . . 0.0 111.081 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.83 HG13 ' CD2' ' A' ' 33' ' ' LEU . 70.7 t -143.97 115.98 2.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.707 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.4 ttpt -116.13 117.57 30.43 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.642 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.4 p -120.12 149.83 22.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.156 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.906 ' HB1' ' HB2' ' A' ' 25' ' ' ALA . . . -112.53 103.54 11.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.308 -0.406 . . . . 0.0 109.915 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.402 HG13 ' N ' ' A' ' 43' ' ' THR . 2.4 tp -86.11 146.36 6.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.44 HG22 ' H ' ' A' ' 43' ' ' THR . 0.7 OUTLIER -87.31 17.15 4.58 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.755 -178.28 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.12 149.77 36.08 Favored Pre-proline 0 C--O 1.234 0.276 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.55 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.532 ' HB2' HG22 ' A' ' 47' ' ' VAL . 3.9 Cg_exo -51.54 175.9 0.06 OUTLIER 'Trans proline' 0 N--CA 1.491 1.371 0 C-N-CA 123.241 2.627 . . . . 0.0 112.212 178.288 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -80.21 0.36 10.08 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 123.23 2.62 . . . . 0.0 112.982 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.532 HG22 ' HB2' ' A' ' 45' ' ' PRO . 0.2 OUTLIER -87.79 158.61 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.988 -179.616 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.445 ' O ' ' N ' ' A' ' 52' ' ' ASN . 17.5 m-20 -73.55 -57.57 3.9 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.001 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . -36.65 -46.4 1.11 Allowed Glycine 0 CA--C 1.529 0.969 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.507 ' HB2' HG23 ' A' ' 47' ' ' VAL . 2.1 mp0 -82.73 -52.16 7.03 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.25 -56.05 26.26 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.937 0.399 . . . . 0.0 110.403 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' A' ' 48' ' ' ASP . 40.1 t-20 -46.34 -54.65 8.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.47 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.7 m -48.81 -52.54 23.49 Favored 'General case' 0 C--O 1.23 0.066 0 C-N-CA 120.624 -0.431 . . . . 0.0 110.107 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -56.33 -56.12 25.01 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.539 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.3 mp -43.3 -60.45 1.69 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.273 0.558 . . . . 0.0 110.134 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.7 t -57.85 -29.33 35.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.312 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -76.3 -68.31 0.6 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.262 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -39.09 -48.28 1.65 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.503 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.4 HD13 ' HZ1' ' A' ' 81' ' ' LYS . 7.4 mp -76.93 -34.79 57.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.84 0.353 . . . . 0.0 110.072 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.36 -35.65 61.36 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.01 -52.16 7.73 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.919 0.39 . . . . 0.0 110.428 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -59.25 -46.93 87.19 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.848 -178.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.497 ' HB3' HG13 ' A' ' 65' ' ' VAL . 2.4 m-85 -86.13 -19.11 30.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.076 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.2 mtt85 59.24 5.27 0.55 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.352 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.529 HG11 HG23 ' A' ' 85' ' ' ILE . 27.0 m -67.35 175.33 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.199 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -86.67 163.44 17.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.263 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 29.1 pttt -70.91 -21.29 62.39 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.658 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.77 -8.76 59.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.296 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -108.43 -5.15 16.78 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.463 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.696 ' O ' HG13 ' A' ' 70' ' ' VAL . 9.8 p -101.21 101.1 11.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 121.286 0.565 . . . . 0.0 110.373 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 59.7 t -115.94 124.9 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 52.6 mt -84.85 93.67 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.905 178.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -70.01 -16.05 63.11 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.159 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt 174.81 163.9 0.24 Allowed 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.57 -2.05 73.06 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -37.94 -31.94 0.05 Allowed 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.554 HD23 ' O ' ' A' ' 77' ' ' LEU . 1.0 OUTLIER -127.04 -45.04 1.58 Allowed 'General case' 0 C--O 1.233 0.187 0 C-N-CA 121.061 -0.255 . . . . 0.0 111.0 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.404 ' C ' ' N ' ' A' ' 80' ' ' HIS . . . -58.84 148.22 39.55 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.435 ' HB3' ' CE1' ' A' ' 20' ' ' TYR . 10.4 mtt180 -50.19 -18.55 0.6 Allowed 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.404 ' N ' ' C ' ' A' ' 78' ' ' GLY . 1.7 m80 -69.87 165.35 21.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.493 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.596 ' HE3' HD12 ' A' ' 83' ' ' ILE . 2.0 tttt -151.97 132.87 14.18 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -139.77 82.06 1.86 Allowed 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.596 HD12 ' HE3' ' A' ' 81' ' ' LYS . 92.2 mt -95.11 139.61 18.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.839 -179.323 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.521 ' HZ1' ' HA3' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -108.49 126.44 52.91 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.211 -179.129 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.589 HG22 ' O ' ' A' ' 85' ' ' ILE . 1.4 mp -106.1 98.75 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.967 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.401 ' O ' ' C ' ' A' ' 87' ' ' ASN . 95.5 mt -80.59 151.8 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 86' ' ' ILE . 3.0 m120 38.09 85.41 0.16 Allowed Pre-proline 0 N--CA 1.464 0.226 0 O-C-N 123.235 0.334 . . . . 0.0 110.804 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -72.32 133.09 20.36 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.403 2.068 . . . . 0.0 112.365 -179.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -108.08 -30.19 8.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.419 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -147.31 121.05 9.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.123 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.571 HG23 ' O ' ' A' ' 91' ' ' ILE . 2.9 tt -113.39 114.17 48.03 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.454 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -66.01 173.86 6.58 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 121.985 1.79 . . . . 0.0 111.069 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.556 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 3.3 Cg_exo -73.66 -19.19 21.64 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.445 2.097 . . . . 0.0 111.591 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -52.94 -62.5 1.61 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.255 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.3 t -73.57 -24.58 20.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.975 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.556 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -70.4 -28.4 65.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.666 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.62 -22.29 8.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.551 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.9 mt -108.02 -41.55 4.91 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.784 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 79.0 mt -76.24 -13.57 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.767 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.078 179.566 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.513 0 CA-C-O 121.224 0.535 . . . . 0.0 110.141 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -153.62 -16.81 0.14 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.239 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.416 ' CG2' ' N ' ' A' ' 9' ' ' THR . 0.7 OUTLIER -160.88 155.72 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.488 179.632 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.416 ' N ' ' CG2' ' A' ' 8' ' ' VAL . 1.8 m -150.37 139.81 21.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.683 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.84 105.67 19.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.85 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -92.4 -152.29 0.31 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.595 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -107.59 5.33 26.87 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -109.4 -23.1 11.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.163 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 161.93 -125.48 1.43 Allowed Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -145.26 145.69 31.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.981 0.42 . . . . 0.0 110.971 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.2 t -105.58 129.0 59.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.84 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.28 99.81 8.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.215 0.531 . . . . 0.0 110.446 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.526 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -103.56 127.18 51.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.037 -179.876 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.465 ' H ' ' HB3' ' A' ' 81' ' ' LYS . 0.6 OUTLIER -149.88 176.69 10.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.512 0.672 . . . . 0.0 112.121 -179.196 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -108.0 92.66 4.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.638 -1.165 . . . . 0.0 108.792 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.551 HG22 ' HA ' ' A' ' 79' ' ' ARG . 1.6 tp -75.77 137.01 23.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.037 -178.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.01 93.87 42.86 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.915 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.446 ' HA ' HG23 ' A' ' 42' ' ' ILE . 3.0 Cg_exo -73.54 157.33 49.02 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.478 2.119 . . . . 0.0 112.226 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt 72.33 47.93 0.26 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.106 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.996 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . . . -95.92 -68.37 0.8 Allowed 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.414 ' CB ' ' O ' ' A' ' 25' ' ' ALA . 6.1 p 157.38 -24.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.504 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 44.4 ttm180 -171.29 139.85 1.38 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.206 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.42 93.62 0.35 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.393 0.616 . . . . 0.0 109.999 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.8 m -124.92 129.09 49.67 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.654 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.46 HG22 HD21 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -85.56 63.03 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.714 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -93.67 17.67 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.725 -178.277 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . -143.38 28.25 2.08 Favored Glycine 0 C--N 1.318 -0.444 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -178.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.46 HD21 HG22 ' A' ' 30' ' ' ILE . 10.7 mt -60.81 111.01 1.47 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.421 ' ND1' ' N ' ' A' ' 35' ' ' GLY . 3.7 t60 -99.44 152.53 19.88 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.398 -178.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.421 ' N ' ' ND1' ' A' ' 34' ' ' HIS . . . -67.75 -15.5 66.75 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -121.94 -17.38 7.32 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.747 0.308 . . . . 0.0 110.392 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -139.05 -173.03 3.47 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.833 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.459 HG12 ' HB2' ' A' ' 19' ' ' LEU . 16.9 t -142.7 112.87 2.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 5.6 mtpt -110.89 109.36 19.5 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.035 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.506 ' CG1' HD12 ' A' ' 21' ' ' ILE . 7.7 p -121.98 132.44 70.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.458 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.996 ' HB1' ' HB2' ' A' ' 25' ' ' ALA . . . -99.65 99.86 10.77 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.272 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.583 HD11 ' CB ' ' A' ' 54' ' ' HIS . 19.6 tt -84.66 149.52 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.433 HG23 ' O ' ' A' ' 43' ' ' THR . 9.4 t -95.59 48.24 1.14 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.016 0.436 . . . . 0.0 110.626 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.725 ' HB1' ' HB2' ' A' ' 50' ' ' GLN . . . -118.79 142.89 32.56 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.529 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.515 ' HG2' ' HB3' ' A' ' 50' ' ' GLN . 1.6 Cg_endo -54.51 169.66 0.72 Allowed 'Trans proline' 0 N--CA 1.503 2.058 0 C-N-CA 123.751 2.967 . . . . 0.0 112.236 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -83.56 87.09 1.29 Allowed 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.831 2.354 . . . . 0.0 111.081 177.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 1.028 HG22 ' H ' ' A' ' 48' ' ' ASP . 9.8 p -172.24 -160.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.241 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 1.028 ' H ' HG22 ' A' ' 47' ' ' VAL . 1.7 m-20 -88.03 -66.89 0.87 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.041 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -44.55 -28.77 1.65 Allowed Glycine 0 CA--C 1.526 0.734 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.35 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.725 ' HB2' ' HB1' ' A' ' 44' ' ' ALA . 1.3 pp0? -61.9 -69.78 0.23 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.206 0.527 . . . . 0.0 111.474 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.679 ' H ' ' CG ' ' A' ' 50' ' ' GLN . . . -80.63 -39.84 26.69 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.224 -178.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -54.01 -54.96 31.87 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.359 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.4 p -64.12 -48.7 75.07 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.0 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.583 ' CB ' HD11 ' A' ' 42' ' ' ILE . 0.2 OUTLIER -57.99 -52.81 63.99 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.652 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.594 HD21 HD11 ' A' ' 83' ' ' ILE . 5.5 tp -49.36 -58.3 5.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.028 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -53.74 -23.41 8.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.6 ttpp -85.16 -64.75 1.1 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.494 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -45.7 -59.77 2.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.382 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.553 HD22 HD13 ' A' ' 83' ' ' ILE . 6.0 tp -70.74 -48.0 56.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.951 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -49.21 -30.1 10.45 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -81.16 -63.06 1.48 Allowed 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.772 0.32 . . . . 0.0 111.217 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.49 ' O ' ' NE2' ' A' ' 90' ' ' GLN . 14.0 mm100 -58.63 -36.76 74.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.671 -178.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.901 ' HB3' HG23 ' A' ' 65' ' ' VAL . 1.4 m-85 -87.02 -18.96 29.39 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.412 ' HE ' ' HB2' ' A' ' 90' ' ' GLN . 0.1 OUTLIER 56.7 11.05 0.81 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.371 -0.832 . . . . 0.0 112.642 178.378 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.901 HG23 ' HB3' ' A' ' 63' ' ' PHE . 2.2 t -69.15 -141.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.871 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.607 ' O ' HG12 ' A' ' 70' ' ' VAL . . . -125.39 156.39 38.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.918 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.407 ' HA ' HG12 ' A' ' 70' ' ' VAL . 46.0 pttt -69.55 -26.29 64.42 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.13 -16.44 37.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.35 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.45 ' CG ' ' HB3' ' A' ' 66' ' ' ALA . 25.5 mm-40 -97.03 -20.63 17.91 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.566 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.694 ' O ' HG13 ' A' ' 70' ' ' VAL . 14.8 p -101.53 98.14 6.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.033 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 t -115.2 131.32 67.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.96 -178.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 68.1 mt -83.04 91.01 2.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.42 ' O ' ' CB ' ' A' ' 74' ' ' LYS . 7.8 mt-10 -57.91 -7.01 0.64 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.666 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.42 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 3.5 mtpp 162.11 126.48 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 132.77 -3.08 4.94 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -40.8 -30.53 0.13 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.8 tt -128.5 -37.85 1.77 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 121.023 -0.271 . . . . 0.0 111.654 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -70.99 158.32 53.72 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.772 -0.531 . . . . 0.0 111.772 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.551 ' HA ' HG22 ' A' ' 21' ' ' ILE . 13.3 mtm180 -61.41 -29.32 69.86 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.2 p-80 -69.01 146.99 52.24 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 5.8 ttmm -139.64 142.27 37.02 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.53 -178.324 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.409 ' HG2' ' C ' ' A' ' 81' ' ' LYS . 2.1 mm100 -144.3 80.72 1.65 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.594 HD11 HD21 ' A' ' 55' ' ' LEU . 81.9 mt -81.85 156.13 4.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.234 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.454 ' HE3' ' N ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -136.25 104.94 5.81 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.828 -179.64 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.695 HG23 HG21 ' A' ' 65' ' ' VAL . 3.1 mp -96.81 103.12 14.3 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.796 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 53.7 mt -85.6 133.44 29.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.883 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 51.4 t30 52.16 82.47 0.24 Allowed Pre-proline 0 CA--C 1.53 0.202 0 CA-C-O 120.906 0.384 . . . . 0.0 110.03 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -69.73 144.79 55.29 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.61 2.207 . . . . 0.0 112.497 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -117.99 -29.77 5.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.118 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.49 ' NE2' ' O ' ' A' ' 62' ' ' GLN . 26.5 tt0 -147.12 122.27 10.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.785 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.502 HG23 ' O ' ' A' ' 91' ' ' ILE . 4.3 tt -116.6 117.28 38.18 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.073 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -69.4 143.54 52.9 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 122.333 2.022 . . . . 0.0 112.165 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.564 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 2.5 Cg_endo -49.25 -25.15 9.28 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 122.945 2.43 . . . . 0.0 111.899 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -61.35 -56.89 15.31 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.564 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.3 t -71.39 -19.83 20.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.564 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -75.33 -22.97 57.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.502 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -64.55 -19.26 65.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.006 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 67.9 mt -105.68 -16.7 14.61 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.31 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 44.1 mt -104.17 -36.53 4.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.81 0.338 . . . . 0.0 110.659 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.923 -179.979 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.591 0 CA-C-O 121.283 0.563 . . . . 0.0 110.382 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -144.55 -30.23 0.46 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.291 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.9 m -147.07 165.75 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.817 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 m -151.29 130.5 12.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.725 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.4 m -95.19 97.6 6.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.115 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -84.93 -163.02 0.76 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.297 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -102.67 9.79 39.03 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -117.77 -21.47 8.43 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 114.682 -1.145 . . . . 0.0 110.461 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.41 -126.49 1.51 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.422 HD21 ' CG2' ' A' ' 85' ' ' ILE . 1.4 pt? -144.37 150.99 38.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.858 0.361 . . . . 0.0 110.693 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 35.8 t -105.51 143.05 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.208 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 82' ' ' GLN . 0.5 OUTLIER -124.49 92.23 3.61 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.976 0.417 . . . . 0.0 110.762 -179.82 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 2.3 mmm-85 -95.87 113.49 25.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.428 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.69 171.8 13.71 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.593 0.711 . . . . 0.0 112.672 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -102.57 94.88 5.88 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.289 -1.323 . . . . 0.0 108.121 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -72.32 128.63 35.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.52 -177.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -125.4 90.1 51.34 Favored Pre-proline 0 C--O 1.232 0.159 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.905 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.27 156.24 37.34 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.67 2.246 . . . . 0.0 111.975 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt 72.19 53.15 0.18 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.658 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 1.005 ' CB ' ' HB1' ' A' ' 41' ' ' ALA . . . -99.65 -59.83 1.64 Allowed 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 25' ' ' ALA . 0.4 OUTLIER 157.44 -31.45 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.142 179.41 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.434 ' CG ' ' O ' ' A' ' 26' ' ' SER . 18.5 mtm180 -167.05 146.75 5.38 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.344 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.449 ' HA ' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -64.08 92.36 0.08 Allowed 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.078 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.422 ' HB3' HG23 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -129.61 120.1 24.7 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.851 -178.464 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.487 HG22 HD21 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -84.24 76.47 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.502 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.694 ' O ' HG12 ' A' ' 31' ' ' VAL . 41.3 t -107.01 19.56 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 114.858 -1.064 . . . . 0.0 112.069 -177.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -143.56 27.72 2.07 Favored Glycine 0 C--N 1.333 0.366 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.673 ' CD2' HG13 ' A' ' 38' ' ' VAL . 15.9 mt -62.62 126.69 28.18 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.955 -0.623 . . . . 0.0 110.094 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.421 ' HB3' ' H ' ' A' ' 37' ' ' GLU . 4.8 t60 -113.25 157.02 22.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.165 -178.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -69.57 -20.1 75.29 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.516 -1.033 . . . . 0.0 110.516 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -116.17 -17.09 10.91 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.831 -0.184 . . . . 0.0 110.609 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.421 ' H ' ' HB3' ' A' ' 34' ' ' HIS . 24.7 mm-40 -140.53 -174.99 4.11 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.831 0.348 . . . . 0.0 110.537 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.673 HG13 ' CD2' ' A' ' 33' ' ' LEU . 14.8 t -142.74 113.33 2.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -107.99 112.36 24.89 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.396 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.469 HG23 HG23 ' A' ' 30' ' ' ILE . 9.9 p -117.0 144.42 24.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.349 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 1.005 ' HB1' ' CB ' ' A' ' 25' ' ' ALA . . . -110.23 100.84 9.66 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.47 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.829 HD11 ' HB3' ' A' ' 54' ' ' HIS . 19.5 tt -91.91 148.14 4.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.73 28.3 1.82 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.503 -179.079 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.96 163.2 19.22 Favored Pre-proline 0 C--O 1.235 0.303 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.107 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.44 ' HG2' ' CB ' ' A' ' 50' ' ' GLN . 3.4 Cg_exo -77.55 176.46 10.03 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 123.433 2.756 . . . . 0.0 111.978 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -77.05 3.6 6.5 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 123.071 2.514 . . . . 0.0 112.606 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.417 HG12 ' HB2' ' A' ' 45' ' ' PRO . 14.8 p -99.2 148.09 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.719 0.295 . . . . 0.0 110.564 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' A' ' 52' ' ' ASN . 1.3 t0 -66.94 -52.41 43.26 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.033 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . -37.05 -51.95 1.58 Allowed Glycine 0 CA--C 1.531 1.058 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.452 ' N ' ' CD ' ' A' ' 50' ' ' GLN . 2.0 mp0 -82.72 -45.53 14.31 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.39 -58.8 4.51 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.155 0.503 . . . . 0.0 110.376 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.5 ' N ' ' O ' ' A' ' 48' ' ' ASP . 11.5 t-20 -46.88 -49.92 19.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.93 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.5 p -55.73 -48.34 75.37 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.791 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.829 ' HB3' HD11 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -54.47 -59.79 4.22 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.296 179.584 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.451 ' HA ' HD13 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -44.86 -57.91 3.46 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.916 0.388 . . . . 0.0 110.532 -179.745 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -54.27 -32.21 23.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.912 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 34.3 tttm -76.75 -65.97 0.87 Allowed 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.704 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -46.67 -56.18 6.54 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.072 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.811 HD21 HD11 ' A' ' 85' ' ' ILE . 1.7 tp -64.49 -58.74 5.57 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.751 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -46.03 -29.54 3.42 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.634 -0.586 . . . . 0.0 111.634 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.1 mttp -80.91 -63.84 1.32 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.961 0.41 . . . . 0.0 111.103 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.531 HE22 ' CG ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -58.75 -31.91 68.77 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.118 -178.668 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.887 ' HB3' HG23 ' A' ' 65' ' ' VAL . 0.8 OUTLIER -88.84 -19.56 25.77 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.402 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 67.15 2.06 2.63 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.734 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.887 HG23 ' HB3' ' A' ' 63' ' ' PHE . 2.0 t -68.2 -136.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.038 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.449 ' O ' HG23 ' A' ' 70' ' ' VAL . . . -140.08 167.79 21.31 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.905 0.383 . . . . 0.0 111.295 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.5 ptmt -73.42 -25.41 60.51 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.327 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.8 t -79.91 -20.17 46.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.965 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.428 ' O ' ' O ' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -95.96 -11.69 26.19 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.261 179.782 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 66' ' ' ALA . 54.8 t -100.63 99.24 8.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.231 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.5 t -112.98 116.43 52.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.239 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.423 ' C ' ' H ' ' A' ' 74' ' ' LYS . 67.2 mt -88.06 87.06 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.186 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -76.35 15.18 0.62 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.164 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.423 ' H ' ' C ' ' A' ' 72' ' ' ILE . 8.9 tttt 174.33 137.74 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 76' ' ' GLU . . . 128.28 -14.95 6.16 Favored Glycine 0 CA--C 1.518 0.264 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -178.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 75' ' ' GLY . 12.2 tt0 -30.68 -57.81 0.21 Allowed 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.855 0.385 . . . . 0.0 111.293 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.2 mt -133.43 -33.44 1.1 Allowed 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.848 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.58 145.47 45.6 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.901 -0.879 . . . . 0.0 110.901 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 15.7 mtp180 -58.38 -33.51 69.68 Favored 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.401 ' O ' ' HA2' ' A' ' 75' ' ' GLY . 6.8 m-70 -68.86 138.76 54.97 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 177.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 2.2 ttmm -145.42 151.99 39.12 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 119.961 -0.696 . . . . 0.0 110.203 -177.228 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.411 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 19.6 tt0 -148.24 123.59 10.28 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 9.7 mt -120.45 143.18 33.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.583 -178.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.458 ' HE3' ' N ' ' A' ' 85' ' ' ILE . 0.2 OUTLIER -114.16 106.62 14.58 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.2 -179.454 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.811 HD11 HD21 ' A' ' 59' ' ' LEU . 2.4 mp -91.39 101.6 12.66 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.36 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 64.4 mt -81.16 143.66 11.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.031 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 47.31 77.15 0.48 Allowed Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.778 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -74.08 144.54 33.99 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 122.87 2.38 . . . . 0.0 112.003 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -107.43 -39.78 5.55 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.65 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -147.51 125.5 12.04 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 120.98 0.419 . . . . 0.0 109.977 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.569 HG23 ' O ' ' A' ' 91' ' ' ILE . 3.4 tt -107.01 112.86 63.06 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.359 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.531 ' CG ' HE22 ' A' ' 62' ' ' GLN . 3.4 Cg_exo -70.44 153.78 65.54 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.683 2.256 . . . . 0.0 112.623 -179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.531 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 2.6 Cg_endo -47.96 -30.27 13.45 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 123.273 2.648 . . . . 0.0 111.897 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 65.6 tt0 -51.71 -59.25 4.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.736 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.413 HG23 ' H ' ' A' ' 95' ' ' VAL . 0.6 OUTLIER -84.04 -24.54 7.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.157 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.531 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -75.24 -19.88 59.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.972 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 93' ' ' PRO . . . -66.41 -25.27 66.69 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.111 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 18.7 mt -103.67 -14.61 16.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.001 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 46.8 mt -103.6 -50.45 9.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.346 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.59 179.594 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.609 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 79.1 p . . . . . 0 N--CA 1.442 -0.861 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.609 ' HB2' ' O ' ' A' ' 6' ' ' SER . . . 158.96 -22.26 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.664 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 16' ' ' VAL . 4.0 p -157.31 154.86 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.072 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 m -150.71 144.57 25.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.523 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.8 m -113.61 103.71 15.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.326 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -93.26 -152.65 0.33 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.301 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -106.1 2.76 27.41 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -107.77 -22.36 12.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.38 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.562 ' HA3' ' HZ1' ' A' ' 84' ' ' LYS . . . 159.37 -122.05 1.1 Allowed Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -148.58 138.6 22.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.006 0.431 . . . . 0.0 111.255 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 8' ' ' VAL . 71.8 t -100.91 141.43 17.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.1 tp -122.34 104.17 9.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.187 0.518 . . . . 0.0 110.787 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.513 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 1.1 mtt-85 -94.02 127.71 39.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.682 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.765 HD11 HG12 ' A' ' 21' ' ' ILE . 2.2 pp -153.18 178.29 9.9 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.618 0.723 . . . . 0.0 112.482 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.574 ' C ' HD12 ' A' ' 19' ' ' LEU . 20.5 t80 -111.0 95.7 5.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.442 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.765 HG12 HD11 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -72.59 127.17 34.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.439 -178.321 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -119.9 90.46 43.89 Favored Pre-proline 0 N--CA 1.462 0.172 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.033 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.435 ' O ' ' HB2' ' A' ' 24' ' ' LYS . 3.1 Cg_exo -74.91 151.5 40.07 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.66 2.24 . . . . 0.0 112.788 -179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 23' ' ' PRO . 6.4 mtmp? 79.73 43.45 0.06 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.982 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.902 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . . . -101.8 169.46 8.79 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 177.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.0 p -63.28 -19.24 64.4 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.073 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.451 ' O ' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -176.59 163.09 2.34 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.151 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.457 ' HA ' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -80.76 93.03 6.13 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.398 0.618 . . . . 0.0 109.476 178.179 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.562 ' HB3' HG23 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -130.49 135.83 48.36 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.782 -178.986 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.61 HG22 HD21 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -90.56 66.23 0.49 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-O 121.637 0.732 . . . . 0.0 109.455 178.747 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.663 ' O ' HG12 ' A' ' 31' ' ' VAL . 41.3 t -98.32 18.77 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.417 -178.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -143.6 32.12 1.86 Allowed Glycine 0 C--N 1.333 0.368 0 N-CA-C 110.376 -1.089 . . . . 0.0 110.376 -178.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.772 ' CD2' HG13 ' A' ' 38' ' ' VAL . 19.1 mt -71.26 122.38 20.13 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.838 -0.681 . . . . 0.0 110.13 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.433 ' O ' ' O ' ' A' ' 37' ' ' GLU . 37.8 t-80 -110.01 157.03 19.72 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.287 -178.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.79 -22.55 70.23 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.456 ' O ' ' O ' ' A' ' 6' ' ' SER . 29.3 m-20 -121.53 0.54 9.96 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.433 ' O ' ' O ' ' A' ' 34' ' ' HIS . 5.1 mm-40 -148.45 176.38 10.35 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-O 121.07 0.462 . . . . 0.0 110.249 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.772 HG13 ' CD2' ' A' ' 33' ' ' LEU . 30.3 t -142.56 108.68 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -109.77 107.79 17.91 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.295 -178.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.473 HG12 HD13 ' A' ' 19' ' ' LEU . 9.8 p -117.74 131.31 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.592 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.902 ' HB1' ' HB2' ' A' ' 25' ' ' ALA . . . -100.45 107.72 19.52 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.092 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.705 HD11 ' HB3' ' A' ' 54' ' ' HIS . 19.7 tt -97.42 152.26 4.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.4 t -92.97 21.55 5.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.44 -178.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.1 160.89 54.03 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.821 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.465 ' HB2' HG12 ' A' ' 47' ' ' VAL . 3.9 Cg_exo -76.51 171.59 17.77 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 123.269 2.646 . . . . 0.0 112.169 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.11 8.33 2.51 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 123.25 2.633 . . . . 0.0 112.745 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.486 HG13 ' H ' ' A' ' 50' ' ' GLN . 14.4 p -101.37 142.62 15.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.404 ' O ' ' N ' ' A' ' 52' ' ' ASN . 0.2 OUTLIER -62.53 -45.7 91.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.262 -179.261 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -45.11 -54.42 7.08 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.298 -0.477 . . . . 0.0 111.919 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.486 ' H ' HG13 ' A' ' 47' ' ' VAL . 15.5 mt-30 -80.44 -38.1 30.76 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 -179.116 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.35 -60.26 2.58 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.863 0.363 . . . . 0.0 110.687 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.404 ' N ' ' O ' ' A' ' 48' ' ' ASP . 37.3 t-20 -50.53 -40.97 53.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.512 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.7 t -52.9 -50.87 63.05 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.787 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.705 ' HB3' HD11 ' A' ' 42' ' ' ILE . 0.2 OUTLIER -54.75 -55.09 33.73 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.889 -179.665 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.518 ' HA ' HD13 ' A' ' 55' ' ' LEU . 3.4 mm? -49.39 -51.27 36.15 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.66 -0.416 . . . . 0.0 109.895 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -56.35 -26.82 23.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.88 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.441 ' O ' ' HB2' ' A' ' 61' ' ' LYS . 6.0 ttpm? -84.29 -64.95 1.07 Allowed 'General case' 0 C--O 1.227 -0.13 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.286 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -51.69 -54.82 24.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.121 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.513 HD22 ' HA ' ' A' ' 59' ' ' LEU . 0.2 OUTLIER -65.09 -53.3 47.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.66 179.657 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -53.89 -42.91 70.75 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-N 116.363 -0.38 . . . . 0.0 112.153 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 3.9 ttpt -73.94 -44.22 55.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.589 0.233 . . . . 0.0 111.028 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 -65.35 -43.48 90.71 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.074 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.464 ' HB3' HG22 ' A' ' 65' ' ' VAL . 3.6 m-85 -85.91 -19.22 30.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.879 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.9 mtt-85 60.44 5.27 0.83 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.927 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.464 HG22 ' HB3' ' A' ' 63' ' ' PHE . 34.5 m -76.12 155.17 5.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.448 ' HB3' ' HG2' ' A' ' 69' ' ' GLN . . . -51.53 159.14 0.78 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.524 -178.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.8 pttp -69.94 -27.16 64.52 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.892 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.7 t -81.25 -12.33 59.14 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.257 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.448 ' HG2' ' HB3' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -89.97 -12.99 37.08 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.598 -179.78 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.1 p -105.6 100.1 9.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-O 121.161 0.505 . . . . 0.0 110.325 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.2 t -117.24 122.08 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.907 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.444 ' C ' ' H ' ' A' ' 74' ' ' LYS . 46.7 mt -89.96 90.76 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.635 178.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -66.46 3.98 0.85 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.95 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.444 ' H ' ' C ' ' A' ' 72' ' ' ILE . 10.4 mttt 169.53 140.62 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 76' ' ' GLU . . . 130.88 -16.99 5.25 Favored Glycine 0 C--N 1.321 -0.294 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -178.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 75' ' ' GLY . 50.3 mt-10 -35.11 -46.32 0.33 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.373 -0.414 . . . . 0.0 111.034 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.4 tt -130.02 -42.97 1.22 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.872 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -60.88 159.01 28.3 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.842 -0.503 . . . . 0.0 111.842 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.4 mtm-85 -72.99 -32.8 65.41 Favored 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.405 ' O ' ' HA2' ' A' ' 75' ' ' GLY . 6.9 m-70 -69.42 144.48 53.33 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 177.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.516 ' NZ ' ' HG ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -152.38 150.64 29.91 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 118.96 -1.096 . . . . 0.0 111.507 -177.714 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -147.79 113.42 5.68 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.443 ' CD1' HD12 ' A' ' 55' ' ' LEU . 8.4 mt -109.63 132.27 58.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.348 -178.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.562 ' HZ1' ' HA3' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -102.93 117.43 34.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.271 -179.315 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.485 HG22 ' O ' ' A' ' 85' ' ' ILE . 1.8 mp -105.59 98.94 7.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.209 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 20.6 mt -81.51 151.52 4.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.478 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 9.4 m-20 42.11 80.48 0.28 Allowed Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.861 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -73.31 133.58 19.53 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.771 2.314 . . . . 0.0 112.455 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -118.26 -26.38 6.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.533 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -145.86 117.49 8.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.939 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.556 HG23 ' O ' ' A' ' 91' ' ' ILE . 4.3 tt -112.11 113.98 51.49 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.509 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -65.9 143.49 73.26 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.253 1.968 . . . . 0.0 111.757 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.631 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 2.7 Cg_endo -49.01 -24.56 7.61 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.956 2.437 . . . . 0.0 111.684 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -59.47 -58.77 7.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.401 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.0 t -75.98 -24.85 16.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.513 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.631 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -75.28 -28.56 59.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.784 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 93' ' ' PRO . . . -54.95 -31.23 60.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.62 0.248 . . . . 0.0 111.198 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.26 -4.72 48.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.078 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 51.2 mm -116.95 -18.48 6.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.729 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.557 ' N ' ' O ' ' A' ' 96' ' ' ALA . 3.8 m-20 . . . . . 0 C--N 1.332 -0.195 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.005 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 mtt . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -125.61 -106.78 0.33 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.44 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -135.66 87.81 0.24 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.478 HG23 ' N ' ' A' ' 5' ' ' MET . 17.4 m -149.05 -46.62 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-O 120.702 0.287 . . . . 0.0 110.325 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.478 ' N ' HG23 ' A' ' 4' ' ' VAL . 1.8 ttm 56.09 91.57 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.17 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.624 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 62.0 p -126.19 -169.68 2.06 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.624 ' HB2' ' O ' ' A' ' 6' ' ' SER . . . 151.19 -25.85 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.449 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 16' ' ' VAL . 0.7 OUTLIER -159.51 151.44 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.595 -179.768 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 m -139.05 136.2 35.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.326 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 10' ' ' VAL . 30.8 m -101.35 99.8 9.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.262 0.553 . . . . 0.0 110.181 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -80.28 -151.97 0.08 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.533 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -107.77 6.79 27.89 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -117.77 -25.35 6.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.488 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 170.25 -126.91 1.4 Allowed Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.468 ' N ' HD23 ' A' ' 15' ' ' LEU . 1.6 pt? -147.89 150.77 34.73 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.97 0.414 . . . . 0.0 111.208 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.46 ' O ' HG23 ' A' ' 8' ' ' VAL . 61.7 t -106.88 139.63 27.76 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.117 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.74 102.65 9.6 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.562 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 9.1 mtm180 -107.91 111.04 22.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.02 -179.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.648 HD13 HG12 ' A' ' 40' ' ' VAL . 4.1 pp -142.02 -179.64 6.34 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.904 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.623 ' N ' HD12 ' A' ' 19' ' ' LEU . 53.6 t80 -111.06 105.22 13.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.756 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.42 HD11 HD11 ' A' ' 55' ' ' LEU . 6.0 mm -71.96 135.25 28.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.573 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -124.12 87.72 53.23 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.672 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.2 161.67 42.47 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.622 2.214 . . . . 0.0 112.555 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.26 46.9 2.53 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.661 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.884 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . . . -92.22 -70.95 0.67 Allowed 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.411 ' CB ' ' O ' ' A' ' 25' ' ' ALA . 0.9 OUTLIER 160.01 -22.09 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.06 179.3 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -171.36 140.73 1.47 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.049 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.9 86.89 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 121.429 0.633 . . . . 0.0 109.918 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.49 133.53 46.36 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.481 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.521 HG23 HG23 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -89.16 86.91 2.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.237 179.039 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -113.71 19.33 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.853 -178.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -143.74 37.39 1.45 Allowed Glycine 0 C--N 1.333 0.406 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.826 ' CD2' HG13 ' A' ' 38' ' ' VAL . 21.3 mt -73.27 120.11 18.43 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.798 -0.701 . . . . 0.0 109.913 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.487 ' HB3' ' H ' ' A' ' 37' ' ' GLU . 26.8 t-80 -102.05 157.97 16.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.023 0.44 . . . . 0.0 111.383 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.97 -18.76 73.01 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.48 -18.35 8.5 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.487 ' H ' ' HB3' ' A' ' 34' ' ' HIS . 11.2 mm-40 -134.32 -176.43 4.2 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.988 0.423 . . . . 0.0 110.66 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.826 HG13 ' CD2' ' A' ' 33' ' ' LEU . 55.6 t -143.66 121.98 6.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.5 ttpp -121.86 113.7 20.01 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.879 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.648 HG12 HD13 ' A' ' 19' ' ' LEU . 10.1 p -114.88 142.88 26.05 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.921 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.884 ' HB1' ' HB2' ' A' ' 25' ' ' ALA . . . -107.84 107.67 18.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.322 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.419 HG13 ' N ' ' A' ' 43' ' ' THR . 1.4 tp -93.15 148.12 4.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.419 ' N ' HG13 ' A' ' 42' ' ' ILE . 14.1 t -95.28 38.79 1.13 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.05 0.452 . . . . 0.0 110.831 -178.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.99 144.59 28.86 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.013 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.511 ' HG2' ' CB ' ' A' ' 50' ' ' GLN . 3.7 Cg_exo -51.98 175.36 0.07 OUTLIER 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 123.059 2.506 . . . . 0.0 112.441 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.92 3.67 5.88 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 123.134 2.556 . . . . 0.0 113.342 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.5 p -102.68 143.99 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.597 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.466 ' O ' ' C ' ' A' ' 49' ' ' GLY . 3.7 m-20 -62.06 -60.92 2.91 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.018 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.466 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . -30.72 -43.98 0.08 OUTLIER Glycine 0 CA--C 1.53 1.026 0 N-CA-C 111.744 -0.543 . . . . 0.0 111.744 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.511 ' CB ' ' HG2' ' A' ' 45' ' ' PRO . 0.8 OUTLIER -82.6 -42.07 18.73 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.478 0.18 . . . . 0.0 111.28 -179.612 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 48' ' ' ASP . . . -68.17 -54.16 19.89 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.948 0.404 . . . . 0.0 109.966 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 48' ' ' ASP . 19.3 t-20 -48.72 -44.72 38.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.147 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 58.2 m -54.56 -44.7 73.14 Favored 'General case' 0 N--CA 1.461 0.075 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.46 -42.58 82.79 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.059 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.434 ' CD2' HD11 ' A' ' 83' ' ' ILE . 2.0 tp -54.45 -60.69 3.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.625 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -58.04 -23.41 21.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.2 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.401 ' O ' ' C ' ' A' ' 58' ' ' PHE . 32.8 tttp -79.32 -65.49 0.99 Allowed 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.528 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.401 ' C ' ' O ' ' A' ' 57' ' ' LYS . 3.8 t80 -36.33 -55.37 0.81 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.89 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.562 HD13 ' CD1' ' A' ' 63' ' ' PHE . 4.3 mm? -68.42 -66.16 0.61 Allowed 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.157 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -40.07 -36.28 0.83 Allowed Glycine 0 CA--C 1.529 0.963 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.066 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -82.02 -60.76 2.11 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.762 0.315 . . . . 0.0 111.112 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -58.61 -40.71 84.04 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.533 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.736 ' HB3' HG23 ' A' ' 65' ' ' VAL . 15.1 m-85 -86.27 -18.26 32.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.266 -0.425 . . . . 0.0 109.916 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.9 mtm180 60.41 4.16 0.66 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.759 178.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.736 HG23 ' HB3' ' A' ' 63' ' ' PHE . 6.1 t -65.42 -125.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 120.905 0.383 . . . . 0.0 110.154 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.485 ' N ' HG12 ' A' ' 65' ' ' VAL . . . -145.65 164.15 32.65 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.23 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.9 ptmt -75.28 -27.75 59.5 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.496 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.1 t -78.38 -14.74 59.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.637 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.402 ' O ' ' O ' ' A' ' 84' ' ' LYS . 0.9 OUTLIER -97.73 -15.02 20.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.752 179.718 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.465 HG13 HG23 ' A' ' 83' ' ' ILE . 10.9 t -95.43 99.6 9.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.906 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -107.48 121.55 60.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.503 -179.071 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 63.0 mt -84.94 95.41 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.168 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -72.86 -4.06 29.47 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.92 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 10.6 mttp 165.9 142.31 0.02 OUTLIER 'General case' 0 C--N 1.339 0.151 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.6 -15.36 6.7 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -35.03 -39.08 0.09 Allowed 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.4 mt -132.13 10.4 4.55 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -123.55 154.03 17.34 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -55.91 -27.7 53.32 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.949 0.404 . . . . 0.0 110.044 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -69.0 160.7 30.45 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.662 ' HE3' HD12 ' A' ' 83' ' ' ILE . 7.7 tttt -150.87 137.86 19.14 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -140.62 75.93 1.53 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.662 HD12 ' HE3' ' A' ' 81' ' ' LYS . 52.6 mt -82.56 151.03 4.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.908 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.447 ' HE3' ' N ' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -123.45 122.57 38.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.751 179.808 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.447 ' N ' ' HE3' ' A' ' 84' ' ' LYS . 1.9 mp -99.79 104.82 16.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.823 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 43.4 mt -87.64 149.8 3.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.437 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 57.5 t-20 43.64 54.11 10.71 Favored Pre-proline 0 CA--C 1.532 0.262 0 CA-C-O 120.816 0.341 . . . . 0.0 110.11 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.437 ' CD ' ' N ' ' A' ' 87' ' ' ASN . 2.7 Cg_endo -45.16 146.13 2.96 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.979 2.452 . . . . 0.0 112.202 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 -121.26 -38.33 2.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.503 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -143.96 117.73 9.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.062 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.9 tt -111.25 116.74 50.79 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.237 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -65.29 151.05 86.54 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 122.351 2.034 . . . . 0.0 111.734 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.617 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 2.5 Cg_endo -51.47 -35.16 54.35 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.786 2.324 . . . . 0.0 111.991 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -45.23 -58.29 3.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.378 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.7 t -77.39 -19.89 14.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.245 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.617 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -74.63 -30.8 61.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.907 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.18 -22.91 31.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.635 0.255 . . . . 0.0 111.213 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -99.85 -16.19 18.13 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.163 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 87.7 mt -104.55 -35.66 3.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.062 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -82.97 -9.96 59.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.324 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.8 tp 47.77 82.76 0.04 OUTLIER 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.019 0.438 . . . . 0.0 110.499 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -65.59 -1.28 2.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.739 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -91.91 155.29 18.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.626 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 5.8 p-80 -143.43 153.08 42.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.196 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -150.08 56.97 0.96 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.523 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 7.3 t-160 43.61 35.83 1.09 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.069 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 24.0 t60 -82.62 149.75 27.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.478 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 29.8 p-80 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.611 179.958 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.5 mtt . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -52.73 112.82 0.9 Allowed 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.686 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -94.12 -108.5 2.05 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.537 ' C ' ' H ' ' A' ' 6' ' ' SER . 0.9 OUTLIER -108.93 -23.09 4.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.57 0.224 . . . . 0.0 110.407 179.742 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 1.1 ttt -68.09 30.52 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.139 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.624 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 15.1 m -104.0 -168.53 1.51 Allowed 'General case' 0 N--CA 1.435 -1.175 0 CA-C-O 121.107 0.479 . . . . 0.0 110.078 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.624 ' HB2' ' O ' ' A' ' 6' ' ' SER . . . 153.99 -19.61 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.034 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.0 p -154.67 154.27 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.276 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.2 m -144.89 117.82 8.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.363 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.405 ' H ' HG22 ' A' ' 10' ' ' VAL . 2.8 m -88.27 97.75 7.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.792 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.84 -155.32 0.06 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.434 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -107.62 10.45 29.09 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -123.24 -24.67 4.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.312 -178.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.576 ' HA3' ' HZ1' ' A' ' 84' ' ' LYS . . . 172.06 -125.15 1.15 Allowed Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -152.36 148.45 27.51 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 120.862 0.363 . . . . 0.0 111.344 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.4 t -107.29 142.72 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.751 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.51 ' HB3' ' HZ3' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -115.37 104.6 11.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.001 0.429 . . . . 0.0 110.322 179.866 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.557 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 2.3 mtm180 -105.96 119.28 38.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.194 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.663 HD11 HG12 ' A' ' 21' ' ' ILE . 3.9 pp -149.59 179.65 7.82 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.281 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.656 ' N ' HD12 ' A' ' 19' ' ' LEU . 53.9 t80 -105.71 99.36 8.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.515 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.663 HG12 HD11 ' A' ' 19' ' ' LEU . 2.2 mm -69.31 124.9 26.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.599 ' NE2' ' O ' ' A' ' 23' ' ' PRO . 0.3 OUTLIER -121.23 86.64 43.37 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.945 -179.493 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.599 ' O ' ' NE2' ' A' ' 22' ' ' GLN . 3.4 Cg_exo -74.11 161.1 41.59 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.706 2.271 . . . . 0.0 111.735 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.502 ' CB ' ' O ' ' A' ' 23' ' ' PRO . 2.5 mmpt? 88.33 30.05 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.275 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.906 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . . . -99.16 172.64 7.24 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.2 m -75.64 -12.77 60.27 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.069 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -176.68 163.4 2.33 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.154 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.492 ' HA ' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -79.43 90.98 5.06 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.269 0.556 . . . . 0.0 109.532 177.866 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.2 m -132.15 134.28 45.23 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.526 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.447 HG22 HD21 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -86.69 73.34 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.363 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.92 18.68 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 114.863 -1.062 . . . . 0.0 112.35 -178.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -143.41 38.29 1.4 Allowed Glycine 0 N--CA 1.459 0.209 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.807 ' CD2' HG13 ' A' ' 38' ' ' VAL . 12.1 mt -74.06 128.94 36.84 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.533 -0.833 . . . . 0.0 110.192 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.417 ' HB3' ' H ' ' A' ' 37' ' ' GLU . 13.0 t-80 -111.75 156.33 22.1 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.174 0.512 . . . . 0.0 111.355 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.24 -25.75 66.93 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.413 ' HB3' ' O ' ' A' ' 4' ' ' VAL . 10.2 m-20 -119.18 -13.04 9.37 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 121.226 -0.19 . . . . 0.0 110.737 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.417 ' H ' ' HB3' ' A' ' 34' ' ' HIS . 45.3 mm-40 -134.81 -178.27 5.0 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.868 0.366 . . . . 0.0 110.503 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.807 HG13 ' CD2' ' A' ' 33' ' ' LEU . 43.0 t -143.6 117.73 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -116.37 110.36 18.59 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.702 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.485 HG12 HD13 ' A' ' 19' ' ' LEU . 7.9 p -110.8 136.16 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.821 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.906 ' HB1' ' HB2' ' A' ' 25' ' ' ALA . . . -100.83 111.12 23.27 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.575 HD11 ' HB3' ' A' ' 54' ' ' HIS . 20.4 tt -101.68 151.02 5.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.8 t -91.06 19.85 5.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.676 -177.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.437 ' HB1' ' CD ' ' A' ' 45' ' ' PRO . . . -97.33 168.87 9.45 Favored Pre-proline 0 C--N 1.328 -0.351 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.488 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.58 ' HB2' HG12 ' A' ' 47' ' ' VAL . 3.7 Cg_exo -78.87 166.87 22.92 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 123.402 2.735 . . . . 0.0 111.94 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -74.77 8.52 2.29 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 123.027 2.485 . . . . 0.0 112.551 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.58 HG12 ' HB2' ' A' ' 45' ' ' PRO . 14.8 p -95.89 150.4 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.43 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.449 ' O ' ' N ' ' A' ' 52' ' ' ASN . 0.7 OUTLIER -64.21 -61.78 2.03 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.114 -179.33 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . -33.28 -56.52 0.56 Allowed Glycine 0 CA--C 1.529 0.956 0 N-CA-C 111.971 -0.451 . . . . 0.0 111.971 -179.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.434 ' N ' ' CD ' ' A' ' 50' ' ' GLN . 3.0 mp0 -78.09 -49.89 13.07 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.64 -60.38 3.94 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.882 0.372 . . . . 0.0 110.546 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.449 ' N ' ' O ' ' A' ' 48' ' ' ASP . 39.3 t-20 -42.32 -54.27 3.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.836 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.8 m -41.57 -51.67 3.9 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.75 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.575 ' HB3' HD11 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -63.99 -48.59 75.82 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.166 -179.952 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.3 mp -47.53 -45.86 27.13 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.672 0.272 . . . . 0.0 110.928 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -66.45 -26.77 38.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.223 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 15.1 ttmm -82.18 -48.08 11.73 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.515 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -53.02 -49.32 66.49 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.737 -0.21 . . . . 0.0 111.424 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.569 ' N ' HD22 ' A' ' 59' ' ' LEU . 3.8 mm? -79.56 -41.56 26.95 Favored 'General case' 0 C--O 1.225 -0.237 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.62 -38.5 71.9 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.464 ' CG ' ' N ' ' A' ' 62' ' ' GLN . 5.9 ptmm? -81.91 -42.77 19.05 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.464 ' N ' ' CG ' ' A' ' 61' ' ' LYS . 33.0 mm-40 -71.22 -45.91 62.27 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.727 0.299 . . . . 0.0 111.024 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.445 ' HB3' HG22 ' A' ' 65' ' ' VAL . 0.7 OUTLIER -84.26 -18.15 37.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.164 -179.889 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.0 mtp180 60.67 15.94 6.21 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.02 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.445 HG22 ' HB3' ' A' ' 63' ' ' PHE . 33.7 m -89.6 149.76 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -49.34 157.64 0.47 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.355 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -73.43 -28.5 62.01 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.591 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.5 t -71.86 -11.8 60.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.901 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -97.93 -10.51 24.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.198 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.8 t -95.81 98.68 8.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.4 t -111.16 122.8 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.25 -178.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.3 mt -84.48 88.89 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.898 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.418 ' O ' ' CB ' ' A' ' 74' ' ' LYS . 33.3 mt-10 -66.66 0.44 2.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.309 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.418 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 8.2 mttm 160.44 127.67 0.0 OUTLIER 'General case' 0 C--N 1.34 0.159 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.456 ' O ' ' C ' ' A' ' 76' ' ' GLU . . . 140.35 -8.88 2.93 Favored Glycine 0 CA--C 1.517 0.176 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.456 ' C ' ' O ' ' A' ' 75' ' ' GLY . 6.3 mm-40 -29.95 -47.65 0.08 Allowed 'General case' 0 N--CA 1.466 0.335 0 O-C-N 123.757 0.328 . . . . 0.0 111.054 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.0 tt -126.83 -42.39 1.76 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.187 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -55.52 153.57 13.64 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 116.289 -0.414 . . . . 0.0 112.255 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.625 ' HE ' ' N ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -62.78 -34.06 76.47 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.003 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.453 ' O ' ' HA2' ' A' ' 75' ' ' GLY . 25.3 t60 -68.49 143.99 54.79 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.838 ' CE ' HD12 ' A' ' 83' ' ' ILE . 9.8 tttm -139.59 145.72 38.92 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.211 -178.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.421 ' HG2' ' NE2' ' A' ' 80' ' ' HIS . 2.4 mt-30 -146.94 79.05 1.51 Allowed 'General case' 0 C--O 1.233 0.2 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.838 HD12 ' CE ' ' A' ' 81' ' ' LYS . 40.2 mt -82.38 143.39 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.045 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.576 ' HZ1' ' HA3' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -109.67 121.06 44.37 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.671 -179.569 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.526 HG22 ' O ' ' A' ' 85' ' ' ILE . 1.5 mp -105.33 94.39 3.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.274 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 55.5 mt -82.27 144.38 10.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 55.36 79.25 0.35 Allowed Pre-proline 0 C--N 1.33 -0.248 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.203 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -74.56 128.94 12.27 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.77 2.313 . . . . 0.0 112.36 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -112.32 -29.7 7.44 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.236 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -143.64 114.28 7.6 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.189 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.587 HG23 ' O ' ' A' ' 91' ' ' ILE . 3.5 tt -109.2 110.17 60.48 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.456 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -65.81 174.6 5.41 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 122.353 2.035 . . . . 0.0 112.03 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.666 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 3.2 Cg_exo -71.83 -19.81 26.81 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.661 2.241 . . . . 0.0 112.201 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -49.48 -59.3 3.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.96 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 54.8 t -78.99 -25.54 13.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.288 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.666 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -74.2 -28.81 61.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.138 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 93' ' ' PRO . . . -65.43 -21.34 66.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.185 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.8 pp -116.68 -8.18 11.46 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.13 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.49 HD13 ' HA ' ' A' ' 99' ' ' ILE . 17.4 mm -103.88 -47.97 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -83.82 -11.12 57.48 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.425 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.1 tp 53.66 73.29 0.38 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.826 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -92.67 -8.72 43.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.535 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -76.07 93.7 3.34 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.882 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -167.61 -64.22 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.356 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -80.65 22.85 0.56 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.672 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 31.8 m170 51.51 -143.65 0.64 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.622 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -114.51 165.38 12.81 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.477 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 9.5 p-80 . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.455 179.874 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 mmt . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -157.77 110.65 2.43 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.553 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 155.93 37.72 0.02 OUTLIER Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.6 t 53.17 75.23 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-O 121.034 0.445 . . . . 0.0 110.411 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 3.4 ttt -84.58 66.78 9.7 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.182 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.614 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 5.9 m -113.75 -168.59 1.37 Allowed 'General case' 0 N--CA 1.436 -1.167 0 CA-C-O 121.141 0.496 . . . . 0.0 110.449 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.614 ' HB2' ' O ' ' A' ' 6' ' ' SER . . . 150.89 -18.96 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.109 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 16' ' ' VAL . 1.7 p -155.65 154.69 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.801 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.401 ' N ' ' CG2' ' A' ' 8' ' ' VAL . 0.9 OUTLIER -137.9 143.32 40.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.093 -179.913 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.2 m -113.6 105.02 17.93 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.48 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.435 HD21 HG23 ' A' ' 16' ' ' VAL . 9.6 m-80 -92.22 -154.94 0.4 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.36 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -107.6 5.4 26.92 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -113.52 -22.05 10.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.614 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.62 -124.05 1.22 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.19 153.86 35.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.983 0.42 . . . . 0.0 111.398 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.435 HG23 HD21 ' A' ' 11' ' ' ASN . 58.1 t -110.84 131.86 60.88 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.962 179.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.502 HD23 HD21 ' A' ' 59' ' ' LEU . 11.2 tp -109.47 102.73 11.58 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.976 0.417 . . . . 0.0 110.44 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.522 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 49.2 mtt180 -104.08 119.33 38.7 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.534 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.767 HD21 ' NZ ' ' A' ' 81' ' ' LYS . 3.5 pp -148.01 179.62 7.61 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.203 0.525 . . . . 0.0 111.553 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.576 ' N ' HD12 ' A' ' 19' ' ' LEU . 33.3 t80 -112.13 106.22 14.78 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.517 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.648 HG12 HD11 ' A' ' 19' ' ' LEU . 2.8 mm -76.58 135.14 27.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.026 -178.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -122.18 91.2 49.09 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.493 -0.776 . . . . 0.0 108.917 178.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -72.2 154.02 56.78 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.685 2.257 . . . . 0.0 112.822 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.2 mtmp? 76.63 42.64 0.15 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.59 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.904 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . . . -100.24 167.85 10.17 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 178.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 98.1 p -62.05 -19.43 62.89 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.199 -0.6 . . . . 0.0 109.962 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -176.29 170.63 2.57 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.53 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.482 ' HA ' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -83.27 90.3 7.11 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.667 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.3 m -131.06 143.63 50.83 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.775 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.561 HG22 HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -93.03 74.33 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.289 179.05 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -103.64 19.05 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.608 -177.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.431 ' HA3' ' HB3' ' A' ' 39' ' ' LYS . . . -144.41 35.87 1.51 Allowed Glycine 0 C--N 1.332 0.35 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.779 ' CD2' HG13 ' A' ' 38' ' ' VAL . 15.2 mt -71.19 122.09 19.54 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.596 -0.802 . . . . 0.0 109.929 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -110.25 162.52 14.53 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.495 -178.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -72.89 -28.21 67.33 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -110.68 -9.74 14.51 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -144.6 -178.82 6.19 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-O 120.861 0.363 . . . . 0.0 110.796 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.779 HG13 ' CD2' ' A' ' 33' ' ' LEU . 55.3 t -143.39 113.74 2.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.431 ' HB3' ' HA3' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -112.35 118.48 35.34 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.876 -179.688 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.699 HG12 HD13 ' A' ' 19' ' ' LEU . 8.8 p -123.02 133.19 69.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.006 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.904 ' HB1' ' HB2' ' A' ' 25' ' ' ALA . . . -98.27 126.6 43.82 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.675 HD11 ' HB3' ' A' ' 54' ' ' HIS . 20.8 tt -116.4 145.75 21.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.8 t -87.21 23.01 1.93 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.835 -178.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.9 143.86 27.41 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.834 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.481 ' HG2' ' CB ' ' A' ' 50' ' ' GLN . 3.4 Cg_exo -55.78 166.34 2.95 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.566 2.177 . . . . 0.0 111.934 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -76.52 11.56 1.85 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.985 2.457 . . . . 0.0 112.255 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.622 HG13 ' H ' ' A' ' 50' ' ' GLN . 9.5 p -94.72 150.16 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.236 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -63.83 -53.35 52.1 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.881 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -39.91 -47.95 3.31 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 121.234 -0.508 . . . . 0.0 111.904 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.622 ' H ' HG13 ' A' ' 47' ' ' VAL . 1.2 tp60 -85.02 -50.17 7.68 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.57 -49.92 75.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.983 0.42 . . . . 0.0 110.433 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -57.69 -52.32 65.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.054 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.5 p -52.28 -47.47 65.86 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.88 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.675 ' HB3' HD11 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -61.31 -47.03 87.81 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-O 120.726 0.298 . . . . 0.0 110.281 179.393 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.565 HD21 ' NZ ' ' A' ' 81' ' ' LYS . 0.2 OUTLIER -49.43 -61.41 2.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.545 -179.785 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -55.36 -21.63 9.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.649 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -85.11 -60.66 1.97 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.034 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -53.9 -38.69 65.08 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.151 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.502 HD21 HD23 ' A' ' 17' ' ' LEU . 0.8 OUTLIER -83.69 -39.33 20.31 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.675 -179.79 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.08 -37.42 93.89 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.2 ptmm? -80.74 -31.3 36.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.546 0.213 . . . . 0.0 111.297 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.59 -46.51 21.95 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.007 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.775 ' HB3' HG23 ' A' ' 65' ' ' VAL . 40.6 m-85 -85.88 -18.4 32.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.488 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 32.7 mtp180 59.22 5.03 0.52 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.926 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.775 HG23 ' HB3' ' A' ' 63' ' ' PHE . 21.8 t -65.32 -118.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 121.027 0.441 . . . . 0.0 110.088 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.566 ' N ' HG12 ' A' ' 65' ' ' VAL . . . -148.55 155.62 41.37 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.034 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.06 -29.48 63.0 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -75.77 -13.92 60.31 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.883 179.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -103.18 -15.6 15.97 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.97 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.507 HG13 ' CG2' ' A' ' 83' ' ' ILE . 6.7 t -88.42 99.91 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.2 t -105.49 117.0 50.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.25 -178.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.413 HG12 ' CD1' ' A' ' 83' ' ' ILE . 51.8 mt -87.86 85.48 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.376 178.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -67.54 5.22 0.84 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.708 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.2 mttp 162.43 142.1 0.01 OUTLIER 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 80' ' ' HIS . . . 127.95 -12.79 6.46 Favored Glycine 0 C--N 1.323 -0.186 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 75' ' ' GLY . 5.8 mt-10 -33.83 -47.1 0.24 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.417 -0.392 . . . . 0.0 111.151 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.5 tp -125.45 -43.84 1.88 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.44 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -59.64 151.88 35.94 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.9 mtt85 -63.05 -29.31 70.72 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.465 ' O ' ' HA2' ' A' ' 75' ' ' GLY . 0.5 OUTLIER -68.05 157.82 34.34 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.056 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.767 ' NZ ' HD21 ' A' ' 19' ' ' LEU . 6.4 tttt -156.09 147.27 22.39 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.662 -178.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -147.21 111.61 5.22 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.507 ' CG2' HG13 ' A' ' 70' ' ' VAL . 6.1 mm -109.68 140.14 29.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.609 -178.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.87 111.59 23.1 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.048 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.573 HG23 HG21 ' A' ' 65' ' ' VAL . 1.8 mp -96.51 99.89 9.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.351 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 36.9 mt -85.23 148.66 4.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.578 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 46.1 58.31 16.08 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.651 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -46.05 129.27 12.41 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.882 2.388 . . . . 0.0 112.06 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.436 ' H ' HG22 ' A' ' 65' ' ' VAL . 41.1 tp60 -109.69 -30.01 8.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.699 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -147.65 121.61 9.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.609 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 tt -112.33 113.37 51.34 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.067 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -68.59 157.77 60.46 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.419 2.079 . . . . 0.0 112.202 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.66 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 2.5 Cg_endo -51.82 -27.73 28.24 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 123.035 2.49 . . . . 0.0 111.893 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -53.82 -59.4 4.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.834 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 16.9 t -76.57 -20.9 14.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.871 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.66 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -75.6 -31.7 60.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.7 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -65.74 -19.71 66.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.249 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 77.0 mt -102.09 -21.07 14.51 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.048 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 66.1 mt -98.73 -31.89 3.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.991 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -72.18 -12.26 61.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.459 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.9 tp 71.9 -61.21 0.5 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.366 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 50.57 -94.97 0.03 OUTLIER 'General case' 0 C--O 1.232 0.165 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 21.5 t60 52.7 17.71 0.88 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.636 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.4 ' CG ' ' N ' ' A' ' 105' ' ' HIS . 8.2 t60 -75.67 167.65 21.49 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.549 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.4 ' N ' ' CG ' ' A' ' 104' ' ' HIS . 59.1 m80 -63.64 178.94 0.53 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.669 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.512 ' CG ' ' H ' ' A' ' 107' ' ' HIS . 5.3 t-80 -95.59 -136.33 0.22 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.674 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.512 ' H ' ' CG ' ' A' ' 106' ' ' HIS . 85.6 t60 -156.42 70.83 0.68 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.013 0.435 . . . . 0.0 110.05 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 79.9 t60 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.419 -179.908 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.9 mmt . . . . . 0 N--CA 1.492 1.666 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 61.42 20.96 11.61 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.678 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -67.11 -106.31 0.02 OUTLIER Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.4 t -126.25 -31.86 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.87 0.367 . . . . 0.0 110.349 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.76 99.76 11.12 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.613 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.586 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -126.03 131.48 52.17 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 121.32 0.581 . . . . 0.0 109.76 178.5 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.586 ' HB2' ' O ' ' A' ' 6' ' ' SER . . . 159.68 -17.59 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.584 -1.189 . . . . 0.0 109.206 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.491 HG22 ' N ' ' A' ' 9' ' ' THR . 8.0 p -160.28 160.01 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.575 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.491 ' N ' HG22 ' A' ' 8' ' ' VAL . 1.7 m -150.95 125.6 9.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.427 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.407 HG22 ' H ' ' A' ' 10' ' ' VAL . 2.4 m -91.65 101.28 12.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.062 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -79.58 -158.04 0.15 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.11 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -107.05 11.26 29.86 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -124.07 -18.92 5.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.337 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.504 ' HA3' ' HZ3' ' A' ' 84' ' ' LYS . . . 166.43 -123.71 1.17 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.409 HD11 ' CZ ' ' A' ' 63' ' ' PHE . 0.3 OUTLIER -149.24 138.34 21.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.0 0.429 . . . . 0.0 111.391 -179.747 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 48.6 t -99.39 106.35 18.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.198 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.0 tp -87.39 114.0 23.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.024 0.44 . . . . 0.0 111.142 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.561 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 14.8 mtt-85 -111.17 126.29 54.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.658 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.463 ' HB2' HG12 ' A' ' 38' ' ' VAL . 0.8 OUTLIER -149.45 175.16 11.72 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 121.956 0.884 . . . . 0.0 112.86 -179.038 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -106.23 91.81 3.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 113.867 -1.515 . . . . 0.0 108.565 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.418 HG13 ' NZ ' ' A' ' 81' ' ' LYS . 1.0 OUTLIER -73.53 131.14 35.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.222 -178.104 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.14 88.8 53.62 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.903 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.14 161.0 39.05 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.767 2.311 . . . . 0.0 112.793 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 20.3 mtmt 73.59 48.61 0.15 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.207 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.933 ' CB ' ' HB1' ' A' ' 41' ' ' ALA . . . -99.55 -62.88 1.18 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 25' ' ' ALA . 4.3 t 153.08 -28.52 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.991 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.443 ' CG ' ' O ' ' A' ' 26' ' ' SER . 79.1 mtt180 -163.4 142.1 8.11 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.81 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.47 94.22 0.08 Allowed 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.448 0.642 . . . . 0.0 109.973 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.4 p -123.02 126.88 47.95 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.874 -179.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.673 HG22 HD21 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -92.07 63.01 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.454 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.607 HG13 ' O ' ' A' ' 31' ' ' VAL . 0.3 OUTLIER -96.56 17.89 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 114.583 -1.19 . . . . 0.0 112.338 -177.821 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . -141.59 22.6 2.52 Favored Glycine 0 C--N 1.32 -0.351 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -178.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.673 HD21 HG22 ' A' ' 30' ' ' ILE . 19.3 mt -59.45 120.66 9.78 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.07 -0.565 . . . . 0.0 109.824 178.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.405 ' O ' ' O ' ' A' ' 37' ' ' GLU . 2.3 t60 -111.6 155.06 23.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.492 -178.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -66.93 -19.7 69.97 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.649 -0.981 . . . . 0.0 110.649 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -121.15 -5.07 9.48 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.555 0.217 . . . . 0.0 110.614 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.405 ' O ' ' O ' ' A' ' 34' ' ' HIS . 57.2 mt-10 -148.54 -178.46 6.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.991 0.424 . . . . 0.0 110.651 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.463 HG12 ' HB2' ' A' ' 19' ' ' LEU . 6.8 t -141.72 110.96 2.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 13.0 mtpt -110.36 103.15 11.76 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.146 -0.621 . . . . 0.0 110.785 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.7 p -114.27 136.43 50.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.701 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.933 ' HB1' ' CB ' ' A' ' 25' ' ' ALA . . . -99.98 93.95 6.03 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.979 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.758 HD11 ' HB3' ' A' ' 54' ' ' HIS . 19.7 tt -80.04 148.59 5.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.3 t -93.81 29.41 2.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.001 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.37 161.09 26.46 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.855 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -77.21 177.61 8.65 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 123.478 2.785 . . . . 0.0 112.093 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -77.31 5.5 5.05 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 123.168 2.578 . . . . 0.0 112.644 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.437 HG13 ' H ' ' A' ' 50' ' ' GLN . 11.7 p -98.96 155.86 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 120.791 0.329 . . . . 0.0 110.738 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.42 ' N ' HG22 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -69.41 -61.37 1.82 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.055 -179.709 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . -34.87 -51.93 0.83 Allowed Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.884 -0.486 . . . . 0.0 111.884 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.437 ' H ' HG13 ' A' ' 47' ' ' VAL . 2.4 mm100 -76.39 -50.56 13.87 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.121 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.74 -61.72 2.22 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.766 0.317 . . . . 0.0 110.915 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -47.07 -39.85 13.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.731 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.5 m -61.25 -51.39 69.14 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.586 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.758 ' HB3' HD11 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -55.85 -57.98 9.79 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.572 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -44.16 -57.93 3.15 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.044 0.45 . . . . 0.0 110.262 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.3 t -54.36 -26.07 15.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.127 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.421 ' N ' ' O ' ' A' ' 54' ' ' HIS . 8.4 ttpt -85.17 -63.46 1.32 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.918 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -50.74 -41.8 56.78 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.203 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.1 tp -84.67 -40.43 17.41 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.504 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -58.99 -33.64 75.08 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.0 ptmt -80.59 -37.27 31.57 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 120.59 0.233 . . . . 0.0 111.035 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -74.94 -42.39 57.79 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.431 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.549 ' HB3' HG13 ' A' ' 65' ' ' VAL . 0.7 OUTLIER -86.09 -18.83 31.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.535 179.767 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.4 mtp180 60.47 8.1 1.55 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.777 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.894 HG11 HG23 ' A' ' 85' ' ' ILE . 35.8 m -67.53 177.03 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -89.63 164.81 14.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.948 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -21.2 62.6 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -86.55 -12.65 48.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.464 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -101.62 -1.17 33.4 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.492 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.557 ' O ' HG13 ' A' ' 70' ' ' VAL . 7.7 p -110.94 100.69 11.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.014 0.435 . . . . 0.0 110.014 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 79.7 t -114.22 116.92 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.756 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.426 ' C ' ' H ' ' A' ' 74' ' ' LYS . 76.3 mt -89.94 88.48 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.23 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -72.81 10.3 0.91 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.671 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.426 ' H ' ' C ' ' A' ' 72' ' ' ILE . 7.6 mttp 167.93 145.59 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.408 ' HA2' ' O ' ' A' ' 80' ' ' HIS . . . 123.59 -17.01 7.87 Favored Glycine 0 CA--C 1.518 0.269 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -39.18 -44.33 1.19 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.655 -0.273 . . . . 0.0 111.066 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.411 ' O ' HD13 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -134.18 -43.43 0.79 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.192 -179.71 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.96 151.47 52.47 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -60.82 -32.67 72.03 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.408 ' O ' ' HA2' ' A' ' 75' ' ' GLY . 3.9 p-80 -68.89 129.97 41.45 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 177.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.561 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.6 OUTLIER -137.86 141.5 40.72 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 120.196 -0.601 . . . . 0.0 110.49 -177.312 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -139.48 114.62 9.63 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.557 HD11 ' HD3' ' A' ' 81' ' ' LYS . 4.7 mt -117.01 135.87 55.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.396 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.504 ' HZ3' ' HA3' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -104.67 106.67 17.26 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.876 -179.819 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.894 HG23 HG11 ' A' ' 65' ' ' VAL . 1.5 mp -94.68 92.06 3.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.067 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.401 HG22 ' N ' ' A' ' 87' ' ' ASN . 55.5 mt -77.47 155.39 5.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.733 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.401 ' N ' HG22 ' A' ' 86' ' ' ILE . 3.1 m120 38.39 73.32 0.78 Allowed Pre-proline 0 N--CA 1.464 0.243 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.005 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -74.32 132.92 16.98 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.673 2.249 . . . . 0.0 111.847 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -110.63 -24.16 10.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.089 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -147.52 120.19 8.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.255 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.493 HG23 ' O ' ' A' ' 91' ' ' ILE . 3.9 tt -113.96 119.55 40.66 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.951 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -66.26 147.72 83.75 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 122.224 1.949 . . . . 0.0 112.522 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.679 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 2.5 Cg_endo -51.03 -30.22 30.43 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 123.048 2.498 . . . . 0.0 112.24 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -54.23 -57.77 9.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.699 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.436 ' H ' HG23 ' A' ' 95' ' ' VAL . 1.5 t -75.11 -21.66 16.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.732 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.679 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -75.59 -34.53 60.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.024 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.71 -20.1 32.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.738 0.304 . . . . 0.0 111.075 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 27.2 mt -103.04 -25.1 13.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.077 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 86.1 mt -96.65 -27.69 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.872 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -84.9 -11.04 56.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.679 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.7 tp -68.11 -80.77 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.031 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 48.97 23.36 0.7 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.017 0.437 . . . . 0.0 110.47 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -143.01 117.4 9.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.795 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -50.7 147.48 4.73 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.11 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -157.48 -159.18 0.81 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.275 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 5.0 m80 -143.61 129.04 19.0 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.408 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.43 ' CG ' ' N ' ' A' ' 108' ' ' HIS . 49.9 p-80 -139.31 -41.86 0.46 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.574 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.43 ' N ' ' CG ' ' A' ' 107' ' ' HIS . 3.4 t60 . . . . . 0 C--N 1.331 -0.197 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.426 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.5 mtm . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -163.41 -60.51 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.573 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 177.93 73.52 0.06 OUTLIER Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.7 p -97.24 7.09 8.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-O 120.826 0.346 . . . . 0.0 110.703 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 13.1 ttm -157.03 51.6 0.48 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.65 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.619 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 22.7 t -99.89 -168.77 1.64 Allowed 'General case' 0 N--CA 1.435 -1.184 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.195 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.619 ' HB2' ' O ' ' A' ' 6' ' ' SER . . . 152.63 -17.48 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.563 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.448 ' CG2' ' N ' ' A' ' 9' ' ' THR . 0.7 OUTLIER -160.27 157.73 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.6 -179.809 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.448 ' N ' ' CG2' ' A' ' 8' ' ' VAL . 1.1 m -147.66 134.46 20.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.136 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 10' ' ' VAL . 33.2 m -102.65 104.0 15.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.224 0.535 . . . . 0.0 110.492 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 35.9 m-20 -87.2 -149.98 0.16 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.166 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -107.18 2.68 24.95 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -109.17 -22.23 12.2 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.441 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.49 ' HA3' ' HZ1' ' A' ' 84' ' ' LYS . . . 160.47 -122.14 1.1 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.508 HD11 ' CE2' ' A' ' 63' ' ' PHE . 0.3 OUTLIER -147.36 147.31 30.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.946 0.403 . . . . 0.0 111.244 -179.722 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.1 t -103.85 137.23 33.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.488 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.03 99.17 7.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.935 0.398 . . . . 0.0 110.521 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.526 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 38.7 mtt180 -97.3 114.76 26.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.836 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.596 ' C ' HD12 ' A' ' 19' ' ' LEU . 4.3 pp -147.05 179.75 7.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.284 0.564 . . . . 0.0 111.664 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.565 ' N ' HD12 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -113.81 95.78 5.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.949 179.522 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.1 tp -75.35 130.78 35.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.273 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.405 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -120.51 91.83 47.13 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.638 -179.388 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.454 ' O ' ' HB2' ' A' ' 24' ' ' LYS . 3.1 Cg_exo -71.66 165.29 32.99 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.454 2.103 . . . . 0.0 112.29 -178.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 23' ' ' PRO . 16.5 mtmm 77.37 37.25 0.26 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.511 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.921 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . . . -102.41 167.41 9.97 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 17.0 t -75.41 -10.32 59.34 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 119.996 -0.682 . . . . 0.0 109.666 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.7 ttp180 -176.6 163.8 2.42 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.666 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.503 ' HA ' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -84.82 95.22 8.92 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.613 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.1 m -126.42 135.66 51.68 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.722 -178.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.469 HG22 HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -91.01 76.1 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.689 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.3 17.55 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.053 -178.023 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . -142.4 21.75 2.4 Favored Glycine 0 C--N 1.32 -0.322 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.753 ' CD2' HG13 ' A' ' 38' ' ' VAL . 19.4 mt -57.75 107.01 0.41 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.434 ' O ' ' O ' ' A' ' 37' ' ' GLU . 44.7 t-80 -94.46 157.4 16.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.559 -178.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -66.6 -29.26 74.47 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -112.41 -10.08 13.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.737 -0.231 . . . . 0.0 110.472 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.434 ' O ' ' O ' ' A' ' 34' ' ' HIS . 8.4 mt-10 -140.68 -176.81 4.79 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.975 0.417 . . . . 0.0 110.734 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.753 HG13 ' CD2' ' A' ' 33' ' ' LEU . 45.9 t -142.78 112.79 2.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -111.13 132.69 54.08 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.262 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.526 HG13 ' O ' ' A' ' 40' ' ' VAL . 8.5 p -147.59 124.18 2.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.651 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.921 ' HB1' ' HB2' ' A' ' 25' ' ' ALA . . . -86.94 122.4 30.75 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.828 HD11 ' HB3' ' A' ' 54' ' ' HIS . 21.2 tt -109.33 147.95 13.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.1 t -90.66 38.42 0.95 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.937 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -105.24 139.14 19.85 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.449 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.548 ' HG2' ' CB ' ' A' ' 50' ' ' GLN . 3.2 Cg_exo -56.25 170.47 1.16 Allowed 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 122.689 2.259 . . . . 0.0 112.572 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.61 24.74 0.45 Allowed 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 123.36 2.707 . . . . 0.0 113.391 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.461 HG13 ' H ' ' A' ' 50' ' ' GLN . 13.9 p -120.28 138.2 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.446 ' O ' ' C ' ' A' ' 49' ' ' GLY . 0.7 OUTLIER -53.75 -58.87 5.66 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.104 -179.427 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . -34.65 -52.9 0.81 Allowed Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.548 ' CB ' ' HG2' ' A' ' 45' ' ' PRO . 43.1 mm-40 -78.12 -39.37 41.47 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.07 -62.87 1.2 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.834 0.35 . . . . 0.0 110.511 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.439 ' N ' ' O ' ' A' ' 48' ' ' ASP . 46.2 t-20 -43.58 -47.24 7.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.876 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 18.4 m -52.99 -57.55 9.99 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.305 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.828 ' HB3' HD11 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -51.5 -50.75 59.29 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.787 0.327 . . . . 0.0 110.679 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.651 HD12 HD11 ' A' ' 83' ' ' ILE . 3.1 mm? -50.91 -43.77 59.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.198 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -69.37 -27.12 33.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.99 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -79.32 -60.5 2.34 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.842 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -46.9 -58.39 3.98 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.249 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.413 ' O ' ' HB2' ' A' ' 63' ' ' PHE . 4.6 mp -71.17 -41.47 70.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.103 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -51.17 -35.42 34.03 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.3 mttp -80.92 -58.26 3.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.662 0.268 . . . . 0.0 111.02 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -56.03 -43.87 78.21 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.102 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.508 ' CE2' HD11 ' A' ' 15' ' ' LEU . 1.6 m-85 -82.72 -18.54 40.47 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.111 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.2 mtt-85 61.59 8.48 2.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.533 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.2 m -82.9 163.14 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.443 ' O ' HG23 ' A' ' 70' ' ' VAL . . . -65.3 156.63 31.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.806 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 28.2 pttt -70.96 -28.58 64.58 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -71.42 -11.94 61.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.927 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.428 ' O ' ' O ' ' A' ' 84' ' ' LYS . 80.8 mt-30 -100.14 -7.94 24.25 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.335 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 66' ' ' ALA . 31.0 t -104.06 97.76 5.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.4 t -116.78 123.18 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -178.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.424 ' C ' ' H ' ' A' ' 74' ' ' LYS . 54.3 mt -82.33 84.55 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.166 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -60.25 -3.68 0.67 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.035 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.424 ' H ' ' C ' ' A' ' 72' ' ' ILE . 5.3 mttp 168.15 116.55 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.081 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.567 ' HA3' ' HZ2' ' A' ' 81' ' ' LYS . . . 148.62 -10.43 1.08 Allowed Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -34.14 -41.03 0.1 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.3 tp -131.47 -42.96 1.04 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.701 0.286 . . . . 0.0 111.355 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.5 149.2 48.67 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.785 -0.526 . . . . 0.0 111.785 -178.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.462 ' HD3' ' H ' ' A' ' 79' ' ' ARG . 0.1 OUTLIER -60.99 -29.43 69.68 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.387 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.429 ' O ' ' HA2' ' A' ' 75' ' ' GLY . 76.5 t60 -67.27 145.85 54.75 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 177.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.567 ' HZ2' ' HA3' ' A' ' 75' ' ' GLY . 0.0 OUTLIER -144.73 154.02 42.3 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 119.706 -0.798 . . . . 0.0 111.537 -177.195 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -162.87 78.71 0.47 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.651 HD11 HD12 ' A' ' 55' ' ' LEU . 46.8 mt -80.46 153.61 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.398 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.49 ' HZ1' ' HA3' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -120.47 111.86 18.24 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.969 -178.973 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.474 ' N ' ' HE3' ' A' ' 84' ' ' LYS . 1.4 mp -100.54 102.85 14.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.182 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 55.3 mt -85.99 153.55 3.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.551 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 18.4 m-20 40.05 79.77 0.31 Allowed Pre-proline 0 N--CA 1.467 0.41 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.692 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.51 146.1 30.51 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 123.014 2.476 . . . . 0.0 112.65 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 60.6 mm-40 -124.12 -28.91 3.66 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.043 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -146.8 117.48 7.57 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.138 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.9 tt -114.36 120.49 38.07 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.599 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.2 141.22 92.68 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.479 2.119 . . . . 0.0 112.342 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.462 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 2.5 Cg_endo -50.49 -33.94 40.18 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 123.266 2.644 . . . . 0.0 112.632 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -53.04 -54.43 35.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.13 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 16.3 t -72.22 -19.45 19.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.462 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -75.0 -25.44 58.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.809 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -62.53 -26.34 68.51 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.888 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 20.1 mt -94.99 -10.94 29.42 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.5 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 97.6 mt -102.36 -30.98 2.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.943 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -78.05 -42.42 32.38 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.821 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.559 HD23 ' O ' ' A' ' 101' ' ' LEU . 2.0 tt 74.9 -45.65 0.58 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.698 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 101' ' ' LEU . 51.5 mt-10 -37.55 97.78 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 O-C-N 123.355 0.409 . . . . 0.0 110.427 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.52 ' O ' ' CG ' ' A' ' 103' ' ' HIS . 11.5 p-80 -137.27 66.78 1.45 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.444 -178.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -45.71 -78.72 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.978 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -147.24 108.58 4.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.92 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.437 ' O ' ' CG ' ' A' ' 106' ' ' HIS . 49.1 t-80 48.61 57.77 5.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.119 0.485 . . . . 0.0 109.965 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -79.62 104.91 10.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.242 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.73 179.861 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.4 mmt . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -169.42 -51.56 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.788 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 89.85 -10.14 74.82 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.3 t 50.09 64.81 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 110.439 -0.208 . . . . 0.0 110.439 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 32.83 95.75 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 O-C-N 123.659 0.599 . . . . 0.0 112.024 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.639 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 9.6 p -124.36 -168.33 1.79 Allowed 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.639 ' HB2' ' O ' ' A' ' 6' ' ' SER . . . 157.87 -17.46 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.985 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.454 ' CG2' ' N ' ' A' ' 9' ' ' THR . 0.2 OUTLIER -159.38 157.76 2.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.843 -179.607 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.454 ' N ' ' CG2' ' A' ' 8' ' ' VAL . 1.3 m -144.62 141.78 29.66 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.349 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 m -107.19 101.36 12.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.298 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -81.24 -155.4 0.12 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.311 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -107.65 10.52 29.02 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -122.83 -25.26 4.66 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.241 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.62 -129.11 1.54 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.425 HD11 ' CE2' ' A' ' 63' ' ' PHE . 0.2 OUTLIER -145.46 158.74 43.79 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.171 0.51 . . . . 0.0 111.31 -179.757 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.8 t -110.03 138.47 37.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.329 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.646 HD12 HD23 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -115.61 91.16 3.52 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.689 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 4.6 mtm180 -97.06 109.26 22.05 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.4 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.731 HD12 ' N ' ' A' ' 20' ' ' TYR . 3.4 pp -145.42 178.89 7.77 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.878 0.371 . . . . 0.0 110.998 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.731 ' N ' HD12 ' A' ' 19' ' ' LEU . 31.8 t80 -110.93 104.62 13.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.3 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.465 HG22 ' HD3' ' A' ' 23' ' ' PRO . 1.7 mm -70.68 126.72 31.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.38 86.24 55.04 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.129 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.465 ' HD3' HG22 ' A' ' 21' ' ' ILE . 3.3 Cg_exo -74.77 161.18 39.76 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.634 2.223 . . . . 0.0 111.84 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.6 mtmt 73.87 43.48 0.32 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.007 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.907 ' CB ' ' HB1' ' A' ' 41' ' ' ALA . . . -91.66 -71.12 0.65 Allowed 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.2 p 162.51 -23.12 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.016 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -171.75 143.16 1.64 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.041 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.403 ' HA ' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -63.05 89.66 0.04 OUTLIER 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.673 0.749 . . . . 0.0 110.055 179.493 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.3 m -130.77 127.28 38.4 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.192 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.538 HG22 HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -83.29 65.62 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.78 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -94.03 18.28 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 114.669 -1.151 . . . . 0.0 113.016 -177.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -143.05 39.14 1.35 Allowed Glycine 0 N--CA 1.46 0.289 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.851 ' CD2' HG13 ' A' ' 38' ' ' VAL . 22.9 mt -77.78 117.69 19.4 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.557 -0.822 . . . . 0.0 109.799 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.585 ' CD2' ' H ' ' A' ' 35' ' ' GLY . 11.0 t-160 -102.25 159.46 15.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.416 -178.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.585 ' H ' ' CD2' ' A' ' 34' ' ' HIS . . . -73.47 -19.66 79.72 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -115.96 -14.05 11.26 Favored 'General case' 0 N--CA 1.461 0.11 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.413 ' H ' ' HB3' ' A' ' 34' ' ' HIS . 19.2 mt-10 -143.39 -176.23 4.86 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.322 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.851 HG13 ' CD2' ' A' ' 33' ' ' LEU . 73.2 t -144.15 121.12 5.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.37 118.48 29.56 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.646 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.496 HG23 HG23 ' A' ' 30' ' ' ILE . 8.5 p -113.42 135.01 54.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.064 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.907 ' HB1' ' CB ' ' A' ' 25' ' ' ALA . . . -100.0 104.8 16.42 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.729 HD13 ' CE1' ' A' ' 54' ' ' HIS . 0.6 OUTLIER -99.39 156.19 3.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 -179.147 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.421 ' H ' HG13 ' A' ' 42' ' ' ILE . 8.4 t -93.22 26.75 2.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.744 -178.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.462 ' H ' HG23 ' A' ' 42' ' ' ILE . . . -97.0 167.44 12.01 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.866 0.365 . . . . 0.0 110.913 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.691 ' HB2' HG22 ' A' ' 47' ' ' VAL . 3.6 Cg_exo -77.98 177.63 8.56 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 123.56 2.84 . . . . 0.0 112.165 179.119 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -77.5 0.75 9.47 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 123.009 2.473 . . . . 0.0 111.435 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.691 HG22 ' HB2' ' A' ' 45' ' ' PRO . 35.2 m -93.19 160.16 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.666 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 52' ' ' ASN . 2.3 m-20 -82.21 -47.34 12.59 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.905 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -43.07 -46.8 6.39 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.501 ' NE2' HG21 ' A' ' 47' ' ' VAL . 0.9 OUTLIER -81.49 -49.81 10.15 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 121.219 -0.192 . . . . 0.0 111.511 -179.453 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.53 -56.53 20.25 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.837 0.351 . . . . 0.0 110.06 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.452 ' N ' ' O ' ' A' ' 48' ' ' ASP . 30.8 t-20 -46.12 -46.38 17.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.086 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.5 p -50.18 -48.14 54.24 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.729 ' CE1' HD13 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -63.05 -45.58 91.56 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.11 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.599 HD22 ' CE1' ' A' ' 54' ' ' HIS . 0.1 OUTLIER -49.24 -60.92 2.39 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.308 -178.537 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -53.7 -26.53 13.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.795 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.413 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 19.1 tttt -82.16 -72.64 0.43 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.058 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.406 ' C ' ' O ' ' A' ' 57' ' ' LYS . 0.8 OUTLIER -33.85 -64.09 0.24 Allowed 'General case' 0 N--CA 1.467 0.377 0 O-C-N 123.167 0.292 . . . . 0.0 111.292 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.429 ' CD2' ' N ' ' A' ' 59' ' ' LEU . 3.6 mm? -64.99 -37.96 89.39 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 64' ' ' ARG . . . -55.17 -41.53 78.94 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.413 ' HG3' ' O ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -81.1 -52.54 7.27 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.066 0.46 . . . . 0.0 110.229 179.531 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.1 mm100 -56.11 -49.72 73.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.711 -178.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.496 ' CD2' HG21 ' A' ' 85' ' ' ILE . 2.3 m-85 -87.14 -18.99 29.14 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.627 -0.261 . . . . 0.0 111.393 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.408 ' HA ' ' O ' ' A' ' 60' ' ' GLY . 18.6 mtt180 59.98 4.1 0.57 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.582 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.441 HG21 HG23 ' A' ' 85' ' ' ILE . 33.6 m -76.35 152.3 5.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.511 ' HB3' ' NE2' ' A' ' 69' ' ' GLN . . . -48.77 158.74 0.29 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.542 -179.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.68 -29.56 65.91 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.308 0.575 . . . . 0.0 109.66 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.32 -13.88 59.84 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.59 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.511 ' NE2' ' HB3' ' A' ' 66' ' ' ALA . 1.2 mp0 -89.93 -6.26 55.9 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.259 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.4 t -106.0 97.23 5.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.6 t -114.42 124.53 71.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.206 0.527 . . . . 0.0 111.814 -178.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 64.2 mt -86.95 93.22 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.435 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -77.35 -1.66 31.12 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.938 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 38.8 tttt 179.6 118.95 0.05 Allowed 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.543 ' O ' ' C ' ' A' ' 76' ' ' GLU . . . 146.66 -20.27 1.65 Allowed Glycine 0 CA--C 1.516 0.122 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.543 ' C ' ' O ' ' A' ' 75' ' ' GLY . 11.1 mp0 -10.6 -66.59 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 O-C-N 124.291 0.642 . . . . 0.0 112.037 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.7 tt -118.65 -42.87 2.71 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.369 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -51.11 157.68 2.49 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 44.4 mtt-85 -68.14 -16.44 64.0 Favored 'General case' 0 CA--C 1.519 -0.231 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.516 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 62.3 t-80 -69.17 155.95 39.52 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.483 ' CE ' HD21 ' A' ' 55' ' ' LEU . 36.1 tttt -148.68 125.37 11.12 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.139 -0.625 . . . . 0.0 109.997 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.442 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 8.3 tt0 -131.55 104.74 7.13 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 15.9 mm -102.09 129.69 53.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.767 -178.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.99 99.33 9.08 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.496 HG21 ' CD2' ' A' ' 63' ' ' PHE . 2.2 mp -89.53 96.62 6.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.139 -178.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 33.4 mt -82.2 146.09 7.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.717 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 51.89 75.04 0.69 Allowed Pre-proline 0 N--CA 1.463 0.215 0 CA-C-O 120.759 0.314 . . . . 0.0 110.529 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -74.27 130.48 14.13 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 122.594 2.196 . . . . 0.0 112.096 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 21.4 mm100 -114.55 -26.08 8.06 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.948 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -145.39 116.18 7.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.399 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.558 HG23 ' O ' ' A' ' 91' ' ' ILE . 4.1 tt -112.56 114.45 50.02 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.064 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -67.13 145.62 73.67 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.29 1.993 . . . . 0.0 111.504 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.603 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 2.7 Cg_endo -51.61 -19.69 7.87 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 122.62 2.214 . . . . 0.0 111.873 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -61.14 -56.31 22.31 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.97 0.414 . . . . 0.0 110.331 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.25 -25.39 12.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.745 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.603 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -75.41 -44.61 43.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.975 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -50.33 -19.78 0.91 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.57 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 80.5 mt -102.42 -25.44 13.63 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.944 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 95.8 mt -92.14 -21.18 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.997 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.469 HD22 ' HG3' ' A' ' 102' ' ' GLU . 33.3 p-10 -94.68 -23.59 17.52 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.658 0.266 . . . . 0.0 111.096 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.414 ' N ' ' OD1' ' A' ' 100' ' ' ASN . 2.0 tp 55.47 68.43 0.86 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.604 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.469 ' HG3' HD22 ' A' ' 100' ' ' ASN . 0.0 OUTLIER -86.71 -14.56 42.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.542 179.675 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 27.6 m80 -67.74 109.77 3.49 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.257 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.419 ' O ' ' ND1' ' A' ' 106' ' ' HIS . 0.0 OUTLIER -124.94 39.79 3.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.576 -179.873 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -61.0 96.78 0.05 Allowed 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.422 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.419 ' ND1' ' O ' ' A' ' 104' ' ' HIS . 16.7 p-80 -124.51 173.98 8.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.271 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 3.6 p80 -148.76 145.76 27.75 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.643 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 13.0 m80 . . . . . 0 CA--C 1.529 0.145 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.809 -179.833 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 tpt . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -54.1 126.52 23.05 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.74 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 5' ' ' MET . . . -86.2 -31.71 19.07 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.0 t 64.31 -71.72 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 120.725 0.297 . . . . 0.0 110.481 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.433 ' N ' ' O ' ' A' ' 3' ' ' GLY . 0.0 OUTLIER -94.1 98.29 10.88 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.063 179.404 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.604 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 6.7 t -125.03 -167.75 1.72 Allowed 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.304 0.573 . . . . 0.0 110.349 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.604 ' HB2' ' O ' ' A' ' 6' ' ' SER . . . 156.36 -20.65 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.735 -1.12 . . . . 0.0 108.956 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.4 m -149.02 168.2 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.115 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 m -150.73 120.77 7.17 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.431 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.2 m -92.34 97.09 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.194 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -82.68 -163.27 0.68 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.189 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -101.39 11.71 38.7 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -119.16 -24.11 6.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.11 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.521 ' HA3' ' HZ1' ' A' ' 84' ' ' LYS . . . 165.87 -124.35 1.23 Allowed Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.414 HD11 ' CE2' ' A' ' 63' ' ' PHE . 0.3 OUTLIER -150.87 150.77 31.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.976 0.417 . . . . 0.0 111.134 -179.582 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.1 t -107.74 142.8 19.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.928 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -113.49 96.28 5.8 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 22.9 mtp85 -104.47 110.86 23.29 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.789 -179.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.458 HD12 ' N ' ' A' ' 20' ' ' TYR . 3.0 pp -147.52 179.66 7.51 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.051 0.453 . . . . 0.0 111.427 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.458 ' N ' HD12 ' A' ' 19' ' ' LEU . 16.0 t80 -108.36 114.64 28.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.086 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.9 mm -84.26 133.78 28.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.928 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -120.87 87.48 42.95 Favored Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -70.09 156.82 61.6 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.62 2.213 . . . . 0.0 113.413 -178.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? 69.83 49.79 0.5 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.239 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.906 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . . . -96.68 -66.92 0.87 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' A' ' 25' ' ' ALA . 1.1 m 158.56 -24.41 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.293 -0.867 . . . . 0.0 108.724 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -171.1 144.24 2.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.87 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.47 92.8 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 59.8 p -124.29 130.19 52.08 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.52 -178.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.611 HG22 HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -94.78 63.55 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.111 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.734 ' O ' HG12 ' A' ' 31' ' ' VAL . 92.7 t -96.03 19.51 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.944 -178.095 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -144.04 32.08 1.81 Allowed Glycine 0 C--N 1.334 0.457 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.83 ' CD2' HG13 ' A' ' 38' ' ' VAL . 31.8 mt -66.61 126.24 28.29 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.63 -0.785 . . . . 0.0 109.926 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.428 ' O ' ' O ' ' A' ' 37' ' ' GLU . 23.2 t-80 -112.67 157.41 21.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.042 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.06 -27.54 73.66 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -109.26 -14.49 14.46 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 115.569 -0.315 . . . . 0.0 110.81 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.428 ' O ' ' O ' ' A' ' 34' ' ' HIS . 9.0 mt-10 -141.94 -177.67 5.32 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.001 0.429 . . . . 0.0 111.081 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.83 HG13 ' CD2' ' A' ' 33' ' ' LEU . 70.7 t -143.97 115.98 2.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.707 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.4 ttpt -116.13 117.57 30.43 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.642 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.4 p -120.12 149.83 22.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.156 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.906 ' HB1' ' HB2' ' A' ' 25' ' ' ALA . . . -112.53 103.54 11.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.308 -0.406 . . . . 0.0 109.915 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.402 HG13 ' N ' ' A' ' 43' ' ' THR . 2.4 tp -86.11 146.36 6.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.44 HG22 ' H ' ' A' ' 43' ' ' THR . 0.7 OUTLIER -87.31 17.15 4.58 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.755 -178.28 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.12 149.77 36.08 Favored Pre-proline 0 C--O 1.234 0.276 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.55 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.532 ' HB2' HG22 ' A' ' 47' ' ' VAL . 3.9 Cg_exo -51.54 175.9 0.06 OUTLIER 'Trans proline' 0 N--CA 1.491 1.371 0 C-N-CA 123.241 2.627 . . . . 0.0 112.212 178.288 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -80.21 0.36 10.08 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 123.23 2.62 . . . . 0.0 112.982 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.532 HG22 ' HB2' ' A' ' 45' ' ' PRO . 0.2 OUTLIER -87.79 158.61 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.988 -179.616 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.445 ' O ' ' N ' ' A' ' 52' ' ' ASN . 17.5 m-20 -73.55 -57.57 3.9 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.001 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . -36.65 -46.4 1.11 Allowed Glycine 0 CA--C 1.529 0.969 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.507 ' HB2' HG23 ' A' ' 47' ' ' VAL . 2.1 mp0 -82.73 -52.16 7.03 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.25 -56.05 26.26 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.937 0.399 . . . . 0.0 110.403 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' A' ' 48' ' ' ASP . 40.1 t-20 -46.34 -54.65 8.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.47 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.7 m -48.81 -52.54 23.49 Favored 'General case' 0 C--O 1.23 0.066 0 C-N-CA 120.624 -0.431 . . . . 0.0 110.107 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -56.33 -56.12 25.01 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.539 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.3 mp -43.3 -60.45 1.69 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.273 0.558 . . . . 0.0 110.134 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.7 t -57.85 -29.33 35.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.312 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -76.3 -68.31 0.6 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.262 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -39.09 -48.28 1.65 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.503 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.4 HD13 ' HZ1' ' A' ' 81' ' ' LYS . 7.4 mp -76.93 -34.79 57.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.84 0.353 . . . . 0.0 110.072 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.36 -35.65 61.36 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.01 -52.16 7.73 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.919 0.39 . . . . 0.0 110.428 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -59.25 -46.93 87.19 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.848 -178.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.497 ' HB3' HG13 ' A' ' 65' ' ' VAL . 2.4 m-85 -86.13 -19.11 30.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.076 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.2 mtt85 59.24 5.27 0.55 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.352 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.529 HG11 HG23 ' A' ' 85' ' ' ILE . 27.0 m -67.35 175.33 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.199 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -86.67 163.44 17.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.263 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 29.1 pttt -70.91 -21.29 62.39 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.658 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.77 -8.76 59.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.296 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -108.43 -5.15 16.78 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.463 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.696 ' O ' HG13 ' A' ' 70' ' ' VAL . 9.8 p -101.21 101.1 11.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 121.286 0.565 . . . . 0.0 110.373 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 59.7 t -115.94 124.9 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 52.6 mt -84.85 93.67 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.905 178.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -70.01 -16.05 63.11 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.159 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt 174.81 163.9 0.24 Allowed 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.57 -2.05 73.06 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -37.94 -31.94 0.05 Allowed 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.554 HD23 ' O ' ' A' ' 77' ' ' LEU . 1.0 OUTLIER -127.04 -45.04 1.58 Allowed 'General case' 0 C--O 1.233 0.187 0 C-N-CA 121.061 -0.255 . . . . 0.0 111.0 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.404 ' C ' ' N ' ' A' ' 80' ' ' HIS . . . -58.84 148.22 39.55 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.435 ' HB3' ' CE1' ' A' ' 20' ' ' TYR . 10.4 mtt180 -50.19 -18.55 0.6 Allowed 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.404 ' N ' ' C ' ' A' ' 78' ' ' GLY . 1.7 m80 -69.87 165.35 21.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.493 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.596 ' HE3' HD12 ' A' ' 83' ' ' ILE . 2.0 tttt -151.97 132.87 14.18 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -139.77 82.06 1.86 Allowed 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.596 HD12 ' HE3' ' A' ' 81' ' ' LYS . 92.2 mt -95.11 139.61 18.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.839 -179.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.521 ' HZ1' ' HA3' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -108.49 126.44 52.91 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.211 -179.129 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.589 HG22 ' O ' ' A' ' 85' ' ' ILE . 1.4 mp -106.1 98.75 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.967 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.401 ' O ' ' C ' ' A' ' 87' ' ' ASN . 95.5 mt -80.59 151.8 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 86' ' ' ILE . 3.0 m120 38.09 85.41 0.16 Allowed Pre-proline 0 N--CA 1.464 0.226 0 O-C-N 123.235 0.334 . . . . 0.0 110.804 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -72.32 133.09 20.36 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.403 2.068 . . . . 0.0 112.365 -179.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -108.08 -30.19 8.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.419 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -147.31 121.05 9.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.123 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.571 HG23 ' O ' ' A' ' 91' ' ' ILE . 2.9 tt -113.39 114.17 48.03 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.454 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -66.01 173.86 6.58 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 121.985 1.79 . . . . 0.0 111.069 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.556 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 3.3 Cg_exo -73.66 -19.19 21.64 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.445 2.097 . . . . 0.0 111.591 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -52.94 -62.5 1.61 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.255 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.3 t -73.57 -24.58 20.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.975 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.556 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -70.4 -28.4 65.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.666 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.62 -22.29 8.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.551 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.9 mt -108.02 -41.55 4.91 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.784 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 79.0 mt -76.24 -13.57 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.767 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -104.6 -33.82 8.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.078 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.2 tp 48.04 72.37 0.27 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.155 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.512 ' O ' ' N ' ' A' ' 104' ' ' HIS . 5.4 mm-40 -89.17 -11.24 44.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.173 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 10.6 m80 -55.96 81.58 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.729 0.299 . . . . 0.0 110.217 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.512 ' N ' ' O ' ' A' ' 102' ' ' GLU . 12.4 t-80 45.08 -138.16 0.47 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.177 -179.017 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.497 ' N ' ' ND1' ' A' ' 105' ' ' HIS . 1.8 m-70 64.74 -68.51 0.1 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.553 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.441 ' N ' ' O ' ' A' ' 104' ' ' HIS . 61.7 m170 37.8 63.32 0.8 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.871 0.367 . . . . 0.0 110.829 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.456 ' CG ' ' N ' ' A' ' 108' ' ' HIS . 38.3 p-80 -48.75 -50.04 35.67 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.693 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.456 ' N ' ' CG ' ' A' ' 107' ' ' HIS . 83.2 t60 . . . . . 0 C--N 1.332 -0.153 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.35 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -164.33 -38.83 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.575 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.619 ' C ' HG13 ' A' ' 4' ' ' VAL . . . -99.93 -64.64 0.81 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.619 HG13 ' C ' ' A' ' 3' ' ' GLY . 0.8 OUTLIER 65.73 -20.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 122.81 0.444 . . . . 0.0 111.536 -179.814 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.549 ' H ' ' C ' ' A' ' 3' ' ' GLY . 0.3 OUTLIER -117.88 105.72 12.22 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 120.646 0.26 . . . . 0.0 110.403 179.541 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.64 111.34 14.86 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.224 0.535 . . . . 0.0 110.141 178.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -153.62 -16.81 0.14 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.239 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.416 ' CG2' ' N ' ' A' ' 9' ' ' THR . 0.7 OUTLIER -160.88 155.72 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.488 179.632 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.416 ' N ' ' CG2' ' A' ' 8' ' ' VAL . 1.8 m -150.37 139.81 21.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.683 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.84 105.67 19.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.85 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -92.4 -152.29 0.31 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.595 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -107.59 5.33 26.87 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -109.4 -23.1 11.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.163 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 161.93 -125.48 1.43 Allowed Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -145.26 145.69 31.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.981 0.42 . . . . 0.0 110.971 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.2 t -105.58 129.0 59.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.84 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.28 99.81 8.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.215 0.531 . . . . 0.0 110.446 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.526 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -103.56 127.18 51.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.037 -179.876 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.465 ' H ' ' HB3' ' A' ' 81' ' ' LYS . 0.6 OUTLIER -149.88 176.69 10.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.512 0.672 . . . . 0.0 112.121 -179.196 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -108.0 92.66 4.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.638 -1.165 . . . . 0.0 108.792 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.551 HG22 ' HA ' ' A' ' 79' ' ' ARG . 1.6 tp -75.77 137.01 23.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.037 -178.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.01 93.87 42.86 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.915 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.446 ' HA ' HG23 ' A' ' 42' ' ' ILE . 3.0 Cg_exo -73.54 157.33 49.02 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.478 2.119 . . . . 0.0 112.226 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt 72.33 47.93 0.26 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.106 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.996 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . . . -95.92 -68.37 0.8 Allowed 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.414 ' CB ' ' O ' ' A' ' 25' ' ' ALA . 6.1 p 157.38 -24.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.504 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 44.4 ttm180 -171.29 139.85 1.38 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.206 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.42 93.62 0.35 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.393 0.616 . . . . 0.0 109.999 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.8 m -124.92 129.09 49.67 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.654 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.46 HG22 HD21 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -85.56 63.03 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.714 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -93.67 17.67 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.725 -178.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . -143.38 28.25 2.08 Favored Glycine 0 C--N 1.318 -0.444 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -178.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.46 HD21 HG22 ' A' ' 30' ' ' ILE . 10.7 mt -60.81 111.01 1.47 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.421 ' ND1' ' N ' ' A' ' 35' ' ' GLY . 3.7 t60 -99.44 152.53 19.88 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.398 -178.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.421 ' N ' ' ND1' ' A' ' 34' ' ' HIS . . . -67.75 -15.5 66.75 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -121.94 -17.38 7.32 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.747 0.308 . . . . 0.0 110.392 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -139.05 -173.03 3.47 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.833 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.459 HG12 ' HB2' ' A' ' 19' ' ' LEU . 16.9 t -142.7 112.87 2.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 5.6 mtpt -110.89 109.36 19.5 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.035 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.506 ' CG1' HD12 ' A' ' 21' ' ' ILE . 7.7 p -121.98 132.44 70.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.458 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.996 ' HB1' ' HB2' ' A' ' 25' ' ' ALA . . . -99.65 99.86 10.77 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.272 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.583 HD11 ' CB ' ' A' ' 54' ' ' HIS . 19.6 tt -84.66 149.52 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.433 HG23 ' O ' ' A' ' 43' ' ' THR . 9.4 t -95.59 48.24 1.14 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.016 0.436 . . . . 0.0 110.626 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.725 ' HB1' ' HB2' ' A' ' 50' ' ' GLN . . . -118.79 142.89 32.56 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.529 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.515 ' HG2' ' HB3' ' A' ' 50' ' ' GLN . 1.6 Cg_endo -54.51 169.66 0.72 Allowed 'Trans proline' 0 N--CA 1.503 2.058 0 C-N-CA 123.751 2.967 . . . . 0.0 112.236 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -83.56 87.09 1.29 Allowed 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.831 2.354 . . . . 0.0 111.081 177.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 1.028 HG22 ' H ' ' A' ' 48' ' ' ASP . 9.8 p -172.24 -160.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.241 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 1.028 ' H ' HG22 ' A' ' 47' ' ' VAL . 1.7 m-20 -88.03 -66.89 0.87 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.041 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -44.55 -28.77 1.65 Allowed Glycine 0 CA--C 1.526 0.734 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.35 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.725 ' HB2' ' HB1' ' A' ' 44' ' ' ALA . 1.3 pp0? -61.9 -69.78 0.23 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.206 0.527 . . . . 0.0 111.474 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.679 ' H ' ' CG ' ' A' ' 50' ' ' GLN . . . -80.63 -39.84 26.69 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.224 -178.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -54.01 -54.96 31.87 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.359 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.4 p -64.12 -48.7 75.07 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.0 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.583 ' CB ' HD11 ' A' ' 42' ' ' ILE . 0.2 OUTLIER -57.99 -52.81 63.99 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.652 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.594 HD21 HD11 ' A' ' 83' ' ' ILE . 5.5 tp -49.36 -58.3 5.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.028 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -53.74 -23.41 8.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.6 ttpp -85.16 -64.75 1.1 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.494 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -45.7 -59.77 2.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.382 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.553 HD22 HD13 ' A' ' 83' ' ' ILE . 6.0 tp -70.74 -48.0 56.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.951 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -49.21 -30.1 10.45 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -81.16 -63.06 1.48 Allowed 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.772 0.32 . . . . 0.0 111.217 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.49 ' O ' ' NE2' ' A' ' 90' ' ' GLN . 14.0 mm100 -58.63 -36.76 74.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.671 -178.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.901 ' HB3' HG23 ' A' ' 65' ' ' VAL . 1.4 m-85 -87.02 -18.96 29.39 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.412 ' HE ' ' HB2' ' A' ' 90' ' ' GLN . 0.1 OUTLIER 56.7 11.05 0.81 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.371 -0.832 . . . . 0.0 112.642 178.378 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.901 HG23 ' HB3' ' A' ' 63' ' ' PHE . 2.2 t -69.15 -141.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.871 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.607 ' O ' HG12 ' A' ' 70' ' ' VAL . . . -125.39 156.39 38.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.918 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.407 ' HA ' HG12 ' A' ' 70' ' ' VAL . 46.0 pttt -69.55 -26.29 64.42 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.13 -16.44 37.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.35 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.45 ' CG ' ' HB3' ' A' ' 66' ' ' ALA . 25.5 mm-40 -97.03 -20.63 17.91 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.566 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.694 ' O ' HG13 ' A' ' 70' ' ' VAL . 14.8 p -101.53 98.14 6.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.033 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 t -115.2 131.32 67.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.96 -178.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 68.1 mt -83.04 91.01 2.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.42 ' O ' ' CB ' ' A' ' 74' ' ' LYS . 7.8 mt-10 -57.91 -7.01 0.64 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.666 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.42 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 3.5 mtpp 162.11 126.48 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 132.77 -3.08 4.94 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -40.8 -30.53 0.13 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.8 tt -128.5 -37.85 1.77 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 121.023 -0.271 . . . . 0.0 111.654 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -70.99 158.32 53.72 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.772 -0.531 . . . . 0.0 111.772 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.551 ' HA ' HG22 ' A' ' 21' ' ' ILE . 13.3 mtm180 -61.41 -29.32 69.86 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.2 p-80 -69.01 146.99 52.24 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 5.8 ttmm -139.64 142.27 37.02 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.53 -178.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.409 ' HG2' ' C ' ' A' ' 81' ' ' LYS . 2.1 mm100 -144.3 80.72 1.65 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.594 HD11 HD21 ' A' ' 55' ' ' LEU . 81.9 mt -81.85 156.13 4.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.234 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.454 ' HE3' ' N ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -136.25 104.94 5.81 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.828 -179.64 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.695 HG23 HG21 ' A' ' 65' ' ' VAL . 3.1 mp -96.81 103.12 14.3 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.796 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 53.7 mt -85.6 133.44 29.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.883 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 51.4 t30 52.16 82.47 0.24 Allowed Pre-proline 0 CA--C 1.53 0.202 0 CA-C-O 120.906 0.384 . . . . 0.0 110.03 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -69.73 144.79 55.29 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.61 2.207 . . . . 0.0 112.497 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -117.99 -29.77 5.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.118 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.49 ' NE2' ' O ' ' A' ' 62' ' ' GLN . 26.5 tt0 -147.12 122.27 10.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.785 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.502 HG23 ' O ' ' A' ' 91' ' ' ILE . 4.3 tt -116.6 117.28 38.18 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.073 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -69.4 143.54 52.9 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 122.333 2.022 . . . . 0.0 112.165 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.564 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 2.5 Cg_endo -49.25 -25.15 9.28 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 122.945 2.43 . . . . 0.0 111.899 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -61.35 -56.89 15.31 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.564 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.3 t -71.39 -19.83 20.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.564 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -75.33 -22.97 57.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.502 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -64.55 -19.26 65.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.006 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 67.9 mt -105.68 -16.7 14.61 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.31 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 44.1 mt -104.17 -36.53 4.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.81 0.338 . . . . 0.0 110.659 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.436 ' O ' ' C ' ' A' ' 101' ' ' LEU . 10.5 t-20 -78.18 -5.78 52.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.923 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.436 ' C ' ' O ' ' A' ' 100' ' ' ASN . 3.8 mt -29.9 -91.49 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 O-C-N 123.701 0.625 . . . . 0.0 111.374 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 35.79 35.28 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.381 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 36.3 t60 -58.82 -49.48 77.54 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.429 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 10.3 p-80 -82.24 110.46 17.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.418 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.01 12.77 0.59 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.392 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 70.1 t60 -152.88 141.67 21.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.183 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.441 ' CG ' ' H ' ' A' ' 108' ' ' HIS . 17.7 t-160 -149.56 -126.25 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.261 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.441 ' H ' ' CG ' ' A' ' 107' ' ' HIS . 28.1 m80 . . . . . 0 C--N 1.331 -0.212 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.594 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.464 ' CG ' ' H ' ' A' ' 3' ' ' GLY . 2.5 p-10 -104.11 -94.09 0.33 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.903 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.464 ' H ' ' CG ' ' A' ' 2' ' ' ASP . . . 90.28 21.77 37.14 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 19.2 t 59.77 100.93 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 120.926 0.393 . . . . 0.0 111.021 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -96.9 94.39 7.19 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.574 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.2 117.7 22.84 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.283 0.563 . . . . 0.0 110.382 179.086 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -144.55 -30.23 0.46 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.291 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.9 m -147.07 165.75 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.817 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 m -151.29 130.5 12.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.725 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.4 m -95.19 97.6 6.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.115 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -84.93 -163.02 0.76 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.297 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -102.67 9.79 39.03 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -117.77 -21.47 8.43 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 114.682 -1.145 . . . . 0.0 110.461 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.41 -126.49 1.51 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.422 HD21 ' CG2' ' A' ' 85' ' ' ILE . 1.4 pt? -144.37 150.99 38.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.858 0.361 . . . . 0.0 110.693 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 35.8 t -105.51 143.05 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.208 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 82' ' ' GLN . 0.5 OUTLIER -124.49 92.23 3.61 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.976 0.417 . . . . 0.0 110.762 -179.82 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 2.3 mmm-85 -95.87 113.49 25.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.428 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.69 171.8 13.71 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.593 0.711 . . . . 0.0 112.672 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -102.57 94.88 5.88 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.289 -1.323 . . . . 0.0 108.121 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -72.32 128.63 35.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.52 -177.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -125.4 90.1 51.34 Favored Pre-proline 0 C--O 1.232 0.159 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.905 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.27 156.24 37.34 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.67 2.246 . . . . 0.0 111.975 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt 72.19 53.15 0.18 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.658 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 1.005 ' CB ' ' HB1' ' A' ' 41' ' ' ALA . . . -99.65 -59.83 1.64 Allowed 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 25' ' ' ALA . 0.4 OUTLIER 157.44 -31.45 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.142 179.41 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.434 ' CG ' ' O ' ' A' ' 26' ' ' SER . 18.5 mtm180 -167.05 146.75 5.38 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.344 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.449 ' HA ' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -64.08 92.36 0.08 Allowed 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.078 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.422 ' HB3' HG23 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -129.61 120.1 24.7 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.851 -178.464 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.487 HG22 HD21 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -84.24 76.47 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.502 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.694 ' O ' HG12 ' A' ' 31' ' ' VAL . 41.3 t -107.01 19.56 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 114.858 -1.064 . . . . 0.0 112.069 -177.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -143.56 27.72 2.07 Favored Glycine 0 C--N 1.333 0.366 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.673 ' CD2' HG13 ' A' ' 38' ' ' VAL . 15.9 mt -62.62 126.69 28.18 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.955 -0.623 . . . . 0.0 110.094 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.421 ' HB3' ' H ' ' A' ' 37' ' ' GLU . 4.8 t60 -113.25 157.02 22.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.165 -178.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -69.57 -20.1 75.29 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.516 -1.033 . . . . 0.0 110.516 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -116.17 -17.09 10.91 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.831 -0.184 . . . . 0.0 110.609 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.421 ' H ' ' HB3' ' A' ' 34' ' ' HIS . 24.7 mm-40 -140.53 -174.99 4.11 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.831 0.348 . . . . 0.0 110.537 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.673 HG13 ' CD2' ' A' ' 33' ' ' LEU . 14.8 t -142.74 113.33 2.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -107.99 112.36 24.89 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.396 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.469 HG23 HG23 ' A' ' 30' ' ' ILE . 9.9 p -117.0 144.42 24.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.349 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 1.005 ' HB1' ' CB ' ' A' ' 25' ' ' ALA . . . -110.23 100.84 9.66 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.47 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.829 HD11 ' HB3' ' A' ' 54' ' ' HIS . 19.5 tt -91.91 148.14 4.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.73 28.3 1.82 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.503 -179.079 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.96 163.2 19.22 Favored Pre-proline 0 C--O 1.235 0.303 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.107 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.44 ' HG2' ' CB ' ' A' ' 50' ' ' GLN . 3.4 Cg_exo -77.55 176.46 10.03 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 123.433 2.756 . . . . 0.0 111.978 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -77.05 3.6 6.5 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 123.071 2.514 . . . . 0.0 112.606 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.417 HG12 ' HB2' ' A' ' 45' ' ' PRO . 14.8 p -99.2 148.09 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.719 0.295 . . . . 0.0 110.564 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' A' ' 52' ' ' ASN . 1.3 t0 -66.94 -52.41 43.26 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.033 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . -37.05 -51.95 1.58 Allowed Glycine 0 CA--C 1.531 1.058 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.452 ' N ' ' CD ' ' A' ' 50' ' ' GLN . 2.0 mp0 -82.72 -45.53 14.31 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.39 -58.8 4.51 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.155 0.503 . . . . 0.0 110.376 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.5 ' N ' ' O ' ' A' ' 48' ' ' ASP . 11.5 t-20 -46.88 -49.92 19.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.93 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.5 p -55.73 -48.34 75.37 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.791 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.829 ' HB3' HD11 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -54.47 -59.79 4.22 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.296 179.584 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.451 ' HA ' HD13 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -44.86 -57.91 3.46 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.916 0.388 . . . . 0.0 110.532 -179.745 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -54.27 -32.21 23.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.912 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 34.3 tttm -76.75 -65.97 0.87 Allowed 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.704 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -46.67 -56.18 6.54 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.072 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.811 HD21 HD11 ' A' ' 85' ' ' ILE . 1.7 tp -64.49 -58.74 5.57 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.751 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -46.03 -29.54 3.42 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.634 -0.586 . . . . 0.0 111.634 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.1 mttp -80.91 -63.84 1.32 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.961 0.41 . . . . 0.0 111.103 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.531 HE22 ' CG ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -58.75 -31.91 68.77 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.118 -178.668 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.887 ' HB3' HG23 ' A' ' 65' ' ' VAL . 0.8 OUTLIER -88.84 -19.56 25.77 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.402 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 67.15 2.06 2.63 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.734 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.887 HG23 ' HB3' ' A' ' 63' ' ' PHE . 2.0 t -68.2 -136.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.038 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.449 ' O ' HG23 ' A' ' 70' ' ' VAL . . . -140.08 167.79 21.31 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.905 0.383 . . . . 0.0 111.295 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.5 ptmt -73.42 -25.41 60.51 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.327 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.8 t -79.91 -20.17 46.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.965 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.428 ' O ' ' O ' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -95.96 -11.69 26.19 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.261 179.782 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 66' ' ' ALA . 54.8 t -100.63 99.24 8.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.231 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.5 t -112.98 116.43 52.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.239 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.423 ' C ' ' H ' ' A' ' 74' ' ' LYS . 67.2 mt -88.06 87.06 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.186 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -76.35 15.18 0.62 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.164 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.423 ' H ' ' C ' ' A' ' 72' ' ' ILE . 8.9 tttt 174.33 137.74 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 76' ' ' GLU . . . 128.28 -14.95 6.16 Favored Glycine 0 CA--C 1.518 0.264 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -178.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 75' ' ' GLY . 12.2 tt0 -30.68 -57.81 0.21 Allowed 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.855 0.385 . . . . 0.0 111.293 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.2 mt -133.43 -33.44 1.1 Allowed 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.848 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.58 145.47 45.6 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.901 -0.879 . . . . 0.0 110.901 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 15.7 mtp180 -58.38 -33.51 69.68 Favored 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.401 ' O ' ' HA2' ' A' ' 75' ' ' GLY . 6.8 m-70 -68.86 138.76 54.97 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 177.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 2.2 ttmm -145.42 151.99 39.12 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 119.961 -0.696 . . . . 0.0 110.203 -177.228 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.411 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 19.6 tt0 -148.24 123.59 10.28 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 9.7 mt -120.45 143.18 33.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.583 -178.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.458 ' HE3' ' N ' ' A' ' 85' ' ' ILE . 0.2 OUTLIER -114.16 106.62 14.58 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.2 -179.454 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.811 HD11 HD21 ' A' ' 59' ' ' LEU . 2.4 mp -91.39 101.6 12.66 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.36 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 64.4 mt -81.16 143.66 11.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.031 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 47.31 77.15 0.48 Allowed Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.778 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -74.08 144.54 33.99 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 122.87 2.38 . . . . 0.0 112.003 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -107.43 -39.78 5.55 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.65 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -147.51 125.5 12.04 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 120.98 0.419 . . . . 0.0 109.977 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.569 HG23 ' O ' ' A' ' 91' ' ' ILE . 3.4 tt -107.01 112.86 63.06 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.359 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.531 ' CG ' HE22 ' A' ' 62' ' ' GLN . 3.4 Cg_exo -70.44 153.78 65.54 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.683 2.256 . . . . 0.0 112.623 -179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.531 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 2.6 Cg_endo -47.96 -30.27 13.45 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 123.273 2.648 . . . . 0.0 111.897 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 65.6 tt0 -51.71 -59.25 4.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.736 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.413 HG23 ' H ' ' A' ' 95' ' ' VAL . 0.6 OUTLIER -84.04 -24.54 7.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.157 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.531 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -75.24 -19.88 59.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.972 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 93' ' ' PRO . . . -66.41 -25.27 66.69 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.111 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 18.7 mt -103.67 -14.61 16.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.001 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 46.8 mt -103.6 -50.45 9.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.346 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -75.09 1.21 13.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.59 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 60.1 tp -53.36 -13.25 0.53 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.895 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 -71.4 52.61 0.19 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.969 0.414 . . . . 0.0 110.435 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -125.08 99.63 6.2 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.096 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -56.26 -21.4 23.47 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.925 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -46.03 101.84 0.03 OUTLIER 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.907 0.384 . . . . 0.0 110.589 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -72.71 6.06 2.74 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.018 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -48.9 101.6 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.597 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 20.6 m170 . . . . . 0 N--CA 1.462 0.161 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.74 -179.854 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.2 mmt . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -111.29 -77.02 0.59 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.628 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -101.4 -31.32 5.59 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.3 t 56.54 95.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-O 120.886 0.374 . . . . 0.0 110.617 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.478 ' N ' ' SD ' ' A' ' 5' ' ' MET . 0.0 OUTLIER -97.44 91.13 5.32 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.144 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.609 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 79.1 p -127.53 -167.45 1.75 Allowed 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.609 ' HB2' ' O ' ' A' ' 6' ' ' SER . . . 158.96 -22.26 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.664 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 16' ' ' VAL . 4.0 p -157.31 154.86 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.072 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 m -150.71 144.57 25.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.523 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.8 m -113.61 103.71 15.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.326 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -93.26 -152.65 0.33 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.301 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -106.1 2.76 27.41 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -107.77 -22.36 12.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.38 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.562 ' HA3' ' HZ1' ' A' ' 84' ' ' LYS . . . 159.37 -122.05 1.1 Allowed Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -148.58 138.6 22.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.006 0.431 . . . . 0.0 111.255 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 8' ' ' VAL . 71.8 t -100.91 141.43 17.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.1 tp -122.34 104.17 9.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.187 0.518 . . . . 0.0 110.787 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.513 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 1.1 mtt-85 -94.02 127.71 39.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.682 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.765 HD11 HG12 ' A' ' 21' ' ' ILE . 2.2 pp -153.18 178.29 9.9 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.618 0.723 . . . . 0.0 112.482 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.574 ' C ' HD12 ' A' ' 19' ' ' LEU . 20.5 t80 -111.0 95.7 5.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.442 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.765 HG12 HD11 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -72.59 127.17 34.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.439 -178.321 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -119.9 90.46 43.89 Favored Pre-proline 0 N--CA 1.462 0.172 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.033 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.435 ' O ' ' HB2' ' A' ' 24' ' ' LYS . 3.1 Cg_exo -74.91 151.5 40.07 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.66 2.24 . . . . 0.0 112.788 -179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 23' ' ' PRO . 6.4 mtmp? 79.73 43.45 0.06 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.982 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.902 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . . . -101.8 169.46 8.79 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 177.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.0 p -63.28 -19.24 64.4 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.073 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.451 ' O ' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -176.59 163.09 2.34 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.151 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.457 ' HA ' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -80.76 93.03 6.13 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.398 0.618 . . . . 0.0 109.476 178.179 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.562 ' HB3' HG23 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -130.49 135.83 48.36 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.782 -178.986 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.61 HG22 HD21 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -90.56 66.23 0.49 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-O 121.637 0.732 . . . . 0.0 109.455 178.747 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.663 ' O ' HG12 ' A' ' 31' ' ' VAL . 41.3 t -98.32 18.77 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.417 -178.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -143.6 32.12 1.86 Allowed Glycine 0 C--N 1.333 0.368 0 N-CA-C 110.376 -1.089 . . . . 0.0 110.376 -178.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.772 ' CD2' HG13 ' A' ' 38' ' ' VAL . 19.1 mt -71.26 122.38 20.13 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.838 -0.681 . . . . 0.0 110.13 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.433 ' O ' ' O ' ' A' ' 37' ' ' GLU . 37.8 t-80 -110.01 157.03 19.72 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.287 -178.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.79 -22.55 70.23 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.456 ' O ' ' O ' ' A' ' 6' ' ' SER . 29.3 m-20 -121.53 0.54 9.96 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.433 ' O ' ' O ' ' A' ' 34' ' ' HIS . 5.1 mm-40 -148.45 176.38 10.35 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-O 121.07 0.462 . . . . 0.0 110.249 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.772 HG13 ' CD2' ' A' ' 33' ' ' LEU . 30.3 t -142.56 108.68 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -109.77 107.79 17.91 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.295 -178.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.473 HG12 HD13 ' A' ' 19' ' ' LEU . 9.8 p -117.74 131.31 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.592 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.902 ' HB1' ' HB2' ' A' ' 25' ' ' ALA . . . -100.45 107.72 19.52 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.092 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.705 HD11 ' HB3' ' A' ' 54' ' ' HIS . 19.7 tt -97.42 152.26 4.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.4 t -92.97 21.55 5.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.44 -178.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.1 160.89 54.03 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.821 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.465 ' HB2' HG12 ' A' ' 47' ' ' VAL . 3.9 Cg_exo -76.51 171.59 17.77 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 123.269 2.646 . . . . 0.0 112.169 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.11 8.33 2.51 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 123.25 2.633 . . . . 0.0 112.745 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.486 HG13 ' H ' ' A' ' 50' ' ' GLN . 14.4 p -101.37 142.62 15.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.404 ' O ' ' N ' ' A' ' 52' ' ' ASN . 0.2 OUTLIER -62.53 -45.7 91.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.262 -179.261 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -45.11 -54.42 7.08 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.298 -0.477 . . . . 0.0 111.919 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.486 ' H ' HG13 ' A' ' 47' ' ' VAL . 15.5 mt-30 -80.44 -38.1 30.76 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 -179.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.35 -60.26 2.58 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.863 0.363 . . . . 0.0 110.687 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.404 ' N ' ' O ' ' A' ' 48' ' ' ASP . 37.3 t-20 -50.53 -40.97 53.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.512 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.7 t -52.9 -50.87 63.05 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.787 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.705 ' HB3' HD11 ' A' ' 42' ' ' ILE . 0.2 OUTLIER -54.75 -55.09 33.73 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.889 -179.665 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.518 ' HA ' HD13 ' A' ' 55' ' ' LEU . 3.4 mm? -49.39 -51.27 36.15 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.66 -0.416 . . . . 0.0 109.895 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -56.35 -26.82 23.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.88 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.441 ' O ' ' HB2' ' A' ' 61' ' ' LYS . 6.0 ttpm? -84.29 -64.95 1.07 Allowed 'General case' 0 C--O 1.227 -0.13 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.286 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -51.69 -54.82 24.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.121 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.513 HD22 ' HA ' ' A' ' 59' ' ' LEU . 0.2 OUTLIER -65.09 -53.3 47.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.66 179.657 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -53.89 -42.91 70.75 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-N 116.363 -0.38 . . . . 0.0 112.153 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 3.9 ttpt -73.94 -44.22 55.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.589 0.233 . . . . 0.0 111.028 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 -65.35 -43.48 90.71 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.074 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.464 ' HB3' HG22 ' A' ' 65' ' ' VAL . 3.6 m-85 -85.91 -19.22 30.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.879 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.9 mtt-85 60.44 5.27 0.83 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.927 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.464 HG22 ' HB3' ' A' ' 63' ' ' PHE . 34.5 m -76.12 155.17 5.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.448 ' HB3' ' HG2' ' A' ' 69' ' ' GLN . . . -51.53 159.14 0.78 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.524 -178.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.8 pttp -69.94 -27.16 64.52 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.892 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.7 t -81.25 -12.33 59.14 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.257 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.448 ' HG2' ' HB3' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -89.97 -12.99 37.08 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.598 -179.78 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.1 p -105.6 100.1 9.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-O 121.161 0.505 . . . . 0.0 110.325 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.2 t -117.24 122.08 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.907 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.444 ' C ' ' H ' ' A' ' 74' ' ' LYS . 46.7 mt -89.96 90.76 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.635 178.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -66.46 3.98 0.85 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.95 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.444 ' H ' ' C ' ' A' ' 72' ' ' ILE . 10.4 mttt 169.53 140.62 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 76' ' ' GLU . . . 130.88 -16.99 5.25 Favored Glycine 0 C--N 1.321 -0.294 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -178.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 75' ' ' GLY . 50.3 mt-10 -35.11 -46.32 0.33 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.373 -0.414 . . . . 0.0 111.034 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.4 tt -130.02 -42.97 1.22 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.872 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -60.88 159.01 28.3 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.842 -0.503 . . . . 0.0 111.842 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.4 mtm-85 -72.99 -32.8 65.41 Favored 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.405 ' O ' ' HA2' ' A' ' 75' ' ' GLY . 6.9 m-70 -69.42 144.48 53.33 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 177.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.516 ' NZ ' ' HG ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -152.38 150.64 29.91 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 118.96 -1.096 . . . . 0.0 111.507 -177.714 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -147.79 113.42 5.68 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.443 ' CD1' HD12 ' A' ' 55' ' ' LEU . 8.4 mt -109.63 132.27 58.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.348 -178.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.562 ' HZ1' ' HA3' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -102.93 117.43 34.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.271 -179.315 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.485 HG22 ' O ' ' A' ' 85' ' ' ILE . 1.8 mp -105.59 98.94 7.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.209 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 20.6 mt -81.51 151.52 4.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.478 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 9.4 m-20 42.11 80.48 0.28 Allowed Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.861 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -73.31 133.58 19.53 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.771 2.314 . . . . 0.0 112.455 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -118.26 -26.38 6.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.533 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -145.86 117.49 8.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.939 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.556 HG23 ' O ' ' A' ' 91' ' ' ILE . 4.3 tt -112.11 113.98 51.49 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.509 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -65.9 143.49 73.26 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.253 1.968 . . . . 0.0 111.757 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.631 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 2.7 Cg_endo -49.01 -24.56 7.61 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.956 2.437 . . . . 0.0 111.684 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -59.47 -58.77 7.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.401 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.0 t -75.98 -24.85 16.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.513 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.631 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -75.28 -28.56 59.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.784 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 93' ' ' PRO . . . -54.95 -31.23 60.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.62 0.248 . . . . 0.0 111.198 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.26 -4.72 48.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.078 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 51.2 mm -116.95 -18.48 6.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.729 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.557 ' N ' ' O ' ' A' ' 96' ' ' ALA . 3.8 m-20 -93.21 -8.5 42.19 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.005 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.443 ' C ' ' O ' ' A' ' 100' ' ' ASN . 11.8 mt -27.61 -92.92 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 O-C-N 123.579 0.549 . . . . 0.0 111.77 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 40.84 30.74 0.1 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.151 0.501 . . . . 0.0 110.736 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 28.2 t60 -75.1 0.39 16.31 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.834 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.444 ' C ' ' H ' ' A' ' 106' ' ' HIS . 0.8 OUTLIER -140.0 -32.81 0.6 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.279 -179.875 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -77.39 23.22 0.21 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.472 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.444 ' H ' ' C ' ' A' ' 104' ' ' HIS . 7.0 t60 -63.65 -100.79 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.572 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.434 ' N ' ' CG ' ' A' ' 106' ' ' HIS . 2.4 m-70 48.1 -125.92 1.83 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.866 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.195 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.46 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.624 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 62.0 p . . . . . 0 N--CA 1.439 -0.981 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.624 ' HB2' ' O ' ' A' ' 6' ' ' SER . . . 151.19 -25.85 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.449 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 16' ' ' VAL . 0.7 OUTLIER -159.51 151.44 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.595 -179.768 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 m -139.05 136.2 35.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.326 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 10' ' ' VAL . 30.8 m -101.35 99.8 9.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.262 0.553 . . . . 0.0 110.181 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.403 HD21 HG23 ' A' ' 16' ' ' VAL . 42.4 m-80 -80.28 -151.97 0.08 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.533 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -107.77 6.79 27.89 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -117.77 -25.35 6.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.488 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 170.25 -126.91 1.4 Allowed Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.468 ' N ' HD23 ' A' ' 15' ' ' LEU . 1.6 pt? -147.89 150.77 34.73 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.97 0.414 . . . . 0.0 111.208 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.46 ' O ' HG23 ' A' ' 8' ' ' VAL . 61.7 t -106.88 139.63 27.76 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.117 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.74 102.65 9.6 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.562 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 9.1 mtm180 -107.91 111.04 22.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.02 -179.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.648 HD13 HG12 ' A' ' 40' ' ' VAL . 4.1 pp -142.02 -179.64 6.34 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.904 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.623 ' N ' HD12 ' A' ' 19' ' ' LEU . 53.6 t80 -111.06 105.22 13.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.756 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.42 HD11 HD11 ' A' ' 55' ' ' LEU . 6.0 mm -71.96 135.25 28.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.573 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -124.12 87.72 53.23 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.672 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.2 161.67 42.47 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.622 2.214 . . . . 0.0 112.555 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.26 46.9 2.53 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.661 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.884 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . . . -92.22 -70.95 0.67 Allowed 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.411 ' CB ' ' O ' ' A' ' 25' ' ' ALA . 0.9 OUTLIER 160.01 -22.09 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.06 179.3 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -171.36 140.73 1.47 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.049 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.9 86.89 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 121.429 0.633 . . . . 0.0 109.918 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.49 133.53 46.36 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.481 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.521 HG23 HG23 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -89.16 86.91 2.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.237 179.039 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -113.71 19.33 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.853 -178.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -143.74 37.39 1.45 Allowed Glycine 0 C--N 1.333 0.406 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.826 ' CD2' HG13 ' A' ' 38' ' ' VAL . 21.3 mt -73.27 120.11 18.43 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.798 -0.701 . . . . 0.0 109.913 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.487 ' HB3' ' H ' ' A' ' 37' ' ' GLU . 26.8 t-80 -102.05 157.97 16.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.023 0.44 . . . . 0.0 111.383 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.97 -18.76 73.01 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.48 -18.35 8.5 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.487 ' H ' ' HB3' ' A' ' 34' ' ' HIS . 11.2 mm-40 -134.32 -176.43 4.2 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.988 0.423 . . . . 0.0 110.66 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.826 HG13 ' CD2' ' A' ' 33' ' ' LEU . 55.6 t -143.66 121.98 6.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.5 ttpp -121.86 113.7 20.01 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.879 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.648 HG12 HD13 ' A' ' 19' ' ' LEU . 10.1 p -114.88 142.88 26.05 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.921 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.884 ' HB1' ' HB2' ' A' ' 25' ' ' ALA . . . -107.84 107.67 18.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.322 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.419 HG13 ' N ' ' A' ' 43' ' ' THR . 1.4 tp -93.15 148.12 4.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.419 ' N ' HG13 ' A' ' 42' ' ' ILE . 14.1 t -95.28 38.79 1.13 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.05 0.452 . . . . 0.0 110.831 -178.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.99 144.59 28.86 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.013 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.511 ' HG2' ' CB ' ' A' ' 50' ' ' GLN . 3.7 Cg_exo -51.98 175.36 0.07 OUTLIER 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 123.059 2.506 . . . . 0.0 112.441 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.92 3.67 5.88 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 123.134 2.556 . . . . 0.0 113.342 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.5 p -102.68 143.99 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.597 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.466 ' O ' ' C ' ' A' ' 49' ' ' GLY . 3.7 m-20 -62.06 -60.92 2.91 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.018 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.466 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . -30.72 -43.98 0.08 OUTLIER Glycine 0 CA--C 1.53 1.026 0 N-CA-C 111.744 -0.543 . . . . 0.0 111.744 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.511 ' CB ' ' HG2' ' A' ' 45' ' ' PRO . 0.8 OUTLIER -82.6 -42.07 18.73 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.478 0.18 . . . . 0.0 111.28 -179.612 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 48' ' ' ASP . . . -68.17 -54.16 19.89 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.948 0.404 . . . . 0.0 109.966 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 48' ' ' ASP . 19.3 t-20 -48.72 -44.72 38.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.147 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 58.2 m -54.56 -44.7 73.14 Favored 'General case' 0 N--CA 1.461 0.075 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.46 -42.58 82.79 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.059 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.434 ' CD2' HD11 ' A' ' 83' ' ' ILE . 2.0 tp -54.45 -60.69 3.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.625 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -58.04 -23.41 21.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.2 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.401 ' O ' ' C ' ' A' ' 58' ' ' PHE . 32.8 tttp -79.32 -65.49 0.99 Allowed 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.528 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.401 ' C ' ' O ' ' A' ' 57' ' ' LYS . 3.8 t80 -36.33 -55.37 0.81 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.89 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.562 HD13 ' CD1' ' A' ' 63' ' ' PHE . 4.3 mm? -68.42 -66.16 0.61 Allowed 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.157 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -40.07 -36.28 0.83 Allowed Glycine 0 CA--C 1.529 0.963 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.066 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -82.02 -60.76 2.11 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.762 0.315 . . . . 0.0 111.112 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -58.61 -40.71 84.04 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.533 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.736 ' HB3' HG23 ' A' ' 65' ' ' VAL . 15.1 m-85 -86.27 -18.26 32.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.266 -0.425 . . . . 0.0 109.916 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.9 mtm180 60.41 4.16 0.66 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.759 178.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.736 HG23 ' HB3' ' A' ' 63' ' ' PHE . 6.1 t -65.42 -125.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 120.905 0.383 . . . . 0.0 110.154 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.485 ' N ' HG12 ' A' ' 65' ' ' VAL . . . -145.65 164.15 32.65 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.23 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.9 ptmt -75.28 -27.75 59.5 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.496 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.1 t -78.38 -14.74 59.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.637 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.402 ' O ' ' O ' ' A' ' 84' ' ' LYS . 0.9 OUTLIER -97.73 -15.02 20.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.752 179.718 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.465 HG13 HG23 ' A' ' 83' ' ' ILE . 10.9 t -95.43 99.6 9.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.906 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -107.48 121.55 60.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.503 -179.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 63.0 mt -84.94 95.41 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.168 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -72.86 -4.06 29.47 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.92 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 10.6 mttp 165.9 142.31 0.02 OUTLIER 'General case' 0 C--N 1.339 0.151 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.6 -15.36 6.7 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -35.03 -39.08 0.09 Allowed 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.4 mt -132.13 10.4 4.55 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -123.55 154.03 17.34 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -55.91 -27.7 53.32 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.949 0.404 . . . . 0.0 110.044 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -69.0 160.7 30.45 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.662 ' HE3' HD12 ' A' ' 83' ' ' ILE . 7.7 tttt -150.87 137.86 19.14 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -140.62 75.93 1.53 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.662 HD12 ' HE3' ' A' ' 81' ' ' LYS . 52.6 mt -82.56 151.03 4.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.908 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.447 ' HE3' ' N ' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -123.45 122.57 38.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.751 179.808 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.447 ' N ' ' HE3' ' A' ' 84' ' ' LYS . 1.9 mp -99.79 104.82 16.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.823 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 43.4 mt -87.64 149.8 3.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.437 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 0.4 OUTLIER 43.64 54.11 10.71 Favored Pre-proline 0 CA--C 1.532 0.262 0 CA-C-O 120.816 0.341 . . . . 0.0 110.11 -179.799 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.437 ' CD ' ' N ' ' A' ' 87' ' ' ASN . 2.7 Cg_endo -45.16 146.13 2.96 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.979 2.452 . . . . 0.0 112.202 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -121.26 -38.33 2.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.503 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -143.96 117.73 9.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.062 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.9 tt -111.25 116.74 50.79 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.237 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -65.29 151.05 86.54 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 122.351 2.034 . . . . 0.0 111.734 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.617 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 2.5 Cg_endo -51.47 -35.16 54.35 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.786 2.324 . . . . 0.0 111.991 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -45.23 -58.29 3.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.378 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.7 t -77.39 -19.89 14.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.245 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.617 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -74.63 -30.8 61.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.907 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.18 -22.91 31.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.635 0.255 . . . . 0.0 111.213 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -99.85 -16.19 18.13 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.163 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 87.7 mt -104.55 -35.66 3.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.062 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.324 -179.442 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.624 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 15.1 m . . . . . 0 N--CA 1.435 -1.175 0 CA-C-O 121.107 0.479 . . . . 0.0 110.078 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.624 ' HB2' ' O ' ' A' ' 6' ' ' SER . . . 153.99 -19.61 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.034 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.0 p -154.67 154.27 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.276 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.2 m -144.89 117.82 8.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.363 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.405 ' H ' HG22 ' A' ' 10' ' ' VAL . 2.8 m -88.27 97.75 7.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.792 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.84 -155.32 0.06 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.434 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -107.62 10.45 29.09 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -123.24 -24.67 4.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.312 -178.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.576 ' HA3' ' HZ1' ' A' ' 84' ' ' LYS . . . 172.06 -125.15 1.15 Allowed Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -152.36 148.45 27.51 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 120.862 0.363 . . . . 0.0 111.344 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.4 t -107.29 142.72 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.751 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.51 ' HB3' ' HZ3' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -115.37 104.6 11.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.001 0.429 . . . . 0.0 110.322 179.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.557 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 2.3 mtm180 -105.96 119.28 38.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.194 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.663 HD11 HG12 ' A' ' 21' ' ' ILE . 3.9 pp -149.59 179.65 7.82 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.281 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.656 ' N ' HD12 ' A' ' 19' ' ' LEU . 53.9 t80 -105.71 99.36 8.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.515 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.663 HG12 HD11 ' A' ' 19' ' ' LEU . 2.2 mm -69.31 124.9 26.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.599 ' NE2' ' O ' ' A' ' 23' ' ' PRO . 0.3 OUTLIER -121.23 86.64 43.37 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.945 -179.493 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.599 ' O ' ' NE2' ' A' ' 22' ' ' GLN . 3.4 Cg_exo -74.11 161.1 41.59 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.706 2.271 . . . . 0.0 111.735 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.502 ' CB ' ' O ' ' A' ' 23' ' ' PRO . 2.5 mmpt? 88.33 30.05 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.275 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.906 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . . . -99.16 172.64 7.24 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.2 m -75.64 -12.77 60.27 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.069 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -176.68 163.4 2.33 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.154 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.492 ' HA ' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -79.43 90.98 5.06 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.269 0.556 . . . . 0.0 109.532 177.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.2 m -132.15 134.28 45.23 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.526 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.447 HG22 HD21 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -86.69 73.34 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.363 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.92 18.68 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 114.863 -1.062 . . . . 0.0 112.35 -178.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -143.41 38.29 1.4 Allowed Glycine 0 N--CA 1.459 0.209 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.807 ' CD2' HG13 ' A' ' 38' ' ' VAL . 12.1 mt -74.06 128.94 36.84 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.533 -0.833 . . . . 0.0 110.192 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.417 ' HB3' ' H ' ' A' ' 37' ' ' GLU . 56.7 t60 -111.75 156.33 22.1 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.174 0.512 . . . . 0.0 111.355 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.24 -25.75 66.93 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -119.18 -13.04 9.37 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 121.226 -0.19 . . . . 0.0 110.737 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.417 ' H ' ' HB3' ' A' ' 34' ' ' HIS . 45.3 mm-40 -134.81 -178.27 5.0 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.868 0.366 . . . . 0.0 110.503 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.807 HG13 ' CD2' ' A' ' 33' ' ' LEU . 43.0 t -143.6 117.73 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -116.37 110.36 18.59 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.702 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.485 HG12 HD13 ' A' ' 19' ' ' LEU . 7.9 p -110.8 136.16 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.821 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.906 ' HB1' ' HB2' ' A' ' 25' ' ' ALA . . . -100.83 111.12 23.27 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.575 HD11 ' HB3' ' A' ' 54' ' ' HIS . 20.4 tt -101.68 151.02 5.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.8 t -91.06 19.85 5.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.676 -177.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.437 ' HB1' ' CD ' ' A' ' 45' ' ' PRO . . . -97.33 168.87 9.45 Favored Pre-proline 0 C--N 1.328 -0.351 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.488 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.58 ' HB2' HG12 ' A' ' 47' ' ' VAL . 3.7 Cg_exo -78.87 166.87 22.92 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 123.402 2.735 . . . . 0.0 111.94 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -74.77 8.52 2.29 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 123.027 2.485 . . . . 0.0 112.551 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.58 HG12 ' HB2' ' A' ' 45' ' ' PRO . 14.8 p -95.89 150.4 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.43 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.449 ' O ' ' N ' ' A' ' 52' ' ' ASN . 0.7 OUTLIER -64.21 -61.78 2.03 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.114 -179.33 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . -33.28 -56.52 0.56 Allowed Glycine 0 CA--C 1.529 0.956 0 N-CA-C 111.971 -0.451 . . . . 0.0 111.971 -179.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.434 ' N ' ' CD ' ' A' ' 50' ' ' GLN . 3.0 mp0 -78.09 -49.89 13.07 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.64 -60.38 3.94 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.882 0.372 . . . . 0.0 110.546 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.449 ' N ' ' O ' ' A' ' 48' ' ' ASP . 39.3 t-20 -42.32 -54.27 3.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.836 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.8 m -41.57 -51.67 3.9 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.75 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.575 ' HB3' HD11 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -63.99 -48.59 75.82 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.166 -179.952 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.3 mp -47.53 -45.86 27.13 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.672 0.272 . . . . 0.0 110.928 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -66.45 -26.77 38.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.223 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 15.1 ttmm -82.18 -48.08 11.73 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.515 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -53.02 -49.32 66.49 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.737 -0.21 . . . . 0.0 111.424 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.569 ' N ' HD22 ' A' ' 59' ' ' LEU . 3.8 mm? -79.56 -41.56 26.95 Favored 'General case' 0 C--O 1.225 -0.237 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.62 -38.5 71.9 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.464 ' CG ' ' N ' ' A' ' 62' ' ' GLN . 5.9 ptmm? -81.91 -42.77 19.05 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.464 ' N ' ' CG ' ' A' ' 61' ' ' LYS . 33.0 mm-40 -71.22 -45.91 62.27 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.727 0.299 . . . . 0.0 111.024 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.445 ' HB3' HG22 ' A' ' 65' ' ' VAL . 0.7 OUTLIER -84.26 -18.15 37.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.164 -179.889 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.0 mtp180 60.67 15.94 6.21 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.02 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.445 HG22 ' HB3' ' A' ' 63' ' ' PHE . 33.7 m -89.6 149.76 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -49.34 157.64 0.47 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.355 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -73.43 -28.5 62.01 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.591 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.5 t -71.86 -11.8 60.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.901 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -97.93 -10.51 24.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.198 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.8 t -95.81 98.68 8.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.4 t -111.16 122.8 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.25 -178.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.3 mt -84.48 88.89 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.898 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.418 ' O ' ' CB ' ' A' ' 74' ' ' LYS . 33.3 mt-10 -66.66 0.44 2.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.309 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.418 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 8.2 mttm 160.44 127.67 0.0 OUTLIER 'General case' 0 C--N 1.34 0.159 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.456 ' O ' ' C ' ' A' ' 76' ' ' GLU . . . 140.35 -8.88 2.93 Favored Glycine 0 CA--C 1.517 0.176 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.456 ' C ' ' O ' ' A' ' 75' ' ' GLY . 6.3 mm-40 -29.95 -47.65 0.08 Allowed 'General case' 0 N--CA 1.466 0.335 0 O-C-N 123.757 0.328 . . . . 0.0 111.054 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.0 tt -126.83 -42.39 1.76 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.187 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -55.52 153.57 13.64 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 116.289 -0.414 . . . . 0.0 112.255 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.625 ' HE ' ' N ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -62.78 -34.06 76.47 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.003 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.453 ' O ' ' HA2' ' A' ' 75' ' ' GLY . 25.3 t60 -68.49 143.99 54.79 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.838 ' CE ' HD12 ' A' ' 83' ' ' ILE . 9.8 tttm -139.59 145.72 38.92 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.211 -178.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.421 ' HG2' ' NE2' ' A' ' 80' ' ' HIS . 2.4 mt-30 -146.94 79.05 1.51 Allowed 'General case' 0 C--O 1.233 0.2 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.838 HD12 ' CE ' ' A' ' 81' ' ' LYS . 40.2 mt -82.38 143.39 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.045 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.576 ' HZ1' ' HA3' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -109.67 121.06 44.37 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.671 -179.569 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.526 HG22 ' O ' ' A' ' 85' ' ' ILE . 1.5 mp -105.33 94.39 3.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.274 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 55.5 mt -82.27 144.38 10.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 55.36 79.25 0.35 Allowed Pre-proline 0 C--N 1.33 -0.248 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.203 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -74.56 128.94 12.27 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.77 2.313 . . . . 0.0 112.36 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -112.32 -29.7 7.44 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.236 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -143.64 114.28 7.6 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.189 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.587 HG23 ' O ' ' A' ' 91' ' ' ILE . 3.5 tt -109.2 110.17 60.48 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.456 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -65.81 174.6 5.41 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 122.353 2.035 . . . . 0.0 112.03 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.666 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 3.2 Cg_exo -71.83 -19.81 26.81 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.661 2.241 . . . . 0.0 112.201 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -49.48 -59.3 3.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.96 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 54.8 t -78.99 -25.54 13.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.288 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.666 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -74.2 -28.81 61.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.138 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 93' ' ' PRO . . . -65.43 -21.34 66.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.185 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.8 pp -116.68 -8.18 11.46 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.13 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.49 HD13 ' HA ' ' A' ' 99' ' ' ILE . 17.4 mm -103.88 -47.97 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.3 m120 . . . . . 0 C--N 1.332 -0.159 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.425 179.77 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.614 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 5.9 m . . . . . 0 N--CA 1.436 -1.167 0 CA-C-O 121.141 0.496 . . . . 0.0 110.449 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.614 ' HB2' ' O ' ' A' ' 6' ' ' SER . . . 150.89 -18.96 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.109 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 16' ' ' VAL . 1.7 p -155.65 154.69 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.801 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.401 ' N ' ' CG2' ' A' ' 8' ' ' VAL . 0.9 OUTLIER -137.9 143.32 40.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.093 -179.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.2 m -113.6 105.02 17.93 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.48 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.435 HD21 HG23 ' A' ' 16' ' ' VAL . 9.6 m-80 -92.22 -154.94 0.4 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.36 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -107.6 5.4 26.92 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -113.52 -22.05 10.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.614 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.62 -124.05 1.22 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.19 153.86 35.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.983 0.42 . . . . 0.0 111.398 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.435 HG23 HD21 ' A' ' 11' ' ' ASN . 58.1 t -110.84 131.86 60.88 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.962 179.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.502 HD23 HD21 ' A' ' 59' ' ' LEU . 11.2 tp -109.47 102.73 11.58 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.976 0.417 . . . . 0.0 110.44 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.522 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 49.2 mtt180 -104.08 119.33 38.7 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.534 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.767 HD21 ' NZ ' ' A' ' 81' ' ' LYS . 3.5 pp -148.01 179.62 7.61 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.203 0.525 . . . . 0.0 111.553 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.576 ' N ' HD12 ' A' ' 19' ' ' LEU . 33.3 t80 -112.13 106.22 14.78 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.517 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.648 HG12 HD11 ' A' ' 19' ' ' LEU . 2.8 mm -76.58 135.14 27.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.026 -178.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -122.18 91.2 49.09 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.493 -0.776 . . . . 0.0 108.917 178.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -72.2 154.02 56.78 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.685 2.257 . . . . 0.0 112.822 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.2 mtmp? 76.63 42.64 0.15 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.59 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.904 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . . . -100.24 167.85 10.17 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 178.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 98.1 p -62.05 -19.43 62.89 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.199 -0.6 . . . . 0.0 109.962 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -176.29 170.63 2.57 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.53 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.482 ' HA ' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -83.27 90.3 7.11 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.667 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.3 m -131.06 143.63 50.83 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.775 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.561 HG22 HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -93.03 74.33 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.289 179.05 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -103.64 19.05 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.608 -177.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.431 ' HA3' ' HB3' ' A' ' 39' ' ' LYS . . . -144.41 35.87 1.51 Allowed Glycine 0 C--N 1.332 0.35 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.779 ' CD2' HG13 ' A' ' 38' ' ' VAL . 15.2 mt -71.19 122.09 19.54 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.596 -0.802 . . . . 0.0 109.929 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -110.25 162.52 14.53 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.495 -178.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -72.89 -28.21 67.33 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -110.68 -9.74 14.51 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -144.6 -178.82 6.19 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-O 120.861 0.363 . . . . 0.0 110.796 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.779 HG13 ' CD2' ' A' ' 33' ' ' LEU . 55.3 t -143.39 113.74 2.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.431 ' HB3' ' HA3' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -112.35 118.48 35.34 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.876 -179.688 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.699 HG12 HD13 ' A' ' 19' ' ' LEU . 8.8 p -123.02 133.19 69.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.006 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.904 ' HB1' ' HB2' ' A' ' 25' ' ' ALA . . . -98.27 126.6 43.82 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.675 HD11 ' HB3' ' A' ' 54' ' ' HIS . 20.8 tt -116.4 145.75 21.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.8 t -87.21 23.01 1.93 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.835 -178.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.9 143.86 27.41 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.834 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.481 ' HG2' ' CB ' ' A' ' 50' ' ' GLN . 3.4 Cg_exo -55.78 166.34 2.95 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.566 2.177 . . . . 0.0 111.934 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -76.52 11.56 1.85 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.985 2.457 . . . . 0.0 112.255 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.622 HG13 ' H ' ' A' ' 50' ' ' GLN . 9.5 p -94.72 150.16 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.236 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -63.83 -53.35 52.1 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.881 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -39.91 -47.95 3.31 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 121.234 -0.508 . . . . 0.0 111.904 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.622 ' H ' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -85.02 -50.17 7.68 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -178.894 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.57 -49.92 75.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.983 0.42 . . . . 0.0 110.433 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -57.69 -52.32 65.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.054 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.5 p -52.28 -47.47 65.86 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.88 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.675 ' HB3' HD11 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -61.31 -47.03 87.81 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-O 120.726 0.298 . . . . 0.0 110.281 179.393 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.565 HD21 ' NZ ' ' A' ' 81' ' ' LYS . 0.2 OUTLIER -49.43 -61.41 2.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.545 -179.785 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -55.36 -21.63 9.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.649 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -85.11 -60.66 1.97 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.034 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -53.9 -38.69 65.08 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.151 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.502 HD21 HD23 ' A' ' 17' ' ' LEU . 0.8 OUTLIER -83.69 -39.33 20.31 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.675 -179.79 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.08 -37.42 93.89 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.2 ptmm? -80.74 -31.3 36.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.546 0.213 . . . . 0.0 111.297 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.59 -46.51 21.95 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.007 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.775 ' HB3' HG23 ' A' ' 65' ' ' VAL . 40.6 m-85 -85.88 -18.4 32.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.488 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 32.7 mtp180 59.22 5.03 0.52 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.926 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.775 HG23 ' HB3' ' A' ' 63' ' ' PHE . 21.8 t -65.32 -118.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 121.027 0.441 . . . . 0.0 110.088 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.566 ' N ' HG12 ' A' ' 65' ' ' VAL . . . -148.55 155.62 41.37 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.034 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.06 -29.48 63.0 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -75.77 -13.92 60.31 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.883 179.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -103.18 -15.6 15.97 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.97 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.507 HG13 ' CG2' ' A' ' 83' ' ' ILE . 6.7 t -88.42 99.91 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.2 t -105.49 117.0 50.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.25 -178.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.413 HG12 ' CD1' ' A' ' 83' ' ' ILE . 51.8 mt -87.86 85.48 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.376 178.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -67.54 5.22 0.84 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.708 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.2 mttp 162.43 142.1 0.01 OUTLIER 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 80' ' ' HIS . . . 127.95 -12.79 6.46 Favored Glycine 0 C--N 1.323 -0.186 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 75' ' ' GLY . 5.8 mt-10 -33.83 -47.1 0.24 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.417 -0.392 . . . . 0.0 111.151 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.5 tp -125.45 -43.84 1.88 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.44 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -59.64 151.88 35.94 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.9 mtt85 -63.05 -29.31 70.72 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.465 ' O ' ' HA2' ' A' ' 75' ' ' GLY . 0.5 OUTLIER -68.05 157.82 34.34 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.056 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.767 ' NZ ' HD21 ' A' ' 19' ' ' LEU . 6.4 tttt -156.09 147.27 22.39 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.662 -178.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.21 111.61 5.22 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.507 ' CG2' HG13 ' A' ' 70' ' ' VAL . 6.1 mm -109.68 140.14 29.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.609 -178.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.87 111.59 23.1 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.048 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.573 HG23 HG21 ' A' ' 65' ' ' VAL . 1.8 mp -96.51 99.89 9.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.351 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 36.9 mt -85.23 148.66 4.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.578 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 46.1 58.31 16.08 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.651 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -46.05 129.27 12.41 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.882 2.388 . . . . 0.0 112.06 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.436 ' H ' HG22 ' A' ' 65' ' ' VAL . 41.1 tp60 -109.69 -30.01 8.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.699 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -147.65 121.61 9.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.609 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 tt -112.33 113.37 51.34 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.067 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -68.59 157.77 60.46 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.419 2.079 . . . . 0.0 112.202 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.66 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 2.5 Cg_endo -51.82 -27.73 28.24 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 123.035 2.49 . . . . 0.0 111.893 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -53.82 -59.4 4.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.834 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 16.9 t -76.57 -20.9 14.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.871 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.66 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -75.6 -31.7 60.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.7 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -65.74 -19.71 66.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.249 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 77.0 mt -102.09 -21.07 14.51 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.048 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 66.1 mt -98.73 -31.89 3.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.991 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.5 m120 . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.459 179.839 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.586 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.441 -0.883 0 CA-C-O 121.32 0.581 . . . . 0.0 109.76 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.586 ' HB2' ' O ' ' A' ' 6' ' ' SER . . . 159.68 -17.59 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.584 -1.189 . . . . 0.0 109.206 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.491 HG22 ' N ' ' A' ' 9' ' ' THR . 8.0 p -160.28 160.01 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.575 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.491 ' N ' HG22 ' A' ' 8' ' ' VAL . 1.7 m -150.95 125.6 9.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.427 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.407 HG22 ' H ' ' A' ' 10' ' ' VAL . 2.4 m -91.65 101.28 12.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.062 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -79.58 -158.04 0.15 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.11 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -107.05 11.26 29.86 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -124.07 -18.92 5.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.337 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.504 ' HA3' ' HZ3' ' A' ' 84' ' ' LYS . . . 166.43 -123.71 1.17 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.409 HD11 ' CZ ' ' A' ' 63' ' ' PHE . 0.3 OUTLIER -149.24 138.34 21.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.0 0.429 . . . . 0.0 111.391 -179.747 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 48.6 t -99.39 106.35 18.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.198 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.0 tp -87.39 114.0 23.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.024 0.44 . . . . 0.0 111.142 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.561 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 14.8 mtt-85 -111.17 126.29 54.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.658 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.463 ' HB2' HG12 ' A' ' 38' ' ' VAL . 0.8 OUTLIER -149.45 175.16 11.72 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 121.956 0.884 . . . . 0.0 112.86 -179.038 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -106.23 91.81 3.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 113.867 -1.515 . . . . 0.0 108.565 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.418 HG13 ' NZ ' ' A' ' 81' ' ' LYS . 1.0 OUTLIER -73.53 131.14 35.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.222 -178.104 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.14 88.8 53.62 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.903 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.14 161.0 39.05 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.767 2.311 . . . . 0.0 112.793 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 20.3 mtmt 73.59 48.61 0.15 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.207 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.933 ' CB ' ' HB1' ' A' ' 41' ' ' ALA . . . -99.55 -62.88 1.18 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 25' ' ' ALA . 4.3 t 153.08 -28.52 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.991 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.443 ' CG ' ' O ' ' A' ' 26' ' ' SER . 79.1 mtt180 -163.4 142.1 8.11 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.81 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.47 94.22 0.08 Allowed 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.448 0.642 . . . . 0.0 109.973 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.4 p -123.02 126.88 47.95 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.874 -179.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.673 HG22 HD21 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -92.07 63.01 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.454 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.607 HG13 ' O ' ' A' ' 31' ' ' VAL . 0.3 OUTLIER -96.56 17.89 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 114.583 -1.19 . . . . 0.0 112.338 -177.821 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . -141.59 22.6 2.52 Favored Glycine 0 C--N 1.32 -0.351 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -178.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.673 HD21 HG22 ' A' ' 30' ' ' ILE . 19.3 mt -59.45 120.66 9.78 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.07 -0.565 . . . . 0.0 109.824 178.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.405 ' O ' ' O ' ' A' ' 37' ' ' GLU . 2.3 t60 -111.6 155.06 23.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.492 -178.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -66.93 -19.7 69.97 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.649 -0.981 . . . . 0.0 110.649 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -121.15 -5.07 9.48 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.555 0.217 . . . . 0.0 110.614 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.405 ' O ' ' O ' ' A' ' 34' ' ' HIS . 57.2 mt-10 -148.54 -178.46 6.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.991 0.424 . . . . 0.0 110.651 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.463 HG12 ' HB2' ' A' ' 19' ' ' LEU . 6.8 t -141.72 110.96 2.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 13.0 mtpt -110.36 103.15 11.76 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.146 -0.621 . . . . 0.0 110.785 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.7 p -114.27 136.43 50.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.701 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.933 ' HB1' ' CB ' ' A' ' 25' ' ' ALA . . . -99.98 93.95 6.03 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.979 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.758 HD11 ' HB3' ' A' ' 54' ' ' HIS . 19.7 tt -80.04 148.59 5.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.3 t -93.81 29.41 2.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.001 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.37 161.09 26.46 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.855 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -77.21 177.61 8.65 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 123.478 2.785 . . . . 0.0 112.093 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -77.31 5.5 5.05 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 123.168 2.578 . . . . 0.0 112.644 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.437 HG13 ' H ' ' A' ' 50' ' ' GLN . 11.7 p -98.96 155.86 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 120.791 0.329 . . . . 0.0 110.738 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.42 ' N ' HG22 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -69.41 -61.37 1.82 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.055 -179.709 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . -34.87 -51.93 0.83 Allowed Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.884 -0.486 . . . . 0.0 111.884 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.437 ' H ' HG13 ' A' ' 47' ' ' VAL . 2.4 mm100 -76.39 -50.56 13.87 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.74 -61.72 2.22 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.766 0.317 . . . . 0.0 110.915 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -47.07 -39.85 13.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.731 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.5 m -61.25 -51.39 69.14 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.586 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.758 ' HB3' HD11 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -55.85 -57.98 9.79 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.572 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -44.16 -57.93 3.15 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.044 0.45 . . . . 0.0 110.262 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.3 t -54.36 -26.07 15.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.127 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.421 ' N ' ' O ' ' A' ' 54' ' ' HIS . 8.4 ttpt -85.17 -63.46 1.32 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.918 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -50.74 -41.8 56.78 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.203 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.1 tp -84.67 -40.43 17.41 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.504 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -58.99 -33.64 75.08 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.0 ptmt -80.59 -37.27 31.57 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 120.59 0.233 . . . . 0.0 111.035 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -74.94 -42.39 57.79 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.431 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.549 ' HB3' HG13 ' A' ' 65' ' ' VAL . 0.7 OUTLIER -86.09 -18.83 31.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.535 179.767 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.4 mtp180 60.47 8.1 1.55 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.777 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.894 HG11 HG23 ' A' ' 85' ' ' ILE . 35.8 m -67.53 177.03 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -89.63 164.81 14.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.948 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -21.2 62.6 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -86.55 -12.65 48.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.464 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -101.62 -1.17 33.4 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.492 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.557 ' O ' HG13 ' A' ' 70' ' ' VAL . 7.7 p -110.94 100.69 11.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.014 0.435 . . . . 0.0 110.014 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 79.7 t -114.22 116.92 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.756 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.426 ' C ' ' H ' ' A' ' 74' ' ' LYS . 76.3 mt -89.94 88.48 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.23 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -72.81 10.3 0.91 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.671 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.426 ' H ' ' C ' ' A' ' 72' ' ' ILE . 7.6 mttp 167.93 145.59 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.408 ' HA2' ' O ' ' A' ' 80' ' ' HIS . . . 123.59 -17.01 7.87 Favored Glycine 0 CA--C 1.518 0.269 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -39.18 -44.33 1.19 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.655 -0.273 . . . . 0.0 111.066 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.411 ' O ' HD13 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -134.18 -43.43 0.79 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.192 -179.71 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.96 151.47 52.47 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -60.82 -32.67 72.03 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.408 ' O ' ' HA2' ' A' ' 75' ' ' GLY . 3.9 p-80 -68.89 129.97 41.45 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 177.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.561 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.6 OUTLIER -137.86 141.5 40.72 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 120.196 -0.601 . . . . 0.0 110.49 -177.312 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -139.48 114.62 9.63 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.557 HD11 ' HD3' ' A' ' 81' ' ' LYS . 4.7 mt -117.01 135.87 55.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.396 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.504 ' HZ3' ' HA3' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -104.67 106.67 17.26 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.876 -179.819 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.894 HG23 HG11 ' A' ' 65' ' ' VAL . 1.5 mp -94.68 92.06 3.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.067 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.401 HG22 ' N ' ' A' ' 87' ' ' ASN . 55.5 mt -77.47 155.39 5.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.733 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.401 ' N ' HG22 ' A' ' 86' ' ' ILE . 1.2 m-80 38.39 73.32 0.78 Allowed Pre-proline 0 N--CA 1.464 0.243 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.005 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -74.32 132.92 16.98 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.673 2.249 . . . . 0.0 111.847 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -110.63 -24.16 10.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.089 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -147.52 120.19 8.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.255 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.493 HG23 ' O ' ' A' ' 91' ' ' ILE . 3.9 tt -113.96 119.55 40.66 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.951 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -66.26 147.72 83.75 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 122.224 1.949 . . . . 0.0 112.522 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.679 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 2.5 Cg_endo -51.03 -30.22 30.43 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 123.048 2.498 . . . . 0.0 112.24 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -54.23 -57.77 9.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.699 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.436 ' H ' HG23 ' A' ' 95' ' ' VAL . 1.5 t -75.11 -21.66 16.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.732 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.679 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -75.59 -34.53 60.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.024 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.71 -20.1 32.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.738 0.304 . . . . 0.0 111.075 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 27.2 mt -103.04 -25.1 13.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.077 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 86.1 mt -96.65 -27.69 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.872 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.679 -179.812 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.619 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 22.7 t . . . . . 0 N--CA 1.435 -1.184 0 CA-C-O 121.134 0.492 . . . . 0.0 110.195 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.619 ' HB2' ' O ' ' A' ' 6' ' ' SER . . . 152.63 -17.48 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.563 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.448 ' CG2' ' N ' ' A' ' 9' ' ' THR . 0.7 OUTLIER -160.27 157.73 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.6 -179.809 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.448 ' N ' ' CG2' ' A' ' 8' ' ' VAL . 1.1 m -147.66 134.46 20.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.136 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 10' ' ' VAL . 33.2 m -102.65 104.0 15.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.224 0.535 . . . . 0.0 110.492 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 35.9 m-20 -87.2 -149.98 0.16 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.166 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -107.18 2.68 24.95 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -109.17 -22.23 12.2 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.441 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.49 ' HA3' ' HZ1' ' A' ' 84' ' ' LYS . . . 160.47 -122.14 1.1 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.508 HD11 ' CE2' ' A' ' 63' ' ' PHE . 0.3 OUTLIER -147.36 147.31 30.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.946 0.403 . . . . 0.0 111.244 -179.722 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.1 t -103.85 137.23 33.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.488 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.03 99.17 7.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.935 0.398 . . . . 0.0 110.521 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.526 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 38.7 mtt180 -97.3 114.76 26.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.836 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.596 ' C ' HD12 ' A' ' 19' ' ' LEU . 4.3 pp -147.05 179.75 7.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.284 0.564 . . . . 0.0 111.664 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.565 ' N ' HD12 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -113.81 95.78 5.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.949 179.522 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.1 tp -75.35 130.78 35.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.273 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.405 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 1.3 tp60 -120.51 91.83 47.13 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.638 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.454 ' O ' ' HB2' ' A' ' 24' ' ' LYS . 3.1 Cg_exo -71.66 165.29 32.99 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.454 2.103 . . . . 0.0 112.29 -178.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 23' ' ' PRO . 16.5 mtmm 77.37 37.25 0.26 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.511 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.921 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . . . -102.41 167.41 9.97 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 17.0 t -75.41 -10.32 59.34 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 119.996 -0.682 . . . . 0.0 109.666 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.7 ttp180 -176.6 163.8 2.42 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.666 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.503 ' HA ' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -84.82 95.22 8.92 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.613 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.1 m -126.42 135.66 51.68 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.722 -178.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.469 HG22 HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -91.01 76.1 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.689 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.3 17.55 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.053 -178.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . -142.4 21.75 2.4 Favored Glycine 0 C--N 1.32 -0.322 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.753 ' CD2' HG13 ' A' ' 38' ' ' VAL . 19.4 mt -57.75 107.01 0.41 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.434 ' O ' ' O ' ' A' ' 37' ' ' GLU . 44.7 t-80 -94.46 157.4 16.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.559 -178.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -66.6 -29.26 74.47 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -112.41 -10.08 13.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.737 -0.231 . . . . 0.0 110.472 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.434 ' O ' ' O ' ' A' ' 34' ' ' HIS . 8.4 mt-10 -140.68 -176.81 4.79 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.975 0.417 . . . . 0.0 110.734 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.753 HG13 ' CD2' ' A' ' 33' ' ' LEU . 45.9 t -142.78 112.79 2.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -111.13 132.69 54.08 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.262 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.526 HG13 ' O ' ' A' ' 40' ' ' VAL . 8.5 p -147.59 124.18 2.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.651 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.921 ' HB1' ' HB2' ' A' ' 25' ' ' ALA . . . -86.94 122.4 30.75 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.828 HD11 ' HB3' ' A' ' 54' ' ' HIS . 21.2 tt -109.33 147.95 13.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.1 t -90.66 38.42 0.95 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.937 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -105.24 139.14 19.85 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.449 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.548 ' HG2' ' CB ' ' A' ' 50' ' ' GLN . 3.2 Cg_exo -56.25 170.47 1.16 Allowed 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 122.689 2.259 . . . . 0.0 112.572 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.61 24.74 0.45 Allowed 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 123.36 2.707 . . . . 0.0 113.391 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.461 HG13 ' H ' ' A' ' 50' ' ' GLN . 13.9 p -120.28 138.2 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.446 ' O ' ' C ' ' A' ' 49' ' ' GLY . 0.7 OUTLIER -53.75 -58.87 5.66 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.104 -179.427 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . -34.65 -52.9 0.81 Allowed Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.548 ' CB ' ' HG2' ' A' ' 45' ' ' PRO . 43.1 mm-40 -78.12 -39.37 41.47 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.07 -62.87 1.2 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.834 0.35 . . . . 0.0 110.511 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.439 ' N ' ' O ' ' A' ' 48' ' ' ASP . 46.2 t-20 -43.58 -47.24 7.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.876 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 18.4 m -52.99 -57.55 9.99 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.305 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.828 ' HB3' HD11 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -51.5 -50.75 59.29 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.787 0.327 . . . . 0.0 110.679 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.651 HD12 HD11 ' A' ' 83' ' ' ILE . 3.1 mm? -50.91 -43.77 59.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.198 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -69.37 -27.12 33.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.99 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -79.32 -60.5 2.34 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.842 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -46.9 -58.39 3.98 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.249 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.413 ' O ' ' HB2' ' A' ' 63' ' ' PHE . 4.6 mp -71.17 -41.47 70.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.103 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -51.17 -35.42 34.03 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.3 mttp -80.92 -58.26 3.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.662 0.268 . . . . 0.0 111.02 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -56.03 -43.87 78.21 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.102 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.508 ' CE2' HD11 ' A' ' 15' ' ' LEU . 1.6 m-85 -82.72 -18.54 40.47 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.111 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.2 mtt-85 61.59 8.48 2.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.533 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.2 m -82.9 163.14 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.443 ' O ' HG23 ' A' ' 70' ' ' VAL . . . -65.3 156.63 31.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.806 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 28.2 pttt -70.96 -28.58 64.58 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -71.42 -11.94 61.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.927 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.428 ' O ' ' O ' ' A' ' 84' ' ' LYS . 80.8 mt-30 -100.14 -7.94 24.25 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.335 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 66' ' ' ALA . 31.0 t -104.06 97.76 5.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.4 t -116.78 123.18 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -178.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.424 ' C ' ' H ' ' A' ' 74' ' ' LYS . 54.3 mt -82.33 84.55 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.166 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -60.25 -3.68 0.67 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.035 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.424 ' H ' ' C ' ' A' ' 72' ' ' ILE . 5.3 mttp 168.15 116.55 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.081 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.567 ' HA3' ' HZ2' ' A' ' 81' ' ' LYS . . . 148.62 -10.43 1.08 Allowed Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -34.14 -41.03 0.1 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.3 tp -131.47 -42.96 1.04 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.701 0.286 . . . . 0.0 111.355 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.5 149.2 48.67 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.785 -0.526 . . . . 0.0 111.785 -178.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.462 ' HD3' ' H ' ' A' ' 79' ' ' ARG . 0.1 OUTLIER -60.99 -29.43 69.68 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.387 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.429 ' O ' ' HA2' ' A' ' 75' ' ' GLY . 76.5 t60 -67.27 145.85 54.75 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 177.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.567 ' HZ2' ' HA3' ' A' ' 75' ' ' GLY . 0.0 OUTLIER -144.73 154.02 42.3 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 119.706 -0.798 . . . . 0.0 111.537 -177.195 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -162.87 78.71 0.47 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.651 HD11 HD12 ' A' ' 55' ' ' LEU . 46.8 mt -80.46 153.61 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.398 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.49 ' HZ1' ' HA3' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -120.47 111.86 18.24 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.969 -178.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.474 ' N ' ' HE3' ' A' ' 84' ' ' LYS . 1.4 mp -100.54 102.85 14.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.182 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 55.3 mt -85.99 153.55 3.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.551 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 18.4 m-20 40.05 79.77 0.31 Allowed Pre-proline 0 N--CA 1.467 0.41 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.692 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.51 146.1 30.51 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 123.014 2.476 . . . . 0.0 112.65 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 60.6 mm-40 -124.12 -28.91 3.66 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.043 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -146.8 117.48 7.57 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.138 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.9 tt -114.36 120.49 38.07 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.599 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.2 141.22 92.68 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.479 2.119 . . . . 0.0 112.342 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.462 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 2.5 Cg_endo -50.49 -33.94 40.18 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 123.266 2.644 . . . . 0.0 112.632 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -53.04 -54.43 35.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.13 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 16.3 t -72.22 -19.45 19.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.462 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -75.0 -25.44 58.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.809 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -62.53 -26.34 68.51 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.888 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 20.1 mt -94.99 -10.94 29.42 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.5 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 97.6 mt -102.36 -30.98 2.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.943 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 . . . . . 0 N--CA 1.462 0.15 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.821 -179.738 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.639 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 9.6 p . . . . . 0 N--CA 1.44 -0.948 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.639 ' HB2' ' O ' ' A' ' 6' ' ' SER . . . 157.87 -17.46 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.985 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.454 ' CG2' ' N ' ' A' ' 9' ' ' THR . 0.2 OUTLIER -159.38 157.76 2.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.843 -179.607 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.454 ' N ' ' CG2' ' A' ' 8' ' ' VAL . 1.3 m -144.62 141.78 29.66 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.349 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 m -107.19 101.36 12.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.298 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.452 HD21 ' CG2' ' A' ' 16' ' ' VAL . 14.8 m-80 -81.24 -155.4 0.12 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.311 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -107.65 10.52 29.02 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -122.83 -25.26 4.66 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.241 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.62 -129.11 1.54 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.425 HD11 ' CE2' ' A' ' 63' ' ' PHE . 0.2 OUTLIER -145.46 158.74 43.79 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.171 0.51 . . . . 0.0 111.31 -179.757 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.452 ' CG2' HD21 ' A' ' 11' ' ' ASN . 3.8 t -110.03 138.47 37.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.329 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.646 HD12 HD23 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -115.61 91.16 3.52 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.689 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 4.6 mtm180 -97.06 109.26 22.05 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.4 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.731 HD12 ' N ' ' A' ' 20' ' ' TYR . 3.4 pp -145.42 178.89 7.77 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.878 0.371 . . . . 0.0 110.998 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.731 ' N ' HD12 ' A' ' 19' ' ' LEU . 31.8 t80 -110.93 104.62 13.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.3 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.465 HG22 ' HD3' ' A' ' 23' ' ' PRO . 1.7 mm -70.68 126.72 31.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.38 86.24 55.04 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.129 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.465 ' HD3' HG22 ' A' ' 21' ' ' ILE . 3.3 Cg_exo -74.77 161.18 39.76 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.634 2.223 . . . . 0.0 111.84 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.6 mtmt 73.87 43.48 0.32 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.007 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.907 ' CB ' ' HB1' ' A' ' 41' ' ' ALA . . . -91.66 -71.12 0.65 Allowed 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.2 p 162.51 -23.12 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.016 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -171.75 143.16 1.64 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.041 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.403 ' HA ' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -63.05 89.66 0.04 OUTLIER 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.673 0.749 . . . . 0.0 110.055 179.493 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.3 m -130.77 127.28 38.4 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.192 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.538 HG22 HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -83.29 65.62 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.78 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -94.03 18.28 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 114.669 -1.151 . . . . 0.0 113.016 -177.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -143.05 39.14 1.35 Allowed Glycine 0 N--CA 1.46 0.289 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.851 ' CD2' HG13 ' A' ' 38' ' ' VAL . 22.9 mt -77.78 117.69 19.4 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.557 -0.822 . . . . 0.0 109.799 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.585 ' CD2' ' H ' ' A' ' 35' ' ' GLY . 11.0 t-160 -102.25 159.46 15.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.416 -178.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.585 ' H ' ' CD2' ' A' ' 34' ' ' HIS . . . -73.47 -19.66 79.72 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -115.96 -14.05 11.26 Favored 'General case' 0 N--CA 1.461 0.11 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.413 ' H ' ' HB3' ' A' ' 34' ' ' HIS . 19.2 mt-10 -143.39 -176.23 4.86 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.322 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.851 HG13 ' CD2' ' A' ' 33' ' ' LEU . 73.2 t -144.15 121.12 5.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.37 118.48 29.56 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.646 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.496 HG23 HG23 ' A' ' 30' ' ' ILE . 8.5 p -113.42 135.01 54.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.064 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.907 ' HB1' ' CB ' ' A' ' 25' ' ' ALA . . . -100.0 104.8 16.42 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.729 HD13 ' CE1' ' A' ' 54' ' ' HIS . 0.6 OUTLIER -99.39 156.19 3.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 -179.147 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.421 ' H ' HG13 ' A' ' 42' ' ' ILE . 8.4 t -93.22 26.75 2.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.744 -178.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.462 ' H ' HG23 ' A' ' 42' ' ' ILE . . . -97.0 167.44 12.01 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.866 0.365 . . . . 0.0 110.913 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.691 ' HB2' HG22 ' A' ' 47' ' ' VAL . 3.6 Cg_exo -77.98 177.63 8.56 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 123.56 2.84 . . . . 0.0 112.165 179.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -77.5 0.75 9.47 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 123.009 2.473 . . . . 0.0 111.435 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.691 HG22 ' HB2' ' A' ' 45' ' ' PRO . 35.2 m -93.19 160.16 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.666 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 52' ' ' ASN . 2.3 m-20 -82.21 -47.34 12.59 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.905 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -43.07 -46.8 6.39 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.501 ' NE2' HG21 ' A' ' 47' ' ' VAL . 0.9 OUTLIER -81.49 -49.81 10.15 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 121.219 -0.192 . . . . 0.0 111.511 -179.453 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.53 -56.53 20.25 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.837 0.351 . . . . 0.0 110.06 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.452 ' N ' ' O ' ' A' ' 48' ' ' ASP . 30.8 t-20 -46.12 -46.38 17.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.086 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.5 p -50.18 -48.14 54.24 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.729 ' CE1' HD13 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -63.05 -45.58 91.56 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.11 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.599 HD22 ' CE1' ' A' ' 54' ' ' HIS . 0.1 OUTLIER -49.24 -60.92 2.39 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.308 -178.537 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -53.7 -26.53 13.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.795 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.413 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 19.1 tttt -82.16 -72.64 0.43 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.058 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.406 ' C ' ' O ' ' A' ' 57' ' ' LYS . 0.8 OUTLIER -33.85 -64.09 0.24 Allowed 'General case' 0 N--CA 1.467 0.377 0 O-C-N 123.167 0.292 . . . . 0.0 111.292 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.429 ' CD2' ' N ' ' A' ' 59' ' ' LEU . 3.6 mm? -64.99 -37.96 89.39 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 64' ' ' ARG . . . -55.17 -41.53 78.94 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.413 ' HG3' ' O ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -81.1 -52.54 7.27 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.066 0.46 . . . . 0.0 110.229 179.531 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.1 mm100 -56.11 -49.72 73.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.711 -178.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.496 ' CD2' HG21 ' A' ' 85' ' ' ILE . 2.3 m-85 -87.14 -18.99 29.14 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.627 -0.261 . . . . 0.0 111.393 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.408 ' HA ' ' O ' ' A' ' 60' ' ' GLY . 18.6 mtt180 59.98 4.1 0.57 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.582 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.441 HG21 HG23 ' A' ' 85' ' ' ILE . 33.6 m -76.35 152.3 5.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.511 ' HB3' ' NE2' ' A' ' 69' ' ' GLN . . . -48.77 158.74 0.29 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.542 -179.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.68 -29.56 65.91 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.308 0.575 . . . . 0.0 109.66 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.32 -13.88 59.84 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.59 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.511 ' NE2' ' HB3' ' A' ' 66' ' ' ALA . 1.2 mp0 -89.93 -6.26 55.9 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.259 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.4 t -106.0 97.23 5.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.6 t -114.42 124.53 71.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.206 0.527 . . . . 0.0 111.814 -178.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 64.2 mt -86.95 93.22 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.435 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -77.35 -1.66 31.12 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.938 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 38.8 tttt 179.6 118.95 0.05 Allowed 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.543 ' O ' ' C ' ' A' ' 76' ' ' GLU . . . 146.66 -20.27 1.65 Allowed Glycine 0 CA--C 1.516 0.122 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.543 ' C ' ' O ' ' A' ' 75' ' ' GLY . 11.1 mp0 -10.6 -66.59 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 O-C-N 124.291 0.642 . . . . 0.0 112.037 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.7 tt -118.65 -42.87 2.71 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.369 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -51.11 157.68 2.49 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 44.4 mtt-85 -68.14 -16.44 64.0 Favored 'General case' 0 CA--C 1.519 -0.231 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.516 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.507 ' CD2' ' N ' ' A' ' 81' ' ' LYS . 16.1 t60 -69.17 155.95 39.52 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.507 ' N ' ' CD2' ' A' ' 80' ' ' HIS . 36.1 tttt -148.68 125.37 11.12 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.139 -0.625 . . . . 0.0 109.997 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.442 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 8.3 tt0 -131.55 104.74 7.13 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 15.9 mm -102.09 129.69 53.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.767 -178.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.99 99.33 9.08 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.496 HG21 ' CD2' ' A' ' 63' ' ' PHE . 2.2 mp -89.53 96.62 6.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.139 -178.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 33.4 mt -82.2 146.09 7.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.717 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 51.89 75.04 0.69 Allowed Pre-proline 0 N--CA 1.463 0.215 0 CA-C-O 120.759 0.314 . . . . 0.0 110.529 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -74.27 130.48 14.13 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 122.594 2.196 . . . . 0.0 112.096 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 21.4 mm100 -114.55 -26.08 8.06 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.948 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -145.39 116.18 7.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.399 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.558 HG23 ' O ' ' A' ' 91' ' ' ILE . 4.1 tt -112.56 114.45 50.02 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.064 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -67.13 145.62 73.67 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.29 1.993 . . . . 0.0 111.504 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.603 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 2.7 Cg_endo -51.61 -19.69 7.87 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 122.62 2.214 . . . . 0.0 111.873 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -61.14 -56.31 22.31 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.97 0.414 . . . . 0.0 110.331 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.25 -25.39 12.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.745 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.603 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -75.41 -44.61 43.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.975 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.499 ' HA ' HD21 ' A' ' 100' ' ' ASN . . . -50.33 -19.78 0.91 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.57 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 80.5 mt -102.42 -25.44 13.63 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.944 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 95.8 mt -92.14 -21.18 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.997 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.558 ' H ' HD22 ' A' ' 100' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.463 0.199 0 CA-C-O 120.658 0.266 . . . . 0.0 111.096 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.604 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 6.7 t . . . . . 0 N--CA 1.44 -0.926 0 CA-C-O 121.304 0.573 . . . . 0.0 110.349 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.604 ' HB2' ' O ' ' A' ' 6' ' ' SER . . . 156.36 -20.65 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.735 -1.12 . . . . 0.0 108.956 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.4 m -149.02 168.2 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.115 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 m -150.73 120.77 7.17 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.431 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.2 m -92.34 97.09 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.194 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -82.68 -163.27 0.68 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.189 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -101.39 11.71 38.7 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -119.16 -24.11 6.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.11 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.521 ' HA3' ' HZ1' ' A' ' 84' ' ' LYS . . . 165.87 -124.35 1.23 Allowed Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.414 HD11 ' CE2' ' A' ' 63' ' ' PHE . 0.3 OUTLIER -150.87 150.77 31.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.976 0.417 . . . . 0.0 111.134 -179.582 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.1 t -107.74 142.8 19.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.928 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -113.49 96.28 5.8 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 22.9 mtp85 -104.47 110.86 23.29 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.789 -179.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.458 HD12 ' N ' ' A' ' 20' ' ' TYR . 3.0 pp -147.52 179.66 7.51 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.051 0.453 . . . . 0.0 111.427 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.458 ' N ' HD12 ' A' ' 19' ' ' LEU . 16.0 t80 -108.36 114.64 28.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.086 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.9 mm -84.26 133.78 28.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.928 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -120.87 87.48 42.95 Favored Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -70.09 156.82 61.6 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.62 2.213 . . . . 0.0 113.413 -178.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? 69.83 49.79 0.5 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.239 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.906 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . . . -96.68 -66.92 0.87 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' A' ' 25' ' ' ALA . 1.1 m 158.56 -24.41 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.293 -0.867 . . . . 0.0 108.724 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -171.1 144.24 2.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.87 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.47 92.8 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 59.8 p -124.29 130.19 52.08 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.52 -178.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.611 HG22 HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -94.78 63.55 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.111 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.734 ' O ' HG12 ' A' ' 31' ' ' VAL . 92.7 t -96.03 19.51 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.944 -178.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -144.04 32.08 1.81 Allowed Glycine 0 C--N 1.334 0.457 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.83 ' CD2' HG13 ' A' ' 38' ' ' VAL . 31.8 mt -66.61 126.24 28.29 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.63 -0.785 . . . . 0.0 109.926 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.428 ' O ' ' O ' ' A' ' 37' ' ' GLU . 23.2 t-80 -112.67 157.41 21.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.042 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.06 -27.54 73.66 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -109.26 -14.49 14.46 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 115.569 -0.315 . . . . 0.0 110.81 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.428 ' O ' ' O ' ' A' ' 34' ' ' HIS . 9.0 mt-10 -141.94 -177.67 5.32 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.001 0.429 . . . . 0.0 111.081 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.83 HG13 ' CD2' ' A' ' 33' ' ' LEU . 70.7 t -143.97 115.98 2.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.707 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.4 ttpt -116.13 117.57 30.43 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.642 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.4 p -120.12 149.83 22.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.156 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.906 ' HB1' ' HB2' ' A' ' 25' ' ' ALA . . . -112.53 103.54 11.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.308 -0.406 . . . . 0.0 109.915 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.402 HG13 ' N ' ' A' ' 43' ' ' THR . 2.4 tp -86.11 146.36 6.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.44 HG22 ' H ' ' A' ' 43' ' ' THR . 0.7 OUTLIER -87.31 17.15 4.58 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.755 -178.28 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.501 ' HB2' ' CD2' ' A' ' 54' ' ' HIS . . . -99.12 149.77 36.08 Favored Pre-proline 0 C--O 1.234 0.276 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.55 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.532 ' HB2' HG22 ' A' ' 47' ' ' VAL . 3.9 Cg_exo -51.54 175.9 0.06 OUTLIER 'Trans proline' 0 N--CA 1.491 1.371 0 C-N-CA 123.241 2.627 . . . . 0.0 112.212 178.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -80.21 0.36 10.08 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 123.23 2.62 . . . . 0.0 112.982 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.532 HG22 ' HB2' ' A' ' 45' ' ' PRO . 0.2 OUTLIER -87.79 158.61 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.988 -179.616 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.445 ' O ' ' N ' ' A' ' 52' ' ' ASN . 17.5 m-20 -73.55 -57.57 3.9 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.001 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . -36.65 -46.4 1.11 Allowed Glycine 0 CA--C 1.529 0.969 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.507 ' HB2' HG23 ' A' ' 47' ' ' VAL . 2.1 mp0 -82.73 -52.16 7.03 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.25 -56.05 26.26 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.937 0.399 . . . . 0.0 110.403 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' A' ' 48' ' ' ASP . 40.1 t-20 -46.34 -54.65 8.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.47 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.7 m -48.81 -52.54 23.49 Favored 'General case' 0 C--O 1.23 0.066 0 C-N-CA 120.624 -0.431 . . . . 0.0 110.107 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.501 ' CD2' ' HB2' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -56.33 -56.12 25.01 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.539 179.65 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.3 mp -43.3 -60.45 1.69 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.273 0.558 . . . . 0.0 110.134 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.7 t -57.85 -29.33 35.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.312 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -76.3 -68.31 0.6 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.262 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -39.09 -48.28 1.65 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.503 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.4 HD13 ' HZ1' ' A' ' 81' ' ' LYS . 7.4 mp -76.93 -34.79 57.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.84 0.353 . . . . 0.0 110.072 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.36 -35.65 61.36 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.01 -52.16 7.73 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.919 0.39 . . . . 0.0 110.428 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -59.25 -46.93 87.19 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.848 -178.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.497 ' HB3' HG13 ' A' ' 65' ' ' VAL . 2.4 m-85 -86.13 -19.11 30.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.076 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.2 mtt85 59.24 5.27 0.55 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.352 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.529 HG11 HG23 ' A' ' 85' ' ' ILE . 27.0 m -67.35 175.33 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.199 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -86.67 163.44 17.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.263 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 29.1 pttt -70.91 -21.29 62.39 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.658 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.77 -8.76 59.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.296 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -108.43 -5.15 16.78 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.463 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.696 ' O ' HG13 ' A' ' 70' ' ' VAL . 9.8 p -101.21 101.1 11.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 121.286 0.565 . . . . 0.0 110.373 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 59.7 t -115.94 124.9 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 52.6 mt -84.85 93.67 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.905 178.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -70.01 -16.05 63.11 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.159 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt 174.81 163.9 0.24 Allowed 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.57 -2.05 73.06 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -37.94 -31.94 0.05 Allowed 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.554 HD23 ' O ' ' A' ' 77' ' ' LEU . 1.0 OUTLIER -127.04 -45.04 1.58 Allowed 'General case' 0 C--O 1.233 0.187 0 C-N-CA 121.061 -0.255 . . . . 0.0 111.0 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.404 ' C ' ' N ' ' A' ' 80' ' ' HIS . . . -58.84 148.22 39.55 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.435 ' HB3' ' CE1' ' A' ' 20' ' ' TYR . 10.4 mtt180 -50.19 -18.55 0.6 Allowed 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.404 ' N ' ' C ' ' A' ' 78' ' ' GLY . 1.7 m80 -69.87 165.35 21.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.493 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.596 ' HE3' HD12 ' A' ' 83' ' ' ILE . 2.0 tttt -151.97 132.87 14.18 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -139.77 82.06 1.86 Allowed 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.596 HD12 ' HE3' ' A' ' 81' ' ' LYS . 92.2 mt -95.11 139.61 18.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.839 -179.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.521 ' HZ1' ' HA3' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -108.49 126.44 52.91 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.211 -179.129 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.589 HG22 ' O ' ' A' ' 85' ' ' ILE . 1.4 mp -106.1 98.75 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.967 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.401 ' O ' ' C ' ' A' ' 87' ' ' ASN . 95.5 mt -80.59 151.8 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 86' ' ' ILE . 1.5 m-80 38.09 85.41 0.16 Allowed Pre-proline 0 N--CA 1.464 0.226 0 O-C-N 123.235 0.334 . . . . 0.0 110.804 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -72.32 133.09 20.36 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.403 2.068 . . . . 0.0 112.365 -179.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -108.08 -30.19 8.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.419 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -147.31 121.05 9.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.123 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.571 HG23 ' O ' ' A' ' 91' ' ' ILE . 2.9 tt -113.39 114.17 48.03 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.454 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -66.01 173.86 6.58 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 121.985 1.79 . . . . 0.0 111.069 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.556 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 3.3 Cg_exo -73.66 -19.19 21.64 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.445 2.097 . . . . 0.0 111.591 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -52.94 -62.5 1.61 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.255 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.3 t -73.57 -24.58 20.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.975 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.556 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -70.4 -28.4 65.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.666 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.62 -22.29 8.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.551 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.9 mt -108.02 -41.55 4.91 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.784 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 79.0 mt -76.24 -13.57 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.767 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.078 179.566 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.513 0 CA-C-O 121.224 0.535 . . . . 0.0 110.141 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -153.62 -16.81 0.14 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.239 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.416 ' CG2' ' N ' ' A' ' 9' ' ' THR . 0.7 OUTLIER -160.88 155.72 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.488 179.632 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.416 ' N ' ' CG2' ' A' ' 8' ' ' VAL . 1.8 m -150.37 139.81 21.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.683 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.84 105.67 19.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.85 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -92.4 -152.29 0.31 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.595 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -107.59 5.33 26.87 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -109.4 -23.1 11.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.163 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 161.93 -125.48 1.43 Allowed Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -145.26 145.69 31.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.981 0.42 . . . . 0.0 110.971 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.2 t -105.58 129.0 59.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.84 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.28 99.81 8.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.215 0.531 . . . . 0.0 110.446 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.526 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -103.56 127.18 51.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.037 -179.876 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.465 ' H ' ' HB3' ' A' ' 81' ' ' LYS . 0.6 OUTLIER -149.88 176.69 10.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.512 0.672 . . . . 0.0 112.121 -179.196 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -108.0 92.66 4.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.638 -1.165 . . . . 0.0 108.792 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.551 HG22 ' HA ' ' A' ' 79' ' ' ARG . 1.6 tp -75.77 137.01 23.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.037 -178.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.01 93.87 42.86 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.915 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.446 ' HA ' HG23 ' A' ' 42' ' ' ILE . 3.0 Cg_exo -73.54 157.33 49.02 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.478 2.119 . . . . 0.0 112.226 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt 72.33 47.93 0.26 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.106 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.996 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . . . -95.92 -68.37 0.8 Allowed 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.414 ' CB ' ' O ' ' A' ' 25' ' ' ALA . 6.1 p 157.38 -24.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.504 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 44.4 ttm180 -171.29 139.85 1.38 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.206 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.42 93.62 0.35 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.393 0.616 . . . . 0.0 109.999 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.8 m -124.92 129.09 49.67 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.654 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.46 HG22 HD21 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -85.56 63.03 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.714 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -93.67 17.67 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.725 -178.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . -143.38 28.25 2.08 Favored Glycine 0 C--N 1.318 -0.444 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -178.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.46 HD21 HG22 ' A' ' 30' ' ' ILE . 10.7 mt -60.81 111.01 1.47 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.421 ' ND1' ' N ' ' A' ' 35' ' ' GLY . 3.7 t60 -99.44 152.53 19.88 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.398 -178.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.421 ' N ' ' ND1' ' A' ' 34' ' ' HIS . . . -67.75 -15.5 66.75 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -121.94 -17.38 7.32 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.747 0.308 . . . . 0.0 110.392 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -139.05 -173.03 3.47 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.833 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.459 HG12 ' HB2' ' A' ' 19' ' ' LEU . 16.9 t -142.7 112.87 2.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 5.6 mtpt -110.89 109.36 19.5 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.035 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.506 ' CG1' HD12 ' A' ' 21' ' ' ILE . 7.7 p -121.98 132.44 70.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.458 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.996 ' HB1' ' HB2' ' A' ' 25' ' ' ALA . . . -99.65 99.86 10.77 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.272 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.583 HD11 ' CB ' ' A' ' 54' ' ' HIS . 19.6 tt -84.66 149.52 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.433 HG23 ' O ' ' A' ' 43' ' ' THR . 9.4 t -95.59 48.24 1.14 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.016 0.436 . . . . 0.0 110.626 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.725 ' HB1' ' HB2' ' A' ' 50' ' ' GLN . . . -118.79 142.89 32.56 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.529 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.566 ' O ' ' NE2' ' A' ' 50' ' ' GLN . 1.6 Cg_endo -54.51 169.66 0.72 Allowed 'Trans proline' 0 N--CA 1.503 2.058 0 C-N-CA 123.751 2.967 . . . . 0.0 112.236 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -83.56 87.09 1.29 Allowed 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.831 2.354 . . . . 0.0 111.081 177.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 1.028 HG22 ' H ' ' A' ' 48' ' ' ASP . 9.8 p -172.24 -160.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 1.028 ' H ' HG22 ' A' ' 47' ' ' VAL . 1.7 m-20 -88.03 -66.89 0.87 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.041 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -44.55 -28.77 1.65 Allowed Glycine 0 CA--C 1.526 0.734 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.35 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.725 ' HB2' ' HB1' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -61.9 -69.78 0.23 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.206 0.527 . . . . 0.0 111.474 -179.644 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.679 ' H ' ' CG ' ' A' ' 50' ' ' GLN . . . -80.63 -39.84 26.69 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.224 -178.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -54.01 -54.96 31.87 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.359 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.4 p -64.12 -48.7 75.07 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.0 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.583 ' CB ' HD11 ' A' ' 42' ' ' ILE . 0.2 OUTLIER -57.99 -52.81 63.99 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.652 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.594 HD21 HD11 ' A' ' 83' ' ' ILE . 5.5 tp -49.36 -58.3 5.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.028 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -53.74 -23.41 8.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.6 ttpp -85.16 -64.75 1.1 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.494 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -45.7 -59.77 2.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.382 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.553 HD22 HD13 ' A' ' 83' ' ' ILE . 6.0 tp -70.74 -48.0 56.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.951 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -49.21 -30.1 10.45 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -81.16 -63.06 1.48 Allowed 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.772 0.32 . . . . 0.0 111.217 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -58.63 -36.76 74.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.671 -178.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.901 ' HB3' HG23 ' A' ' 65' ' ' VAL . 1.4 m-85 -87.02 -18.96 29.39 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.412 ' HE ' ' HB2' ' A' ' 90' ' ' GLN . 0.1 OUTLIER 56.7 11.05 0.81 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.371 -0.832 . . . . 0.0 112.642 178.378 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.901 HG23 ' HB3' ' A' ' 63' ' ' PHE . 2.2 t -69.15 -141.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.871 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.607 ' O ' HG12 ' A' ' 70' ' ' VAL . . . -125.39 156.39 38.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.918 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.407 ' HA ' HG12 ' A' ' 70' ' ' VAL . 46.0 pttt -69.55 -26.29 64.42 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.13 -16.44 37.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.35 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.45 ' CG ' ' HB3' ' A' ' 66' ' ' ALA . 25.5 mm-40 -97.03 -20.63 17.91 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.566 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.694 ' O ' HG13 ' A' ' 70' ' ' VAL . 14.8 p -101.53 98.14 6.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 t -115.2 131.32 67.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.96 -178.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 68.1 mt -83.04 91.01 2.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.42 ' O ' ' CB ' ' A' ' 74' ' ' LYS . 7.8 mt-10 -57.91 -7.01 0.64 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.666 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.42 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 3.5 mtpp 162.11 126.48 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 132.77 -3.08 4.94 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -40.8 -30.53 0.13 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.8 tt -128.5 -37.85 1.77 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 121.023 -0.271 . . . . 0.0 111.654 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -70.99 158.32 53.72 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.772 -0.531 . . . . 0.0 111.772 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.551 ' HA ' HG22 ' A' ' 21' ' ' ILE . 13.3 mtm180 -61.41 -29.32 69.86 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.2 p-80 -69.01 146.99 52.24 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 5.8 ttmm -139.64 142.27 37.02 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.53 -178.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.409 ' HG2' ' C ' ' A' ' 81' ' ' LYS . 2.1 mm100 -144.3 80.72 1.65 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.594 HD11 HD21 ' A' ' 55' ' ' LEU . 81.9 mt -81.85 156.13 4.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.234 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.454 ' HE3' ' N ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -136.25 104.94 5.81 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.828 -179.64 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.695 HG23 HG21 ' A' ' 65' ' ' VAL . 3.1 mp -96.81 103.12 14.3 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.796 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 53.7 mt -85.6 133.44 29.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.883 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 51.4 t30 52.16 82.47 0.24 Allowed Pre-proline 0 CA--C 1.53 0.202 0 CA-C-O 120.906 0.384 . . . . 0.0 110.03 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -69.73 144.79 55.29 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.61 2.207 . . . . 0.0 112.497 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -117.99 -29.77 5.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.118 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.435 ' O ' ' HA ' ' A' ' 63' ' ' PHE . 33.5 tt0 -147.12 122.27 10.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.785 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.502 HG23 ' O ' ' A' ' 91' ' ' ILE . 4.3 tt -116.6 117.28 38.18 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.073 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -69.4 143.54 52.9 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 122.333 2.022 . . . . 0.0 112.165 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.564 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 2.5 Cg_endo -49.25 -25.15 9.28 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 122.945 2.43 . . . . 0.0 111.899 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -61.35 -56.89 15.31 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.564 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.3 t -71.39 -19.83 20.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.564 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -75.33 -22.97 57.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.502 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -64.55 -19.26 65.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.006 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 67.9 mt -105.68 -16.7 14.61 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.31 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 44.1 mt -104.17 -36.53 4.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.81 0.338 . . . . 0.0 110.659 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.923 -179.979 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.591 0 CA-C-O 121.283 0.563 . . . . 0.0 110.382 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -144.55 -30.23 0.46 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.291 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.9 m -147.07 165.75 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.817 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 m -151.29 130.5 12.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.725 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.4 m -95.19 97.6 6.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.115 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -84.93 -163.02 0.76 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.297 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -102.67 9.79 39.03 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -117.77 -21.47 8.43 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 114.682 -1.145 . . . . 0.0 110.461 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.41 -126.49 1.51 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.422 HD21 ' CG2' ' A' ' 85' ' ' ILE . 1.4 pt? -144.37 150.99 38.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.858 0.361 . . . . 0.0 110.693 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 35.8 t -105.51 143.05 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.208 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 82' ' ' GLN . 0.5 OUTLIER -124.49 92.23 3.61 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.976 0.417 . . . . 0.0 110.762 -179.82 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 2.3 mmm-85 -95.87 113.49 25.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.428 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.69 171.8 13.71 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.593 0.711 . . . . 0.0 112.672 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -102.57 94.88 5.88 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.289 -1.323 . . . . 0.0 108.121 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -72.32 128.63 35.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.52 -177.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -125.4 90.1 51.34 Favored Pre-proline 0 C--O 1.232 0.159 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.905 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.27 156.24 37.34 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.67 2.246 . . . . 0.0 111.975 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt 72.19 53.15 0.18 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.658 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 1.005 ' CB ' ' HB1' ' A' ' 41' ' ' ALA . . . -99.65 -59.83 1.64 Allowed 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 25' ' ' ALA . 0.4 OUTLIER 157.44 -31.45 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.142 179.41 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.434 ' CG ' ' O ' ' A' ' 26' ' ' SER . 18.5 mtm180 -167.05 146.75 5.38 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.344 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.449 ' HA ' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -64.08 92.36 0.08 Allowed 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.078 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.422 ' HB3' HG23 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -129.61 120.1 24.7 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.851 -178.464 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.487 HG22 HD21 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -84.24 76.47 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.502 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.694 ' O ' HG12 ' A' ' 31' ' ' VAL . 41.3 t -107.01 19.56 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 114.858 -1.064 . . . . 0.0 112.069 -177.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -143.56 27.72 2.07 Favored Glycine 0 C--N 1.333 0.366 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.673 ' CD2' HG13 ' A' ' 38' ' ' VAL . 15.9 mt -62.62 126.69 28.18 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.955 -0.623 . . . . 0.0 110.094 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.421 ' HB3' ' H ' ' A' ' 37' ' ' GLU . 4.8 t60 -113.25 157.02 22.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.165 -178.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -69.57 -20.1 75.29 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.516 -1.033 . . . . 0.0 110.516 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -116.17 -17.09 10.91 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.831 -0.184 . . . . 0.0 110.609 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.421 ' H ' ' HB3' ' A' ' 34' ' ' HIS . 24.7 mm-40 -140.53 -174.99 4.11 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.831 0.348 . . . . 0.0 110.537 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.673 HG13 ' CD2' ' A' ' 33' ' ' LEU . 14.8 t -142.74 113.33 2.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -107.99 112.36 24.89 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.396 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.469 HG23 HG23 ' A' ' 30' ' ' ILE . 9.9 p -117.0 144.42 24.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.349 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 1.005 ' HB1' ' CB ' ' A' ' 25' ' ' ALA . . . -110.23 100.84 9.66 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.47 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.829 HD11 ' HB3' ' A' ' 54' ' ' HIS . 19.5 tt -91.91 148.14 4.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.73 28.3 1.82 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.503 -179.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.96 163.2 19.22 Favored Pre-proline 0 C--O 1.235 0.303 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.107 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.44 ' HG2' ' CB ' ' A' ' 50' ' ' GLN . 3.4 Cg_exo -77.55 176.46 10.03 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 123.433 2.756 . . . . 0.0 111.978 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -77.05 3.6 6.5 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 123.071 2.514 . . . . 0.0 112.606 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.417 HG12 ' HB2' ' A' ' 45' ' ' PRO . 14.8 p -99.2 148.09 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.719 0.295 . . . . 0.0 110.564 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' A' ' 52' ' ' ASN . 1.3 t0 -66.94 -52.41 43.26 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.033 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . -37.05 -51.95 1.58 Allowed Glycine 0 CA--C 1.531 1.058 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.452 ' N ' ' CD ' ' A' ' 50' ' ' GLN . 2.0 mp0 -82.72 -45.53 14.31 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.39 -58.8 4.51 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.155 0.503 . . . . 0.0 110.376 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.5 ' N ' ' O ' ' A' ' 48' ' ' ASP . 11.5 t-20 -46.88 -49.92 19.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.93 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.5 p -55.73 -48.34 75.37 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.791 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.829 ' HB3' HD11 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -54.47 -59.79 4.22 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.296 179.584 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.451 ' HA ' HD13 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -44.86 -57.91 3.46 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.916 0.388 . . . . 0.0 110.532 -179.745 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -54.27 -32.21 23.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.912 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 34.3 tttm -76.75 -65.97 0.87 Allowed 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.704 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -46.67 -56.18 6.54 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.072 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.811 HD21 HD11 ' A' ' 85' ' ' ILE . 1.7 tp -64.49 -58.74 5.57 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.751 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -46.03 -29.54 3.42 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.634 -0.586 . . . . 0.0 111.634 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.1 mttp -80.91 -63.84 1.32 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.961 0.41 . . . . 0.0 111.103 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.531 HE22 ' CG ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -58.75 -31.91 68.77 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.118 -178.668 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.887 ' HB3' HG23 ' A' ' 65' ' ' VAL . 0.8 OUTLIER -88.84 -19.56 25.77 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.402 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 67.15 2.06 2.63 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.734 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.887 HG23 ' HB3' ' A' ' 63' ' ' PHE . 2.0 t -68.2 -136.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.038 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.449 ' O ' HG23 ' A' ' 70' ' ' VAL . . . -140.08 167.79 21.31 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.905 0.383 . . . . 0.0 111.295 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.5 ptmt -73.42 -25.41 60.51 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.327 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.8 t -79.91 -20.17 46.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.965 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.428 ' O ' ' O ' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -95.96 -11.69 26.19 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.261 179.782 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 66' ' ' ALA . 54.8 t -100.63 99.24 8.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.231 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.5 t -112.98 116.43 52.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.239 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.423 ' C ' ' H ' ' A' ' 74' ' ' LYS . 67.2 mt -88.06 87.06 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.186 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -76.35 15.18 0.62 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.164 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.423 ' H ' ' C ' ' A' ' 72' ' ' ILE . 8.9 tttt 174.33 137.74 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 76' ' ' GLU . . . 128.28 -14.95 6.16 Favored Glycine 0 CA--C 1.518 0.264 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -178.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 75' ' ' GLY . 12.2 tt0 -30.68 -57.81 0.21 Allowed 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.855 0.385 . . . . 0.0 111.293 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.2 mt -133.43 -33.44 1.1 Allowed 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.848 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.58 145.47 45.6 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.901 -0.879 . . . . 0.0 110.901 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 15.7 mtp180 -58.38 -33.51 69.68 Favored 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.401 ' O ' ' HA2' ' A' ' 75' ' ' GLY . 6.8 m-70 -68.86 138.76 54.97 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 177.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 2.2 ttmm -145.42 151.99 39.12 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 119.961 -0.696 . . . . 0.0 110.203 -177.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.411 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 19.6 tt0 -148.24 123.59 10.28 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 9.7 mt -120.45 143.18 33.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.583 -178.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.458 ' HE3' ' N ' ' A' ' 85' ' ' ILE . 0.2 OUTLIER -114.16 106.62 14.58 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.2 -179.454 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.811 HD11 HD21 ' A' ' 59' ' ' LEU . 2.4 mp -91.39 101.6 12.66 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.36 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 64.4 mt -81.16 143.66 11.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.031 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 47.31 77.15 0.48 Allowed Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.778 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -74.08 144.54 33.99 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 122.87 2.38 . . . . 0.0 112.003 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -107.43 -39.78 5.55 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.65 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -147.51 125.5 12.04 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 120.98 0.419 . . . . 0.0 109.977 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.569 HG23 ' O ' ' A' ' 91' ' ' ILE . 3.4 tt -107.01 112.86 63.06 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.359 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.531 ' CG ' HE22 ' A' ' 62' ' ' GLN . 3.4 Cg_exo -70.44 153.78 65.54 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.683 2.256 . . . . 0.0 112.623 -179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.531 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 2.6 Cg_endo -47.96 -30.27 13.45 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 123.273 2.648 . . . . 0.0 111.897 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 65.6 tt0 -51.71 -59.25 4.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.736 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.413 HG23 ' H ' ' A' ' 95' ' ' VAL . 0.6 OUTLIER -84.04 -24.54 7.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.157 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.531 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -75.24 -19.88 59.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.972 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 93' ' ' PRO . . . -66.41 -25.27 66.69 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.111 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 18.7 mt -103.67 -14.61 16.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.001 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 46.8 mt -103.6 -50.45 9.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.346 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.59 179.594 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.609 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 79.1 p . . . . . 0 N--CA 1.442 -0.861 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.609 ' HB2' ' O ' ' A' ' 6' ' ' SER . . . 158.96 -22.26 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.664 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 16' ' ' VAL . 4.0 p -157.31 154.86 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.072 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 m -150.71 144.57 25.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.523 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.8 m -113.61 103.71 15.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.326 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -93.26 -152.65 0.33 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.301 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -106.1 2.76 27.41 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -107.77 -22.36 12.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.38 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.562 ' HA3' ' HZ1' ' A' ' 84' ' ' LYS . . . 159.37 -122.05 1.1 Allowed Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -148.58 138.6 22.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.006 0.431 . . . . 0.0 111.255 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 8' ' ' VAL . 71.8 t -100.91 141.43 17.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.1 tp -122.34 104.17 9.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.187 0.518 . . . . 0.0 110.787 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.513 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 1.1 mtt-85 -94.02 127.71 39.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.682 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.765 HD11 HG12 ' A' ' 21' ' ' ILE . 2.2 pp -153.18 178.29 9.9 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.618 0.723 . . . . 0.0 112.482 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.574 ' C ' HD12 ' A' ' 19' ' ' LEU . 20.5 t80 -111.0 95.7 5.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.442 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.765 HG12 HD11 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -72.59 127.17 34.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.439 -178.321 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -119.9 90.46 43.89 Favored Pre-proline 0 N--CA 1.462 0.172 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.033 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.435 ' O ' ' HB2' ' A' ' 24' ' ' LYS . 3.1 Cg_exo -74.91 151.5 40.07 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.66 2.24 . . . . 0.0 112.788 -179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 23' ' ' PRO . 6.4 mtmp? 79.73 43.45 0.06 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.982 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.902 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . . . -101.8 169.46 8.79 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 177.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.0 p -63.28 -19.24 64.4 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.073 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.451 ' O ' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -176.59 163.09 2.34 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.151 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.457 ' HA ' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -80.76 93.03 6.13 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.398 0.618 . . . . 0.0 109.476 178.179 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.562 ' HB3' HG23 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -130.49 135.83 48.36 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.782 -178.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.61 HG22 HD21 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -90.56 66.23 0.49 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-O 121.637 0.732 . . . . 0.0 109.455 178.747 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.663 ' O ' HG12 ' A' ' 31' ' ' VAL . 41.3 t -98.32 18.77 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.417 -178.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -143.6 32.12 1.86 Allowed Glycine 0 C--N 1.333 0.368 0 N-CA-C 110.376 -1.089 . . . . 0.0 110.376 -178.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.772 ' CD2' HG13 ' A' ' 38' ' ' VAL . 19.1 mt -71.26 122.38 20.13 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.838 -0.681 . . . . 0.0 110.13 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.433 ' O ' ' O ' ' A' ' 37' ' ' GLU . 37.8 t-80 -110.01 157.03 19.72 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.287 -178.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.79 -22.55 70.23 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.456 ' O ' ' O ' ' A' ' 6' ' ' SER . 29.3 m-20 -121.53 0.54 9.96 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.433 ' O ' ' O ' ' A' ' 34' ' ' HIS . 5.1 mm-40 -148.45 176.38 10.35 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-O 121.07 0.462 . . . . 0.0 110.249 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.772 HG13 ' CD2' ' A' ' 33' ' ' LEU . 30.3 t -142.56 108.68 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -109.77 107.79 17.91 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.295 -178.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.473 HG12 HD13 ' A' ' 19' ' ' LEU . 9.8 p -117.74 131.31 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.592 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.902 ' HB1' ' HB2' ' A' ' 25' ' ' ALA . . . -100.45 107.72 19.52 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.705 HD11 ' HB3' ' A' ' 54' ' ' HIS . 19.7 tt -97.42 152.26 4.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.4 t -92.97 21.55 5.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.44 -178.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.1 160.89 54.03 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.821 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.465 ' HB2' HG12 ' A' ' 47' ' ' VAL . 3.9 Cg_exo -76.51 171.59 17.77 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 123.269 2.646 . . . . 0.0 112.169 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.11 8.33 2.51 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 123.25 2.633 . . . . 0.0 112.745 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.486 HG13 ' H ' ' A' ' 50' ' ' GLN . 14.4 p -101.37 142.62 15.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.404 ' O ' ' N ' ' A' ' 52' ' ' ASN . 0.2 OUTLIER -62.53 -45.7 91.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.262 -179.261 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -45.11 -54.42 7.08 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.298 -0.477 . . . . 0.0 111.919 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.486 ' H ' HG13 ' A' ' 47' ' ' VAL . 15.5 mt-30 -80.44 -38.1 30.76 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 -179.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.35 -60.26 2.58 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.863 0.363 . . . . 0.0 110.687 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.404 ' N ' ' O ' ' A' ' 48' ' ' ASP . 37.3 t-20 -50.53 -40.97 53.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.512 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.7 t -52.9 -50.87 63.05 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.787 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.705 ' HB3' HD11 ' A' ' 42' ' ' ILE . 0.2 OUTLIER -54.75 -55.09 33.73 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.889 -179.665 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.518 ' HA ' HD13 ' A' ' 55' ' ' LEU . 3.4 mm? -49.39 -51.27 36.15 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.66 -0.416 . . . . 0.0 109.895 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -56.35 -26.82 23.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.88 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.441 ' O ' ' HB2' ' A' ' 61' ' ' LYS . 6.0 ttpm? -84.29 -64.95 1.07 Allowed 'General case' 0 C--O 1.227 -0.13 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.286 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -51.69 -54.82 24.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.121 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.513 HD22 ' HA ' ' A' ' 59' ' ' LEU . 0.2 OUTLIER -65.09 -53.3 47.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.66 179.657 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -53.89 -42.91 70.75 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-N 116.363 -0.38 . . . . 0.0 112.153 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 3.9 ttpt -73.94 -44.22 55.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.589 0.233 . . . . 0.0 111.028 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 -65.35 -43.48 90.71 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.074 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.464 ' HB3' HG22 ' A' ' 65' ' ' VAL . 3.6 m-85 -85.91 -19.22 30.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.879 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.9 mtt-85 60.44 5.27 0.83 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.927 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.464 HG22 ' HB3' ' A' ' 63' ' ' PHE . 34.5 m -76.12 155.17 5.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.448 ' HB3' ' HG2' ' A' ' 69' ' ' GLN . . . -51.53 159.14 0.78 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.524 -178.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.8 pttp -69.94 -27.16 64.52 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.892 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.7 t -81.25 -12.33 59.14 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.257 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.448 ' HG2' ' HB3' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -89.97 -12.99 37.08 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.598 -179.78 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.1 p -105.6 100.1 9.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-O 121.161 0.505 . . . . 0.0 110.325 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.2 t -117.24 122.08 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.907 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.444 ' C ' ' H ' ' A' ' 74' ' ' LYS . 46.7 mt -89.96 90.76 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.635 178.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -66.46 3.98 0.85 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.95 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.444 ' H ' ' C ' ' A' ' 72' ' ' ILE . 10.4 mttt 169.53 140.62 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 76' ' ' GLU . . . 130.88 -16.99 5.25 Favored Glycine 0 C--N 1.321 -0.294 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -178.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 75' ' ' GLY . 50.3 mt-10 -35.11 -46.32 0.33 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.373 -0.414 . . . . 0.0 111.034 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.4 tt -130.02 -42.97 1.22 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.872 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -60.88 159.01 28.3 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.842 -0.503 . . . . 0.0 111.842 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.4 mtm-85 -72.99 -32.8 65.41 Favored 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.405 ' O ' ' HA2' ' A' ' 75' ' ' GLY . 6.9 m-70 -69.42 144.48 53.33 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 177.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.516 ' NZ ' ' HG ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -152.38 150.64 29.91 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 118.96 -1.096 . . . . 0.0 111.507 -177.714 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -147.79 113.42 5.68 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.443 ' CD1' HD12 ' A' ' 55' ' ' LEU . 8.4 mt -109.63 132.27 58.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.348 -178.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.562 ' HZ1' ' HA3' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -102.93 117.43 34.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.271 -179.315 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.485 HG22 ' O ' ' A' ' 85' ' ' ILE . 1.8 mp -105.59 98.94 7.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.209 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 20.6 mt -81.51 151.52 4.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.478 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 9.4 m-20 42.11 80.48 0.28 Allowed Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.861 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -73.31 133.58 19.53 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.771 2.314 . . . . 0.0 112.455 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -118.26 -26.38 6.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.533 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -145.86 117.49 8.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.939 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.556 HG23 ' O ' ' A' ' 91' ' ' ILE . 4.3 tt -112.11 113.98 51.49 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.509 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -65.9 143.49 73.26 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.253 1.968 . . . . 0.0 111.757 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.631 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 2.7 Cg_endo -49.01 -24.56 7.61 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.956 2.437 . . . . 0.0 111.684 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -59.47 -58.77 7.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.401 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.0 t -75.98 -24.85 16.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.513 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.631 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -75.28 -28.56 59.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.784 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 93' ' ' PRO . . . -54.95 -31.23 60.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.62 0.248 . . . . 0.0 111.198 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.26 -4.72 48.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.078 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 51.2 mm -116.95 -18.48 6.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.729 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.557 ' N ' ' O ' ' A' ' 96' ' ' ALA . 1.1 m-80 . . . . . 0 C--N 1.332 -0.195 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.005 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 mtt . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -125.61 -106.78 0.33 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.44 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -135.66 87.81 0.24 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.478 HG23 ' N ' ' A' ' 5' ' ' MET . 17.4 m -149.05 -46.62 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-O 120.702 0.287 . . . . 0.0 110.325 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.478 ' N ' HG23 ' A' ' 4' ' ' VAL . 1.8 ttm 56.09 91.57 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.17 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.624 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 62.0 p -126.19 -169.68 2.06 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.624 ' HB2' ' O ' ' A' ' 6' ' ' SER . . . 151.19 -25.85 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.449 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 16' ' ' VAL . 0.7 OUTLIER -159.51 151.44 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.595 -179.768 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 m -139.05 136.2 35.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.326 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 10' ' ' VAL . 30.8 m -101.35 99.8 9.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.262 0.553 . . . . 0.0 110.181 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.403 HD21 HG23 ' A' ' 16' ' ' VAL . 42.4 m-80 -80.28 -151.97 0.08 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.533 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -107.77 6.79 27.89 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -117.77 -25.35 6.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.488 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 170.25 -126.91 1.4 Allowed Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.468 ' N ' HD23 ' A' ' 15' ' ' LEU . 1.6 pt? -147.89 150.77 34.73 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.97 0.414 . . . . 0.0 111.208 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.46 ' O ' HG23 ' A' ' 8' ' ' VAL . 61.7 t -106.88 139.63 27.76 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.117 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.74 102.65 9.6 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.562 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 9.1 mtm180 -107.91 111.04 22.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.02 -179.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.648 HD13 HG12 ' A' ' 40' ' ' VAL . 4.1 pp -142.02 -179.64 6.34 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.904 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.623 ' N ' HD12 ' A' ' 19' ' ' LEU . 53.6 t80 -111.06 105.22 13.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.756 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.42 HD11 HD11 ' A' ' 55' ' ' LEU . 6.0 mm -71.96 135.25 28.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.573 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -124.12 87.72 53.23 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.672 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.2 161.67 42.47 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.622 2.214 . . . . 0.0 112.555 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.26 46.9 2.53 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.661 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.884 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . . . -92.22 -70.95 0.67 Allowed 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.411 ' CB ' ' O ' ' A' ' 25' ' ' ALA . 0.9 OUTLIER 160.01 -22.09 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.06 179.3 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -171.36 140.73 1.47 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.049 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.9 86.89 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 121.429 0.633 . . . . 0.0 109.918 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.49 133.53 46.36 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.481 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.521 HG23 HG23 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -89.16 86.91 2.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.237 179.039 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -113.71 19.33 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.853 -178.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -143.74 37.39 1.45 Allowed Glycine 0 C--N 1.333 0.406 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.826 ' CD2' HG13 ' A' ' 38' ' ' VAL . 21.3 mt -73.27 120.11 18.43 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.798 -0.701 . . . . 0.0 109.913 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.487 ' HB3' ' H ' ' A' ' 37' ' ' GLU . 26.8 t-80 -102.05 157.97 16.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.023 0.44 . . . . 0.0 111.383 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.97 -18.76 73.01 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.48 -18.35 8.5 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.487 ' H ' ' HB3' ' A' ' 34' ' ' HIS . 11.2 mm-40 -134.32 -176.43 4.2 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.988 0.423 . . . . 0.0 110.66 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.826 HG13 ' CD2' ' A' ' 33' ' ' LEU . 55.6 t -143.66 121.98 6.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.5 ttpp -121.86 113.7 20.01 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.879 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.648 HG12 HD13 ' A' ' 19' ' ' LEU . 10.1 p -114.88 142.88 26.05 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.921 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.884 ' HB1' ' HB2' ' A' ' 25' ' ' ALA . . . -107.84 107.67 18.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.322 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.419 HG13 ' N ' ' A' ' 43' ' ' THR . 1.4 tp -93.15 148.12 4.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.419 ' N ' HG13 ' A' ' 42' ' ' ILE . 14.1 t -95.28 38.79 1.13 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.05 0.452 . . . . 0.0 110.831 -178.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.99 144.59 28.86 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.013 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.511 ' HG2' ' CB ' ' A' ' 50' ' ' GLN . 3.7 Cg_exo -51.98 175.36 0.07 OUTLIER 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 123.059 2.506 . . . . 0.0 112.441 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.92 3.67 5.88 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 123.134 2.556 . . . . 0.0 113.342 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.5 p -102.68 143.99 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.597 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.466 ' O ' ' C ' ' A' ' 49' ' ' GLY . 3.7 m-20 -62.06 -60.92 2.91 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.018 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.466 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . -30.72 -43.98 0.08 OUTLIER Glycine 0 CA--C 1.53 1.026 0 N-CA-C 111.744 -0.543 . . . . 0.0 111.744 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.511 ' CB ' ' HG2' ' A' ' 45' ' ' PRO . 0.8 OUTLIER -82.6 -42.07 18.73 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.478 0.18 . . . . 0.0 111.28 -179.612 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 48' ' ' ASP . . . -68.17 -54.16 19.89 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.948 0.404 . . . . 0.0 109.966 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 48' ' ' ASP . 19.3 t-20 -48.72 -44.72 38.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.147 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 58.2 m -54.56 -44.7 73.14 Favored 'General case' 0 N--CA 1.461 0.075 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.46 -42.58 82.79 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.059 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.434 ' CD2' HD11 ' A' ' 83' ' ' ILE . 2.0 tp -54.45 -60.69 3.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.625 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -58.04 -23.41 21.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.2 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.401 ' O ' ' C ' ' A' ' 58' ' ' PHE . 32.8 tttp -79.32 -65.49 0.99 Allowed 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.528 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.401 ' C ' ' O ' ' A' ' 57' ' ' LYS . 3.8 t80 -36.33 -55.37 0.81 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.89 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.562 HD13 ' CD1' ' A' ' 63' ' ' PHE . 4.3 mm? -68.42 -66.16 0.61 Allowed 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.157 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -40.07 -36.28 0.83 Allowed Glycine 0 CA--C 1.529 0.963 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.066 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -82.02 -60.76 2.11 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.762 0.315 . . . . 0.0 111.112 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -58.61 -40.71 84.04 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.533 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.736 ' HB3' HG23 ' A' ' 65' ' ' VAL . 15.1 m-85 -86.27 -18.26 32.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.266 -0.425 . . . . 0.0 109.916 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.9 mtm180 60.41 4.16 0.66 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.759 178.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.736 HG23 ' HB3' ' A' ' 63' ' ' PHE . 6.1 t -65.42 -125.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 120.905 0.383 . . . . 0.0 110.154 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.485 ' N ' HG12 ' A' ' 65' ' ' VAL . . . -145.65 164.15 32.65 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.23 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.9 ptmt -75.28 -27.75 59.5 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.496 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.1 t -78.38 -14.74 59.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.637 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.402 ' O ' ' O ' ' A' ' 84' ' ' LYS . 0.9 OUTLIER -97.73 -15.02 20.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.752 179.718 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.465 HG13 HG23 ' A' ' 83' ' ' ILE . 10.9 t -95.43 99.6 9.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.906 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -107.48 121.55 60.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.503 -179.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 63.0 mt -84.94 95.41 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.168 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -72.86 -4.06 29.47 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.92 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 10.6 mttp 165.9 142.31 0.02 OUTLIER 'General case' 0 C--N 1.339 0.151 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.6 -15.36 6.7 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -35.03 -39.08 0.09 Allowed 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.4 mt -132.13 10.4 4.55 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -123.55 154.03 17.34 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -55.91 -27.7 53.32 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.949 0.404 . . . . 0.0 110.044 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -69.0 160.7 30.45 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.662 ' HE3' HD12 ' A' ' 83' ' ' ILE . 7.7 tttt -150.87 137.86 19.14 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -140.62 75.93 1.53 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.662 HD12 ' HE3' ' A' ' 81' ' ' LYS . 52.6 mt -82.56 151.03 4.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.908 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.447 ' HE3' ' N ' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -123.45 122.57 38.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.751 179.808 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.447 ' N ' ' HE3' ' A' ' 84' ' ' LYS . 1.9 mp -99.79 104.82 16.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.823 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 43.4 mt -87.64 149.8 3.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.437 ' N ' ' CD ' ' A' ' 88' ' ' PRO . 0.4 OUTLIER 43.64 54.11 10.71 Favored Pre-proline 0 CA--C 1.532 0.262 0 CA-C-O 120.816 0.341 . . . . 0.0 110.11 -179.799 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.437 ' CD ' ' N ' ' A' ' 87' ' ' ASN . 2.7 Cg_endo -45.16 146.13 2.96 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.979 2.452 . . . . 0.0 112.202 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -121.26 -38.33 2.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.503 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -143.96 117.73 9.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.062 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.9 tt -111.25 116.74 50.79 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.237 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -65.29 151.05 86.54 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 122.351 2.034 . . . . 0.0 111.734 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.617 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 2.5 Cg_endo -51.47 -35.16 54.35 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.786 2.324 . . . . 0.0 111.991 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -45.23 -58.29 3.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.378 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.7 t -77.39 -19.89 14.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.245 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.617 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -74.63 -30.8 61.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.907 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.18 -22.91 31.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.635 0.255 . . . . 0.0 111.213 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -99.85 -16.19 18.13 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.163 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 87.7 mt -104.55 -35.66 3.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.062 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -82.97 -9.96 59.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.324 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.8 tp 47.77 82.76 0.04 OUTLIER 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.019 0.438 . . . . 0.0 110.499 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -65.59 -1.28 2.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.739 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -91.91 155.29 18.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.626 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 5.8 p-80 -143.43 153.08 42.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.196 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.44 ' CD2' ' N ' ' A' ' 105' ' ' HIS . 3.0 p80 -150.08 56.97 0.96 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.523 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 7.3 t-160 43.61 35.83 1.09 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.069 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 24.0 t60 -82.62 149.75 27.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.478 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 29.8 p-80 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.611 179.958 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.5 mtt . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -52.73 112.82 0.9 Allowed 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.686 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -94.12 -108.5 2.05 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.537 ' C ' ' H ' ' A' ' 6' ' ' SER . 0.9 OUTLIER -108.93 -23.09 4.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.57 0.224 . . . . 0.0 110.407 179.742 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 1.1 ttt -68.09 30.52 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.139 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.624 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 15.1 m -104.0 -168.53 1.51 Allowed 'General case' 0 N--CA 1.435 -1.175 0 CA-C-O 121.107 0.479 . . . . 0.0 110.078 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.624 ' HB2' ' O ' ' A' ' 6' ' ' SER . . . 153.99 -19.61 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.034 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.0 p -154.67 154.27 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.276 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.2 m -144.89 117.82 8.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.363 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.405 ' H ' HG22 ' A' ' 10' ' ' VAL . 2.8 m -88.27 97.75 7.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.792 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.84 -155.32 0.06 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.434 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -107.62 10.45 29.09 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -123.24 -24.67 4.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.312 -178.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.576 ' HA3' ' HZ1' ' A' ' 84' ' ' LYS . . . 172.06 -125.15 1.15 Allowed Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -152.36 148.45 27.51 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 120.862 0.363 . . . . 0.0 111.344 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.4 t -107.29 142.72 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.751 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.51 ' HB3' ' HZ3' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -115.37 104.6 11.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.001 0.429 . . . . 0.0 110.322 179.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.557 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 2.3 mtm180 -105.96 119.28 38.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.194 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.663 HD11 HG12 ' A' ' 21' ' ' ILE . 3.9 pp -149.59 179.65 7.82 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.281 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.656 ' N ' HD12 ' A' ' 19' ' ' LEU . 53.9 t80 -105.71 99.36 8.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.515 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.663 HG12 HD11 ' A' ' 19' ' ' LEU . 2.2 mm -69.31 124.9 26.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.599 ' NE2' ' O ' ' A' ' 23' ' ' PRO . 0.3 OUTLIER -121.23 86.64 43.37 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.945 -179.493 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.599 ' O ' ' NE2' ' A' ' 22' ' ' GLN . 3.4 Cg_exo -74.11 161.1 41.59 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.706 2.271 . . . . 0.0 111.735 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.502 ' CB ' ' O ' ' A' ' 23' ' ' PRO . 2.5 mmpt? 88.33 30.05 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.275 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.906 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . . . -99.16 172.64 7.24 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.2 m -75.64 -12.77 60.27 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.069 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -176.68 163.4 2.33 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.154 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.492 ' HA ' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -79.43 90.98 5.06 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.269 0.556 . . . . 0.0 109.532 177.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.2 m -132.15 134.28 45.23 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.526 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.447 HG22 HD21 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -86.69 73.34 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.363 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.92 18.68 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 114.863 -1.062 . . . . 0.0 112.35 -178.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -143.41 38.29 1.4 Allowed Glycine 0 N--CA 1.459 0.209 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.807 ' CD2' HG13 ' A' ' 38' ' ' VAL . 12.1 mt -74.06 128.94 36.84 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.533 -0.833 . . . . 0.0 110.192 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.417 ' HB3' ' H ' ' A' ' 37' ' ' GLU . 56.7 t60 -111.75 156.33 22.1 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.174 0.512 . . . . 0.0 111.355 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.24 -25.75 66.93 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.413 ' HB3' ' O ' ' A' ' 4' ' ' VAL . 10.2 m-20 -119.18 -13.04 9.37 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 121.226 -0.19 . . . . 0.0 110.737 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.417 ' H ' ' HB3' ' A' ' 34' ' ' HIS . 45.3 mm-40 -134.81 -178.27 5.0 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.868 0.366 . . . . 0.0 110.503 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.807 HG13 ' CD2' ' A' ' 33' ' ' LEU . 43.0 t -143.6 117.73 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -116.37 110.36 18.59 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.702 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.485 HG12 HD13 ' A' ' 19' ' ' LEU . 7.9 p -110.8 136.16 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.821 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.906 ' HB1' ' HB2' ' A' ' 25' ' ' ALA . . . -100.83 111.12 23.27 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.575 HD11 ' HB3' ' A' ' 54' ' ' HIS . 20.4 tt -101.68 151.02 5.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.8 t -91.06 19.85 5.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.676 -177.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.437 ' HB1' ' CD ' ' A' ' 45' ' ' PRO . . . -97.33 168.87 9.45 Favored Pre-proline 0 C--N 1.328 -0.351 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.488 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.58 ' HB2' HG12 ' A' ' 47' ' ' VAL . 3.7 Cg_exo -78.87 166.87 22.92 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 123.402 2.735 . . . . 0.0 111.94 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -74.77 8.52 2.29 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 123.027 2.485 . . . . 0.0 112.551 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.58 HG12 ' HB2' ' A' ' 45' ' ' PRO . 14.8 p -95.89 150.4 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.43 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.449 ' O ' ' N ' ' A' ' 52' ' ' ASN . 0.7 OUTLIER -64.21 -61.78 2.03 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.114 -179.33 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . -33.28 -56.52 0.56 Allowed Glycine 0 CA--C 1.529 0.956 0 N-CA-C 111.971 -0.451 . . . . 0.0 111.971 -179.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.434 ' N ' ' CD ' ' A' ' 50' ' ' GLN . 3.0 mp0 -78.09 -49.89 13.07 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.64 -60.38 3.94 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.882 0.372 . . . . 0.0 110.546 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.449 ' N ' ' O ' ' A' ' 48' ' ' ASP . 39.3 t-20 -42.32 -54.27 3.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.836 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.8 m -41.57 -51.67 3.9 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.75 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.575 ' HB3' HD11 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -63.99 -48.59 75.82 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.166 -179.952 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.3 mp -47.53 -45.86 27.13 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.672 0.272 . . . . 0.0 110.928 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -66.45 -26.77 38.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.223 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 15.1 ttmm -82.18 -48.08 11.73 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.515 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -53.02 -49.32 66.49 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.737 -0.21 . . . . 0.0 111.424 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.569 ' N ' HD22 ' A' ' 59' ' ' LEU . 3.8 mm? -79.56 -41.56 26.95 Favored 'General case' 0 C--O 1.225 -0.237 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.62 -38.5 71.9 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.464 ' CG ' ' N ' ' A' ' 62' ' ' GLN . 5.9 ptmm? -81.91 -42.77 19.05 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.464 ' N ' ' CG ' ' A' ' 61' ' ' LYS . 33.0 mm-40 -71.22 -45.91 62.27 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.727 0.299 . . . . 0.0 111.024 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.445 ' HB3' HG22 ' A' ' 65' ' ' VAL . 0.7 OUTLIER -84.26 -18.15 37.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.164 -179.889 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.0 mtp180 60.67 15.94 6.21 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.02 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.445 HG22 ' HB3' ' A' ' 63' ' ' PHE . 33.7 m -89.6 149.76 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -49.34 157.64 0.47 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.355 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -73.43 -28.5 62.01 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.591 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.5 t -71.86 -11.8 60.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.901 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -97.93 -10.51 24.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.198 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.8 t -95.81 98.68 8.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.4 t -111.16 122.8 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.25 -178.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.3 mt -84.48 88.89 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.898 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.418 ' O ' ' CB ' ' A' ' 74' ' ' LYS . 33.3 mt-10 -66.66 0.44 2.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.309 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.418 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 8.2 mttm 160.44 127.67 0.0 OUTLIER 'General case' 0 C--N 1.34 0.159 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.456 ' O ' ' C ' ' A' ' 76' ' ' GLU . . . 140.35 -8.88 2.93 Favored Glycine 0 CA--C 1.517 0.176 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.456 ' C ' ' O ' ' A' ' 75' ' ' GLY . 6.3 mm-40 -29.95 -47.65 0.08 Allowed 'General case' 0 N--CA 1.466 0.335 0 O-C-N 123.757 0.328 . . . . 0.0 111.054 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.0 tt -126.83 -42.39 1.76 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.187 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -55.52 153.57 13.64 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 116.289 -0.414 . . . . 0.0 112.255 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.625 ' HE ' ' N ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -62.78 -34.06 76.47 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.003 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.453 ' O ' ' HA2' ' A' ' 75' ' ' GLY . 25.3 t60 -68.49 143.99 54.79 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.838 ' CE ' HD12 ' A' ' 83' ' ' ILE . 9.8 tttm -139.59 145.72 38.92 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.211 -178.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.421 ' HG2' ' NE2' ' A' ' 80' ' ' HIS . 2.4 mt-30 -146.94 79.05 1.51 Allowed 'General case' 0 C--O 1.233 0.2 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.838 HD12 ' CE ' ' A' ' 81' ' ' LYS . 40.2 mt -82.38 143.39 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.045 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.576 ' HZ1' ' HA3' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -109.67 121.06 44.37 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.671 -179.569 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.526 HG22 ' O ' ' A' ' 85' ' ' ILE . 1.5 mp -105.33 94.39 3.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.274 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 55.5 mt -82.27 144.38 10.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 55.36 79.25 0.35 Allowed Pre-proline 0 C--N 1.33 -0.248 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.203 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -74.56 128.94 12.27 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.77 2.313 . . . . 0.0 112.36 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -112.32 -29.7 7.44 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.236 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -143.64 114.28 7.6 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.189 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.587 HG23 ' O ' ' A' ' 91' ' ' ILE . 3.5 tt -109.2 110.17 60.48 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.456 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -65.81 174.6 5.41 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 122.353 2.035 . . . . 0.0 112.03 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.666 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 3.2 Cg_exo -71.83 -19.81 26.81 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.661 2.241 . . . . 0.0 112.201 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -49.48 -59.3 3.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.96 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 54.8 t -78.99 -25.54 13.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.288 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.666 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -74.2 -28.81 61.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.138 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 93' ' ' PRO . . . -65.43 -21.34 66.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.185 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.8 pp -116.68 -8.18 11.46 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.13 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.49 HD13 ' HA ' ' A' ' 99' ' ' ILE . 17.4 mm -103.88 -47.97 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -83.82 -11.12 57.48 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.425 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.1 tp 53.66 73.29 0.38 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.826 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -92.67 -8.72 43.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.535 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -76.07 93.7 3.34 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.882 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -167.61 -64.22 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.356 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -80.65 22.85 0.56 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.672 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 31.8 m170 51.51 -143.65 0.64 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.622 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -114.51 165.38 12.81 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.477 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 9.5 p-80 . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.455 179.874 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 mmt . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -157.77 110.65 2.43 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.553 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 155.93 37.72 0.02 OUTLIER Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.6 t 53.17 75.23 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-O 121.034 0.445 . . . . 0.0 110.411 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 3.4 ttt -84.58 66.78 9.7 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.182 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.614 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 5.9 m -113.75 -168.59 1.37 Allowed 'General case' 0 N--CA 1.436 -1.167 0 CA-C-O 121.141 0.496 . . . . 0.0 110.449 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.614 ' HB2' ' O ' ' A' ' 6' ' ' SER . . . 150.89 -18.96 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.109 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 16' ' ' VAL . 1.7 p -155.65 154.69 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.801 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.401 ' N ' ' CG2' ' A' ' 8' ' ' VAL . 0.9 OUTLIER -137.9 143.32 40.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.093 -179.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.2 m -113.6 105.02 17.93 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.48 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.435 HD21 HG23 ' A' ' 16' ' ' VAL . 9.6 m-80 -92.22 -154.94 0.4 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.36 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -107.6 5.4 26.92 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -113.52 -22.05 10.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.614 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.62 -124.05 1.22 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.19 153.86 35.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.983 0.42 . . . . 0.0 111.398 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.435 HG23 HD21 ' A' ' 11' ' ' ASN . 58.1 t -110.84 131.86 60.88 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.962 179.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.502 HD23 HD21 ' A' ' 59' ' ' LEU . 11.2 tp -109.47 102.73 11.58 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.976 0.417 . . . . 0.0 110.44 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.522 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 49.2 mtt180 -104.08 119.33 38.7 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.534 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.767 HD21 ' NZ ' ' A' ' 81' ' ' LYS . 3.5 pp -148.01 179.62 7.61 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.203 0.525 . . . . 0.0 111.553 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.576 ' N ' HD12 ' A' ' 19' ' ' LEU . 33.3 t80 -112.13 106.22 14.78 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.517 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.648 HG12 HD11 ' A' ' 19' ' ' LEU . 2.8 mm -76.58 135.14 27.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.026 -178.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -122.18 91.2 49.09 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.493 -0.776 . . . . 0.0 108.917 178.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -72.2 154.02 56.78 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.685 2.257 . . . . 0.0 112.822 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.2 mtmp? 76.63 42.64 0.15 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.59 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.904 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . . . -100.24 167.85 10.17 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 178.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 98.1 p -62.05 -19.43 62.89 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.199 -0.6 . . . . 0.0 109.962 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -176.29 170.63 2.57 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.53 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.482 ' HA ' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -83.27 90.3 7.11 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.667 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.3 m -131.06 143.63 50.83 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.775 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.561 HG22 HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -93.03 74.33 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.289 179.05 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -103.64 19.05 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.608 -177.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.431 ' HA3' ' HB3' ' A' ' 39' ' ' LYS . . . -144.41 35.87 1.51 Allowed Glycine 0 C--N 1.332 0.35 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.779 ' CD2' HG13 ' A' ' 38' ' ' VAL . 15.2 mt -71.19 122.09 19.54 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.596 -0.802 . . . . 0.0 109.929 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -110.25 162.52 14.53 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.495 -178.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -72.89 -28.21 67.33 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -110.68 -9.74 14.51 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -144.6 -178.82 6.19 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-O 120.861 0.363 . . . . 0.0 110.796 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.779 HG13 ' CD2' ' A' ' 33' ' ' LEU . 55.3 t -143.39 113.74 2.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.431 ' HB3' ' HA3' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -112.35 118.48 35.34 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.876 -179.688 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.699 HG12 HD13 ' A' ' 19' ' ' LEU . 8.8 p -123.02 133.19 69.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.006 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.904 ' HB1' ' HB2' ' A' ' 25' ' ' ALA . . . -98.27 126.6 43.82 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.675 HD11 ' HB3' ' A' ' 54' ' ' HIS . 20.8 tt -116.4 145.75 21.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.8 t -87.21 23.01 1.93 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.835 -178.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.9 143.86 27.41 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.834 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.481 ' HG2' ' CB ' ' A' ' 50' ' ' GLN . 3.4 Cg_exo -55.78 166.34 2.95 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.566 2.177 . . . . 0.0 111.934 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -76.52 11.56 1.85 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.985 2.457 . . . . 0.0 112.255 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.622 HG13 ' H ' ' A' ' 50' ' ' GLN . 9.5 p -94.72 150.16 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.236 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -63.83 -53.35 52.1 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.881 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -39.91 -47.95 3.31 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 121.234 -0.508 . . . . 0.0 111.904 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.622 ' H ' HG13 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -85.02 -50.17 7.68 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -178.894 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.57 -49.92 75.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.983 0.42 . . . . 0.0 110.433 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -57.69 -52.32 65.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.054 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.5 p -52.28 -47.47 65.86 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.88 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.675 ' HB3' HD11 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -61.31 -47.03 87.81 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-O 120.726 0.298 . . . . 0.0 110.281 179.393 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.565 HD21 ' NZ ' ' A' ' 81' ' ' LYS . 0.2 OUTLIER -49.43 -61.41 2.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.545 -179.785 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -55.36 -21.63 9.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.649 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -85.11 -60.66 1.97 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.034 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -53.9 -38.69 65.08 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.151 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.502 HD21 HD23 ' A' ' 17' ' ' LEU . 0.8 OUTLIER -83.69 -39.33 20.31 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.675 -179.79 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.08 -37.42 93.89 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.2 ptmm? -80.74 -31.3 36.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.546 0.213 . . . . 0.0 111.297 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.59 -46.51 21.95 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.007 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.775 ' HB3' HG23 ' A' ' 65' ' ' VAL . 40.6 m-85 -85.88 -18.4 32.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.488 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 32.7 mtp180 59.22 5.03 0.52 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.926 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.775 HG23 ' HB3' ' A' ' 63' ' ' PHE . 21.8 t -65.32 -118.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 121.027 0.441 . . . . 0.0 110.088 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.566 ' N ' HG12 ' A' ' 65' ' ' VAL . . . -148.55 155.62 41.37 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.034 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.06 -29.48 63.0 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -75.77 -13.92 60.31 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.883 179.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -103.18 -15.6 15.97 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.97 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.507 HG13 ' CG2' ' A' ' 83' ' ' ILE . 6.7 t -88.42 99.91 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.2 t -105.49 117.0 50.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.25 -178.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.413 HG12 ' CD1' ' A' ' 83' ' ' ILE . 51.8 mt -87.86 85.48 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.376 178.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -67.54 5.22 0.84 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.708 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.2 mttp 162.43 142.1 0.01 OUTLIER 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 80' ' ' HIS . . . 127.95 -12.79 6.46 Favored Glycine 0 C--N 1.323 -0.186 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 75' ' ' GLY . 5.8 mt-10 -33.83 -47.1 0.24 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.417 -0.392 . . . . 0.0 111.151 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.5 tp -125.45 -43.84 1.88 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.44 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -59.64 151.88 35.94 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.9 mtt85 -63.05 -29.31 70.72 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.465 ' O ' ' HA2' ' A' ' 75' ' ' GLY . 0.5 OUTLIER -68.05 157.82 34.34 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.056 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.767 ' NZ ' HD21 ' A' ' 19' ' ' LEU . 6.4 tttt -156.09 147.27 22.39 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.662 -178.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.21 111.61 5.22 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.507 ' CG2' HG13 ' A' ' 70' ' ' VAL . 6.1 mm -109.68 140.14 29.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.609 -178.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.87 111.59 23.1 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.048 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.573 HG23 HG21 ' A' ' 65' ' ' VAL . 1.8 mp -96.51 99.89 9.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.351 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 36.9 mt -85.23 148.66 4.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.578 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 46.1 58.31 16.08 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.651 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -46.05 129.27 12.41 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.882 2.388 . . . . 0.0 112.06 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.436 ' H ' HG22 ' A' ' 65' ' ' VAL . 41.1 tp60 -109.69 -30.01 8.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.699 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -147.65 121.61 9.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.609 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 tt -112.33 113.37 51.34 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.067 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -68.59 157.77 60.46 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.419 2.079 . . . . 0.0 112.202 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.66 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 2.5 Cg_endo -51.82 -27.73 28.24 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 123.035 2.49 . . . . 0.0 111.893 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -53.82 -59.4 4.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.834 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 16.9 t -76.57 -20.9 14.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.871 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.66 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -75.6 -31.7 60.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.7 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -65.74 -19.71 66.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.249 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 77.0 mt -102.09 -21.07 14.51 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.048 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 66.1 mt -98.73 -31.89 3.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.991 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -72.18 -12.26 61.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.459 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.9 tp 71.9 -61.21 0.5 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.366 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 50.57 -94.97 0.03 OUTLIER 'General case' 0 C--O 1.232 0.165 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 21.5 t60 52.7 17.71 0.88 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.636 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.4 ' CG ' ' N ' ' A' ' 105' ' ' HIS . 8.2 t60 -75.67 167.65 21.49 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.549 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.4 ' N ' ' CG ' ' A' ' 104' ' ' HIS . 59.1 m80 -63.64 178.94 0.53 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.669 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.512 ' CG ' ' H ' ' A' ' 107' ' ' HIS . 26.7 t60 -95.59 -136.33 0.22 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.674 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.512 ' H ' ' CG ' ' A' ' 106' ' ' HIS . 85.6 t60 -156.42 70.83 0.68 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.013 0.435 . . . . 0.0 110.05 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 79.9 t60 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.419 -179.908 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.9 mmt . . . . . 0 N--CA 1.492 1.666 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 61.42 20.96 11.61 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.678 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -67.11 -106.31 0.02 OUTLIER Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.4 t -126.25 -31.86 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.87 0.367 . . . . 0.0 110.349 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.76 99.76 11.12 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.613 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.586 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -126.03 131.48 52.17 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 121.32 0.581 . . . . 0.0 109.76 178.5 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.586 ' HB2' ' O ' ' A' ' 6' ' ' SER . . . 159.68 -17.59 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.584 -1.189 . . . . 0.0 109.206 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.491 HG22 ' N ' ' A' ' 9' ' ' THR . 8.0 p -160.28 160.01 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.575 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.491 ' N ' HG22 ' A' ' 8' ' ' VAL . 1.7 m -150.95 125.6 9.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.427 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.407 HG22 ' H ' ' A' ' 10' ' ' VAL . 2.4 m -91.65 101.28 12.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.062 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -79.58 -158.04 0.15 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.11 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -107.05 11.26 29.86 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -124.07 -18.92 5.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.337 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.504 ' HA3' ' HZ3' ' A' ' 84' ' ' LYS . . . 166.43 -123.71 1.17 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.409 HD11 ' CZ ' ' A' ' 63' ' ' PHE . 0.3 OUTLIER -149.24 138.34 21.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.0 0.429 . . . . 0.0 111.391 -179.747 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 48.6 t -99.39 106.35 18.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.198 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.0 tp -87.39 114.0 23.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.024 0.44 . . . . 0.0 111.142 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.561 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 14.8 mtt-85 -111.17 126.29 54.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.658 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.463 ' HB2' HG12 ' A' ' 38' ' ' VAL . 0.8 OUTLIER -149.45 175.16 11.72 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 121.956 0.884 . . . . 0.0 112.86 -179.038 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -106.23 91.81 3.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 113.867 -1.515 . . . . 0.0 108.565 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.418 HG13 ' NZ ' ' A' ' 81' ' ' LYS . 1.0 OUTLIER -73.53 131.14 35.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.222 -178.104 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.14 88.8 53.62 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.903 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.14 161.0 39.05 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.767 2.311 . . . . 0.0 112.793 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 20.3 mtmt 73.59 48.61 0.15 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.207 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.933 ' CB ' ' HB1' ' A' ' 41' ' ' ALA . . . -99.55 -62.88 1.18 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 25' ' ' ALA . 4.3 t 153.08 -28.52 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.991 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.443 ' CG ' ' O ' ' A' ' 26' ' ' SER . 79.1 mtt180 -163.4 142.1 8.11 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.81 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.47 94.22 0.08 Allowed 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.448 0.642 . . . . 0.0 109.973 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.4 p -123.02 126.88 47.95 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.874 -179.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.673 HG22 HD21 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -92.07 63.01 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.454 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.607 HG13 ' O ' ' A' ' 31' ' ' VAL . 0.3 OUTLIER -96.56 17.89 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 114.583 -1.19 . . . . 0.0 112.338 -177.821 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . -141.59 22.6 2.52 Favored Glycine 0 C--N 1.32 -0.351 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -178.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.673 HD21 HG22 ' A' ' 30' ' ' ILE . 19.3 mt -59.45 120.66 9.78 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.07 -0.565 . . . . 0.0 109.824 178.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.405 ' O ' ' O ' ' A' ' 37' ' ' GLU . 2.3 t60 -111.6 155.06 23.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.492 -178.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -66.93 -19.7 69.97 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.649 -0.981 . . . . 0.0 110.649 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -121.15 -5.07 9.48 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.555 0.217 . . . . 0.0 110.614 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.405 ' O ' ' O ' ' A' ' 34' ' ' HIS . 57.2 mt-10 -148.54 -178.46 6.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.991 0.424 . . . . 0.0 110.651 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.463 HG12 ' HB2' ' A' ' 19' ' ' LEU . 6.8 t -141.72 110.96 2.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 13.0 mtpt -110.36 103.15 11.76 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.146 -0.621 . . . . 0.0 110.785 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.7 p -114.27 136.43 50.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.701 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.933 ' HB1' ' CB ' ' A' ' 25' ' ' ALA . . . -99.98 93.95 6.03 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.979 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.758 HD11 ' HB3' ' A' ' 54' ' ' HIS . 19.7 tt -80.04 148.59 5.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.3 t -93.81 29.41 2.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.001 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.37 161.09 26.46 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.855 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -77.21 177.61 8.65 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 123.478 2.785 . . . . 0.0 112.093 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -77.31 5.5 5.05 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 123.168 2.578 . . . . 0.0 112.644 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.437 HG13 ' H ' ' A' ' 50' ' ' GLN . 11.7 p -98.96 155.86 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 120.791 0.329 . . . . 0.0 110.738 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.42 ' N ' HG22 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -69.41 -61.37 1.82 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.055 -179.709 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . -34.87 -51.93 0.83 Allowed Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.884 -0.486 . . . . 0.0 111.884 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.437 ' H ' HG13 ' A' ' 47' ' ' VAL . 2.4 mm100 -76.39 -50.56 13.87 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.74 -61.72 2.22 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.766 0.317 . . . . 0.0 110.915 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -47.07 -39.85 13.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.731 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.5 m -61.25 -51.39 69.14 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.586 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.758 ' HB3' HD11 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -55.85 -57.98 9.79 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.572 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -44.16 -57.93 3.15 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.044 0.45 . . . . 0.0 110.262 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.3 t -54.36 -26.07 15.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.127 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.421 ' N ' ' O ' ' A' ' 54' ' ' HIS . 8.4 ttpt -85.17 -63.46 1.32 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.918 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -50.74 -41.8 56.78 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.203 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.1 tp -84.67 -40.43 17.41 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.504 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -58.99 -33.64 75.08 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.0 ptmt -80.59 -37.27 31.57 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 120.59 0.233 . . . . 0.0 111.035 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -74.94 -42.39 57.79 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.431 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.549 ' HB3' HG13 ' A' ' 65' ' ' VAL . 0.7 OUTLIER -86.09 -18.83 31.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.535 179.767 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.4 mtp180 60.47 8.1 1.55 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.777 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.894 HG11 HG23 ' A' ' 85' ' ' ILE . 35.8 m -67.53 177.03 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -89.63 164.81 14.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.948 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -21.2 62.6 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -86.55 -12.65 48.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.464 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -101.62 -1.17 33.4 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.492 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.557 ' O ' HG13 ' A' ' 70' ' ' VAL . 7.7 p -110.94 100.69 11.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.014 0.435 . . . . 0.0 110.014 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 79.7 t -114.22 116.92 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.756 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.426 ' C ' ' H ' ' A' ' 74' ' ' LYS . 76.3 mt -89.94 88.48 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.23 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -72.81 10.3 0.91 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.671 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.426 ' H ' ' C ' ' A' ' 72' ' ' ILE . 7.6 mttp 167.93 145.59 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.408 ' HA2' ' O ' ' A' ' 80' ' ' HIS . . . 123.59 -17.01 7.87 Favored Glycine 0 CA--C 1.518 0.269 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -39.18 -44.33 1.19 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.655 -0.273 . . . . 0.0 111.066 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.411 ' O ' HD13 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -134.18 -43.43 0.79 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.192 -179.71 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.96 151.47 52.47 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -60.82 -32.67 72.03 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.408 ' O ' ' HA2' ' A' ' 75' ' ' GLY . 3.9 p-80 -68.89 129.97 41.45 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 177.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.561 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 0.6 OUTLIER -137.86 141.5 40.72 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 120.196 -0.601 . . . . 0.0 110.49 -177.312 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -139.48 114.62 9.63 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.557 HD11 ' HD3' ' A' ' 81' ' ' LYS . 4.7 mt -117.01 135.87 55.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.396 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.504 ' HZ3' ' HA3' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -104.67 106.67 17.26 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.876 -179.819 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.894 HG23 HG11 ' A' ' 65' ' ' VAL . 1.5 mp -94.68 92.06 3.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.067 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.401 HG22 ' N ' ' A' ' 87' ' ' ASN . 55.5 mt -77.47 155.39 5.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.733 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.401 ' N ' HG22 ' A' ' 86' ' ' ILE . 1.2 m-80 38.39 73.32 0.78 Allowed Pre-proline 0 N--CA 1.464 0.243 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.005 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -74.32 132.92 16.98 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.673 2.249 . . . . 0.0 111.847 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -110.63 -24.16 10.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.089 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -147.52 120.19 8.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.255 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.493 HG23 ' O ' ' A' ' 91' ' ' ILE . 3.9 tt -113.96 119.55 40.66 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.951 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -66.26 147.72 83.75 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 122.224 1.949 . . . . 0.0 112.522 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.679 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 2.5 Cg_endo -51.03 -30.22 30.43 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 123.048 2.498 . . . . 0.0 112.24 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -54.23 -57.77 9.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.699 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.436 ' H ' HG23 ' A' ' 95' ' ' VAL . 1.5 t -75.11 -21.66 16.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.732 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.679 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -75.59 -34.53 60.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.024 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.71 -20.1 32.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.738 0.304 . . . . 0.0 111.075 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 27.2 mt -103.04 -25.1 13.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.077 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 86.1 mt -96.65 -27.69 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.872 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -84.9 -11.04 56.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.679 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.7 tp -68.11 -80.77 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.031 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 48.97 23.36 0.7 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.017 0.437 . . . . 0.0 110.47 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -143.01 117.4 9.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.795 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -50.7 147.48 4.73 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.11 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -157.48 -159.18 0.81 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.275 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 5.0 m80 -143.61 129.04 19.0 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.408 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.43 ' CG ' ' N ' ' A' ' 108' ' ' HIS . 49.9 p-80 -139.31 -41.86 0.46 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.574 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.43 ' N ' ' CG ' ' A' ' 107' ' ' HIS . 3.4 t60 . . . . . 0 C--N 1.331 -0.197 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.426 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.5 mtm . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -163.41 -60.51 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.573 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 177.93 73.52 0.06 OUTLIER Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.7 p -97.24 7.09 8.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-O 120.826 0.346 . . . . 0.0 110.703 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 13.1 ttm -157.03 51.6 0.48 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.65 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.619 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 22.7 t -99.89 -168.77 1.64 Allowed 'General case' 0 N--CA 1.435 -1.184 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.195 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.619 ' HB2' ' O ' ' A' ' 6' ' ' SER . . . 152.63 -17.48 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.563 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.448 ' CG2' ' N ' ' A' ' 9' ' ' THR . 0.7 OUTLIER -160.27 157.73 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.6 -179.809 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.448 ' N ' ' CG2' ' A' ' 8' ' ' VAL . 1.1 m -147.66 134.46 20.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.136 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 10' ' ' VAL . 33.2 m -102.65 104.0 15.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.224 0.535 . . . . 0.0 110.492 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 35.9 m-20 -87.2 -149.98 0.16 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.166 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -107.18 2.68 24.95 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -109.17 -22.23 12.2 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.441 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.49 ' HA3' ' HZ1' ' A' ' 84' ' ' LYS . . . 160.47 -122.14 1.1 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.508 HD11 ' CE2' ' A' ' 63' ' ' PHE . 0.3 OUTLIER -147.36 147.31 30.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.946 0.403 . . . . 0.0 111.244 -179.722 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.1 t -103.85 137.23 33.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.488 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.03 99.17 7.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.935 0.398 . . . . 0.0 110.521 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.526 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 38.7 mtt180 -97.3 114.76 26.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.836 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.596 ' C ' HD12 ' A' ' 19' ' ' LEU . 4.3 pp -147.05 179.75 7.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.284 0.564 . . . . 0.0 111.664 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.565 ' N ' HD12 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -113.81 95.78 5.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.949 179.522 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.1 tp -75.35 130.78 35.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.273 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.405 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 1.3 tp60 -120.51 91.83 47.13 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.638 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.454 ' O ' ' HB2' ' A' ' 24' ' ' LYS . 3.1 Cg_exo -71.66 165.29 32.99 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.454 2.103 . . . . 0.0 112.29 -178.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 23' ' ' PRO . 16.5 mtmm 77.37 37.25 0.26 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.511 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.921 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . . . -102.41 167.41 9.97 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 17.0 t -75.41 -10.32 59.34 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 119.996 -0.682 . . . . 0.0 109.666 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.7 ttp180 -176.6 163.8 2.42 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.666 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.503 ' HA ' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -84.82 95.22 8.92 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.613 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.1 m -126.42 135.66 51.68 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.722 -178.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.469 HG22 HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -91.01 76.1 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.689 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.3 17.55 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.053 -178.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . -142.4 21.75 2.4 Favored Glycine 0 C--N 1.32 -0.322 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.753 ' CD2' HG13 ' A' ' 38' ' ' VAL . 19.4 mt -57.75 107.01 0.41 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.434 ' O ' ' O ' ' A' ' 37' ' ' GLU . 44.7 t-80 -94.46 157.4 16.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.559 -178.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -66.6 -29.26 74.47 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -112.41 -10.08 13.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.737 -0.231 . . . . 0.0 110.472 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.434 ' O ' ' O ' ' A' ' 34' ' ' HIS . 8.4 mt-10 -140.68 -176.81 4.79 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.975 0.417 . . . . 0.0 110.734 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.753 HG13 ' CD2' ' A' ' 33' ' ' LEU . 45.9 t -142.78 112.79 2.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -111.13 132.69 54.08 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.262 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.526 HG13 ' O ' ' A' ' 40' ' ' VAL . 8.5 p -147.59 124.18 2.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.651 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.921 ' HB1' ' HB2' ' A' ' 25' ' ' ALA . . . -86.94 122.4 30.75 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.828 HD11 ' HB3' ' A' ' 54' ' ' HIS . 21.2 tt -109.33 147.95 13.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.1 t -90.66 38.42 0.95 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.937 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -105.24 139.14 19.85 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.449 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.548 ' HG2' ' CB ' ' A' ' 50' ' ' GLN . 3.2 Cg_exo -56.25 170.47 1.16 Allowed 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 122.689 2.259 . . . . 0.0 112.572 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.61 24.74 0.45 Allowed 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 123.36 2.707 . . . . 0.0 113.391 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.461 HG13 ' H ' ' A' ' 50' ' ' GLN . 13.9 p -120.28 138.2 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.446 ' O ' ' C ' ' A' ' 49' ' ' GLY . 0.7 OUTLIER -53.75 -58.87 5.66 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.104 -179.427 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . -34.65 -52.9 0.81 Allowed Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.548 ' CB ' ' HG2' ' A' ' 45' ' ' PRO . 43.1 mm-40 -78.12 -39.37 41.47 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.07 -62.87 1.2 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.834 0.35 . . . . 0.0 110.511 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.439 ' N ' ' O ' ' A' ' 48' ' ' ASP . 46.2 t-20 -43.58 -47.24 7.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.876 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 18.4 m -52.99 -57.55 9.99 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.305 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.828 ' HB3' HD11 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -51.5 -50.75 59.29 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.787 0.327 . . . . 0.0 110.679 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.651 HD12 HD11 ' A' ' 83' ' ' ILE . 3.1 mm? -50.91 -43.77 59.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.198 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -69.37 -27.12 33.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.99 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -79.32 -60.5 2.34 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.842 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -46.9 -58.39 3.98 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.249 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.413 ' O ' ' HB2' ' A' ' 63' ' ' PHE . 4.6 mp -71.17 -41.47 70.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.103 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -51.17 -35.42 34.03 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.3 mttp -80.92 -58.26 3.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.662 0.268 . . . . 0.0 111.02 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -56.03 -43.87 78.21 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.102 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.508 ' CE2' HD11 ' A' ' 15' ' ' LEU . 1.6 m-85 -82.72 -18.54 40.47 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.111 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.2 mtt-85 61.59 8.48 2.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.533 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.2 m -82.9 163.14 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.443 ' O ' HG23 ' A' ' 70' ' ' VAL . . . -65.3 156.63 31.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.806 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 28.2 pttt -70.96 -28.58 64.58 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -71.42 -11.94 61.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.927 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.428 ' O ' ' O ' ' A' ' 84' ' ' LYS . 80.8 mt-30 -100.14 -7.94 24.25 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.335 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 66' ' ' ALA . 31.0 t -104.06 97.76 5.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.4 t -116.78 123.18 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -178.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.424 ' C ' ' H ' ' A' ' 74' ' ' LYS . 54.3 mt -82.33 84.55 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.166 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -60.25 -3.68 0.67 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.035 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.424 ' H ' ' C ' ' A' ' 72' ' ' ILE . 5.3 mttp 168.15 116.55 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.081 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.567 ' HA3' ' HZ2' ' A' ' 81' ' ' LYS . . . 148.62 -10.43 1.08 Allowed Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -34.14 -41.03 0.1 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.3 tp -131.47 -42.96 1.04 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.701 0.286 . . . . 0.0 111.355 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.5 149.2 48.67 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.785 -0.526 . . . . 0.0 111.785 -178.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.462 ' HD3' ' H ' ' A' ' 79' ' ' ARG . 0.1 OUTLIER -60.99 -29.43 69.68 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.387 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.429 ' O ' ' HA2' ' A' ' 75' ' ' GLY . 76.5 t60 -67.27 145.85 54.75 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 177.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.567 ' HZ2' ' HA3' ' A' ' 75' ' ' GLY . 0.0 OUTLIER -144.73 154.02 42.3 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 119.706 -0.798 . . . . 0.0 111.537 -177.195 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -162.87 78.71 0.47 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.651 HD11 HD12 ' A' ' 55' ' ' LEU . 46.8 mt -80.46 153.61 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.398 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.49 ' HZ1' ' HA3' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -120.47 111.86 18.24 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.969 -178.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.474 ' N ' ' HE3' ' A' ' 84' ' ' LYS . 1.4 mp -100.54 102.85 14.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.182 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 55.3 mt -85.99 153.55 3.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.551 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 18.4 m-20 40.05 79.77 0.31 Allowed Pre-proline 0 N--CA 1.467 0.41 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.692 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.51 146.1 30.51 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 123.014 2.476 . . . . 0.0 112.65 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 60.6 mm-40 -124.12 -28.91 3.66 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.043 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -146.8 117.48 7.57 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.138 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.9 tt -114.36 120.49 38.07 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.599 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.2 141.22 92.68 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.479 2.119 . . . . 0.0 112.342 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.462 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 2.5 Cg_endo -50.49 -33.94 40.18 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 123.266 2.644 . . . . 0.0 112.632 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -53.04 -54.43 35.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.13 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 16.3 t -72.22 -19.45 19.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.462 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -75.0 -25.44 58.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.809 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -62.53 -26.34 68.51 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.888 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 20.1 mt -94.99 -10.94 29.42 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.5 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 97.6 mt -102.36 -30.98 2.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.943 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -78.05 -42.42 32.38 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.821 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.559 HD23 ' O ' ' A' ' 101' ' ' LEU . 2.0 tt 74.9 -45.65 0.58 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.698 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 101' ' ' LEU . 51.5 mt-10 -37.55 97.78 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 O-C-N 123.355 0.409 . . . . 0.0 110.427 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.52 ' O ' ' CG ' ' A' ' 103' ' ' HIS . 11.5 p-80 -137.27 66.78 1.45 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.444 -178.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -45.71 -78.72 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.978 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -147.24 108.58 4.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.92 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.437 ' O ' ' CG ' ' A' ' 106' ' ' HIS . 49.1 t-80 48.61 57.77 5.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.119 0.485 . . . . 0.0 109.965 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -79.62 104.91 10.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.242 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.73 179.861 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.4 mmt . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -169.42 -51.56 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.788 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 89.85 -10.14 74.82 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.3 t 50.09 64.81 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 110.439 -0.208 . . . . 0.0 110.439 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 32.83 95.75 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 O-C-N 123.659 0.599 . . . . 0.0 112.024 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.639 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 9.6 p -124.36 -168.33 1.79 Allowed 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.639 ' HB2' ' O ' ' A' ' 6' ' ' SER . . . 157.87 -17.46 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.985 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.454 ' CG2' ' N ' ' A' ' 9' ' ' THR . 0.2 OUTLIER -159.38 157.76 2.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.843 -179.607 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.454 ' N ' ' CG2' ' A' ' 8' ' ' VAL . 1.3 m -144.62 141.78 29.66 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.349 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 m -107.19 101.36 12.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.298 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.452 HD21 ' CG2' ' A' ' 16' ' ' VAL . 14.8 m-80 -81.24 -155.4 0.12 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.311 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -107.65 10.52 29.02 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -122.83 -25.26 4.66 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.241 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.62 -129.11 1.54 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.425 HD11 ' CE2' ' A' ' 63' ' ' PHE . 0.2 OUTLIER -145.46 158.74 43.79 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.171 0.51 . . . . 0.0 111.31 -179.757 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.452 ' CG2' HD21 ' A' ' 11' ' ' ASN . 3.8 t -110.03 138.47 37.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.329 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.646 HD12 HD23 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -115.61 91.16 3.52 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.689 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 4.6 mtm180 -97.06 109.26 22.05 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.4 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.731 HD12 ' N ' ' A' ' 20' ' ' TYR . 3.4 pp -145.42 178.89 7.77 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.878 0.371 . . . . 0.0 110.998 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.731 ' N ' HD12 ' A' ' 19' ' ' LEU . 31.8 t80 -110.93 104.62 13.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.3 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.465 HG22 ' HD3' ' A' ' 23' ' ' PRO . 1.7 mm -70.68 126.72 31.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.38 86.24 55.04 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.129 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.465 ' HD3' HG22 ' A' ' 21' ' ' ILE . 3.3 Cg_exo -74.77 161.18 39.76 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.634 2.223 . . . . 0.0 111.84 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.6 mtmt 73.87 43.48 0.32 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.007 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.907 ' CB ' ' HB1' ' A' ' 41' ' ' ALA . . . -91.66 -71.12 0.65 Allowed 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.2 p 162.51 -23.12 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.016 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -171.75 143.16 1.64 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.041 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.403 ' HA ' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -63.05 89.66 0.04 OUTLIER 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.673 0.749 . . . . 0.0 110.055 179.493 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.3 m -130.77 127.28 38.4 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.192 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.538 HG22 HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -83.29 65.62 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.78 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -94.03 18.28 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 114.669 -1.151 . . . . 0.0 113.016 -177.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -143.05 39.14 1.35 Allowed Glycine 0 N--CA 1.46 0.289 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.851 ' CD2' HG13 ' A' ' 38' ' ' VAL . 22.9 mt -77.78 117.69 19.4 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.557 -0.822 . . . . 0.0 109.799 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.585 ' CD2' ' H ' ' A' ' 35' ' ' GLY . 11.0 t-160 -102.25 159.46 15.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.416 -178.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.585 ' H ' ' CD2' ' A' ' 34' ' ' HIS . . . -73.47 -19.66 79.72 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -115.96 -14.05 11.26 Favored 'General case' 0 N--CA 1.461 0.11 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.413 ' H ' ' HB3' ' A' ' 34' ' ' HIS . 19.2 mt-10 -143.39 -176.23 4.86 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.322 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.851 HG13 ' CD2' ' A' ' 33' ' ' LEU . 73.2 t -144.15 121.12 5.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.37 118.48 29.56 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.646 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.496 HG23 HG23 ' A' ' 30' ' ' ILE . 8.5 p -113.42 135.01 54.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.064 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.907 ' HB1' ' CB ' ' A' ' 25' ' ' ALA . . . -100.0 104.8 16.42 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.729 HD13 ' CE1' ' A' ' 54' ' ' HIS . 0.6 OUTLIER -99.39 156.19 3.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 -179.147 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.421 ' H ' HG13 ' A' ' 42' ' ' ILE . 8.4 t -93.22 26.75 2.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.744 -178.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.462 ' H ' HG23 ' A' ' 42' ' ' ILE . . . -97.0 167.44 12.01 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.866 0.365 . . . . 0.0 110.913 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.691 ' HB2' HG22 ' A' ' 47' ' ' VAL . 3.6 Cg_exo -77.98 177.63 8.56 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 123.56 2.84 . . . . 0.0 112.165 179.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -77.5 0.75 9.47 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 123.009 2.473 . . . . 0.0 111.435 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.691 HG22 ' HB2' ' A' ' 45' ' ' PRO . 35.2 m -93.19 160.16 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.666 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 52' ' ' ASN . 2.3 m-20 -82.21 -47.34 12.59 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.905 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -43.07 -46.8 6.39 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.501 ' NE2' HG21 ' A' ' 47' ' ' VAL . 0.9 OUTLIER -81.49 -49.81 10.15 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 121.219 -0.192 . . . . 0.0 111.511 -179.453 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.53 -56.53 20.25 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.837 0.351 . . . . 0.0 110.06 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.452 ' N ' ' O ' ' A' ' 48' ' ' ASP . 30.8 t-20 -46.12 -46.38 17.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.086 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.5 p -50.18 -48.14 54.24 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.729 ' CE1' HD13 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -63.05 -45.58 91.56 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.11 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.599 HD22 ' CE1' ' A' ' 54' ' ' HIS . 0.1 OUTLIER -49.24 -60.92 2.39 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.308 -178.537 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -53.7 -26.53 13.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.795 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.413 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 19.1 tttt -82.16 -72.64 0.43 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.058 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.406 ' C ' ' O ' ' A' ' 57' ' ' LYS . 0.8 OUTLIER -33.85 -64.09 0.24 Allowed 'General case' 0 N--CA 1.467 0.377 0 O-C-N 123.167 0.292 . . . . 0.0 111.292 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.429 ' CD2' ' N ' ' A' ' 59' ' ' LEU . 3.6 mm? -64.99 -37.96 89.39 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 64' ' ' ARG . . . -55.17 -41.53 78.94 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.413 ' HG3' ' O ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -81.1 -52.54 7.27 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.066 0.46 . . . . 0.0 110.229 179.531 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.1 mm100 -56.11 -49.72 73.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.711 -178.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.496 ' CD2' HG21 ' A' ' 85' ' ' ILE . 2.3 m-85 -87.14 -18.99 29.14 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.627 -0.261 . . . . 0.0 111.393 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.408 ' HA ' ' O ' ' A' ' 60' ' ' GLY . 18.6 mtt180 59.98 4.1 0.57 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.582 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.441 HG21 HG23 ' A' ' 85' ' ' ILE . 33.6 m -76.35 152.3 5.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.511 ' HB3' ' NE2' ' A' ' 69' ' ' GLN . . . -48.77 158.74 0.29 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.542 -179.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.68 -29.56 65.91 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.308 0.575 . . . . 0.0 109.66 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.32 -13.88 59.84 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.59 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.511 ' NE2' ' HB3' ' A' ' 66' ' ' ALA . 1.2 mp0 -89.93 -6.26 55.9 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.259 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.4 t -106.0 97.23 5.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.6 t -114.42 124.53 71.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.206 0.527 . . . . 0.0 111.814 -178.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 64.2 mt -86.95 93.22 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.435 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -77.35 -1.66 31.12 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.938 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 38.8 tttt 179.6 118.95 0.05 Allowed 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.543 ' O ' ' C ' ' A' ' 76' ' ' GLU . . . 146.66 -20.27 1.65 Allowed Glycine 0 CA--C 1.516 0.122 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.543 ' C ' ' O ' ' A' ' 75' ' ' GLY . 11.1 mp0 -10.6 -66.59 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 O-C-N 124.291 0.642 . . . . 0.0 112.037 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.7 tt -118.65 -42.87 2.71 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.369 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -51.11 157.68 2.49 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 44.4 mtt-85 -68.14 -16.44 64.0 Favored 'General case' 0 CA--C 1.519 -0.231 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.516 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.507 ' CD2' ' N ' ' A' ' 81' ' ' LYS . 16.1 t60 -69.17 155.95 39.52 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.507 ' N ' ' CD2' ' A' ' 80' ' ' HIS . 36.1 tttt -148.68 125.37 11.12 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.139 -0.625 . . . . 0.0 109.997 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.442 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 8.3 tt0 -131.55 104.74 7.13 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 15.9 mm -102.09 129.69 53.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.767 -178.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.99 99.33 9.08 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.496 HG21 ' CD2' ' A' ' 63' ' ' PHE . 2.2 mp -89.53 96.62 6.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.139 -178.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 33.4 mt -82.2 146.09 7.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.717 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 51.89 75.04 0.69 Allowed Pre-proline 0 N--CA 1.463 0.215 0 CA-C-O 120.759 0.314 . . . . 0.0 110.529 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -74.27 130.48 14.13 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 122.594 2.196 . . . . 0.0 112.096 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 21.4 mm100 -114.55 -26.08 8.06 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.948 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -145.39 116.18 7.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.399 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.558 HG23 ' O ' ' A' ' 91' ' ' ILE . 4.1 tt -112.56 114.45 50.02 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.064 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -67.13 145.62 73.67 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.29 1.993 . . . . 0.0 111.504 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.603 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 2.7 Cg_endo -51.61 -19.69 7.87 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 122.62 2.214 . . . . 0.0 111.873 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -61.14 -56.31 22.31 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.97 0.414 . . . . 0.0 110.331 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.25 -25.39 12.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.745 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.603 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -75.41 -44.61 43.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.975 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.499 ' HA ' HD21 ' A' ' 100' ' ' ASN . . . -50.33 -19.78 0.91 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.57 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 80.5 mt -102.42 -25.44 13.63 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.944 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 95.8 mt -92.14 -21.18 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.997 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.597 HD22 ' H ' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -94.68 -23.59 17.52 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.658 0.266 . . . . 0.0 111.096 -179.883 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.597 ' H ' HD22 ' A' ' 100' ' ' ASN . 2.0 tp 55.47 68.43 0.86 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.604 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.489 ' HG3' HD21 ' A' ' 100' ' ' ASN . 0.0 OUTLIER -86.71 -14.56 42.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.542 179.675 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 27.6 m80 -67.74 109.77 3.49 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.257 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.419 ' O ' ' ND1' ' A' ' 106' ' ' HIS . 0.0 OUTLIER -124.94 39.79 3.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.576 -179.873 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -61.0 96.78 0.05 Allowed 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.422 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.419 ' ND1' ' O ' ' A' ' 104' ' ' HIS . 16.7 p-80 -124.51 173.98 8.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.271 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 3.6 p80 -148.76 145.76 27.75 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.643 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 13.0 m80 . . . . . 0 CA--C 1.529 0.145 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.809 -179.833 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 tpt . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -54.1 126.52 23.05 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.74 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 5' ' ' MET . . . -86.2 -31.71 19.07 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.0 t 64.31 -71.72 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 120.725 0.297 . . . . 0.0 110.481 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.433 ' N ' ' O ' ' A' ' 3' ' ' GLY . 0.0 OUTLIER -94.1 98.29 10.88 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.063 179.404 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.604 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 6.7 t -125.03 -167.75 1.72 Allowed 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.304 0.573 . . . . 0.0 110.349 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.604 ' HB2' ' O ' ' A' ' 6' ' ' SER . . . 156.36 -20.65 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.735 -1.12 . . . . 0.0 108.956 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.4 m -149.02 168.2 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.115 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 m -150.73 120.77 7.17 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.431 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.2 m -92.34 97.09 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.194 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -82.68 -163.27 0.68 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.189 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -101.39 11.71 38.7 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -119.16 -24.11 6.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.11 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.521 ' HA3' ' HZ1' ' A' ' 84' ' ' LYS . . . 165.87 -124.35 1.23 Allowed Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.414 HD11 ' CE2' ' A' ' 63' ' ' PHE . 0.3 OUTLIER -150.87 150.77 31.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.976 0.417 . . . . 0.0 111.134 -179.582 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.1 t -107.74 142.8 19.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.928 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -113.49 96.28 5.8 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 22.9 mtp85 -104.47 110.86 23.29 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.789 -179.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.458 HD12 ' N ' ' A' ' 20' ' ' TYR . 3.0 pp -147.52 179.66 7.51 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.051 0.453 . . . . 0.0 111.427 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.458 ' N ' HD12 ' A' ' 19' ' ' LEU . 16.0 t80 -108.36 114.64 28.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.086 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.9 mm -84.26 133.78 28.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.928 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -120.87 87.48 42.95 Favored Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -70.09 156.82 61.6 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.62 2.213 . . . . 0.0 113.413 -178.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? 69.83 49.79 0.5 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.239 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.906 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . . . -96.68 -66.92 0.87 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' A' ' 25' ' ' ALA . 1.1 m 158.56 -24.41 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.293 -0.867 . . . . 0.0 108.724 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -171.1 144.24 2.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.87 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.47 92.8 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 59.8 p -124.29 130.19 52.08 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.52 -178.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.611 HG22 HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -94.78 63.55 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.111 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.734 ' O ' HG12 ' A' ' 31' ' ' VAL . 92.7 t -96.03 19.51 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.944 -178.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -144.04 32.08 1.81 Allowed Glycine 0 C--N 1.334 0.457 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.83 ' CD2' HG13 ' A' ' 38' ' ' VAL . 31.8 mt -66.61 126.24 28.29 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.63 -0.785 . . . . 0.0 109.926 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.428 ' O ' ' O ' ' A' ' 37' ' ' GLU . 23.2 t-80 -112.67 157.41 21.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.042 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.06 -27.54 73.66 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -109.26 -14.49 14.46 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 115.569 -0.315 . . . . 0.0 110.81 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.428 ' O ' ' O ' ' A' ' 34' ' ' HIS . 9.0 mt-10 -141.94 -177.67 5.32 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.001 0.429 . . . . 0.0 111.081 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.83 HG13 ' CD2' ' A' ' 33' ' ' LEU . 70.7 t -143.97 115.98 2.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.707 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.4 ttpt -116.13 117.57 30.43 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.642 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.4 p -120.12 149.83 22.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.156 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.906 ' HB1' ' HB2' ' A' ' 25' ' ' ALA . . . -112.53 103.54 11.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.308 -0.406 . . . . 0.0 109.915 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.402 HG13 ' N ' ' A' ' 43' ' ' THR . 2.4 tp -86.11 146.36 6.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.44 HG22 ' H ' ' A' ' 43' ' ' THR . 0.7 OUTLIER -87.31 17.15 4.58 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.755 -178.28 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.501 ' HB2' ' CD2' ' A' ' 54' ' ' HIS . . . -99.12 149.77 36.08 Favored Pre-proline 0 C--O 1.234 0.276 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.55 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.532 ' HB2' HG22 ' A' ' 47' ' ' VAL . 3.9 Cg_exo -51.54 175.9 0.06 OUTLIER 'Trans proline' 0 N--CA 1.491 1.371 0 C-N-CA 123.241 2.627 . . . . 0.0 112.212 178.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -80.21 0.36 10.08 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 123.23 2.62 . . . . 0.0 112.982 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.532 HG22 ' HB2' ' A' ' 45' ' ' PRO . 0.2 OUTLIER -87.79 158.61 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.988 -179.616 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.445 ' O ' ' N ' ' A' ' 52' ' ' ASN . 17.5 m-20 -73.55 -57.57 3.9 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.001 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . -36.65 -46.4 1.11 Allowed Glycine 0 CA--C 1.529 0.969 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.507 ' HB2' HG23 ' A' ' 47' ' ' VAL . 2.1 mp0 -82.73 -52.16 7.03 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.25 -56.05 26.26 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.937 0.399 . . . . 0.0 110.403 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' A' ' 48' ' ' ASP . 40.1 t-20 -46.34 -54.65 8.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.47 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.7 m -48.81 -52.54 23.49 Favored 'General case' 0 C--O 1.23 0.066 0 C-N-CA 120.624 -0.431 . . . . 0.0 110.107 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.501 ' CD2' ' HB2' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -56.33 -56.12 25.01 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.539 179.65 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.3 mp -43.3 -60.45 1.69 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.273 0.558 . . . . 0.0 110.134 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.7 t -57.85 -29.33 35.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.312 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -76.3 -68.31 0.6 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.262 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -39.09 -48.28 1.65 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.503 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.4 HD13 ' HZ1' ' A' ' 81' ' ' LYS . 7.4 mp -76.93 -34.79 57.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.84 0.353 . . . . 0.0 110.072 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.36 -35.65 61.36 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.01 -52.16 7.73 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.919 0.39 . . . . 0.0 110.428 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -59.25 -46.93 87.19 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.848 -178.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.497 ' HB3' HG13 ' A' ' 65' ' ' VAL . 2.4 m-85 -86.13 -19.11 30.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.076 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.2 mtt85 59.24 5.27 0.55 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.352 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.529 HG11 HG23 ' A' ' 85' ' ' ILE . 27.0 m -67.35 175.33 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.199 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -86.67 163.44 17.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.263 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 29.1 pttt -70.91 -21.29 62.39 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.658 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.77 -8.76 59.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.296 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -108.43 -5.15 16.78 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.463 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.696 ' O ' HG13 ' A' ' 70' ' ' VAL . 9.8 p -101.21 101.1 11.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 121.286 0.565 . . . . 0.0 110.373 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 59.7 t -115.94 124.9 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 52.6 mt -84.85 93.67 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.905 178.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -70.01 -16.05 63.11 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.159 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt 174.81 163.9 0.24 Allowed 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.57 -2.05 73.06 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -37.94 -31.94 0.05 Allowed 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.554 HD23 ' O ' ' A' ' 77' ' ' LEU . 1.0 OUTLIER -127.04 -45.04 1.58 Allowed 'General case' 0 C--O 1.233 0.187 0 C-N-CA 121.061 -0.255 . . . . 0.0 111.0 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.404 ' C ' ' N ' ' A' ' 80' ' ' HIS . . . -58.84 148.22 39.55 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.435 ' HB3' ' CE1' ' A' ' 20' ' ' TYR . 10.4 mtt180 -50.19 -18.55 0.6 Allowed 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.404 ' N ' ' C ' ' A' ' 78' ' ' GLY . 1.7 m80 -69.87 165.35 21.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.493 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.596 ' HE3' HD12 ' A' ' 83' ' ' ILE . 2.0 tttt -151.97 132.87 14.18 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -139.77 82.06 1.86 Allowed 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.596 HD12 ' HE3' ' A' ' 81' ' ' LYS . 92.2 mt -95.11 139.61 18.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.839 -179.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.521 ' HZ1' ' HA3' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -108.49 126.44 52.91 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.211 -179.129 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.589 HG22 ' O ' ' A' ' 85' ' ' ILE . 1.4 mp -106.1 98.75 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.967 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.401 ' O ' ' C ' ' A' ' 87' ' ' ASN . 95.5 mt -80.59 151.8 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 86' ' ' ILE . 1.5 m-80 38.09 85.41 0.16 Allowed Pre-proline 0 N--CA 1.464 0.226 0 O-C-N 123.235 0.334 . . . . 0.0 110.804 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -72.32 133.09 20.36 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.403 2.068 . . . . 0.0 112.365 -179.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -108.08 -30.19 8.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.419 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -147.31 121.05 9.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.123 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.571 HG23 ' O ' ' A' ' 91' ' ' ILE . 2.9 tt -113.39 114.17 48.03 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.454 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -66.01 173.86 6.58 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 121.985 1.79 . . . . 0.0 111.069 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.556 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 3.3 Cg_exo -73.66 -19.19 21.64 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.445 2.097 . . . . 0.0 111.591 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -52.94 -62.5 1.61 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.255 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.3 t -73.57 -24.58 20.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.975 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.556 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -70.4 -28.4 65.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.666 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.62 -22.29 8.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.551 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.9 mt -108.02 -41.55 4.91 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.784 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 79.0 mt -76.24 -13.57 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.767 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -104.6 -33.82 8.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.078 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.2 tp 48.04 72.37 0.27 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.155 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.512 ' O ' ' N ' ' A' ' 104' ' ' HIS . 5.4 mm-40 -89.17 -11.24 44.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.173 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 10.6 m80 -55.96 81.58 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.729 0.299 . . . . 0.0 110.217 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.512 ' N ' ' O ' ' A' ' 102' ' ' GLU . 12.4 t-80 45.08 -138.16 0.47 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.177 -179.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.497 ' N ' ' ND1' ' A' ' 105' ' ' HIS . 1.8 m-70 64.74 -68.51 0.1 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.553 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.441 ' N ' ' O ' ' A' ' 104' ' ' HIS . 61.7 m170 37.8 63.32 0.8 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.871 0.367 . . . . 0.0 110.829 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.456 ' CG ' ' N ' ' A' ' 108' ' ' HIS . 8.5 p80 -48.75 -50.04 35.67 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.693 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.456 ' N ' ' CG ' ' A' ' 107' ' ' HIS . 83.2 t60 . . . . . 0 C--N 1.332 -0.153 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.35 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -164.33 -38.83 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.575 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.619 ' C ' HG13 ' A' ' 4' ' ' VAL . . . -99.93 -64.64 0.81 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.619 HG13 ' C ' ' A' ' 3' ' ' GLY . 0.8 OUTLIER 65.73 -20.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 122.81 0.444 . . . . 0.0 111.536 -179.814 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.549 ' H ' ' C ' ' A' ' 3' ' ' GLY . 0.3 OUTLIER -117.88 105.72 12.22 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 120.646 0.26 . . . . 0.0 110.403 179.541 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.64 111.34 14.86 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.224 0.535 . . . . 0.0 110.141 178.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -153.62 -16.81 0.14 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.239 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.416 ' CG2' ' N ' ' A' ' 9' ' ' THR . 0.7 OUTLIER -160.88 155.72 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.488 179.632 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.416 ' N ' ' CG2' ' A' ' 8' ' ' VAL . 1.8 m -150.37 139.81 21.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.683 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.84 105.67 19.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.85 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -92.4 -152.29 0.31 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.595 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -107.59 5.33 26.87 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -109.4 -23.1 11.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.163 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 161.93 -125.48 1.43 Allowed Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -145.26 145.69 31.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.981 0.42 . . . . 0.0 110.971 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.2 t -105.58 129.0 59.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.84 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.28 99.81 8.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.215 0.531 . . . . 0.0 110.446 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.526 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -103.56 127.18 51.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.037 -179.876 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.465 ' H ' ' HB3' ' A' ' 81' ' ' LYS . 0.6 OUTLIER -149.88 176.69 10.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.512 0.672 . . . . 0.0 112.121 -179.196 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -108.0 92.66 4.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.638 -1.165 . . . . 0.0 108.792 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.551 HG22 ' HA ' ' A' ' 79' ' ' ARG . 1.6 tp -75.77 137.01 23.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.037 -178.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.01 93.87 42.86 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.915 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.446 ' HA ' HG23 ' A' ' 42' ' ' ILE . 3.0 Cg_exo -73.54 157.33 49.02 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.478 2.119 . . . . 0.0 112.226 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt 72.33 47.93 0.26 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.106 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.996 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . . . -95.92 -68.37 0.8 Allowed 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.414 ' CB ' ' O ' ' A' ' 25' ' ' ALA . 6.1 p 157.38 -24.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.504 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 44.4 ttm180 -171.29 139.85 1.38 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.206 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.42 93.62 0.35 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.393 0.616 . . . . 0.0 109.999 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.8 m -124.92 129.09 49.67 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.654 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.46 HG22 HD21 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -85.56 63.03 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.714 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -93.67 17.67 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.725 -178.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 39' ' ' LYS . . . -143.38 28.25 2.08 Favored Glycine 0 C--N 1.318 -0.444 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -178.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.46 HD21 HG22 ' A' ' 30' ' ' ILE . 10.7 mt -60.81 111.01 1.47 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.421 ' ND1' ' N ' ' A' ' 35' ' ' GLY . 3.7 t60 -99.44 152.53 19.88 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.398 -178.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.421 ' N ' ' ND1' ' A' ' 34' ' ' HIS . . . -67.75 -15.5 66.75 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -121.94 -17.38 7.32 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.747 0.308 . . . . 0.0 110.392 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -139.05 -173.03 3.47 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.833 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.459 HG12 ' HB2' ' A' ' 19' ' ' LEU . 16.9 t -142.7 112.87 2.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 5.6 mtpt -110.89 109.36 19.5 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.035 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.506 ' CG1' HD12 ' A' ' 21' ' ' ILE . 7.7 p -121.98 132.44 70.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.458 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.996 ' HB1' ' HB2' ' A' ' 25' ' ' ALA . . . -99.65 99.86 10.77 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.272 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.583 HD11 ' CB ' ' A' ' 54' ' ' HIS . 19.6 tt -84.66 149.52 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.433 HG23 ' O ' ' A' ' 43' ' ' THR . 9.4 t -95.59 48.24 1.14 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.016 0.436 . . . . 0.0 110.626 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.725 ' HB1' ' HB2' ' A' ' 50' ' ' GLN . . . -118.79 142.89 32.56 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.529 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.566 ' O ' ' NE2' ' A' ' 50' ' ' GLN . 1.6 Cg_endo -54.51 169.66 0.72 Allowed 'Trans proline' 0 N--CA 1.503 2.058 0 C-N-CA 123.751 2.967 . . . . 0.0 112.236 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -83.56 87.09 1.29 Allowed 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.831 2.354 . . . . 0.0 111.081 177.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 1.028 HG22 ' H ' ' A' ' 48' ' ' ASP . 9.8 p -172.24 -160.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 1.028 ' H ' HG22 ' A' ' 47' ' ' VAL . 1.7 m-20 -88.03 -66.89 0.87 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.041 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -44.55 -28.77 1.65 Allowed Glycine 0 CA--C 1.526 0.734 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.35 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.725 ' HB2' ' HB1' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -61.9 -69.78 0.23 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.206 0.527 . . . . 0.0 111.474 -179.644 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.679 ' H ' ' CG ' ' A' ' 50' ' ' GLN . . . -80.63 -39.84 26.69 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.224 -178.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -54.01 -54.96 31.87 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.359 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.4 p -64.12 -48.7 75.07 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.0 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.583 ' CB ' HD11 ' A' ' 42' ' ' ILE . 0.2 OUTLIER -57.99 -52.81 63.99 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.652 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.594 HD21 HD11 ' A' ' 83' ' ' ILE . 5.5 tp -49.36 -58.3 5.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.028 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -53.74 -23.41 8.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.6 ttpp -85.16 -64.75 1.1 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.494 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -45.7 -59.77 2.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.382 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.553 HD22 HD13 ' A' ' 83' ' ' ILE . 6.0 tp -70.74 -48.0 56.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.951 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -49.21 -30.1 10.45 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -81.16 -63.06 1.48 Allowed 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.772 0.32 . . . . 0.0 111.217 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -58.63 -36.76 74.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.671 -178.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.901 ' HB3' HG23 ' A' ' 65' ' ' VAL . 1.4 m-85 -87.02 -18.96 29.39 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.412 ' HE ' ' HB2' ' A' ' 90' ' ' GLN . 0.1 OUTLIER 56.7 11.05 0.81 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.371 -0.832 . . . . 0.0 112.642 178.378 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.901 HG23 ' HB3' ' A' ' 63' ' ' PHE . 2.2 t -69.15 -141.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.871 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.607 ' O ' HG12 ' A' ' 70' ' ' VAL . . . -125.39 156.39 38.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.918 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.407 ' HA ' HG12 ' A' ' 70' ' ' VAL . 46.0 pttt -69.55 -26.29 64.42 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.13 -16.44 37.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.35 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.45 ' CG ' ' HB3' ' A' ' 66' ' ' ALA . 25.5 mm-40 -97.03 -20.63 17.91 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.566 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.694 ' O ' HG13 ' A' ' 70' ' ' VAL . 14.8 p -101.53 98.14 6.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 t -115.2 131.32 67.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.96 -178.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 68.1 mt -83.04 91.01 2.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.42 ' O ' ' CB ' ' A' ' 74' ' ' LYS . 7.8 mt-10 -57.91 -7.01 0.64 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.666 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.42 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 3.5 mtpp 162.11 126.48 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 132.77 -3.08 4.94 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -40.8 -30.53 0.13 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.8 tt -128.5 -37.85 1.77 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 121.023 -0.271 . . . . 0.0 111.654 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -70.99 158.32 53.72 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.772 -0.531 . . . . 0.0 111.772 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.551 ' HA ' HG22 ' A' ' 21' ' ' ILE . 13.3 mtm180 -61.41 -29.32 69.86 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.2 p-80 -69.01 146.99 52.24 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 5.8 ttmm -139.64 142.27 37.02 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.53 -178.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.409 ' HG2' ' C ' ' A' ' 81' ' ' LYS . 2.1 mm100 -144.3 80.72 1.65 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.594 HD11 HD21 ' A' ' 55' ' ' LEU . 81.9 mt -81.85 156.13 4.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.234 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.454 ' HE3' ' N ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -136.25 104.94 5.81 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.828 -179.64 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.695 HG23 HG21 ' A' ' 65' ' ' VAL . 3.1 mp -96.81 103.12 14.3 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.796 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 53.7 mt -85.6 133.44 29.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.883 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 51.4 t30 52.16 82.47 0.24 Allowed Pre-proline 0 CA--C 1.53 0.202 0 CA-C-O 120.906 0.384 . . . . 0.0 110.03 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -69.73 144.79 55.29 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.61 2.207 . . . . 0.0 112.497 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -117.99 -29.77 5.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.118 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.435 ' O ' ' HA ' ' A' ' 63' ' ' PHE . 33.5 tt0 -147.12 122.27 10.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.785 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.502 HG23 ' O ' ' A' ' 91' ' ' ILE . 4.3 tt -116.6 117.28 38.18 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.073 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -69.4 143.54 52.9 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 122.333 2.022 . . . . 0.0 112.165 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.564 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 2.5 Cg_endo -49.25 -25.15 9.28 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 122.945 2.43 . . . . 0.0 111.899 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -61.35 -56.89 15.31 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.564 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.3 t -71.39 -19.83 20.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.564 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -75.33 -22.97 57.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.502 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -64.55 -19.26 65.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.006 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 67.9 mt -105.68 -16.7 14.61 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.31 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 44.1 mt -104.17 -36.53 4.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.81 0.338 . . . . 0.0 110.659 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.436 ' O ' ' C ' ' A' ' 101' ' ' LEU . 10.5 t-20 -78.18 -5.78 52.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.923 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.436 ' C ' ' O ' ' A' ' 100' ' ' ASN . 3.8 mt -29.9 -91.49 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 O-C-N 123.701 0.625 . . . . 0.0 111.374 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 35.79 35.28 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.381 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 36.3 t60 -58.82 -49.48 77.54 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.429 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 10.3 p-80 -82.24 110.46 17.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.418 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -152.01 12.77 0.59 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.392 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 70.1 t60 -152.88 141.67 21.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.183 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.441 ' CG ' ' H ' ' A' ' 108' ' ' HIS . 17.7 t-160 -149.56 -126.25 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.261 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.441 ' H ' ' CG ' ' A' ' 107' ' ' HIS . 28.1 m80 . . . . . 0 C--N 1.331 -0.212 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.594 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.464 ' CG ' ' H ' ' A' ' 3' ' ' GLY . 2.5 p-10 -104.11 -94.09 0.33 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.903 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.464 ' H ' ' CG ' ' A' ' 2' ' ' ASP . . . 90.28 21.77 37.14 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 19.2 t 59.77 100.93 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 120.926 0.393 . . . . 0.0 111.021 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -96.9 94.39 7.19 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.574 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.2 117.7 22.84 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.283 0.563 . . . . 0.0 110.382 179.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -144.55 -30.23 0.46 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.291 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.9 m -147.07 165.75 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.817 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 m -151.29 130.5 12.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.725 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.4 m -95.19 97.6 6.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.115 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -84.93 -163.02 0.76 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.297 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -102.67 9.79 39.03 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -117.77 -21.47 8.43 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 114.682 -1.145 . . . . 0.0 110.461 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.41 -126.49 1.51 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.422 HD21 ' CG2' ' A' ' 85' ' ' ILE . 1.4 pt? -144.37 150.99 38.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.858 0.361 . . . . 0.0 110.693 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 35.8 t -105.51 143.05 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.208 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 82' ' ' GLN . 0.5 OUTLIER -124.49 92.23 3.61 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.976 0.417 . . . . 0.0 110.762 -179.82 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 2.3 mmm-85 -95.87 113.49 25.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.428 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.69 171.8 13.71 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.593 0.711 . . . . 0.0 112.672 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -102.57 94.88 5.88 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.289 -1.323 . . . . 0.0 108.121 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -72.32 128.63 35.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.52 -177.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -125.4 90.1 51.34 Favored Pre-proline 0 C--O 1.232 0.159 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.905 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.27 156.24 37.34 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.67 2.246 . . . . 0.0 111.975 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt 72.19 53.15 0.18 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.658 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 1.005 ' CB ' ' HB1' ' A' ' 41' ' ' ALA . . . -99.65 -59.83 1.64 Allowed 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 25' ' ' ALA . 0.4 OUTLIER 157.44 -31.45 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.142 179.41 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.434 ' CG ' ' O ' ' A' ' 26' ' ' SER . 18.5 mtm180 -167.05 146.75 5.38 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.344 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.449 ' HA ' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -64.08 92.36 0.08 Allowed 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.078 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.422 ' HB3' HG23 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -129.61 120.1 24.7 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.851 -178.464 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.487 HG22 HD21 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -84.24 76.47 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.502 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.694 ' O ' HG12 ' A' ' 31' ' ' VAL . 41.3 t -107.01 19.56 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 114.858 -1.064 . . . . 0.0 112.069 -177.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -143.56 27.72 2.07 Favored Glycine 0 C--N 1.333 0.366 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.673 ' CD2' HG13 ' A' ' 38' ' ' VAL . 15.9 mt -62.62 126.69 28.18 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.955 -0.623 . . . . 0.0 110.094 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.421 ' HB3' ' H ' ' A' ' 37' ' ' GLU . 4.8 t60 -113.25 157.02 22.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.165 -178.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -69.57 -20.1 75.29 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.516 -1.033 . . . . 0.0 110.516 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -116.17 -17.09 10.91 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.831 -0.184 . . . . 0.0 110.609 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.421 ' H ' ' HB3' ' A' ' 34' ' ' HIS . 24.7 mm-40 -140.53 -174.99 4.11 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.831 0.348 . . . . 0.0 110.537 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.673 HG13 ' CD2' ' A' ' 33' ' ' LEU . 14.8 t -142.74 113.33 2.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -107.99 112.36 24.89 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.396 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.469 HG23 HG23 ' A' ' 30' ' ' ILE . 9.9 p -117.0 144.42 24.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.349 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 1.005 ' HB1' ' CB ' ' A' ' 25' ' ' ALA . . . -110.23 100.84 9.66 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.47 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.829 HD11 ' HB3' ' A' ' 54' ' ' HIS . 19.5 tt -91.91 148.14 4.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.73 28.3 1.82 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.503 -179.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.96 163.2 19.22 Favored Pre-proline 0 C--O 1.235 0.303 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.107 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.44 ' HG2' ' CB ' ' A' ' 50' ' ' GLN . 3.4 Cg_exo -77.55 176.46 10.03 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 123.433 2.756 . . . . 0.0 111.978 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -77.05 3.6 6.5 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 123.071 2.514 . . . . 0.0 112.606 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.417 HG12 ' HB2' ' A' ' 45' ' ' PRO . 14.8 p -99.2 148.09 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.719 0.295 . . . . 0.0 110.564 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' A' ' 52' ' ' ASN . 1.3 t0 -66.94 -52.41 43.26 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.033 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 48' ' ' ASP . . . -37.05 -51.95 1.58 Allowed Glycine 0 CA--C 1.531 1.058 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.452 ' N ' ' CD ' ' A' ' 50' ' ' GLN . 2.0 mp0 -82.72 -45.53 14.31 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.39 -58.8 4.51 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.155 0.503 . . . . 0.0 110.376 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.5 ' N ' ' O ' ' A' ' 48' ' ' ASP . 11.5 t-20 -46.88 -49.92 19.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.93 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.5 p -55.73 -48.34 75.37 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.791 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.829 ' HB3' HD11 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -54.47 -59.79 4.22 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.296 179.584 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.451 ' HA ' HD13 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -44.86 -57.91 3.46 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.916 0.388 . . . . 0.0 110.532 -179.745 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.8 t -54.27 -32.21 23.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.912 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 34.3 tttm -76.75 -65.97 0.87 Allowed 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.704 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -46.67 -56.18 6.54 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.072 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.811 HD21 HD11 ' A' ' 85' ' ' ILE . 1.7 tp -64.49 -58.74 5.57 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.751 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -46.03 -29.54 3.42 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.634 -0.586 . . . . 0.0 111.634 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.1 mttp -80.91 -63.84 1.32 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.961 0.41 . . . . 0.0 111.103 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.531 HE22 ' CG ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -58.75 -31.91 68.77 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.118 -178.668 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.887 ' HB3' HG23 ' A' ' 65' ' ' VAL . 0.8 OUTLIER -88.84 -19.56 25.77 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.402 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 67.15 2.06 2.63 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.734 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.887 HG23 ' HB3' ' A' ' 63' ' ' PHE . 2.0 t -68.2 -136.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.038 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.449 ' O ' HG23 ' A' ' 70' ' ' VAL . . . -140.08 167.79 21.31 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.905 0.383 . . . . 0.0 111.295 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.5 ptmt -73.42 -25.41 60.51 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.327 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.8 t -79.91 -20.17 46.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.965 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.428 ' O ' ' O ' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -95.96 -11.69 26.19 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.261 179.782 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 66' ' ' ALA . 54.8 t -100.63 99.24 8.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.231 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.5 t -112.98 116.43 52.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.239 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.423 ' C ' ' H ' ' A' ' 74' ' ' LYS . 67.2 mt -88.06 87.06 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.186 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -76.35 15.18 0.62 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.164 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.423 ' H ' ' C ' ' A' ' 72' ' ' ILE . 8.9 tttt 174.33 137.74 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 76' ' ' GLU . . . 128.28 -14.95 6.16 Favored Glycine 0 CA--C 1.518 0.264 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -178.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 75' ' ' GLY . 12.2 tt0 -30.68 -57.81 0.21 Allowed 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.855 0.385 . . . . 0.0 111.293 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.2 mt -133.43 -33.44 1.1 Allowed 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.848 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.58 145.47 45.6 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.901 -0.879 . . . . 0.0 110.901 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 15.7 mtp180 -58.38 -33.51 69.68 Favored 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.401 ' O ' ' HA2' ' A' ' 75' ' ' GLY . 6.8 m-70 -68.86 138.76 54.97 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 177.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 18' ' ' ARG . 2.2 ttmm -145.42 151.99 39.12 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 119.961 -0.696 . . . . 0.0 110.203 -177.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.411 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 19.6 tt0 -148.24 123.59 10.28 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 9.7 mt -120.45 143.18 33.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.583 -178.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.458 ' HE3' ' N ' ' A' ' 85' ' ' ILE . 0.2 OUTLIER -114.16 106.62 14.58 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.2 -179.454 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.811 HD11 HD21 ' A' ' 59' ' ' LEU . 2.4 mp -91.39 101.6 12.66 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.36 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 64.4 mt -81.16 143.66 11.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.031 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 47.31 77.15 0.48 Allowed Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.778 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -74.08 144.54 33.99 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 122.87 2.38 . . . . 0.0 112.003 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -107.43 -39.78 5.55 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.65 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -147.51 125.5 12.04 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 120.98 0.419 . . . . 0.0 109.977 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.569 HG23 ' O ' ' A' ' 91' ' ' ILE . 3.4 tt -107.01 112.86 63.06 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.359 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.531 ' CG ' HE22 ' A' ' 62' ' ' GLN . 3.4 Cg_exo -70.44 153.78 65.54 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.683 2.256 . . . . 0.0 112.623 -179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.531 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 2.6 Cg_endo -47.96 -30.27 13.45 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 123.273 2.648 . . . . 0.0 111.897 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 65.6 tt0 -51.71 -59.25 4.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.736 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.413 HG23 ' H ' ' A' ' 95' ' ' VAL . 0.6 OUTLIER -84.04 -24.54 7.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.157 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.531 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -75.24 -19.88 59.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.972 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 93' ' ' PRO . . . -66.41 -25.27 66.69 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.111 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 18.7 mt -103.67 -14.61 16.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.001 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 46.8 mt -103.6 -50.45 9.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.346 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -75.09 1.21 13.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.59 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 60.1 tp -53.36 -13.25 0.53 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.895 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 -71.4 52.61 0.19 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.969 0.414 . . . . 0.0 110.435 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -125.08 99.63 6.2 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.096 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -56.26 -21.4 23.47 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.925 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -46.03 101.84 0.03 OUTLIER 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.907 0.384 . . . . 0.0 110.589 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -72.71 6.06 2.74 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.018 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -48.9 101.6 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.597 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 20.6 m170 . . . . . 0 N--CA 1.462 0.161 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.74 -179.854 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.2 mmt . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -111.29 -77.02 0.59 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.628 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -101.4 -31.32 5.59 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.3 t 56.54 95.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-O 120.886 0.374 . . . . 0.0 110.617 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.478 ' N ' ' SD ' ' A' ' 5' ' ' MET . 0.0 OUTLIER -97.44 91.13 5.32 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.144 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.609 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 79.1 p -127.53 -167.45 1.75 Allowed 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.609 ' HB2' ' O ' ' A' ' 6' ' ' SER . . . 158.96 -22.26 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.664 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 16' ' ' VAL . 4.0 p -157.31 154.86 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.072 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 m -150.71 144.57 25.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.523 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.8 m -113.61 103.71 15.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.326 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -93.26 -152.65 0.33 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.301 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -106.1 2.76 27.41 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -107.77 -22.36 12.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.38 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.562 ' HA3' ' HZ1' ' A' ' 84' ' ' LYS . . . 159.37 -122.05 1.1 Allowed Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -148.58 138.6 22.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.006 0.431 . . . . 0.0 111.255 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 8' ' ' VAL . 71.8 t -100.91 141.43 17.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.1 tp -122.34 104.17 9.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.187 0.518 . . . . 0.0 110.787 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.513 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 1.1 mtt-85 -94.02 127.71 39.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.682 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.765 HD11 HG12 ' A' ' 21' ' ' ILE . 2.2 pp -153.18 178.29 9.9 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.618 0.723 . . . . 0.0 112.482 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.574 ' C ' HD12 ' A' ' 19' ' ' LEU . 20.5 t80 -111.0 95.7 5.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.442 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.765 HG12 HD11 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -72.59 127.17 34.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.439 -178.321 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -119.9 90.46 43.89 Favored Pre-proline 0 N--CA 1.462 0.172 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.033 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.435 ' O ' ' HB2' ' A' ' 24' ' ' LYS . 3.1 Cg_exo -74.91 151.5 40.07 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.66 2.24 . . . . 0.0 112.788 -179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 23' ' ' PRO . 6.4 mtmp? 79.73 43.45 0.06 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.982 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.902 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . . . -101.8 169.46 8.79 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 177.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.0 p -63.28 -19.24 64.4 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.073 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.451 ' O ' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -176.59 163.09 2.34 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.151 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.457 ' HA ' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -80.76 93.03 6.13 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.398 0.618 . . . . 0.0 109.476 178.179 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.562 ' HB3' HG23 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -130.49 135.83 48.36 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.782 -178.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.61 HG22 HD21 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -90.56 66.23 0.49 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-O 121.637 0.732 . . . . 0.0 109.455 178.747 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.663 ' O ' HG12 ' A' ' 31' ' ' VAL . 41.3 t -98.32 18.77 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 114.766 -1.106 . . . . 0.0 111.417 -178.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -143.6 32.12 1.86 Allowed Glycine 0 C--N 1.333 0.368 0 N-CA-C 110.376 -1.089 . . . . 0.0 110.376 -178.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.772 ' CD2' HG13 ' A' ' 38' ' ' VAL . 19.1 mt -71.26 122.38 20.13 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.838 -0.681 . . . . 0.0 110.13 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.433 ' O ' ' O ' ' A' ' 37' ' ' GLU . 37.8 t-80 -110.01 157.03 19.72 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.287 -178.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -65.79 -22.55 70.23 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.456 ' O ' ' O ' ' A' ' 6' ' ' SER . 29.3 m-20 -121.53 0.54 9.96 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.433 ' O ' ' O ' ' A' ' 34' ' ' HIS . 5.1 mm-40 -148.45 176.38 10.35 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-O 121.07 0.462 . . . . 0.0 110.249 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.772 HG13 ' CD2' ' A' ' 33' ' ' LEU . 30.3 t -142.56 108.68 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -109.77 107.79 17.91 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.295 -178.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.473 HG12 HD13 ' A' ' 19' ' ' LEU . 9.8 p -117.74 131.31 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.592 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.902 ' HB1' ' HB2' ' A' ' 25' ' ' ALA . . . -100.45 107.72 19.52 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.705 HD11 ' HB3' ' A' ' 54' ' ' HIS . 19.7 tt -97.42 152.26 4.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.4 t -92.97 21.55 5.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.44 -178.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.1 160.89 54.03 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.821 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.465 ' HB2' HG12 ' A' ' 47' ' ' VAL . 3.9 Cg_exo -76.51 171.59 17.77 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 123.269 2.646 . . . . 0.0 112.169 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.11 8.33 2.51 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 123.25 2.633 . . . . 0.0 112.745 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.486 HG13 ' H ' ' A' ' 50' ' ' GLN . 14.4 p -101.37 142.62 15.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.404 ' O ' ' N ' ' A' ' 52' ' ' ASN . 0.2 OUTLIER -62.53 -45.7 91.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.262 -179.261 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -45.11 -54.42 7.08 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.298 -0.477 . . . . 0.0 111.919 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.486 ' H ' HG13 ' A' ' 47' ' ' VAL . 15.5 mt-30 -80.44 -38.1 30.76 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 -179.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.35 -60.26 2.58 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.863 0.363 . . . . 0.0 110.687 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.404 ' N ' ' O ' ' A' ' 48' ' ' ASP . 37.3 t-20 -50.53 -40.97 53.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.512 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.7 t -52.9 -50.87 63.05 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.787 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.705 ' HB3' HD11 ' A' ' 42' ' ' ILE . 0.2 OUTLIER -54.75 -55.09 33.73 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.889 -179.665 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.518 ' HA ' HD13 ' A' ' 55' ' ' LEU . 3.4 mm? -49.39 -51.27 36.15 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.66 -0.416 . . . . 0.0 109.895 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -56.35 -26.82 23.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.88 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.441 ' O ' ' HB2' ' A' ' 61' ' ' LYS . 6.0 ttpm? -84.29 -64.95 1.07 Allowed 'General case' 0 C--O 1.227 -0.13 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.286 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -51.69 -54.82 24.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.121 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.513 HD22 ' HA ' ' A' ' 59' ' ' LEU . 0.2 OUTLIER -65.09 -53.3 47.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.66 179.657 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -53.89 -42.91 70.75 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-N 116.363 -0.38 . . . . 0.0 112.153 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 57' ' ' LYS . 3.9 ttpt -73.94 -44.22 55.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.589 0.233 . . . . 0.0 111.028 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 -65.35 -43.48 90.71 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.074 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.464 ' HB3' HG22 ' A' ' 65' ' ' VAL . 3.6 m-85 -85.91 -19.22 30.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.879 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.9 mtt-85 60.44 5.27 0.83 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.927 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.464 HG22 ' HB3' ' A' ' 63' ' ' PHE . 34.5 m -76.12 155.17 5.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.448 ' HB3' ' HG2' ' A' ' 69' ' ' GLN . . . -51.53 159.14 0.78 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.524 -178.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.8 pttp -69.94 -27.16 64.52 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.892 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.7 t -81.25 -12.33 59.14 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.257 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.448 ' HG2' ' HB3' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -89.97 -12.99 37.08 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.598 -179.78 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.1 p -105.6 100.1 9.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-O 121.161 0.505 . . . . 0.0 110.325 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.2 t -117.24 122.08 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.907 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.444 ' C ' ' H ' ' A' ' 74' ' ' LYS . 46.7 mt -89.96 90.76 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.635 178.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -66.46 3.98 0.85 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.95 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.444 ' H ' ' C ' ' A' ' 72' ' ' ILE . 10.4 mttt 169.53 140.62 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 76' ' ' GLU . . . 130.88 -16.99 5.25 Favored Glycine 0 C--N 1.321 -0.294 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -178.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 75' ' ' GLY . 50.3 mt-10 -35.11 -46.32 0.33 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.373 -0.414 . . . . 0.0 111.034 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.4 tt -130.02 -42.97 1.22 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.872 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -60.88 159.01 28.3 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.842 -0.503 . . . . 0.0 111.842 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.4 mtm-85 -72.99 -32.8 65.41 Favored 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.405 ' O ' ' HA2' ' A' ' 75' ' ' GLY . 6.9 m-70 -69.42 144.48 53.33 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 177.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.516 ' NZ ' ' HG ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -152.38 150.64 29.91 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 118.96 -1.096 . . . . 0.0 111.507 -177.714 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -147.79 113.42 5.68 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.443 ' CD1' HD12 ' A' ' 55' ' ' LEU . 8.4 mt -109.63 132.27 58.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.348 -178.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.562 ' HZ1' ' HA3' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -102.93 117.43 34.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.271 -179.315 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.485 HG22 ' O ' ' A' ' 85' ' ' ILE . 1.8 mp -105.59 98.94 7.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.209 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 20.6 mt -81.51 151.52 4.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.478 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 9.4 m-20 42.11 80.48 0.28 Allowed Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.861 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -73.31 133.58 19.53 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.771 2.314 . . . . 0.0 112.455 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -118.26 -26.38 6.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.533 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -145.86 117.49 8.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.939 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.556 HG23 ' O ' ' A' ' 91' ' ' ILE . 4.3 tt -112.11 113.98 51.49 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.509 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -65.9 143.49 73.26 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.253 1.968 . . . . 0.0 111.757 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.631 ' HA ' ' HB3' ' A' ' 96' ' ' ALA . 2.7 Cg_endo -49.01 -24.56 7.61 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.956 2.437 . . . . 0.0 111.684 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -59.47 -58.77 7.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.401 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.0 t -75.98 -24.85 16.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.513 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.631 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -75.28 -28.56 59.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.784 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 93' ' ' PRO . . . -54.95 -31.23 60.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.62 0.248 . . . . 0.0 111.198 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.26 -4.72 48.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.078 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 51.2 mm -116.95 -18.48 6.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.729 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.557 ' N ' ' O ' ' A' ' 96' ' ' ALA . 1.1 m-80 -93.21 -8.5 42.19 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.005 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.443 ' C ' ' O ' ' A' ' 100' ' ' ASN . 11.8 mt -27.61 -92.92 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 O-C-N 123.579 0.549 . . . . 0.0 111.77 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 40.84 30.74 0.1 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.151 0.501 . . . . 0.0 110.736 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 28.2 t60 -75.1 0.39 16.31 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.834 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.444 ' C ' ' H ' ' A' ' 106' ' ' HIS . 0.8 OUTLIER -140.0 -32.81 0.6 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.279 -179.875 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -77.39 23.22 0.21 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.472 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.444 ' H ' ' C ' ' A' ' 104' ' ' HIS . 7.0 t60 -63.65 -100.79 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.572 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.434 ' N ' ' CG ' ' A' ' 106' ' ' HIS . 17.2 m170 48.1 -125.92 1.83 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.866 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.195 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.46 179.909 . . . . . . . . 1 1 . 1 stop_ save_